id,summary
0,"GPT4 Correct Assistant: This study aims to investigate the role of personality traits, defense mechanisms, central sensitization, and early traumatic experiences in patients with chronic migraine, fibromyalgia, and vulvodynia. The study will involve the administration of self-report questionnaires to assess these factors and their potential association with the onset and maintenance of each condition. The results may help identify specific psychological factors that characterize these chronic pain disorders and inform tailored interventions for each condition."
1,"GPT4 Correct Assistant: This clinical trial aims to compare the pressure ulcer prevention effects of two mattresses with different support surfaces used in bedridden patients. The experimental group uses a massage mattress with a cube/block system, while the control group uses a standard viscoelastic pressure sore prevention mattress. The study includes participants aged 18 and over, with a low risk rating on the Braden Scale and no pressure sores upon admission. The primary outcome measure is the number of patients without pressure ulcers after four weeks of monitoring."
2,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of exercise with augmented reality glasses on metabolic parameters, anthropometric measurement values, and quality of life in children aged 10-12 with Type 1 Diabetes Mellitus (T1DM). The study will be conducted in two groups: the experimental group will participate in moderate exercise sessions with augmented reality glasses for 12 weeks, while the control group will not receive any intervention. The primary outcome measures include changes in HbA1c levels, body mass index, and quality of life over the 12-week sessions."
3,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effect of virtual reality on preoperative anxiety levels in patients undergoing abdominal surgery. The study will use a randomized experimental design, with three groups: an intervention group using virtual reality glasses, a placebo group watching the same video without virtual glasses, and a control group without intervention. The primary outcome measures are preoperative anxiety levels measured by a smart wristband and the Visual Anxiety Scale (VAS-A) before and after watching the video. The study will be conducted at the Trakya University Health Research Center General Surgery Clinic between 01.03.2023 and 01.12.2023, with a total of 96 participants."
4,"GPT4 Correct Assistant: The study ""Clinical Performance and Safety of Suture-TOOL for Abdominal Wound Closure in Men and Women Patients Undergoing Elective Open Abdominal Surgery"" aims to evaluate the efficacy and safety of the Suture-TOOL device for abdominal wound closure in adult patients undergoing elective open abdominal surgery. The primary outcome measure is the proportion of patients with a Suture length/Wound length (SL/WL) ratio of ≥ 4. Secondary outcome measures include stitch count, number of sutures used, incision closure time, and surgeons' comfort and satisfaction with the device. The study is a single-arm, prospective interventional study with an open-label design."
5,"GPT4 Correct Assistant: The Immune Biomarker Study for Salivary Gland Carcinoma is a study that aims to observe changes in an established immune matrix and longitudinal immunophenotyping of patients with salivary gland carcinoma and benign salivary gland tumors. The study will evaluate immune characteristics using patient's stool, saliva, and blood samples and analyze cytokines in peripheral blood, patient's metabolic state, and patient's microbiomic state by examining saliva, tumor, and stool samples. The study will observe changes in immune matrix, immunophenotyping, cytokine expression, metabolites, and microbiome from baseline to the end of the study period, up to 5 years."
6,"GPT4 Correct Assistant: This clinical trial aims to determine compliance with the Mediterranean diet, the use of various nutritional supplements, physical activity habits, walking-related problems, and quality of life in patients with Multiple Sclerosis (MS). The study will use the 14-item Mediterranean Diet Adaptation Scale (PREDIMED) to measure the participants' compliance with the Mediterranean diet. The quality of life will be determined using the Multiple Sclerosis International Quality of Life Scale, and the impacts on walking will be assessed using the 12-item Ms Gait Scale. The study will also evaluate the Expanded Disability Status Scale (EDSS) to measure the disability status of the patients."
7,"GPT4 Correct Assistant: The SIIT-CD Study is a multicenter, prospective, randomized, controlled trial investigating the efficacy and safety of selective intensive induction therapy based on ustekinumab clinical decision-making tools in patients with Crohn's disease. The study includes participants aged 18-75 with moderate to low responsive activity and excludes those with extensive colectomy, significant liver/kidney diseases, or contraindications to ustekinumab. The study compares the clinical response rate at week 24 between the intensive induction regimen and the standard induction regimen."
8,"GPT4 Correct Assistant: This clinical trial, titled ""The Preference of a Culturally and Linguistic Diverse (CALD) Population for Second Line OAB Therapy: a Discrete Choice Experiment,"" aims to study the preferences of a diverse population for second-line therapy for overactive bladder (OAB). The study involves adult patients with OAB who have not undergone sacral neuromodulation (SNM) or Botox in the past. Participants will complete a one-hour discrete choice questionnaire, choosing between two fictive therapies with different characteristics of Botox and sacral neuromodulation."
9,"GPT4 Correct Assistant: The study aims to investigate the effectiveness, feasibility, acceptability, and cost of using continuous glucose monitoring (CGM) devices among people with type 1 diabetes in South Africa. It is a three-arm pragmatic randomized controlled study with a total of 6 study visits for all participants, including those randomized to standard of care. The primary outcome measure is the impact of continuous and intermittent CGM use on blood glucose levels in comparison to standard care. Secondary outcome measures include variability of blood glucose concentrations, unplanned clinic visits, quality of life, and cost of CGM use. The study will enroll 300 participants aged 4 years and older, with an expected study duration of 15 months."
10,"GPT4 Correct Assistant: This clinical trial is investigating the effectiveness of Stereotactic Body Radiotherapy (SBRT) with focal dose escalation on Dominant Lesion in Localized Prostate Cancer. The study is designed for male participants aged 18 years or older with primary localized prostate cancer of intermediate or high-risk disease. The intervention involves SBRT with a focal boost to the entire prostate and a simultaneous integrated boost to the dominant lesion, guided by magnetic resonance imaging (MRI). The primary outcome measure is biochemical progression-free survival, while secondary outcome measures include local control, incidence and severity of treatment-related adverse events, and patient-reported outcomes and quality of life assessment."
11,"GPT4 Correct Assistant: The SMILER study is a clinical trial investigating the use of serious games as an emerging e-health intervention for young people with neurological or respiratory disorders, specifically focusing on children with controlled asthma. The study compares two groups: one that uses a serious game as a support for asthma treatment and one that follows the standard treatment plan without the serious game. The primary outcome measure is the Pediatric Quality of Life Inventory (PedsQL), and the secondary outcome measure is the Skills and Difficulties Questionnaire (SDQ-Ita). The study will run for six months, and data will be collected and analyzed to determine the effectiveness of the serious game intervention in improving the quality of life for children with asthma."
12,"GPT4 Correct Assistant: This study aims to investigate the effects of acute and chronic stress on Pavlovian-to-Instrumental Transfer (PIT) in participants with Alcohol Use Disorder (AUD) and healthy controls. The study consists of three experiments, which assess PIT effects in a general and outcome-specific manner. The primary outcomes include neural PIT effects, measured using functional magnetic resonance imaging (fMRI), and behavioral PIT effects, measured using the PIT paradigm. Secondary outcomes include cognitive control measures, such as the Stroop task, No-go Simon task, and Stop Signal task. The study also investigates the relationship between PIT effects and chronic stress levels, as well as the effects of acute stress on PIT."
13,"GPT4 Correct Assistant: This is a multicenter, non-blinded, randomized control trial investigating the ideal time to wean CPAP off in extremely low birth weight infants. The study aims to recruit 130 infants born between 23 0/7 and 29 6/7 weeks gestational age, and will take place in four Neonatal Intensive Care Units within the Rady Children's/University of California, San Diego network. The primary endpoint is the number of participants with CPAP/NIS weaning failure within 72 hours after weaning off of CPAP. The study will compare a standardized maintenance/weaning protocol with routine care."
14,GPT4 Correct Assistant: This is a Phase 3 study comparing the efficacy and safety of Frexalimab (SAR441344) to a placebo in adults with nonrelapsing secondary progressive multiple sclerosis (SPMS). The primary outcome measure is time to onset of composite confirmed disability progression (cCDP) confirmed over 6 months. The study duration is up to 204 weeks.
15,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of the Modified Millard and Mishra techniques in unilateral cleft lip repair. The study includes infants aged 2-6 months with unilateral isolated cleft lip and excludes those with bilateral cleft lip, recurrent repair cleft lip cases, and facial cleft cases. The primary outcome measures are vertical lip height, horizontal lip length, and philtral length measured at 3 months post-operative. The study is designed as a randomized controlled study with three groups: control group (unilateral cleft lip repair with a standard procedure), Group A (unilateral cleft lip repair with Mishra technique), and Group B (unilateral cleft lip repair with Modified Millard technique)."
16,GPT4 Correct Assistant: The study investigates the use of endoscopic management of controlled colo-cutaneous fistula as a complication of acute sigmoid diverticulitis. It is a randomized controlled trial that compares endoscopic management using the OTSC system to surgical management. The primary outcome measure is the incidence of recurrence of fistula within one week after the endoscopy. The secondary outcome measure is the incidence of side effects of endoscopy within one month after the surgery. The study aims to evaluate the advantages and safety of endoscopic management and its effect on reducing morbidity and postoperative hospital stay.
17,"GPT4 Correct Assistant: This is a randomized, un-blinded study comparing usual care to an intervention group receiving early heart failure testing for high risk patients in Canada. The primary outcome measures are the number of participants diagnosed with heart failure, number of outpatient heart failure visits, number of urgent heart failure visits, and number of heart failure hospitalizations. The intervention group will have NT-proBNP drawn, and those with an elevated NT-proBNP (>125pg/mL) will have a study visit with assessments including physical examination, electrocardiogram, and study AI echocardiogram. The study aims to improve early diagnosis and screening of heart failure in high risk patients."
18,GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of Propofol dose according to lean body weight in patients with a body mass index (BMI) below 35 undergoing general anesthesia for 2-6 hours. Patients will be divided into three groups based on their BMI and will receive routine anesthesia procedures. The primary outcome measure is the ratio of Propofol dose with sufficient depth of anesthesia according to total and lean body weight.
19,"GPT4 Correct Assistant: The study is a prospective cohort design comparing the efficacy and tolerability of letermovir for CMV prophylaxis in heart or lung transplant recipients with those who received standard valganciclovir prophylaxis in the two years before the study. The primary outcome measures are CMV viral load and the proportion of days during which appropriately renally-dosed prophylaxis is provided. Secondary outcome measures include frequency of acute cellular rejection, proportion of subjects who develop CMV resistance, proportion of subjects who develop neutropenia or severe thrombocytopenia, and proportion of subjects with unplanned discontinuation of MMF or azathioprine."
20,"GPT4 Correct Assistant: The study aims to develop and validate the PHYSIOSCORE, a tool to assess the complexity level and physical therapy care in hospitalized patients. It consists of 106 items divided into three domains: respiratory, imaging, and neuromuscular. The study involves three phases: questionnaire validation, concordance and inter-rater reliability, and clinical validation. In the first phase, a committee of ten physical therapists with over ten years of experience developed and validated the questionnaire. In the second phase, another ten physical therapists assessed the concordance and inter-rater reliability using the PHYSIOSCORE on a cohort of 110 patients hospitalized for clinical or surgical cardiac conditions. The third phase involved the clinical validation of the PHYSIOSCORE on 110 consecutive clinical and surgical patients. The study aims to measure respiratory variables like lung function, breath sounds, PaO2/FiO2, and chest X-ray, and neuromuscular variables like muscle strength, muscle tone, and postural control."
21,"GPT4 Correct Assistant: The SAVAL trial is a single-arm phase II trial evaluating selective adjuvant therapy for HPV-mediated oropharynx squamous cell carcinomas (OPSCCs) based on residual circulating tumor DNA (ctDNA) levels. The primary objective is to determine the progression-free survival (PFS) rate at 2 years post-treatment. Participants with p16+OPSCC who are candidates for surgery (TORS) and have positive ctDNA will be offered registration for the study prior to surgical resection. After TORS, all patients will have ctDNA drawn within 2-14 days post-operatively. Patients will be stratified into low, intermediate, or high risk groups based on pathological criteria and ctDNA levels. The low risk group will be observed, the intermediate group will be observed, and the high risk group will receive adjuvant treatment (RT +/- chemotherapy) per standard of care. The trial aims to determine if patients currently recommended for adjuvant RT based on intermediate risk factors can be observed post-TORS when ctDNA is cleared."
22,"GPT4 Correct Assistant: This study is a single-institution, prospective, phase 2 trial comparing ultra-hypofractionated whole breast irradiation (WBI) and partial breast irradiation (PBI) in patients with breast cancer. The primary purpose is to assess the acute and late toxicity of the two radiotherapy regimens. The study includes patients aged 50 or older with invasive ductal carcinoma, tumor size ≤ 3 cm, and R0 resection. The trial will measure local-regional control, disease-free survival, overall survival, distant metastasis occurrence, cosmetic outcome, and quality of life."
23,"GPT4 Correct Assistant: The study, titled ""Evaluating Patient-Reported Outcomes and Wearable Data Among Individuals With Relapsed/Refractory Multiple Myeloma,"" aims to explore the use of symptom monitoring and digital life coaching (DLC) to better understand the impact of multiple myeloma on symptom burden, health self-efficacy, and financial, physiologic, and psychosocial well-being among a diverse U.S.-based, contemporary sample. The study will enroll 100 individuals with relapsed/refractory multiple myeloma in a 3-month digital health coaching program and provide them with a Fitbit device for activity tracking. The primary outcome measure is the feasibility of the digital health coaching intervention, while the secondary outcome measure is the change in Cancer Behavior Inventory-Brief Form (CBI-B) scores."
24,"GPT4 Correct Assistant: This clinical trial aims to explore the effect of a 4-week WholeFiberTM intervention on fecal calprotectin, IBD-complaints, QoL, serum markers, and changes in the gut microbiota and increase in fecal SCFA-production in patients with Crohn's Disease (CD) and Ulcerative Colitis (UC). Patients will receive 10-20 grams of WholeFiberTM daily, consisting of a dried vegetable rich in prebiotic fiber. The primary parameter is the change in fecal calprotectin after the intervention. Secondary parameters include improvements in IBD-complaints, QoL, serum markers, and changes in the gut microbiota and increase in fecal SCFA-production. Additionally, the study will assess whether the response on the intervention will be different between UC and CD."
25,"GPT4 Correct Assistant: This is a multicenter randomized clinical trial investigating the use of porcine acellular dermal matrix (PADM) for the treatment of localized gingival recessions. The study includes participants aged 18 to 60 years with gingival recessions ranging from 3 to 5 mm in height and at least 2 mm of keratinized tissue width. Participants are randomly assigned to either a control group receiving coronally advanced flap (CAF) or an experimental group receiving CAF associated with PADM. The primary outcome measure is the reduction of gingival recession height, and the secondary outcome measure is the evaluation of keratinized tissue thickness after periodontal plastic surgery. Measurements are taken at baseline, 6 months, and 12 months."
26,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of physical exercise performed through virtual reality games and conventional exercise on heart rate variability modulation in chronic renal patients undergoing hemodialysis. Participants will be randomly assigned to one of two groups: Group A will perform virtual reality exercises, while Group B will perform conventional exercises. After a 1-week washout period, the groups will switch exercises. The primary outcome measure is heart rate variability behavior during the interventions, while secondary outcome measures include blood pressure, heart rate, respiratory rate, and oxygen saturation. The study will help determine the relative effectiveness of virtual reality exercises compared to conventional exercises in improving heart rate variability modulation in chronic renal patients during hemodialysis."
27,"GPT4 Correct Assistant: The Respiratory Variability and Dyspnea During Spontaneous Breathing Trial is a study that aims to analyze the relationship between ventilatory variability and dyspnea in patients under invasive mechanical ventilation during a weaning trial. The study includes patients who have been ventilated for more than 48 hours and are ready for weaning. The primary outcomes measured are clinically significant dyspnea defined by a Dyspnea visual analog scale (D-VAS) > 30 mm for communicating patients and Mechanical Ventilation Respiratory Distress Observation Scale (MV-RDOS) ≥ 2.6 for all patients during the weaning trial. Secondary outcomes include the intensity of dyspnea, success or failure of the weaning trial, and EMG signal measurements."
28,"GPT4 Correct Assistant: This randomized control trial aims to compare the outcome of a modified mini-incision approach versus the conventional approach for carpal tunnel release in patients with primary carpal tunnel syndrome. The study will follow patients for six months postoperative to assess improvement in symptoms, postoperative complications, scar effect, and recurrence of symptoms."
29,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of Action Observation Therapy (AOT) among patients with mild cognitive impairment (MCI). The intervention involves observing and imitating motor gestures, which has been shown to improve motor skills and brain plasticity. The study will compare the effects of AOT when performed under the guidance of a therapist or by observing peers without cognitive impairment. The primary outcome measures include changes in cognitive impairment, activities of daily living, functionality, upper limb dexterity, balance, and gait. The study will enroll participants aged 65 to 100 years with MCI and a MoCA score of less than 26. The intervention will last for 5 weeks, with data collected before and after the program."
30,"GPT4 Correct Assistant: This clinical trial aims to study the effectiveness of central line placement using an ultraportable ultrasound device compared to conventional methods. The study includes patients aged 18 years or older who are scheduled to have a central venous line placed preoperatively or in the ICU. The primary outcome measure is the length of the procedure. The study is designed as a randomized, parallel assignment, single-masked trial with two arms: one using an ultraportable ultrasound device and the other using conventional ultrasound."
31,"GPT4 Correct Assistant: This study aims to investigate the therapeutic efficacy of the Er:YAG laser in postpartum patients with episiotomy scars in respect of genital pelvic pain and scar tissue healing. The study is a randomized, sham-controlled, prospective study involving 40 participants. The experimental group will receive treatment with the Fotona Dynamis Er:YAG Laser System, while the control group will receive a sham treatment with the same device. The primary outcomes measured are the rate of change of pain and the rate of scar tissue healing. Secondary outcomes include the rate of improvement in sexual function and the incidence and severity of device-related adverse events."
32,"GPT4 Correct Assistant: This study aims to investigate the effects of Sense for Kids therapy compared to an equal dose of motor therapy on upper limb sensorimotor outcomes in children and adolescents with unilateral cerebral palsy. The study will involve 50 children and adolescents aged between 7 and 15 years old with spastic unilateral cerebral palsy. Participants will be randomized to either the Sense for Kids therapy group or the motor therapy group, both receiving three sessions of 45-minute upper limb therapy per week for a period of 8 weeks. The primary outcome measure is the Assisting Hand Assessment, which measures the spontaneous use of the more impaired upper limb during bimanual activities. The study will also assess various secondary outcomes, such as functional hand use, bimanual coordination, proprioception, tactile perception, unimanual motor skills, self-perceived occupational performance, and goal attainment. The study will provide valuable insights into the effectiveness of Sense for Kids therapy in improving upper limb sensorimotor outcomes in children and adolescents with unilateral cerebral palsy."
33,"GPT4 Correct Assistant: This pilot study aims to understand the gut microbiome profile of adult patients diagnosed with gallstone disease and its relationship with patient outcomes, including complications and post-operative outcomes. A prospective cohort design will be used to collect data from 75 adult patients presenting with newly diagnosed gallstone disease at East Kent University Hospitals NHS Foundation Trust Hospitals. Stool samples will be collected at various time points, and the study aims to identify differences in the gut microbiome between patients who experience complications and those who do not. The findings could help determine interventions to reduce the development of complications and alleviate the financial burden on the NHS."
34,"GPT4 Correct Assistant: This clinical trial aims to investigate the association between elevated initial APRI value and the development of sepsis-associated liver dysfunction (SALD) in adult patients with sepsis. The study includes adult sepsis patients aged 18 or older, excluding those with chronic liver diseases or specific conditions. The primary outcome measure is the occurrence of SALD within 30 days after ICU admission. Secondary outcomes include mortality within the same time frame. The study assesses the correlation between APRI and SALD occurrence and validates the results using the MIMIC IV database."
35,"GPT4 Correct Assistant: The trial is a randomized, double-blind, active-controlled clinical study evaluating the safety and immunogenicity of the Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells) in individuals aged 18 and older with different immunization programs. The study includes four participant groups: two experimental groups receiving the Omicron BA.4/5-Delta strain vaccine and two active comparator groups receiving the recombinant novel coronavirus protein vaccine (CHO cells). The primary outcome measures include adverse events, laboratory markers of immunity, and immunogenic endpoints. The secondary outcome measures include laboratory markers of immunity and immunogenic endpoints for different coronavirus strains."
36,"GPT4 Correct Assistant: This clinical trial aims to analyze the impact of early skin-to-skin contact on maternal-infant bonding and the perception of traumatic birth in puerperant women who gave normal birth between December 2021 and May 2022 in Batman Training and Research Hospital TDL service. The study includes 350 women, divided into an experimental group (n:175) who received skin-to-skin contact for at least 15 minutes after delivery, and a control group (n:175) who received standard midwifery practices. The primary outcome measures are the Maternal Attachment Scale Score and the Traumatic Birth Perception Scale Score, collected at various time points."
37,"GPT4 Correct Assistant: This is a prospective, randomized, controlled, double-blind study examining the effect of a sacral erector spinae plane block (ESPB) on post-operative pain in patients undergoing elective lumbar discectomy. The study included 54 patients, divided into two groups: those receiving the ESPB (Group 1) and a control group (Group 2). Both groups underwent standard general anesthesia, and a patient-controlled analgesia device was given to both groups. Visual Analogue Scale (VAS) scores were assessed for 24 hours. The primary outcome measures were patient pain scores and total opioid consumption. Secondary outcome measures included nausea-vomiting, patient satisfaction, and side effects."
38,"GPT4 Correct Assistant: The study aims to use multimodal ultrasound imaging to develop and validate a practical and inexpensive biomarker for lumbar myofascial pain. Myofascial pain is a common cause of chronic low back pain and is associated with tissue abnormalities. The investigators will study the echogenicity of trigger points, the spatial-temporal tissue deformation quantified by strain tensors, and the viscoelastic properties of the fascia and muscles measured by ultrasound shear wave elastography. The biomarker will be integrated using deep learning and tested for its ability to predict myofascial pain. The study will include participants with chronic low back pain, myofascial pain, and healthy volunteers."
39,"GPT4 Correct Assistant: The Pain Intervention Via Video Optimization Trial is a two-arm, blinded, randomized controlled trial that aims to estimate the effect of an adapted telehealth video intervention on pain recovery and opioid use at 3 months among opioid-naïve adult Emergency Department (ED) and urgent care patients with musculoskeletal pain. The study will encompass 200 ED/urgent care patients with acute musculoskeletal pain. Participants will be randomized into either the intervention (telehealth video) or usual care (standard care provided by ED/urgent care provider and staff) group. The video intervention consists of an interactive pain management video that provides essential pain treatment information and encourages patients to discuss treatment options with their ED/urgent care provider. Data collection will occur at baseline, 1, and 3 months after ED/urgent care discharge via phone call interviews. The primary outcome measure is the combined pain severity and interference scores from the Brief Pain Inventory-short form (BPI-SF). Secondary outcome measures include pain severity and interference on the BPI-SF, opioid use, PROMIS measures of physical function and global health, and healthcare utilization (ED/urgent care and non-ED/urgent care visits)."
40,"GPT4 Correct Assistant: The trial aims to investigate the impact of Neuro-linguistic Programming (NLP) on the academic performance of primary school students in Lebanon, aged between 5 and 11 years. The intervention includes NLP techniques such as Anchoring, Reframing, and Meta-modeling. The study measures the impact of the intervention on school triggers, strengths and difficulties progression, and concentration, hyperactivity, and reasoning of schoolchildren through the Vanderbilt Assessment Scale. The study design is a single group assignment with triple masking and the intervention is conducted for 6 sessions."
41,"GPT4 Correct Assistant: The study titled ""Effect of Using the ECOX Teaching Tool in the Emergency Department on OSCEs for Medical Students: Randomized Controlled Trial"" aims to assess the impact of the ECOX tool on medical students' performance in the end-of-course OSCEs. The study participants are divided into two groups: the control group, who will use standard learning methods, and the ECOX interventional group, who will use the ECOX tool. The primary outcome measure is the students' average score on the end-of-course OSCEs, while the secondary outcome measures are the average STAI-Y scores and the average scores on the behavioral assessment during the service ECOS between the two groups."
42,"GPT4 Correct Assistant: This clinical trial investigates the effects of a web-based health care program on symptom management, social support, activity tolerance, and quality of life in patients with pulmonary hypertension. The study includes participants aged 20 to 90 years, with pulmonary hypertension diagnosed by clinical specialists. The intervention group receives a web-based health care program, while the control group receives usual care. The primary outcome measure is the change from baseline pulmonary arterial hypertension symptom at six months, and secondary outcome measures include changes in social support, activity ability, and quality of life."
43,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of long-term ventilation support on the quality of life of ALS patients and their families. The study includes two groups: one with long-term mechanical ventilation support and one without. The primary outcome measure is the Quality of Life Scale, assessed at various time points up to 21 months after inclusion. Secondary outcome measures include health-related quality of life assessments using the Severe Respiratory Insufficiency Questionnaire, Kidsscreen-27, Zarit Burden Interview, and EQ-5D-5L. The study also explores disease-specific quality of life using the Amyotrophic Lateral Sclerosis Assessment Scale - 5 items (ALSAQ-5)."
44,"GPT4 Correct Assistant: The study, titled ""Neurologic Deficits and Recovery in Chronic Subdural Hematoma,"" aims to investigate the neurological deficits and recovery in patients with chronic subdural hematoma through the use of ECoG monitoring. The study includes participants aged 40 years and older, with chronic or subacute subdural hematoma requiring surgical evacuation. The primary outcome measure is post-operative neurologic deterioration, while secondary outcome measures include extended Glasgow outcome scale, Montreal Cognitive Assessment, NIH toolbox cognitive battery, PROMIS 29 profile, TBI QOL, and Headache Disability Index at 30 days, 90 days, and 180 days post-surgery."
45,"GPT4 Correct Assistant: This is a multicenter, randomized, controlled, non-inferiority trial examining the impact of annual versus biannual infusions of Ocrelizumab in patients with active Multiple Sclerosis (MS) after 2 years of initial treatment on freedom from radiological disease activity at two years. The study includes patients 18 years or older, with active MS, RR or SP form, no relapse for at least 18 months, EDSS between 0 and 6 inclusive, and French language proficiency. The primary outcome measure is the percentage of patients with no new or enlarged T2 lesion >3mm on cerebrospinal MRI at 24 months compared with inclusion MRI. The study is designed with allocation to either annual or semestrial administration of Ocrelizumab."
46,"GPT4 Correct Assistant: The SPARCOL Study is a clinical trial investigating the effectiveness of Combined Endoscopic Laparoscopic Surgery (CELS) compared to Standard Surgery for early stage colon cancer in elderly frail patients. The primary outcome measure is the change in patient-reported postoperative recovery, measured using the Quality of Recovery 15 (QoR-15) scale. Secondary outcome measures include changes in exercise capacity and physical condition, quality of life, and long-term oncological outcomes. The study aims to determine if CELS is a more effective and less invasive treatment option for eligible patients."
47,"GPT4 Correct Assistant: This is a Phase 2 open-label pilot study to evaluate the effectiveness of nebulised 6% hypertonic saline in decreasing respiratory exacerbations in people with neuromuscular diseases or neurodisabilities. The study includes participants aged 5 years and above, with a history of at least one respiratory exacerbation requiring antibiotic treatment within the past 12 months. The primary outcome measure is the full course of antibiotics for respiratory infections from baseline to week 52. Secondary outcome measures include lung clearance index, forced oscillation technique, lung ultrasound, electrical impedance tomography, airway inflammation, bacterial diversity, ease of airway clearance, health-related quality of life, treatment satisfaction, family impact, and health economics."
48,"GPT4 Correct Assistant: This clinical trial is a case-control study investigating paraphilic disorders and other conditions with risk for sexual violence. The study seeks to understand the factors contributing to sexual violence and develop a better understanding of paraphilic disorders. The study includes both clinical and healthy control participants and involves assessments, interviews, and questionnaires. The primary outcome measure is the Karolinska Interpersonal Violence Scale (KIVS). The study aims to provide insights into the progression of paraphilic disorders and inform potential interventions for those at risk for sexual violence."
49,"GPT4 Correct Assistant: This clinical trial aims to develop a new metabolic imaging approach (aMRI) for evaluating neurological disease in patients with gliomas. The primary objective is to characterize how the metabolic aMRI parameter kᵢₒ*V differs in tumor versus normal brain regions, comparing it to a standard metabolic imaging approach, ¹⁸FDG PET. Secondary objectives include assessing the utility of aMRI in differentiating metabolically active tumor periphery and necrotic core regions, and comparing it to ¹⁸FDG PET. The exploratory objective is to compare how the aMRI metabolic parameter kᵢₒ*V changes with different disease types, their disease stage, and their treatment status. The study involves simultaneous MRI and PET scanning, with a total scanning time of 45-60 minutes. Adult patients with glioma who require MRI and ¹⁸FDG-PET imaging are eligible for participation."
50,"GPT4 Correct Assistant: The GDMT Research, Education & Assist Trial for Heart Failure Care (GREAT-HF Care) is a cluster randomized study designed to evaluate the effectiveness of interventions aimed at improving Guideline Directed Medical Therapy (GDMT) in patients with Heart Failure with Reduced Ejection Fraction (HFrEF). The study will have five arms: no intervention (control), multiprong CDS with GDMT order set, multiprong CDS with referral to pharmacist co-management, focused education, and multiprong CDS with GDMT order set plus focused education. The primary outcome measure is the increase in HF GDMT prescription within 30 days of the index visit, while secondary outcome measures include the increase in HF GDMT prescription within 60 and 90 days of the index visit and the addition of SGLT2i or ARNI for HFrEF within 30, 60, and 90 days of the index visit."
51,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of extracorporeal shock wave lithotripsy (ESWL) alone and ESWL combined with tamsulosin therapy in patients with upper ureteric stones. The study includes participants aged 18-70 with single upper ureteric stones and excludes those with urinary tract infections, multiple ureteric stones, and other specific conditions. The primary outcome measure is stone clearance, assessed at 4 weeks."
52,"GPT4 Correct Assistant: This clinical trial is a study of interventional therapy for tracheal stenosis that occurs after percutaneous tracheotomy. The trial is designed to measure the rate of successful decannulations, technical success, number of reinterventions, type of intervention, clinical success, and additional treatments required within a 12-month time frame. The study is open to participants aged 18 years and older, of any sex, and excludes pregnant or breast-feeding women, those who refuse pregnancy tests, those who have undergone surgical tracheotomy, and those with involvement of the larynx."
53,"GPT4 Correct Assistant: The DRIVE-Mind II study is a non-randomized parallel assignment study comparing people who inject drugs (PWID) diagnosed with a psychiatric disorder (depression, psychotic disorder, suicide risk) and receiving a community-based psychiatric intervention to a control group of PWID free of psychiatric disorders. The study aims to compare the two groups in terms of HIV/HCV exposure, severity of substance use, quality of life, and sustainability of mental health improvement. Participants in the intervention group receive free psychiatric consultation and medication on community-based organization sites, while the control group receives linkage to care when needed and harm reduction services. The primary outcome measures include viral exposure score, severity of substance use score, and quality of life score, while secondary outcome measures include percentage of compliant participants, percentage of participants facing difficulty to access care, percentage of participants with methamphetamine-induced psychotic disorder, and incidence of HIV/HCV. The study aims to enroll 600 participants, with 200 in the intervention group and 400 in the control group."
54,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of conventional endodontic treatment with endodontic treatment combined with Photodynamic Therapy (PDT) in patients with apical lesion. The study is a randomized, clinical, superiority trial with 3 parallel arms. Patients will be randomized into three treatment groups: a placebo group receiving conventional endodontic treatment, a group receiving conventional endodontic treatment with PDT using a diode laser at 660 nm for 10 seconds, and a group receiving conventional endodontic treatment with PDT using a diode laser at 660 nm for 20 seconds. The primary outcome measure is the reduction in lesion size, and the secondary outcome measures are disinfection of the root canals and success rate of the treatment after 6 months."
55,"GPT4 Correct Assistant: This clinical trial aims to investigate the Psychiatric Orders in Psychoanalytic Treatment of Autism Spectrum Disorder (ASD) with high-functioning PTSD, OCD, Agoraphobia With Panic Attacks, Depression, Anxiety, and other related conditions. The study includes participants aged 18 to 70 years and utilizes a combination of diagnostic tests, medications (sertraline and duloxetine), and cognitive behavioral therapy. The primary outcome measures include various anxiety and depression scales, while secondary outcome measures include heart rate, systolic blood pressure, and diastolic blood pressure. The study is designed to assess the effectiveness of this approach in treating the mentioned conditions over a 90-day period."
56,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy of Trastuzumab-deruxtecan (T-DXd) in treating HER2-positive metastatic breast cancer patients who have progressed after receiving one or more lines of treatment, including pertuzumab with trastuzumab or trastuzumab alone. The primary objective is to assess the concordance between the clinical evaluation of progressive disease and the evaluation of liquid biopsy, including the appearance of new mutations or the increase of existing ones. The study will also investigate the molecular stratification of patients, lead time assessment by liquid biopsy, and the association between HER2-2D and outcome in terms of progression."
57,"GPT4 Correct Assistant: This study aims to implement Cognitive Processing Therapy (CPT) in earthquake-affected populations in Turkey to address mental health issues. The study is designed as a pilot randomized controlled trial, comparing the effectiveness of CPT to the Enhanced-Care as Usual (E-CAU) control group. Participants must be 18 years or older and have experienced the earthquakes directly or through a close family member or friend. The primary outcome measure is the change in Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) scores over time. Secondary outcome measures include changes in symptoms of depression, anxiety, and well-being."
58,"GPT4 Correct Assistant: This clinical trial aims to understand the quality of family planning counseling experienced by reproductive aged women in El-Dakhla District, New Valley, using the validated and client-centered Quality of Contraceptive Counseling (QCC) Scale. The study will investigate factors associated with the quality of counseling, such as client, provider, and visit factors. Data will be collected through semi-structured interview administered questionnaires, including socio-demographic characteristics, family planning practice, facility factors, and the QCC Scale. The primary outcome measure is the client-reported quality of family planning counseling and its determinants among 423 women at reproductive age in El-Dakhla District at different primary health centers and El-Dakhla general hospital."
59,"GPT4 Correct Assistant: The PIVCO study aims to determine the optimal ablation strategy for patients with persistent atrial fibrillation (AF) using pulsed-field ablation (PFA) and multielectrode ablation catheters. The primary endpoint is the recurrence of AF lasting >30 seconds as assessed using repeated 7-day ECG Holter monitoring in patients without anti-arrhythmic drugs during the entire post-blanking follow-up, starting three months after the index procedure. Secondary endpoints include the first recurrence of on-AADs AF/AT lasting >6 minutes during the post-blanking follow-up period, hospitalization and emergency out-patient visits related to AF/AT recurrence, worsening of heart failure, or other cardiovascular diseases, number of electrical cardioversions, proportion of patients on AADs at the end of follow-up, PFA-related complications, and assessment of the quality of life using standardized instruments (AFEQT, EQ5D)."
60,"GPT4 Correct Assistant: The Catholic Health Initiatives St. Joseph's Children Home Visiting Study is a longitudinal study that aims to evaluate the effects of home visiting on child development, school readiness, and child maltreatment. The study includes two groups of participants: the home visiting group, which receives the intervention, and the business as usual group, which does not receive the intervention. The primary outcome measures include the Child Behavior Checklist (CBCL), Ages and Stages Questionnaire (ASQ), School Records, Edinburgh Postnatal Depression Scale, Brief Symptom Inventory, CAGE-AID, Program Administrative Records, Adult Adolescent Parenting Inventory (AAPI-2), Modified Checklist for Autism in Toddlers (M-CHAT), Abidin Parenting Stress Index Short Form (PSI-SF), Conflict Tactics Scale Parent-Child Form (CTS-PC), Parenting Sense of Competence (PSOC), and New Mexico Children, Youth and Families Department records. The study will measure these outcomes at various time points over a period of 15 years."
61,"GPT4 Correct Assistant: A phase I clinical trial is being conducted to assess the safety and immunogenicity of the malaria vaccine candidate RH5.1 soluble protein in Matrix-MTM using two dosing regimens. The trial includes healthy adults aged 18 to 50 years and aims to measure the occurrence of solicited and unsolicited reactogenicity and adverse events following vaccination, as well as comparing safety laboratory measures and assessing humoral immunogenicity. The trial will compare two dosing regimens for the RH5.1 soluble protein in Matrix-MTM and analyze the differences in innate immune responses following the first and third vaccinations."
62,"GPT4 Correct Assistant: This study is a monocentric, 18-month randomized, rater-blinded trial evaluating the influence of a multidisciplinary, personalized symptomatic treatment plan with integrated mobile palliative care and telemedicine on the quality of life (QoL) of individuals with Multiple System Atrophy (MSA) compared to a historical European MSA cohort. The study aims to recruit 46 individuals with MSA who will undergo baseline examinations and then receive personalized treatment plans, including telemedicine visits for wheelchair-bound individuals. The primary outcome measure is the change in the EQ-5D-5L score from baseline to 18 months. Secondary outcome measures include changes in the MSA-QoL score, motor and non-motor scales, time to clinical milestones, changes in individual healthcare preferences, in-person and telemedicine medical, psychological, and neurorehabilitation interventional needs, changes in patient and healthcare professional satisfaction, medical complications, and healthcare costs. Informal caregivers of individuals with MSA will also be included in the study to assess their QoL and caregiver burden."
63,"GPT4 Correct Assistant: This clinical trial is titled ""A Study of the Genetic Determinants of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature."" The trial aims to investigate the genetic basis of response to growth hormone treatment in children with idiopathic short stature. The study includes participants aged between 3 and 11 years, who have received at least one year of growth hormone therapy. The primary outcome measure is the frequency of genetic variants that significantly differ between the two responder groups (good and poor responders) one year after growth hormone therapy. The secondary outcome measure is the enrichment of genetic variants per gene/pathway."
64,"GPT4 Correct Assistant: The study, ""Impact of Neurochecks on Sleep in Critically Ill Adults,"" aims to investigate the effect of Neurocheck frequency on sleep in adult patients who have undergone uncomplicated elective coiling of unruptured cerebral aneurysm. The study includes participants aged 25-75 years and randomizes them into two groups: those receiving hourly Neurochecks and those receiving every-other-hour Neurochecks. The primary outcome measure is sleep efficiency, while secondary outcome measures include wakefulness, REM sleep, deep sleep, arousals, and subjective sleep quality."
65,"GPT4 Correct Assistant: This clinical trial aims to investigate the radiologic prognostic importance of extranodal extension (iENE) in head and neck cancer. The study will assess the accuracy of identifying iENE by radiologists and evaluate its prognostic significance in terms of overall survival rates and recurrence rates. The trial will also examine the utility of existing standardized diagnostic classification systems and measure interobserver variability among radiologists in grading radiographic ENE. The study will include patients with head and neck squamous cell carcinoma, extranodal extension, and human papilloma virus-related carcinoma."
66,"GPT4 Correct Assistant: This clinical trial aims to compare the efficiency and safety of bedside bone biopsy (BB) versus conventional bone biopsy in patients with diabetic foot ulcer (DFU) with a suspicion of diabetic foot osteomyelitis (DFO). The primary objective is to demonstrate non-inferiority of bedside BB compared to conventional BB on DFO remission without surgery at 1 year. Secondary objectives include comparing clinical efficacy, microbiological culture results, safety, and DFO remission according to BB results. The study will also assess the health economic aspects of both procedures."
67,"GPT4 Correct Assistant: The ""African Americans (AA) Communities Speak"" trial aims to address disparities in end-of-life (EoL) care for African Americans (AAs) by developing a community-based training program for clinicians caring for AA older adults with serious illnesses. The program, originally focused on rural Southern AA communities, will be adapted for urban-dwelling Southern and Northern AA adults with the help of local Community Advisory Boards. The study will involve a comparative ethnographic study of urban AA communities, adaptation of the existing training program, and a cluster randomized trial. The primary outcome will be patient/family's perception of therapeutic alliance, while secondary outcomes will include family-reported goal-concordant care and clinicians' knowledge of cultural values, awareness of implicit bias, and confidence to change practice."
68,GPT4 Correct Assistant: The study aims to assess genomic alterations and expression profiles in HPV+ and HPV- head and neck cancers. It includes patients with oropharyngeal or oral cavity squamous cell carcinoma and compares the molecular profiles of tumors through genetic analysis. The primary outcome measure is the molecular profile of HPV positive and negative tumors.
69,"GPT4 Correct Assistant: The study aims to validate Visual Analogue Scales to measure satisfaction and well-being at work (SoWell-VAS). The study includes adults aged 18-80 years who have a professional activity. The primary outcomes measure burnout, anxiety, job demand, job control, social support, job demand/job control/social support, effort-reward imbalance, work addiction, and life satisfaction. Secondary outcomes measure sociodemographic factors, occupation, work hours, night and weekend work, alcohol consumption, tobacco consumption, height, weight, sedentary behavior, physical activity, stress at work, ethical conflicts, perceived health, stress at home, fatigue, sleep quality, and mood. The study uses questionnaires and visual analogue scales to collect data at inclusion and one week later."
70,"GPT4 Correct Assistant: The study, titled ""Soft Tissue Contour and Radiographic Evaluation of Ridge Preservation Using Different Techniques,"" aims to evaluate the effects of various techniques for alveolar ridge preservation on soft tissue and hard tissue alterations. The participants, aged 20 and above, undergo tooth extraction and are randomly assigned to one of five experimental groups or a control group. The experimental groups receive alveolar ridge preservation with different grafts and membranes, while the control group undergoes spontaneous healing. The primary outcome measures are soft tissue and hard tissue alterations, assessed using cone-beam computed tomography data and STereoLithography files. Secondary outcome measures include keratinized tissue width changes and patient-reported visual analogue scale. The study plans to follow up with participants for up to 12 months."
71,"GPT4 Correct Assistant: This clinical trial, titled ""Study of Pro-inflammatory Cytokines in Case of Essure® Contraceptive Implants,"" aims to investigate the levels of pro-inflammatory cytokines in patients with Essure® contraceptive implants and compare them to control patients with and without endometriosis or adenomyosis. The study includes female participants aged 18 or older who have undergone removal of the Essure® contraceptive implant or benign laparoscopic gynecological surgery. The primary outcome measure is the level of cytokine IL10 in peritoneal fluid, which will be measured throughout the study, with an average duration of 4 months."
72,"GPT4 Correct Assistant: This is a two-way cohort study of patients with primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH) infected with COVID-19. The study aims to compare the difference of COVID-19 infection rate, disease severity, clinical biochemical indicators, hospital stay and prognosis between UDCA treated and non UDCA treated patients, and to study the impact of UDCA on the occurrence, incidence and prognosis of COVID-19 infection. The study measures the incidence of COVID-19 infection, severity of disease after COVID-19 infection, COVID-19 nucleic acid disappearance time, and COVID-19 infection outcome."
73,"GPT4 Correct Assistant: The study aims to determine if preoperative prone position training can reduce the incidence of postoperative pulmonary complications in patients undergoing laparoscopic colorectal cancer surgery. The study is a prospective, randomized, controlled clinical trial with participants divided into two groups: the prone position training group (PPT) and the control group (C). The primary outcome measure is the incidence of postoperative pulmonary complications (PPCs), including pneumonia, atelectasis, pleural effusion, respiratory failure, and unplanned intubations. Secondary outcome measures include arterial partial pressure of oxygen (PaO2), extubation time, peak airway pressure, arterial partial pressure of carbon dioxide (PaCO2), oxygenation index (OI), and other related parameters."
74,"GPT4 Correct Assistant: This clinical trial aims to evaluate the safety and efficacy of BLEX 404 Oral Liquid combined with Pemetrexed + Cisplatin Therapy in patients with advanced inoperable or metastatic EGFR wild-type non-small cell lung cancer. The study is a Phase I/II, open-label study with three arms: Phase I includes dose escalation to determine the dose-limiting toxicity (DLT) and recommended dose level (RDL), while Phase II investigates the efficacy of the RDL. The primary outcomes are DLT determination and RDL determination, with secondary outcomes including overall response rate and rate of grade 3/4 hematological toxicity."
75,"GPT4 Correct Assistant: The AGE SELF CARE study is a pilot study designed to test the feasibility and acceptability of a virtual group visit program for promoting healthy aging in pre-frail community-dwelling adults aged 65 years and older. The intervention consists of 8 weekly 90-minute virtual group visits, focusing on chronic disease management, healthy lifestyle education, home adaptation, and anticipatory guidance. The study aims to measure recruitment rate, completion of testing, attendance, participant satisfaction, and proportion lost to follow-up. Secondary outcome measures include frailty index, loneliness, self-reported health, physical activity, self-efficacy, depression, anxiety, sleep, and short physical performance battery."
76,"GPT4 Correct Assistant: The Pan-European Study on Geriatric Rehabilitation After COVID-19 is a multi-center observational cohort study aiming to understand the course of functional and clinical outcomes in post-COVID-19 geriatric rehabilitation patients in several European countries. The primary objective is to gain insight into the course of functional and medical recovery in geriatric rehabilitation patients affected by COVID-19 in Europe, and the secondary objective is to understand the treatment modalities and organization of geriatric rehabilitation for these patients. The study collects data on demographics, hospital stay, complications, and recovery measures, and uses descriptive statistics and multilevel models to analyze the data."
77,"GPT4 Correct Assistant: The PREPARE-iVAC trial is a multicentre, open-label, controlled, randomized study investigating the immunogenicity of COVID-19 vaccination in kidney transplant recipients. The primary objective is to determine whether replacement of Mycophenolate Mofetil/Mycophenolic Acid (MMF/MPA) by everolimus results in superior immunogenicity against the Omicron XBB.1.5 strain. Secondary objectives include assessing humoral and cellular immunogenicity, and evaluating safety. The study involves two parts: Part 1 (Run-in and COVID-19 vaccination) and Part 2 (Herpes zoster vaccination). Participants are randomized into two groups: those continuing MMF/MPA and those replacing it with everolimus. Outcomes measured include virus-neutralizing capacity, SARS-CoV-2 antibody concentration, SARS-CoV-2 specific T-cell response, and Varicella Zoster specific antibodies and T-cell response. Safety outcomes include adverse events and kidney function decline."
78,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of resistance exercises on plasma liver enzyme levels in patients with partial thickness burns (30%-50% burned body surface area). Sixty patients, aged 20-45 years, will be randomly assigned to either a study group or a control group. The study group will undergo resistance exercises using dumbbells and sandbags for 8 weeks, in addition to their physical therapy program and medical treatment. The control group will only receive their physical therapy program and medical treatment. The primary outcome measure is the change in plasma liver enzyme levels (AST and ALT) at two months."
79,"GPT4 Correct Assistant: This clinical trial investigates the efficacy of upper trapezius stretching on neck pain, range of motion, and disability in patients with cervical spondylosis. Participants, aged 40-65, are randomly assigned to either an experimental group (upper trapezius stretching) or a control group (standard care). The primary outcomes measured are changes in neck pain intensity and range of motion, while the secondary outcome is changes in neck disability index."
80,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of tecartherapy on the performance of amateur athletes. The study will include athletes aged 18-30 years, involved in sports that require sprinting and jumping. The intervention group will receive a single 25-minute tecartherapy procedure, while the control group will receive a sham treatment. The primary outcomes measured are changes in 30-meter sprint time and electromyographic activity during sprint. Secondary outcomes include countermovement jump, electromyographic activity during countermovement jump, isometric leg extension, and electromyographic activity during isometric leg extension."
81,"GPT4 Correct Assistant: This clinical trial aims to study the quantification of cell-free DNA in patients with endometriosis undergoing medical assistance to procreation, specifically In Vitro Fertilization (IVF) treatment. The study will compare the cell-free DNA rate in serum and follicular fluid between patients with endometriosis and those with other infertility causes. The primary outcome measures include cell-free DNA rate in serum and follicular fluid, while secondary outcome measures include oocyte quality, fragmentation rate, and clinical pregnancy and live birth rates. The study is a non-randomized, parallel assignment trial with a single masking design."
82,"GPT4 Correct Assistant: This study is a comparative prospective study assessing the treatment outcomes of fully edentulous patients with maxillary implant overdentures, supported by four implants, retained by either bars or Locators. The primary outcome measure is the change in marginal peri-implant bone level 10 years after placement of the overdenture. Secondary outcome measures include implant and overdenture survival, peri-implant mucosa health, and patient satisfaction."
83,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of a designed exercise program on pain and sleep quality in patients with Sickle Cell Disease Anemia. The study involves 50 adult patients, aged 18-55 years, who are randomly assigned to either an experimental group or a control group. The experimental group participates in a 6-week exercise program, including diaphragmatic breathing exercises, progressive muscle relaxation, stretching, stabilization, and strengthening exercises, as well as walking exercises. The control group does not receive the exercise program. Assessment instruments include the Pittsburgh Sleep Quality Index, the World Health Organization Quality of Life-BREF, the Fatigue Scale, and the Perceived Stress Scale. The study aims to determine the impact of the exercise program on sleep quality, pain, fatigue, and stress levels in patients with Sickle Cell Disease Anemia."
84,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of Cognitive Stimulation Therapy (CST) for individuals with dementia, including mild to moderate cognitive impairment. The study is a two-armed pragmatic trial, with one group receiving a referral for CST and the other group receiving standard care without a CST referral. The primary outcome measure is the change in Montreal Cognitive Assessment (MoCA) score from baseline to 6-month follow-up, with a clinically meaningful decline being less common in the intervention group. Secondary outcome measures include cognitive improvement, referral acceptance rate, participant attendance, and attrition."
85,"GPT4 Correct Assistant: This study investigates the correlation between anxiety and reflux symptoms in patients with gastroesophageal reflux disease (GERD). The study includes patients who underwent diagnostic tests such as high-resolution manometry, upper-GI endoscopy, and pH-impedance testing and completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. The study aims to assess anxiety and depression levels in patients with physiological and pathological DeMeester scores and examine the modulation of anxiety on the severity of reflux symptoms."
86,"GPT4 Correct Assistant: This clinical trial aims to study the effectiveness of self-guided personalized treatment for women with disordered eating using mobile technology. The study includes participants aged 18-65 who can read and write English and own a smartphone or tablet. The intervention is a two-week smart-phone self-monitoring to identify target problems, followed by two self-guided modules of personalized treatment sent directly to their smartphones. The study measures changes in disordered eating symptoms, anxiety, depression, clinical impairment, and quality of life over eight weeks."
87,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of the CAD-EYE system in screening for neoplastic lesions in patients with Lynch Syndrome. The study compares the adenoma detection rate (ADR) between the CAD-EYE group and the indigo carmin chromoendoscopy (CE) group, which is the reference technique. The trial includes participants aged 18-90 years with confirmed pathogenic mutations and no history of Crohn's disease or ulcerative colitis. The primary outcome measure is the comparison of ADR between the two groups, and secondary outcome measures include detection rates of specific lesions, diagnostic performance of CAD EYE, rate of resect and discard strategy, and time of colonoscopies."
88,"GPT4 Correct Assistant: This study aims to investigate the use of a water-soluble contrast-based protocol to assist in the management of pediatric adhesive small bowel obstruction. The trial is a prospective observational study conducted at nine children's hospitals, with inclusion criteria of children aged 1-20 years diagnosed with adhesive small bowel obstruction undergoing nonoperative management. The study explores the use of enteral contrast challenges to determine the need for surgery. The primary outcome measure is the number of patients who required an operation, while secondary outcome measures include total hospital length of stay and adverse events related to contrast administration."
89,"GPT4 Correct Assistant: This is a Phase 1, single-center, open-label, randomized, parallel group, single-dose study comparing the pharmacokinetics of subcutaneous Itepekimab administered with an autoinjector versus a prefilled syringe in healthy participants. The study aims to evaluate the primary outcome measures, including the maximum plasma concentration of itepekimab (Cmax), area under the plasma concentration versus time curve (AUClast), and area under the plasma concentration versus time curve extrapolated to infinity (AUC). The study will also assess secondary outcome measures such as time to reach Cmax (tmax), area under the serum concentration versus time curve (AUC0-28days), terminal half-life (t1/2), apparent total body clearance (CL/F), and apparent volume of distribution at the steady state (Vss/F). Additionally, the study will evaluate the incidence of treatment-emergent anti-itepekimab antibodies responses, and the number of participants with Adverse Events, Serious Adverse Events, and Adverse Event of Special Interest."
90,"GPT4 Correct Assistant: The CSD201204 study is a multi-site, open-label, randomized, three-arm, 8-week, prospective observational study examining the use of the P12 electronic nicotine delivery system among U.S. adult smokers. The study aims to assess the relative impact of availability and use of different e-liquid flavors on changes in cigarette consumption. Participants, aged 21-60, must be current smokers who smoke at least 5 cigarettes per day on days when cigarettes are smoked. The study follows participants over an 8-week period, measuring the number and proportion of subjects who reduce their cigarettes per day (CPD) consumption by at least 50% at Week 6 compared to baseline, as well as the CPD mean percent reduction at Week 6 compared to baseline."
91,"GPT4 Correct Assistant: This study aims to investigate the efficacy of subcutaneous infliximab in the treatment of moderate to severe Crohn's disease with and without concomitant immunosuppression. The study will randomize patients into two groups: monotherapy and combination therapy. The primary objective is to measure the proportion of patients in corticosteroid-free clinical remission (CDAI<150) and endoscopic response (SES-CD drop of at least 50%) at week 26. Secondary objectives include measuring the proportion of patients in endoscopic remission, clinical remission, symptomatic remission, biochemical remission, and quality of life, as well as assessing adverse events."
92,"GPT4 Correct Assistant: This clinical trial aims to study the pharmacokinetics of rivaroxaban and apixaban in adult cancer patients with venous thromboembolism or atrial fibrillation. The study seeks to identify factors influencing the pharmacokinetic profile of these drugs in these patients. The trial includes participants aged 18 or older with cancer (excluding basal-cell or squamous-cell carcinoma of the skin), either active or diagnosed within 6 months prior to inclusion. The primary outcome measure is the estimated area under the curve (AUC) of each drug, while the secondary outcome measure is any thromboembolic event or major bleeding."
93,"GPT4 Correct Assistant: The study aims to evaluate bronchodilator response in patients with bronchiectasis and determine if this response is influenced by factors other than the direct effect of bronchodilators. The primary outcome measures are the change in forced expiratory volume 1 second (FEV1) and forced vital capacity (FVC) from pre to post salbutamol inhalation, compared to the same change after placebo. Secondary outcomes include bronchodilator response in specific bronchiectatic diseases, comparing bronchiectasis patients to healthy controls, and assessing the influence of age, sex, specific bronchiectatic disease, baseline FEV1, and other clinical factors on bronchodilator response."
94,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of gender identity, genetic sex, and hormone status on pain sensitivity. The study includes six participant groups: cisgender men and women, and transgender men and women both with and without hormone treatment. The primary outcome measures include experimental heat and pressure pain thresholds, and pain sensitivity. Secondary outcome measures encompass sleep quality, depression, social support, perceived discrimination, hormone levels, immune cell populations and activity, community connectedness, bodily pain, quality of life metrics, body image, gender role expectation of pain, and adverse childhood events."
95,"GPT4 Correct Assistant: The study aims to evaluate the feasibility of technology-enhanced stroke rehabilitation during the acute and sub-acute phase after stroke. It will test the use of commercially available technology, such as robotics, adapted treadmills, virtual reality, and mobile digital devices, to increase rehabilitation intensity and improve functional recovery after stroke. The study will involve inpatients on the stroke unit at University Hospital Wishaw, Scotland, who will be prescribed and supported to use the rehabilitation technology, in addition to usual care, by NHS staff. The primary outcomes measured will be duration of time spent on activities within the 'technology enriched rehabilitation space', movement repetitions, rates of recruitment and attrition, and adherence to sessions. Secondary outcomes will include intervention acceptability, measured through audio-recorded semi-structured interviews with participants, family/carers, and NHS staff."
96,"GPT4 Correct Assistant: This study aims to evaluate the effect of immersive virtual reality (IVR) on respiratory discomfort in patients with Amyotrophic Lateral Sclerosis (ALS) treated with non-invasive ventilation (NIV). The study is an open-label, monocentric, randomized, controlled cross-over clinical study. Patients will undergo a digital therapy session based on IVR and music therapy, with each session lasting 15 minutes. The primary outcome measure is the evaluation of the effect of IVR on respiratory discomfort using the Multidimensional Dyspnea Profile (MDP) questionnaire. Secondary outcomes include the evaluation of the effect of IVR on sensory and emotional components of dyspnea, the effect of music therapy on respiratory discomfort, and the comparison of the evolutionary profile of respiratory discomfort under the effect of IVR and music therapy."
97,"GPT4 Correct Assistant: This clinical trial aims to evaluate the impact of selective reporting for antibiotic susceptibility testing on the prescribing of broad-spectrum antibiotics in women with E. coli urinary tract infections. The study will randomize participants into experimental and control arms, where the experimental arm will receive selective antibiotic susceptibility testing reports emphasizing narrower-spectrum antibiotics, while the control arm will receive standard antibiotic susceptibility testing reports. The primary outcome measure is the rate of broad-spectrum antibiotic dispensing, and secondary outcome measures include directed broad-spectrum antibiotic dispensing, antibiotic de-escalation rate, and GP and patient characteristics."
98,"GPT4 Correct Assistant: This study aims to investigate the effectiveness of sodium valproate in improving clinical outcomes for patients with acute ischemic stroke. The trial is a prospective, randomized, double-blind, controlled study, where patients are assigned to either low-dose sodium valproate group, high-dose sodium valproate group, or placebo group. The primary outcome measure is the proportion of patients with favorable outcome (Modified Rankin Scale (mRS) score≤2) at 90 days. Secondary outcome measures include the mRS score at 90 days, favorable outcome at 30 days, NIH Stroke Scale (NIHSS) score at 3 and 7 days, changes of lesion volume from baseline to day 7, and length of hospital stay."
99,"GPT4 Correct Assistant: The clinical trial aims to investigate if a MyChart enabled virtual weight loss coach offers a better solution for weight reduction in ventral hernia patients with obesity compared to standard preoperative weight loss tools. The study includes participants aged 18-90 with a BMI of 30 or above and diagnosed with obesity. The primary outcome measure is the average net amount of weight change per group over 6 months, while secondary outcomes include the number of interactions with the virtual coach, quality of life measured using the Hernia Related Quality of Life Survey (HerQLes), and satisfaction with the virtual coach. The study is a non-randomized parallel assignment with an open-label design."
100,"GPT4 Correct Assistant: This clinical study aims to evaluate the safety and effectiveness of umbilical cord mesenchymal stem cell-derived exosomes (nebulized) combined with conventional therapy for the treatment of moderate, severe, and critically ill COVID-19 patients through a multicenter, randomized controlled, single-blind clinical trial. The study will compare the relief of symptoms and the occurrence of adverse events before and after treatment to assess the safety and efficacy of the treatment."
101,"GPT4 Correct Assistant: This clinical trial is comparing the clinical effectiveness of Calcium Silicate-based Sealer and Epoxy Resin-based Sealer in single-visit root canal treatment for patients with irreversible pulpitis. Patients aged 18 years or older are eligible to participate. The primary outcomes measured are change in pain intensity, change in pain relief, and change in treatment outcome evaluation over time. The study uses a randomized parallel assignment design with a single masking."
102,"GPT4 Correct Assistant: This study aims to evaluate the immunogenicity and immune persistence of two domestically produced bivalent HPV vaccines (Wozehui® and Cecolin®) compared to imported HPV vaccines in adolescent females aged 13-14 years. The study is a multi-center, open, prospective cohort study with a total of 3,000 subjects. Participants were divided into three groups: domestic bivalent HPV vaccine (Wozehui), domestic bivalent HPV vaccine (Cecolin), and imported HPV vaccine. Blood samples were collected at baseline, 12 months, and 36 months after the last dose of vaccination for HPV type 16 and 18 neutralizing antibody testing. The primary outcome measures are the neutralization antibody GMT and antibody positivity testing for HPV types 16 and 18 at baseline, 12-month follow-up, and 36-month follow-up."
103,"GPT4 Correct Assistant: This clinical trial aims to evaluate the feasibility of integrating homeopathic approach in a comprehensive cancer center. The study will assess the main concerns of patients who agree to use this method, patient acceptance of the supportive approach, and obtaining retrospective subjective information from patients through validated quality of life questionnaires. The primary outcome measures include feasibility of a supportive approach and quality of life-level of distress."
104,"GPT4 Correct Assistant: This clinical trial, titled ""Description of Septic Thrombophlebitis on Central Venous Catheter and Midline,"" aims to study the diagnostic test of Doppler ultrasound in patients with septic thrombophlebitis. The study includes adult patients hospitalized at CHM or CHUA with central venous devices or midlines and catheter-related bacteremia. The primary outcome measure is the evaluation of the duration of ultrasound signs of septic thrombophlebitis on central venous catheter and midline. The study is designed as a non-randomized, parallel assignment, open-label trial."
105,"GPT4 Correct Assistant: This trial is designed to determine the safety and effectiveness of Odronextamab in combination with Lenalidomide compared to Rituximab in combination with Lenalidomide in participants with Follicular Lymphoma and Marginal Zone Lymphoma. The study will enroll participants with relapsed/refractory disease who have previously received at least two cycles of systemic chemo-immunotherapy or immunotherapy, including at least one anti-CD20 monoclonal antibody. The primary outcomes measure will be the incidence of dose limiting toxicities and treatment emergent adverse events for Odronextamab in combination with Lenalidomide. Secondary outcomes include progression-free survival, overall response rate, duration of response, and overall survival."
106,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of Proliverenol supplementation on liver function in patients with Non-Alcoholic Fatty Liver Disease (NAFLD). The study involves 4 treatment groups, with 20 subjects in each group receiving different regimens of Proliverenol or placebo for 12 weeks. The primary outcome measures are changes in serum ALT and AST levels from baseline to weeks 4, 8, and 12. Secondary outcome measures include USG examination for CAP and TE measurements, and the AST to ALT ratio at weeks 4, 8, and 12. The study is designed as a randomized, parallel assignment, quadruple-masked trial."
107,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of ozone application in periodontitis patients. The study includes participants aged 18-65 years, both sexes, and healthy volunteers. The study design is a randomized, parallel assignment, double-masked trial with two arms: experimental (ozone therapy) and active comparator (non-surgical periodontal treatment). The primary outcome measures are probing pocket depth at baseline and 3rd month after treatment. Secondary outcome measures include plaque index, gingival index, bleeding on probing, proportions of bacterial species, and inflammatory parameter levels in gingival crevicular fluid."
108,"GPT4 Correct Assistant: This clinical trial aims to study the expression of CD44, PCNA, and E-cadherin in pterygium tissue samples. Sixty patients with pterygium will be enrolled, with 30 patients forming the control group. The expression of the mentioned markers in surgically removed pterygium will be compared with tissue samples from a normal control group. The study uses immunohistochemistry to evaluate the tissue samples, and the findings will be reported using a Nikon light microscope and an image analysis system. The primary outcome measure is immunohistochemistry, with evaluations up to three weeks after pterygium surgery."
109,"GPT4 Correct Assistant: The TINO study aims to investigate the underlying mechanisms and consequences of the loss of nasal T cells in vital and frail older individuals. It focuses on understanding the frequency, phenotype, functionality, transcriptomic cluster composition, clonality, and stability of nasal and blood T cell populations in young adults, healthy older adults, and frail older adults with or without recurrent respiratory tract infections. The study will also examine the effect of sex on aging effects of nasal and blood immune populations."
110,"GPT4 Correct Assistant: This clinical trial investigates the use of the Platelets to Lymphocytes Ratio and Monocytes to Lymphocytes Ratio as predictors of response to treatment in cirrhotic patients with spontaneous bacterial peritonitis (SBP). The study includes participants aged 15-100 years with cirrhosis and SBP, excluding those with certain conditions or receiving specific treatments. The primary outcome measure is the assessment of the platelets to lymphocytes ratio and monocytes to lymphocytes ratio as predictors of response to treatment in cirrhotic patients with SBP. The study is designed as a diagnostic test using ascetic fluid study parameters in the diagnosis of SBP. The trial is scheduled to take place from 19th April 2023 to 30th April 2024."
111,"GPT4 Correct Assistant: This clinical trial aims to evaluate whether point-of-care ultrasound (POCUS) performed by a variety of emergency medicine physicians increases diagnostic accuracy in patients with acute dyspnea compared to routine assessment. The study is a prospective observational study, including adult patients presenting to the Emergency Department with shortness of breath, oxygen saturation less than 90% on room air, or a respiratory rate greater than 25 breaths per minute and oxygen saturation less than 95% on room air. The primary outcome measure is the discharge diagnosis, including conditions such as heart failure, pulmonary embolism, COPD exacerbation, and pneumonia. The study will determine the sensitivity, specificity, and predictive values of the diagnostic accuracy before and after adding POCUS."
112,"GPT4 Correct Assistant: The clinical trial aims to determine whether the implementation of respiratory and relaxation techniques (R&R) during adjuvant radiation therapy in deep inspiration breath hold (DIBH) in breast cancer patients can improve patients' DIBH performance, reduce heart dose, alleviate anxiety and stress, and improve quality of life. The study will randomize patients into two groups: one group receiving R&R training and another group receiving standard DIBH instruction. The primary outcome measure is the change of maximum dose (Dmax) to the heart during adjuvant radiotherapy. Secondary outcome measures include quality of life, heart dose, and clinic workflow efficiency."
113,"GPT4 Correct Assistant: This is a Phase IB study to determine the safety and tolerability of Canakinumab and Tislelizumab in combination with Nab-Paclitaxel and Gemcitabine in the neo-adjuvant treatment of patients with pancreatic cancer. The study includes participants aged 18-100 years who have histologically or cytologically confirmed pancreatic ductal adenocarcinoma. The primary outcome measures are the number of dose limiting toxicities and the number of patients who proceeded to surgical resection. Secondary outcome measures include overall response rate, R0 resection rate, progression free survival, and overall survival."
114,"GPT4 Correct Assistant: The clinical trial aims to study the implementation of mental health navigation models and the Connected for Wellness app to improve connections and access to prevention resources, mental health services, and social supports for youth and families. The study will be conducted among youth aged 13-22 years old and their caregivers in 10 Los Angeles County schools and 10 Riverside County/University of California Riverside primary care clinics. The primary outcome measure is the proportion of youth referred to mental health services who initiate care, while the secondary outcome measure is the proportion of youth completing a mental health screening who are referred to care."
115,"GPT4 Correct Assistant: This study is a double-blinded, randomized, comparative-placebo trial comparing intra-myometrial tranexamic acid and oxytocin injections to reduce blood loss in cesarean sections for primigravida women at term. The study will be conducted at Kasr Al-Ainy Hospital in Cairo, Egypt, and will include 50 eligible women. Participants will be randomly allocated to either the tranexamic acid group or the oxytocin group. The primary outcome measure is the estimation of intraoperative and postoperative blood loss within 24 hours. The study aims to determine the effectiveness of tranexamic acid and oxytocin in reducing blood loss during and after cesarean sections, thus potentially reducing the risk of postpartum hemorrhage."
116,"GPT4 Correct Assistant: The Innovation for Small-scale Experiments: ReceptIVFity Test is a clinical trial that aims to determine the effectiveness of the ReceptIVFity test, a vaginal microbiome swab, in improving pregnancy rates in women undergoing IVF or IVF/ICSI treatments. The study includes naïve IVF or IVF/ICSI patients aged between 18 and 42 years, excluding those on hormonal contraceptives or antibiotics at the time of testing. Participants are randomized into either the Shared-Decision-Making group or the Physician decision group, both of which use the ReceptIVFity test to guide treatment decisions. The primary outcome measures are the rate of successful pregnancy, the number of successful IVF or IVF/ICSI cycles, and the total number of IVF or IVF/ICSI treatment cycles per patient. Secondary outcome measures include patient satisfaction scores and total treatment costs. The study is designed to last for three years."
117,"GPT4 Correct Assistant: This clinical trial aims to investigate the lipid-lowering effect of fenugreek seed consumed as a tea in patients with hyperlipidaemia (elevated lipid levels) but without diabetes over an 8-week intervention period. The study will randomize 114 participants into two groups, one receiving fenugreek seed tea and the other receiving black tea. The primary outcome measure is the change in serum triglycerides between the two groups. Secondary outcome measures include changes in total-cholesterol, LDL-cholesterol, non-HDL-cholesterol, HDL-cholesterol, plasma apolipoprotein B, and plasma microRNA-122 and microRNA-34a as non-invasive therapeutic biomarkers."
118,"GPT4 Correct Assistant: This clinical trial aims to investigate the role of pioglitazone in vascular transcriptional remodeling in individuals undergoing coronary artery bypass grafting (CABG). The study is a prospective, randomized, open clinical trial involving 20 participants. Participants will be randomly assigned to receive pioglitazone hydrochloride 45mg/day for 5 days before the surgery or no intervention. The primary outcome measure is the change in S1P content of isolated HDL between baseline and after treatment with pioglitazone. Secondary outcome measures include differences in SPHK1 expression in various arterial and vein cells."
119,"GPT4 Correct Assistant: This clinical trial aims to assess the pharmacodynamics and pharmacokinetics of three new coated glucose beads formulations (T1, T2, T3) and one coated beads glucose (T4) and one uncoated beads glucose (T5) in 20 obese, healthy volunteers. The primary outcomes are the area under the plasma concentration-time curve (AUC) and adjusted AUC of glucose-like peptide-1 (GLP-1) levels. Secondary outcomes include the pharmacokinetics of caffeine, glucose, appetite, stomach rumbles, tolerability, and safety."
120,"GPT4 Correct Assistant: This study aims to evaluate the effect of using celluloid matrix tapes and oral tapes as a simple and cheap method for proper positioning of the tongue on reducing the palatoglossal airway shadow error in panoramic imaging. The study includes 270 participants, divided into three groups: the control group with no intervention, the fruit leather group, and the chewing gum group. The primary outcome measure is the investigation of the panoramic images and the reduction of the palatoglossal air space shadow error."
121,"GPT4 Correct Assistant: This clinical trial aims to compare the acute effect of Plantar Fasciitis treatment using Extracorporeal Shock Wave Therapy (ESWT), Kinesio Taping (KT) in addition to ESWT, and Placebo ESWT on pain level, lower extremity functionality, and plantar fascia flexibility. The study includes three groups: ESWT (Group 1), ESWT and KT (Group 2), and Placebo/Sham (Group 3) application groups. The primary outcome measure is Visual Analogue Scale (VAS) for pain, and the secondary outcome measure is Lower Extremity Functional Scale. The study includes participants aged 18-65 with Plantar Fasciitis, excluding those with certain medical conditions or receiving other treatments."
122,"GPT4 Correct Assistant: The trial aims to establish a Couple Intervention Program for adults with Autism Spectrum Disorder (ASD). The intervention is behavioral, involving couple group therapy. Participants must be between 20 and 60 years old and have either an ASD diagnosis or an autism spectrum quotient scoring above or equal to 26. The study is designed as a single group assignment with open-label intervention. The primary outcome measures include the Autism Diagnostic Observation Schedule (ADOS), Autism Spectrum Quotient (AQ), Empathy Quotient (EQ), Social Responsiveness Scale (SRS), and Quality of Socialization Questionnaire (QSQ)."
123,"GPT4 Correct Assistant: This study aims to evaluate the effects of an individually tailored exercise program on patients with postural orthostatic tachycardia syndrome (POTS) who have had COVID-19. The study will recruit 60 adult patients and randomly assign them to either a control group receiving standard care or an intervention group receiving standard care plus an individually tailored exercise program for 16 weeks. The primary outcomes are changes in time spent in an upright position and health-related quality of life. Secondary outcomes include changes in walking distance, oxygen saturation, dyspnea, leg fatigue, exertion, heart rate, self-reported POTS symptoms, anxiety, depression, fatigue, physical function, blood pressure, orthostatic symptoms, insomnia, and workability. The study will also assess compliance to the intervention and changes in pharmacological treatment of POTS."
124,"GPT4 Correct Assistant: The Efficacy and Safety of Tirofiban for Patients With Acute Branch Atheromatous Disease (BAD)-Related Stroke (BRANT) study is a multicenter, randomized, open-label, blinded endpoint, parallel controlled trial. The primary objective is to determine if intravenous tirofiban is effective in increasing the proportion of excellent functional outcome (mR: 0-1) at 90 days when initiated within 48 hours of stroke onset. The study includes patients aged 18-75 years with acute ischemic stroke due to branch atheromatous disease. The primary outcome measures are excellent functional outcome (mR: 0-1) at 90 days and the proportion of major bleeding at 90 days. Secondary outcome measures include modified Rankin Scale score, early neurological deterioration, NIHSS score, Barthel index score, ischemic stroke, stroke, TIA, composite endpoint, proportion of major bleeding, serious adverse events, adverse events, all-cause death, and changes in various blood tests and biochemical markers."
125,"GPT4 Correct Assistant: The Allometric-Pace Study aims to investigate the utilization of personalized pacing to improve quality of life in patients with Sinus Node Dysfunction (SND). Patients aged 60 and older with a plan to implant a dual-chamber pacemaker are eligible for participation. The study compares two groups: the PLR group, where the pacemaker lower rate is set at 75 bpm, and the control group with a pacemaker lower rate of 60 bpm. The primary outcome measure is the life quality measurement using the SF-36 questionnaire score within three months after the surgery. Secondary outcome measures include cardiac functional changes (LVEF) and the correlation of elevated blood pressure and bradycardia (24-hour ambulatory blood pressure) within three months after the surgery."
126,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of remote diagnosis and treatment on the 24-hour ambulatory blood pressure rhythm of OSA (Obstructive Sleep Apnea) patients. The study involves patients who came to the hospital for snoring and were randomly divided into the telemedicine group and the outpatient group. The primary outcome measure is the 24-hour ambulatory blood pressure, and secondary outcome measures include compliance of APAP treatment, sleep apnea-related dysfunction, sleepiness symptom, blood lipids and fasting blood glucose test, and cost-effectiveness analysis. The trial will last for 12 weeks, and the results will help explore the mechanism of APAP treatment to improve the ambulatory blood pressure rhythm of OSA patients and provide a foundation for precise treatment of OSA."
127,"GPT4 Correct Assistant: This clinical trial, conducted in the maternity ward at Carmel Hospital, aims to investigate the influence of communication between nursing staff and patients on analgesic response following caesarean section. The study will include 80 patients undergoing elective caesarean section under spinal anesthesia. Participants will be randomly assigned to either enhanced communication or normal communication arms. The primary outcome measure is the change in pain intensity on a 0-10 pain scale one hour after analgesic administration. The Self-Consciousness Scale (SCS-R) and the Short Suggestibility Scale (SSS) will be used to assess relevant personality traits."
128,"GPT4 Correct Assistant: The trial, titled ""Assessment of Novel Biomarkers in Participants Undergoing Targeted Lung Health Checks,"" aims to assess novel molecular, immune, and clinical biomarkers to improve lung cancer screening sensitivity and specificity beyond conventional risk prediction models and low-dose CT scanning. The study includes participants aged between 55 and 74 years who are attending the NCL NHS TLHC programme. The primary outcome measures are proteomics, metabolomics, genomics, and immune repertoire characterization performed on peripheral bloods. The study is designed to last for 5 years."
129,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of telepharmacy on clinical outcomes of patients with arterial hypertension. The study population consists of elderly patients admitted to the service with a diagnosis of systemic arterial hypertension. The study is a randomized clinical trial with two arms: telepharmacy and in-person pharmaceutical care. The primary outcome measure is controlling blood pressure, and secondary outcome measures include patient adherence to treatment, patient satisfaction, and level of clinical significance of interventions. The study will evaluate the acceptance and clinical importance of interventions carried out by the pharmacist between the telepharmacy and in-person groups. The study will run for 3 months."
130,"GPT4 Correct Assistant: The ICU LIBERATION Study is an international, multicenter study investigating the epidemiology and treatment strategies for patients with Acute Respiratory Distress Syndrome (ARDS) after the COVID-19 pandemic. The study aims to clarify the actual implementation of ICU care for ARDS patients requiring ventilators, and evaluate the association between evidence-based ICU care and patient outcomes. The primary outcome measures include mortality, compliance of lung protective ventilation, implementation rate of the ABCDEF bundle, and incidence of Post Intensive Care Syndrome. The study seeks to improve outcomes for ARDS patients and contribute to the development of ICU care guidelines."
131,"GPT4 Correct Assistant: The Effect of Pomanox® on Skin Ageing (POMASKIN) study aims to evaluate the effects of consuming two doses of Pomanox®P30 on hyperpigmented skin spots in humans. The study includes a randomized, parallel, placebo-controlled, triple-blind clinical trial with 66 participants. The primary outcome measure is the change in skin melanin index, while secondary outcome measures include changes in skin wrinkles, elasticity, erythema index, hydration, pores, acne, keratin, collagen and hyaluronic acid metabolism, oxidative stress, anti-glycan effect, inflammatory system, and intestinal and skin microbiota composition."
132,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of prostate hyperplasia medication and androgen deprivation therapy on gut microbiota and metabolism in men with prostatic hyperplasia and prostate cancer. The study will include two participant groups: those with prostatic hyperplasia treated with 5-alpha-reductase inhibitors and those with prostate cancer treated with LHRH antagonist (degarelix). The primary outcome measures include gut microbiota signatures before and after treatment, while the secondary outcome measures involve metabolic characteristics in the gut and systemic circulation before and after treatment."
133,"GPT4 Correct Assistant: This clinical trial, titled ""Magnetic Resonance Spectroscopy Markers of Glioma Genomics,"" aims to study the diagnostic test of MRI in participants with glioma. The study is designed as a single group assignment with an open-label model. The primary outcome measures are metabolite concentrations by MRS, while the secondary outcome measures include diffusion MRI metrics, metabolic changes during an anti-tumor treatment, and diffusion MRI and amide proton transfer signal changes during an anti-tumor treatment."
134,"GPT4 Correct Assistant: This clinical trial aims to evaluate the long-term efficacy and safety of the combination therapy of hydroxyurea and thalidomide in beta-thalassemia patients. The study includes patients with clinical and genetic diagnoses of beta-thalassemia major and intermedia who have shown partial response or a decline in response to hydroxyurea. The intervention consists of hydroxyurea at a daily dosage of 10-20 mg/kg for 6 months, followed by the addition of thalidomide at an initial dosage of 2-5 mg/kg. The primary outcome measures include the frequency of good responders, responders, and non-responders at different time intervals, as well as changes in laboratory levels and liver and spleen size. The study will measure the change in laboratory levels, including hemoglobin, platelets, leukocytes, urea, creatinine, and ferritin levels from baseline. It will also measure the change in the liver and spleen size from baseline. The study will also compare the XmnI polymorphism with the outcome among patients who completed 1-year, 2-years, and 3-years of combination therapy."
135,"GPT4 Correct Assistant: The study aims to determine the role of diagnostic imaging in the patient journey for patients with active or healed ulceration, assess current practices in primary care for venous leg ulcer management, and establish minimum diagnostics for this patient cohort. Participants include primary care practitioners and vascular scientists in the UK. The study uses a questionnaire for primary care practitioners and a Delphi consensus for vascular scientists. The primary outcomes measured are the current practices in primary care for venous leg ulcer management and the current practice for diagnosis and management of suspected venous leg ulcers in vascular scientist departments. The study duration is 3 months for primary care practitioners and 6 months for vascular scientists."
136,"GPT4 Correct Assistant: This clinical trial, titled ""Enhancing Prospective Thinking in Early Recovery,"" aims to study the effects of Virtual Reality on individuals with substance use disorders. The study is designed as a randomized controlled trial with two groups: Experimental (Virtual Reality Avatar) and Control (Treatment As Usual). The primary outcomes measured are reduced drug use days, increased length of abstinence, increased overall abstinence, increased future self-identification, increased future time perspective, and increased preference for delayed rewards. The study will follow participants at study day visit, 30-day follow-up visit, and 6-month follow-up visit."
137,GPT4 Correct Assistant: This clinical trial aims to evaluate the stability of short implants versus standard length implants with internal sinus floor elevation in the posterior maxilla. The study includes patients aged 20-60 with bone height below the maxillary sinus of 7-8mm and a bucco-palatal bone width of ≥6mm. The trial is designed as a randomized controlled study with parallel assignment and single masking. The primary outcome measure is the crestal bone level assessed by periapical standardized radiographs at 1 year.
138,"GPT4 Correct Assistant: This clinical trial investigates the use of Wharton's Jelly Mesenchymal Stromal Cell (WG-MSC) injections as a prophylaxis for GVHD in hematopoietic allogeneic stem cell transplantation using a haploidentical donor. The study is designed as a dose escalation study, with participants receiving WJ-MSC infusions at various doses. The primary outcome measure is the maximum tolerated dose, while secondary outcome measures include incidence of acute and chronic GVHD, toxicity-related mortality, relapse incidence, overall survival, GvHD and relapse-free survival, and poor graft function. The study is open to participants aged 18 to 70 years with AML/ALL/SMD/SMP or lymphoid neoplasm requiring allogeneic stem cell transplantation, and without a HLA matched related donor available."
139,"GPT4 Correct Assistant: The clinical trial aims to deploy a clinical decision support tool called eCARTv5 within the electronic health record of multiple medical-surgical units. The tool combines a real-time machine learning algorithm for identifying patients at increased risk for ICU transfer and death with clinical pathways to standardize care based on a real-time assessment of patient risk. The investigators hypothesize that implementing eCARTv5 will result in decreased ventilator utilization, length of stay, and mortality for high-risk hospitalized adults. The study will include patients aged 18 years or older admitted to an eCART-monitored medical-surgical unit. The primary outcome measure is hospital mortality for elevated risk patients, and secondary outcomes include total hospital length of stay, ICU-free days, and ventilator-free days following an eCART elevation."
140,"GPT4 Correct Assistant: The African-American Social Support Effectiveness Treatment- Partners alleviating Perinatal Depression (ASSET-PPD) trial aims to evaluate the effectiveness of a novel intervention to reduce maternal perinatal depression in African-American mothers. The intervention targets fathers' support of the mothers' mental health treatment and their active engagement in the family. The study includes 50 parent dyads, with mothers in the second trimester receiving psychiatric treatment for depression and fathers providing support. The intervention consists of four prenatal modules and two postpartum review sessions addressing key factors to reduce maternal stress. The primary outcome is maternal depressive symptoms, with secondary outcomes including breastfeeding, parent-infant interactions, and maternal anxiety."
141,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a proactive identification and digital mental health intervention approach in addressing unmet psychosocial needs of individuals living with cancer. The study will compare the impact of a Behavioral Activation Therapy app (Moodivate) and Treatment as Usual on participants' depressive symptoms. The study will include participants aged 18 and above with elevated depressive symptoms, who own a smartphone and are fluent in English. The primary outcome measure is the proportion of eligible participants who accrue to the study during the study duration."
142,GPT4 Correct Assistant: This study aims to test new algorithms for detecting insulin pump malfunctions in individuals with type 1 diabetes. The study consists of three phases: Phase 1 involves collecting data related to glycemic trends and insulin administration in free-living conditions; Phase 2 simulates hyperglycemia by temporarily suspending insulin infusion; Phase 3 retrospectively analyzes the collected data to evaluate the effectiveness of the algorithms in detecting insulin suspension. The study seeks to develop better fault detection methods to reduce the risk of hyperglycemia and ketoacidosis in patients with type 1 diabetes using automated insulin delivery systems.
143,"GPT4 Correct Assistant: This study aims to evaluate the effect of Funk It Cycle Bites on premenstrual syndrome (PMS) in females aged 18-40 with mild to moderate menstrual pain. Participants will consume one Cycle Bite per day for four months, and their symptoms will be assessed using various survey-based questionnaires. The primary outcomes measured will be changes in PMS symptoms, acne, pain levels, mood stability, and energy levels. Secondary outcomes include participant enjoyment of the product."
144,"GPT4 Correct Assistant: The study aims to assess the effectiveness of the personalized risk assessment tool (PERSARC) in reducing decisional conflict and increasing informed choices in high-grade extremity Soft-tissue Sarcoma patients compared to usual care. The study will be conducted in six Dutch hospitals that are Soft-tissue sarcoma expertise centers. Patients (>= 18 years) with primarily diagnosed grade 2-3 extremity Soft-Tissue Sarcoma, who do not have a treatment plan yet and will be treated with curative intent are eligible. The study will measure co-primary outcomes: decisional conflict (Decisional Conflict Scale(DCS) (T1)) and informed choice (T1). Secondary outcomes include regret (Decision_Regret_Scale) (T3, T4), worry (Cancer_Worry_scale) (T1, T2, T3, T4), involvement in decision-making according to patients (SDM-Q-9) (T1), patient-reported outcome using the Patient Reported Outcome Measures (PROMIS Global health) (T1, 2, 3, 4), and (PROMIS physical function) (T1, 2, 3, 4), utilities for the cost-effectiveness analysis (EQ-5D-5L) (T1, T2, T3, T4), health care cost (iMCQ) (T2, T3, T4) and absenteeism/presenteeism from paid work (T2, T3, T4)."
145,"GPT4 Correct Assistant: This clinical trial aims to determine the prevalence of early childhood caries in Jordanian children attending kindergartens, its associated risk factors, and the effectiveness of silver diamine fluoride (SDF) in caries control. The study includes children aged 3-5 years and consists of a control group with no intervention and a study group receiving a single spot application of 38% SDF. The primary outcome measures are the prevalence of early childhood caries, caries prevention, and caries arrest after one year. Secondary outcome measures include risk factors for early childhood caries and parental acceptance of SDF."
146,"GPT4 Correct Assistant: This study aims to evaluate the effectiveness of Pfizer's ABRYSVO vaccine against severe lower respiratory tract infections in older adults using a retrospective case-control study with test negative design and a retrospective cohort design. The study will assess the vaccine's effectiveness against RSV-related lower respiratory tract infection hospitalizations, severe lower respiratory tract infections, and other RSV-related outcomes. Participants will be older adults eligible for vaccination according to current recommendations. The study will also explore the vaccine's effectiveness in high-risk groups and among those with chronic medical conditions."
147,"GPT4 Correct Assistant: The OSsIRIS Study is a post-market clinical follow-up investigation to confirm the performance and safety of the bone substitute b.Bone in extremities and pelvis. It focuses on patients with surgically created bone defects or bone defects/voids resulting from traumatic injury. The study uses b.Bone as a bone substitute in isolation or as a graft expander to promote healing in the pelvis, upper and lower extremities. The primary outcome measure is the radiographic healing/union after surgery, measured by the modified radiographic Union Scale for Tibial fractures (mRUST) classification or the modified Neer classification when applicable. Secondary outcome measures include patient-reported outcomes for pain and quality of life, as well as the safety of b.Bone during the clinical investigation period."
148,"GPT4 Correct Assistant: This is a 1-year prospective cohort study examining the prognostic significance of acute change in liver and splenic stiffness in patients with acute on chronic liver failure (ACLF). The primary objective is to study the change in liver and splenic stiffness values at day 7 from baseline at day 1 between those with or without transplant-free survival at day 90. Secondary objectives include assessing the association of stiffness changes with various aspects of ACLF, such as etiologies, severity, organ failures, and inflammatory markers. The study will enroll 200 patients, and no intervention will be provided. The primary outcome measure is the prediction of liver transplant-free survival at 3 months based on acute changes in liver and splenic stiffness on day 7."
149,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of onabotulinumtoxinA neurotoxin injected at a depth of 2mm versus 4mm for the improvement of glabellar lines. The study will also determine any adverse effects of the treatment at these depths. The trial is randomized, with participants assigned to either treatment group. The primary outcome measure is the improvement of glabellar lines using the Merz aesthetics scales, with a secondary outcome measure being the incidence of any adverse effects."
150,"GPT4 Correct Assistant: This clinical trial aims to evaluate the impact of music therapy on anxiety in breast cancer patients undergoing adjuvant or neoadjuvant chemotherapy. The study is designed as a randomized, parallel assignment, open-label trial with two arms: music therapy and standard care. The primary outcome measure is the change in anxiety levels before the first and third chemotherapy sessions, measured using the State Trait Anxiety Inventory (STAI) score. The study is limited to patients with localized breast cancer, aged 18 or older, and not eligible for curative surgery or who have already received chemotherapy."
151,"GPT4 Correct Assistant: The study ""Optimization of Conditioning Regimen for HLA Matched HSCT in SAA"" is a prospective, multicenter, randomized controlled trial aiming to evaluate different conditioning regimens for HLA matched donor transplantation in patients with severe aplastic anemia (SAA). The intervention includes Busulfan with either Flu/Cy/ATG or Cy/ATG as conditioning regimens. The primary outcome measure is failure-free survival at 1 year post HSCT. Secondary outcomes include incidence of mixed chimerism, regimen-related toxicity, myeloid and platelet engraftment, incidence of graft versus host disease, incidence of CMV and EBV reactivation, transplantation-related mortality, and overall survival at 1 year post HSCT."
152,"GPT4 Correct Assistant: This clinical trial is designed to test the safety and tolerability of switching from Emicizumab to Fitusiran prophylaxis in male participants aged 18 years or older with severe hemophilia A. The primary outcome measures include the number of participants with adverse events during the Fitusiran treatment period, peak thrombin generation, peak antithrombin levels, and emicizumab concentrations in plasma. Secondary outcome measures include treatment satisfaction, participants' treatment preferences, pain intensity, physical functioning and activity, joint health, and annualized bleeding rate while receiving Fitusiran prophylaxis."
153,"GPT4 Correct Assistant: This clinical trial aims to translate and validate the Malay version of the painDETECT Questionnaire (PDQ-M) for patients with neuropathic and nociceptive pain. The study includes participants aged 18 years and above, who can read and understand Malay and have a stable disease condition with pain duration of at least 4 weeks. The primary outcome measure is the PDQ-M scores collected over a 2-5 week period. The study involves the administration of the PDQ-M, NRS, and SF-36 questionnaires to participants with neuropathic and nociceptive pain."
154,"GPT4 Correct Assistant: This clinical trial aims to assess the safety and validity of a community-based complex exercise program for stroke patients. The study involves stroke patients aged 30 years or older who can walk independently and have a score of 3 or higher in the Functional Ambulation Category (FAC). Participants are randomly assigned to either the exercise group or the daily life group. The primary outcome measure is the 6-minute walk test (6WMT), which will be evaluated at baseline and follow-up (through study completion, an average of 6 weeks). Secondary outcome measures include modified Rankin Scale (mRS), Berg balance scale (BBS), Functional ambulation category (FAC), Manual Muscle Testing (MMT), Timed up and go (TUG), Grip strength, body composition, physical activity, Euro-Quality of Life-5 Dimension (EQ-5D), Geriatric depression scale (GDS), sit to stand, flexibility test, and coordination test."
155,"GPT4 Correct Assistant: This clinical trial aims to study the safety, efficacy, pharmacokinetics, and pharmacodynamics of ABBV-552 in participants with mild Alzheimer's disease. The study will assess the change in disease activity using the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog 14) score from baseline to week 12. The study will include participants aged 50 to 90 years with a diagnosis of probable Alzheimer's disease, and they will be randomly assigned to receive either ABBV-552 in doses A, B, or C, or a placebo for 12 weeks."
156,"GPT4 Correct Assistant: This observational study aims to evaluate cases of acute liver failure (ALF) and acute on chronic liver disease (ACLF), determine their most likely causes, complications, and assess mortality and morbidity rates in severe acute liver disease patients admitted to intensive care units. Participants aged 18-75 years with ALF, ACLF, reduced conscious state, jaundice with abnormal liver function tests, coagulopathy, and multiorgan failure are included. The study measures liver and kidney function, fluid overload, and mortality and morbidity rates in these patients."
157,"GPT4 Correct Assistant: This study aims to determine the predictive effects of impulsivity and coping skills on quality of life in patients with bipolar disorder. The study will be conducted at Adıyaman Besni State Hospital between October 2023 and February 2024. The sample size is calculated to be 54 participants. Data will be collected using the Personal Information Form, Brief Quality of Life in Bipolar Disorder Scale, Barratt Impulsivity Scale -11 Short Form, and Coping Attitudes Evaluation Scale. The study will evaluate the primary outcome, the predictive effect of impulsivity on quality of life, and the secondary outcome, the predictive effect of coping skills on quality of life in patients with bipolar disorder."
158,"GPT4 Correct Assistant: This study aims to compare the clinical performance of two different single-color universal composite resin materials, OMNICHROMA and Zenchroma, in the restoration of non-carious cervical lesions with a control group using a multi-color composite resin material, Filtek Z250, 3M. The study is a double-blind, prospective, randomized controlled trial, with participants aged 18-65 years, who have at least three teeth with cervical abrasion and no bruxism or carious formation in worn teeth. The primary outcome measures include clinical performance according to the modified USPHS criteria, and clinical performance of restorations according to the World Dental Organization criteria. The study will measure these outcomes at 6, 12, 18, 24, and 36 months."
159,"GPT4 Correct Assistant: The study aims to investigate the effect of neuromuscular reversal agents on time for neurological assessment after endotracheal intubation in critically ill patients. Participants are randomized into the sugammadex group, neostigmine group, or control group. The primary outcome measure is the time from administration of neuromuscular blocker to the first available neurologic assessment. Secondary outcome measures include time from administration of neuromuscular blocker to first available spontaneous eye opening, changes of Patient State index (PSi) values, changes of regional cerebral oxygen saturation (O3) values, time from intubation to extubation, total length of hospital stay, total length of intensive care unit (ICU) stay, in-ICU mortality, and in-hospital mortality."
160,"GPT4 Correct Assistant: This clinical trial is designed to assess the effectiveness of a behavioral weight loss intervention in promoting primary prevention and uterine preservation in premenopausal women with obesity and endometrial hyperplasia. The study involves two participant groups: one receiving a telemedicine behavioral weight loss intervention with a levonorgestrel-releasing IUD, and another receiving enhanced usual care with the same IUD. The primary outcome measure is the number of participants with atypia-free biopsy with uterine preservation at 2 years. Secondary outcome measures include time to resolution of hyperplasia, change in weight, and change in Cancer Worry Impact Events Scale (CWIES)."
161,"GPT4 Correct Assistant: This clinical trial aims to study a new method called the ""Coconut Technique"" for safe cholecystectomy in patients with stage II acute cholecystitis according to the Tokyo guidelines. The study includes participants aged 50 years or younger, both male and female. The intervention involves a laparoscopic technique to approach and ligate the cystic duct in cases of difficult acute cholecystitis. The study measures the effectiveness of this new technique in subtotal cholecystectomy and will be observed for two years."
162,"GPT4 Correct Assistant: This study aims to examine the effectiveness of the Cognitive Behavioral Therapy (CBT) protocol enriched with the contribution of virtual reality (VR) in supporting physical rehabilitation after anterior cruciate ligament (ACL) operation. The study will involve 60 athletes who meet the inclusion criteria and will be conducted in a 4X5 (groupXmeasurement) mixed factorial design model with four groups. The primary outcome measures include Re-Injury Anxiety Inventory (RIAI), Sport Injury Rehabilitation Adherence Scale (SIRAS), Athletic Injury Self-Efficacy Questionnaire (AISEQ), and Tampa Scale for Kinesiophobia."
163,"GPT4 Correct Assistant: The study aims to assess the development and implementation strategy of the Physical Therapy Frequency Clinical Decision Support Tool (PT-PENCIL) and analyze its effect on improving the proportion of patients discharged home. PT-PENCIL is an electronic clinical decision support tool that uses a statistical model to predict discharge home relative to the frequency of physical therapist treatment. The study will be conducted using a pilot hybrid type 2 design, informed by the PRISM and RE-AIM frameworks. The primary outcome measures are effectiveness of evaluation on discharge home vs facility, reach, adoption, acceptability, appropriateness, and feasibility of PT-PENCIL."
164,"GPT4 Correct Assistant: This study is a single-arm, prospective, exploratory trial to evaluate the feasibility and effect of Medical Tai Chi Exercise Healing in treating metastatic colorectal cancer (mCRC) patients. The intervention is a 7-form of Medical Tai Chi Exercise Healing, lasting 60 minutes, three times a week for eight weeks. The primary outcome measure is adherence rates, while secondary outcomes include the Brief Fatigue Inventory (BFI), the Pittsburgh Sleep Quality Index (PSQI), EORTC - Quality of Life, self-rating anxiety scale (SAS), and self-rating depression scale (SDS). The study includes patients aged 18 to 75 with adenocarcinoma of the colon or rectum, Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-2, and a life expectancy of at least 6 months. Exclusion criteria include uncontrolled medical conditions, mental illness, active alcohol or drug abuse, and other specific conditions."
165,"GPT4 Correct Assistant: The Survivorship ECHO Project is a clinical trial that aims to determine the effectiveness of the Survivorship ECHO's platform by assessing provider knowledge of cancer survivorship best practices using pre- and post-enrollment surveys. Participants, including registered nurses, advanced practice registered nurses, physician assistants, nutritionists, radiation oncologists, and oncologists, will attend 6 sessions of Survivorship ECHO educational intervention over 12 weeks. The primary outcome measures include change in level of understanding in key survivorship knowledge areas, met and unmet needs, acceptability of current structure, and barriers to accessing ECHO."
166,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of Maitland Mobilization and Post Facilitation Stretch in improving range of motion in patients with post-traumatic stiff elbow. The study includes participants aged 18-35 with a limitation of elbow joint range of motion greater than 30 degrees in extension and less than 120 degrees in flexion. The intervention period is 4 weeks, and the primary outcome measures are changes in numeric pain rating scale, range of motion (flexion, extension, supination, and pronation), and disability (measured through the DASH questionnaire)."
167,"GPT4 Correct Assistant: The clinical trial aims to investigate the effectiveness of a multidisciplinary approach for early diagnosis of heart failure in high-risk patients using an AI-enabled handheld echocardiogram device, Us2.ai. The study includes participants aged 40 and above with at least two risk factors for heart failure. The primary outcome measure is the diagnosis of heart failure within 6 months from randomization. The secondary outcome measures include the diagnosis of heart failure with reduced ejection fraction (HFrEF) and the initiation of guideline-directed medical therapy within 6 months."
168,"GPT4 Correct Assistant: The study aims to investigate the central and cerebral hemodynamic effects and volume kinetics of Ringer's acetate compared to no intravenous fluids during experimental hypovolemia in healthy human volunteers. The study includes four participant groups: no intervention with LBNP 0 and no intravenous fluid, experimental with LBNP 0 and Ringer's acetate, active comparator with LBNP 40 and no intravenous fluid, and experimental with LBNP 40 and Ringer's acetate. The primary outcome measures are the half-life of change in cardiac stroke volume and intravascular volume, while the secondary outcome measures are the half-life of change in middle cerebral artery blood flow velocity."
169,"GPT4 Correct Assistant: The study, titled ""Guided Internet-delivered Treatment for Moderate Depression, Social Anxiety Disorder and Panic Disorder - An Open Naturalistic Multicentre Cost-effectiveness Trial,"" aims to assess the effectiveness and cost-effectiveness of the eMeistring program, a therapist-guided internet-based cognitive therapy, for patients with moderate depression, social anxiety disorder, and panic disorder. The study involves four hospitals and includes patients aged 18 and above, with access to computers and the internet. The eMeistring program consists of eight to nine sessions or modules of therapist-guided internet-based cognitive behavioral therapy, with a final face-to-face visit. Outcome measures include depression severity, social phobia, panic disorder symptoms, health-related quality of life, work and social adjustment, anxiety severity, system usability, medication use, work participation, and sickness absenteeism."
170,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of Thoracolumbar Interfascial Plane (TLIP) Block and Erector Spinae Plane (ESP) Block for perioperative analgesia in patients undergoing lumbar spine fusion surgery. The study includes three groups: TLIP Group, ESP Group, and Control Group. The TLIP Group and ESP Group receive their respective blocks under ultrasound guidance before general anesthesia, while the Control Group receives general anesthesia with lidocaine injection for incision anesthesia. The primary outcomes measured are the blockade area, perioperative effectiveness of the blocks during surgery, and pain relief effectiveness after surgery. The study also assesses side effects such as vomiting, nausea, itchiness, urinary retention, respiratory failure, and circulatory failure."
171,"GPT4 Correct Assistant: The study aims to evaluate the wearable Melanin-Adjusted Blood Oxygen Sensor (MABOS) for improved accuracy in patients of color. It includes 12 participants with different skin tones, and the primary outcomes are device safety and comfort. The study measures epidermal melanin estimation and blood oxygen level estimation using MABOS and compares them to an FDA-approved pulse oximeter. The results will help determine the device's accuracy and effectiveness in various skin tones."
172,"GPT4 Correct Assistant: This study aims to evaluate the safety, feasibility, and efficacy of FP-1201 (intravenous interferon-beta-1a) in preventing toxicities after CD19-directed CAR T-cell therapy for patients with recurrent B-cell malignancies. The trial is a dose-escalation study, and participants will undergo various procedures including x-ray imaging, echocardiography, computed tomography, and lumbar puncture. The primary outcome measures are dose-limiting toxicity rates and incidence of adverse events. Secondary outcome measures include cytokine release syndrome rates, immune effector cell-associated neurotoxicity syndrome rates, cumulative corticosteroids dose, and overall response rate."
173,"GPT4 Correct Assistant: This is a randomized, open-label, multicenter phase III study evaluating the efficacy of Camrelizumab Plus Chemotherapy with or without Famitinib as neoadjuvant therapy in participants with Triple Negative Breast Cancer (TNBC). The study aims to measure the pathological complete response (pCR) rate, event-free survival (EFS), disease-free survival (DFS), distant disease-free survival (DDFS), and objective response rate (ORR) in accordance with RECIST v1.1. Participants must be aged between 18 and 70 years, and have early or locally advanced TNBC. The study is divided into two arms: Arm A, receiving Camrelizumab Plus Chemotherapy and Famitinib, and Arm B, receiving Camrelizumab Plus Chemotherapy. The primary outcome measure is the pCR rate, assessed up to approximately 24 weeks. Secondary outcome measures include EFS, DFS, DDFS, and ORR, assessed at least 2 years after surgery."
174,"GPT4 Correct Assistant: The study aims to predict postpartum glucose metabolism abnormalities in Gestational Diabetes Mellitus (GDM) based on gestational metabolic profile and lipid profile. It includes participants who were diagnosed with GDM between 24-28 gestational weeks, with a minimum age of 20 and maximum age of 49 years. The intervention involves a questionnaire survey and specimen collection at 24-28 gestational weeks, and during delivery. The study measures serum lipidomics and serum metabolomics as primary outcome measures to identify markers related to postpartum glucose metabolism abnormalities in GDM."
175,"GPT4 Correct Assistant: This clinical trial, titled ""Assessment of Sleep Quality of Hospitalized Patients Treated With EEG-guided Protection Procedures: Application in Intensive Care Unit (SleepScan), aims to assess the sleep quality of critically ill patients in the intensive care unit (ICU) using EEG-guided sleep protection. The study is a non-randomized trial with two arms: control condition (usual care) and experimental condition (EEG-guided sleep protection). The primary outcome measure is the proportion of continuous sleep on day 1. Secondary outcome measures include sleep fragmentation, environmental noise and light, sleep interruptions by caregivers, sleep quality, workload assessed by nurses, patient agitation, performance of the algorithm, patient-reported sleep quality, anxiety level, respiratory status, presence of delirium, unit care length of stay, and safety of the procedure."
176,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy and safety of SAR441566 in adults with rheumatoid arthritis. The study is a Phase 2, randomized, double-blind, placebo-controlled, dose-ranging trial, with a duration of approximately 149 days. Participants will receive either SAR441566 in one of four dose regimens or a placebo, all taken in combination with methotrexate. The primary outcome measure is the proportion of participants achieving at least a 20% improvement in the American College of Rheumatology (ACR) score at week 12. Secondary outcome measures include change from baseline in Disease activity score - C-reactive protein (DAS-28 CRP) at week 12, proportion of participants achieving at least a 50% improvement in the ACR score at week 12, and the incidence of treatment-emergent adverse events (TEAEs), serious AEs (SAEs), and AEs of special interest (AESIs)."
177,"GPT4 Correct Assistant: The clinical trial is a prospective evaluation of the diagnostic medical device MaGIA IBC for the combined screening of HIV, Hepatitis B, and Hepatitis C. The study includes participants aged 18 years and older, with or without the conditions of interest. The intervention involves using the MaGIA IBC test in capillary blood and other matrices. The primary outcome measures are the performance measurement for diagnostics, sensitivity, and specificity. The secondary outcome measures include the concordance of diagnostic results in different matrices and the number of participants with study-related adverse events."
178,"GPT4 Correct Assistant: The study aims to assess the effects of Endocalyx Pro, a food supplement, on patients with chronic heart failure. The primary objective is to determine if Endocalyx reduces sodium and water excess in these patients. Secondary objectives include evaluating the supplement's impact on physical limitations, patient-reported outcomes, and working mechanisms in heart failure patients. The study is a randomized, double-blind, placebo-controlled trial, with participants receiving either Endocalyx or a placebo for eight weeks. The primary outcome measure is the change in NT-proBNP from baseline to week 8 in Endocalyx-treated patients compared to those receiving the placebo."
179,"GPT4 Correct Assistant: The study aims to evaluate the efficacy of different treatments for adhesive small bowel obstruction (aSBO), specifically the use of nasogastric tubes (NGT) with water-soluble contrast (WSC) or saline. Participants must be 18 years or older and have aSBO, as confirmed by clinical features and CT evidence. The study will have three groups: one treated without NGT, and two groups with NGT, randomized into treatment with WSC or saline. The primary outcome measure is the Patient-Reported Outcomes Measurement Information System (PROMIS®)-29, which assesses quality of life. The study will follow participants for 30 days after surgery."
180,"GPT4 Correct Assistant: This clinical trial aims to test a novel combination therapeutic strategy for functional cure of chronic hepatitis B virus infection, targeting sustained HBsAg loss. The study includes two participant groups: Group 1 receives a combination of anti-PD-1 antibody, NAs, and Peg-IFNα, while Group 2 receives a combination of NAs and Peg-IFNα. The primary outcome measures include serum HBsAg and serum HBV DNA levels at various time points. The trial is designed as a randomized, open-label study."
181,"GPT4 Correct Assistant: This clinical trial, titled ""Wound Healing Comparison of Simple and Continuous Suture Techniques in Oral Surgery,"" aims to compare the effectiveness of simple and continuous suture techniques in wound healing after oral surgery. The study includes participants aged between 40 and 65 years, with a focus on full arch alveoplasty. The primary outcome measures are the Laundry Healing Index and Early Wound Healing Score at days 1, 3, and 7, suturing time, knot looseness, pain at suture removal, and suture removal difficulty. The study is designed as a randomized, parallel assignment, single-masked trial with two experimental arms: the simple suture group and the continuous suture group."
182,"GPT4 Correct Assistant: The study aims to explore the feasibility and utility of using an in-home body weight support harness system in children with Spinal Muscular Atrophy Type I and Type II. The intervention is a portable, adjustable body weight support harness system that allows 360-degree mobility within a 9x9-foot space in the home. The study will measure the impact of the system on motor and non-motor skills, the child's perceived enjoyment, ease of equipment use, and the perceived benefit of the system through caregiver surveys. The study will also assess changes in motor function using various scales and checklists at baseline, 3 months, and 6 months."
183,"GPT4 Correct Assistant: This clinical trial investigates the use of Descemet Membrane Endothelial Keratoplasty (DMEK) in patients with a history of anterior or posterior segment surgery. The study aims to measure the occurrence rate of at least one serious DMEK post-operative complication at 12 months, as well as other outcomes such as graft rejection, macular cystoid edema, intraocular hypertension, graft detachment, surgeon's subjective assessment of surgical complexity, duration of surgical procedure, evolution of visual and refractive results, and endothelial loss. The trial includes patients aged 18 and older, with a history of vitrectomy, trabeculectomy, large iris defects, anterior synechiae, pseudophakia or aphakia, and who are not contraindicated for the procedure."
184,"GPT4 Correct Assistant: This clinical trial aims to analyze the mechanism of efficacy of oral antibiotic prophylaxis in elective colon and rectal surgery with primary anastomosis. The trial focuses on the conditions anastomotic leak and microbial colonization. Participants receive either oral antibiotic prophylaxis (Neomycin Sulfate) or no oral antibiotic prophylaxis. The primary outcome measure is the correlation between septic complications and the microbiome within 30 days post-surgery. The secondary outcome measures include factors affecting the microbiome, such as comorbidities, previous operations, oral antibiotic prophylaxis, and systemic intravenous prophylaxis."
185,"GPT4 Correct Assistant: This clinical trial aims to assess the utility of measurements made at the point of the maximal stenosis of the median nerve in the carpal tunnel to diagnose Carpal Tunnel Syndrome (CTS). Patients with CTS and healthy controls will undergo nerve conduction studies and ultrasound of the symptomatic median nerve with various measurements taken, including at the point of maximal stenosis. The primary outcome measures are the differences in the diameter, cross-sectional area, and echogenicity of the median nerve at the site of maximal compression between patients with CTS and healthy controls. Secondary outcome measures include correlations between these measurements and clinical severity scores (Boston Carpal Tunnel Questionnaire) and electrophysiological severity grades."
186,"GPT4 Correct Assistant: This clinical trial aims to study the safety and symptom burden optimization of Tocilizumab in patients with multiple myeloma undergoing autologous stem cell transplantation (ASCT) following high-dose Melphalan conditioning. The trial is a randomized, parallel assignment, open-label study with two arms: experimental (Tocilizumab) and no intervention (no-Tocilizumab). The primary outcome measures are the MDASI questionnaire and adverse events recorded according to CTCAE5.0. The trial includes patients aged 18 to 70 with multiple myeloma eligible for ASCT, and excludes patients with severe organ dysfunction, active infection, and certain other conditions."
187,"GPT4 Correct Assistant: This clinical trial compares the effectiveness of Testicular Sperm Aspiration (TESA) and Microfluidic Sperm Separation (MSS) in couples with high sperm DNA fragmentation undergoing Intracytoplasmic Sperm Injection (ICSI). The primary outcome measure is the clinical pregnancy rate, and the secondary outcome measure is the number of utilizable blastocysts obtained. The study includes male participants aged 18 years or older with high DNA fragmentation (>20%)."
188,"GPT4 Correct Assistant: This study aims to investigate the effect of stabilization and stabilization-related parameters on shooting performance at the cervical, lumbar, and scapular levels in archery athletes. A total of 40 archery athletes aged between 10 and 18, who have been professionally engaged in archery for at least 1 year, were included in the study. Performance of the athletes was evaluated through various tests such as Upper Extremity Closed Kinetic Chain Stability Test, Hand Grip Strength test, Lateral Scapular Slide Test, Craniocervical Flexion Test, Scapular Muscle Endurance Test, Abdominal Drawing-in Test, and Sahrmann's Core Stability Test. The primary outcome measures include cervical stabilization, lumbar stabilization grade, lumbar stabilizer muscle contraction, scapular dyskinesis type, scapular dyskinesis amount, and sportive performance. Secondary outcome measures include balance assessment, static balance assessment, posture, disability, upper extremity performance, hand grip strength, and muscle tightness."
189,"GPT4 Correct Assistant: This clinical trial aims to improve communication between pediatricians, adolescents, and their mothers regarding contraception. The study involves three stages: Stage 1 involves characterizing communication content and styles through real-life clinical encounters and surveys, Stage 2 develops and refines an AI communication training tool through prompt engineering and performance evaluation, and Stage 3 tests the tool's acceptability and feasibility on 10 pediatrician learners. The primary outcome measures are questionnaires assessing communication interactions before and after training, while secondary outcome measures include acceptability and feasibility questionnaires."
190,"GPT4 Correct Assistant: This study aims to investigate healthcare disparities in Vitiligo among different sociodemographic groups, including age, sex, ethnicity, and deprivation. The study will estimate the cumulative lifetime risk of Vitiligo and perform a subgroup analysis to identify disparities in mental health conditions, healthcare utilisation, and work impact. The study will use survival models and Cox proportional hazards models for the analysis."
191,"GPT4 Correct Assistant: The study aims to investigate the effects of behavior modification by hybrid in caregivers of children with developmental delay. Caregivers are randomly assigned to Hybrid group or Self-learning group, both receiving 8-weeks training. The Hybrid group uses Atomic Habits, a role structure, a game structure, online schedule reminders, and individual counseling sessions. The Self-learning group is designed to provide a description of the goals of the course and a reading of the Atomic Habits book. Outcome measures include Intervention Fidelity, Parenting Sense of Confidence, Parenting Stress Index: Short form, The Conflict Tactics Scales: Parent Version, habit schedule record, and satisfaction questionnaire."
192,"GPT4 Correct Assistant: This clinical trial aims to study the safety and efficacy of trotabresib in combination with vinorelbine and radiation therapy in patients with HER2-positive breast cancer with central nervous system (CNS) metastases or leptomeningeal disease. The primary objective is to determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of trotabresib in combination with vinorelbine in patients with HER2-positive breast cancer. Secondary objectives include assessing progression-free survival (PFS), overall survival (OS), and objective response rate (ORR) in patients with HER2-positive breast cancer with CNS metastases or leptomeningeal disease."
193,"GPT4 Correct Assistant: This clinical trial aims to modify and adapt a validated digital health tool for binge eating and weight management for Black women with obesity. The study will examine the feasibility and preliminary efficacy of the digital health appetite awareness + behavioral weight program in primary care. Participants will be randomized into either the Centering Appetite Intervention or the Attention-Control Group. The primary outcome measures include feasibility, retention, and attendance, while the secondary outcome measures focus on changes in weight regain and binge eating episodes."
194,"GPT4 Correct Assistant: The study aims to investigate the effect of beetroot juice supplementation dose on neuromuscular performance during resistance exercise. Participants will be assigned to consume different doses of beetroot juice or a nitrate-depleted placebo. The primary outcomes are plasma nitrate and nitrite concentrations, and various neuromuscular performance measures during countermovement jumps. The study seeks to provide insights for practitioners and scientists regarding the potential use of beetroot juice as a dietary nitrate supplement to improve muscle contractile function."
195,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of two different intra-abdominal pressure levels, 12 mmHg and 14 mmHg, on mechanical power in patients undergoing laparoscopic cholecystectomy under general anesthesia. The study will measure mechanical power values during the operation and explore the relationship between these values and ventilator-induced lung injury. The trial includes adult patients with ASA 1-2, excluding those with lung disease, morbid obesity, or unstable medical conditions. The primary outcome measure is ventilator-induced lung injury (barotrauma) measured through mechanical power values recorded during the operation."
196,"GPT4 Correct Assistant: The clinical trial titled ""Evaluation of Magnetic Resonance Imaging as Alternative to Cone Beam Computed Tomography for the Assessment of Furcation Involvement in Molars"" aims to assess the effectiveness of using Magnetic Resonance Imaging (MRI) as an alternative to Cone Beam Computed Tomography (CBCT) in evaluating furcation involvement in molars. The study includes participants with furcation involvement grades II or III, aged 18 to 120 years, of any sex, and who do not have contraindications for MRI. The primary outcome measure is the horizontal furcation defects according to Hamp 1975, while the secondary outcome measures are horizontal and vertical bone loss, all measured on day 1."
197,"GPT4 Correct Assistant: This study aims to compare the plaque removal efficacy of electric toothbrushes and manual toothbrushes in children with Attention Deficit Hyperactivity Disorder (ADHD) and healthy children. The study includes 52 children, 26 of whom have ADHD and 26 of whom are healthy. They are divided into four subgroups based on the types of toothbrushes (electric and manual). The primary outcomes measured are the Gingival Index values, while the secondary outcomes are the DMFT and dft indices, and a questionnaire on nutrition, diet, tooth brushing habits, and sociodemographic factors."
198,"GPT4 Correct Assistant: This clinical trial investigates the feasibility and stability of left bundle branch area pacing (LBBAP) for ventricular pacing in symptomatic bradycardia patients with a conventional bipolar, active fixation pacing lead. The study is a prospective, single-arm, open-label, non-randomized, multi-center study with an approximate sample size of 150 patients. The primary outcome measure is the overall success rate of the implanted system at 12 months post-implant. Secondary outcome measures include intra-operative fluoroscopic exposure time, intra-operative intracardiac electrogram, post-operative imaging data, serial paced 12-lead electrocardiogram and intracardiac EGM changes, serial echocardiography changes, and serial changes of pacing parameters."
199,"GPT4 Correct Assistant: The PRE-IOP clinical trial is a randomized study comparing the effects of four different toothbrushes on reducing gingival inflammation in pregnant women aged 18 to 40. The toothbrushes include two sonic electric toothbrushes (Sonicare DiamondClean 9000 Philips® and HydroSonic Easy Curaden®) and two manual toothbrushes (Oral-B 123 and Curaprox CS 5460). The study measures the incidence of gingival bleeding from baseline during pregnancy and assesses the effects on gingival bleeding, inflammation, dental plaque, attachment loss, periodontal pocket, and customer satisfaction score."
200,"GPT4 Correct Assistant: The clinical trial investigates the effect of yoga-based breathing styles on memory performance in adult participants without prior experience in yoga or similar disciplines and without existing health problems. Participants complete a memory test and undergo a two-week training period with daily nasal or mouth breathing training or no training at all. The study aims to determine if nasal breathing results in a significant improvement of memory capacity and a reduction of subjective stress levels. The study is designed as a randomized, parallel assignment trial with three arms: nose-breathing, mouth-breathing, and control. The primary outcome measure is the improvement of learned images, while the secondary outcome measure is the reduction of subjective stress levels."
201,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of calisthenics exercise and pulsed electromagnetic therapy on liver function following burn injuries. The study includes three groups: a calisthenics exercise group, a pulsed electromagnetic therapy group, and a group receiving both treatments. Participants must be aged between 20 and 45 and have burns covering 30% to 50% of their body surface area. The primary outcome measure is the concentration of Alanine transaminase (ALT) and Aspartate transaminase (AST) enzymes in blood plasma, measured before and after three months of treatment."
202,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of a nutritional intervention on the bioavailability and immune-activity of PD-1 immune checkpoint inhibitors in patients with non-small cell lung cancer (NSCLC). The trial is designed to assess the variability of clearance during a 12-week nutritional intervention period and the feasibility for subjects to comply with the study protocol. Participants will receive a nutritional intervention consisting of high energy/high protein nutritional supplements, enriched with nutrients known for their immune- or microbiome-modulation properties, prior to the start of anti-PD-1 ICI immunotherapy and continue for 12 weeks. The primary outcome measure is the variability of clearance of pembrolizumab during the intervention period. Secondary outcomes include the feasibility of recruiting patients and the subjects' compliance with the study protocol."
203,"GPT4 Correct Assistant: This study aims to investigate the role of integrins and protocadherins in glutamatergic circuits and identify common signaling pathways and molecular targets in anxiety and major depressive disorders. The study is divided into two parts: the first part involves recruiting patients with anxiety-depressive disorder and healthy controls, evaluating their depressive/manic dysintomatology through clinical scales and psychopathological tests, and performing a 7T MRI neuroimaging session. The second part involves using murine models to study glutamatergic signaling, the interaction between integrin β3 and protocadherin9, and the functional recovery of behavioral and electrophysiological deficits mediated by CRISPRa."
204,"GPT4 Correct Assistant: This study aims to investigate the association between cardiovascular and nervous system diseases and the intestinal microbiome using multi-omics big data. The study includes patients with idiopathic ventricular tachycardia, post-coronary artery stenosis injury, Moyamoya disease, carotid atherosclerosis, and healthy controls. Fecal and blood samples are collected from the participants, and genome, transcriptome, metagenomic, and metabolic sequencing are performed. The study aims to identify potential biomarkers and genes associated with these diseases, which can improve disease diagnosis, treatment, and prevention."
205,"GPT4 Correct Assistant: The study aims to evaluate the prognostic value of a combined approach based on KEAP1/NFE2L2 mutations and pre-therapeutic FDG-PET/CT radiomic analysis in advanced non-small-cell lung cancer (NSCLC) patients with PD-L1 ≥ 50% treated with pembrolizumab. The primary outcome measure is progression-free survival (PFS), while the secondary outcome measure is overall survival (OS). The study will include patients with unresectable stage III and stage IV NSCLC, who have not received prior systemic treatment for NSCLC."
206,"GPT4 Correct Assistant: The SMART trial is a phase II study evaluating the efficacy and safety of sacituzumab govitecan with or without atezolizumab in patients with advanced rare genitourinary tumors, including small cell carcinoma, adenocarcinoma, squamous cell carcinoma, renal medullary carcinoma, and penile cancer. The primary objective is to determine the objective response rate (ORR) of sacituzumab govitecan as a single agent or in combination with atezolizumab. Secondary objectives include assessing the duration of response (DoR), overall survival (OS), progression-free survival (PFS), clinical benefit rate (CBR), and safety of the treatment regimens."
207,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of proprioceptive neuromuscular facilitation (PNF) with eccentric exercises and electrical stimulation on the weight bearing lunge, lateral step down, and drop jump tests in professional paddle tennis players. The study includes participants aged 18-50, and the primary outcome measures are vertical jump and range of flexion in ankle dorsiflexion."
208,"GPT4 Correct Assistant: The Influence of Nutrition in Depression Treatment (INDEPT) study is a randomized open controlled trial investigating the effectiveness of dietary counselling promoting adherence to the Mediterranean Diet (MedDiet) as an adjuvant treatment for Major Depressive Disorder (MDD) in adults with elevated inflammation biomarkers. The study aims to assess the association between adherence to MedDiet and changes in inflammatory biomarkers, the association between changes in inflammatory biomarkers and MDD symptoms, the association between adherence to MedDiet and the effectiveness of psychiatric treatment of MDD, and the economic cost-effectiveness of dietary counselling as an adjuvant treatment in MDD. The study will follow a 12-week multicentre randomized parallel-group design, with a follow-up assessment at 6- and 12-months after baseline data collection. Participants will be randomly assigned to either the intervention group (six nutrition consultations with a registered nutritionist promoting adherence to MedDiet and MDD treatment as usual) or the control group (MDD treatment as usual). The primary outcome measure is changes in symptoms of MDD, assessed using the self-administered Beck Depression Inventory-II (BDI-II) scale."
209,"GPT4 Correct Assistant: This study aims to support refugee parenting and improve family mental health in Tijuana, Mexico through a community-based participatory approach. The study will involve 120 parents, divided into 8 groups, who will participate in a culturally adapted parenting curriculum, either as an intervention or a control group. The primary outcomes measured are parenting knowledge and child behavior and parental efficacy. Secondary outcomes include observed parent-child interactions, parental stress, and qualitative feedback. The study will analyze the data anonymously and share the results with the community after each phase."
210,"GPT4 Correct Assistant: The study aims to improve healthcare experiences for people with incurable head and neck cancer (HNC) and their families by conducting longitudinal interviews with patients and family carers, and online focus groups with healthcare professionals. The findings from these interviews and focus groups will be used in co-design workshops to identify priority areas for intervention development."
211,"GPT4 Correct Assistant: This clinical trial aims to investigate the use of Indocyanine Green (ICG) fluorescence imaging to assist in the identification of nerve roots during endoscopic spinal surgery. The study will compare the effectiveness of different doses of ICG (0.5mg/kg, 1mg/kg, and 2mg/kg) in improving the fluorescence imaging rate of nerve roots, the fluorescence signal ratio of nerve root to back fluorescence, and reducing the time taken to find the nerve root endoscopically. The trial will also assess ICG-related adverse reactions, pain levels using the Visual Analogue Scale (VAS), and the Oswestry Disability Index (ODI) to evaluate functional impairment. The study will enroll patients aged 20-60 with lumbar disc herniation, who will undergo endoscopic spinal surgery for nerve root decompression."
212,"GPT4 Correct Assistant: This clinical trial evaluates a home-based parenting support program for parents with intellectual and developmental disabilities who are at risk for neglect. The program, called Parenting Young Children, provides 3-6 months of structured coaching sessions with two core modules: Parent-Child Interaction and Child Care Skills and Safety. The study compares this intervention to Treatment as Usual, which consists of a variety of interventions provided by social services. The primary outcome measures are changes in the Canadian Occupational Performance Measure, performance sub-scale and satisfaction sub-scale. Secondary outcome measures include changes in Parental Sense of Competence Scale and Strengths and Difficulties Questionnaire."
213,"GPT4 Correct Assistant: This study aims to evaluate the effectiveness of artificial urinary sphincters and male slings for the treatment of male stress urinary incontinence. Participants undergo surgery using these medical devices, and their outcomes are assessed using various questionnaires and measurements. The primary outcome measure is the success rate (cure plus improvement) at 5 years after surgery. Secondary outcome measures include time being continent, time being revision-free, revision-free rate, patient-reported quality of life, and post-operative adverse events."
214,"GPT4 Correct Assistant: This clinical trial study aims to evaluate 68Ga-NOTA-H006 PET imaging in patients with pancreatic, lung, and bowel cancer. The intervention involves injecting 68Ga-NOTA-H006 intravenously with a dose of 1.8 MBq[0.05MCi]/kg. The study measures the establishment and optimization of imaging method for 68Ga-NOTA-H006 PET by analyzing the standardized uptake value (SUV) of 68Ga-NOTA-H006 on the lesions and comparing the SUV with 5T4 expression in pathological specimens. The study is designed as a single group assignment, open-label study with a primary purpose of diagnosis."
215,"GPT4 Correct Assistant: This clinical trial aims to investigate the biological mechanisms behind resynchronization therapy in heart failure patients. It includes two participant groups: those who receive a cardiac resynchronization therapy (CRT) and those who are treated with medicines without a CRT indication (control group). Blood samples, heart tissue, and clinical data will be collected from both groups at various time points. The study will analyze proteins, exosomal miRNA, and endothelial function to determine biomarkers that can separate CRT responders from non-responders."
216,"GPT4 Correct Assistant: The study aims to provide evidence for medication strategy in heart failure patients, particularly for those who are intolerable to GDMT. It is a randomized controlled trial that compares GDMT to no GDMT in heart failure patients with reduced ejection fraction. The primary outcome measure is all-cause mortality or worsening heart failure in 180 days. Secondary outcome measures include change in symptoms and signs of heart failure, change in NT-proBNP level, change in LVEF, change in LVEDD, change in LVESD, change in LVFS, and change in blood pressure and potassium."
217,"GPT4 Correct Assistant: The study, titled ""Behavioral Economic Strategies to Improve PRO Adherence,"" aims to improve patient-reported outcome (PRO) adherence among cancer patients using behavioral economic strategies. It will be a randomized, three-arm trial comparing usual practice, encounter-based PRO monitoring with patient reminders and triage nurse alerts, and remote PRO monitoring with patient reminders and triage nurse alerts. The primary outcome measure is PRO adherence, measured as the proportion of expected PRO questionnaires completed per patient. The study will also assess secondary outcomes such as percent of patients with at least one note documenting PROs during the study period, time to alert response, percent of patients who trigger an alert for triage nurses, acute care utilization, treatment delays/modifications, and duration of therapy."
218,"GPT4 Correct Assistant: The Prognostic Understanding in ESC (ProgESC Study) is a cross-sectional prospective study aiming to understand the prognostic awareness of patients referred to the Enhanced Supportive Care (ESC) service at University College London Hospital. The primary endpoint is the level of patients' prognostic awareness, assessed by the Prognosis and Treatment Perception Questionnaire. Secondary endpoints include patients' preferences for receiving prognostic information, symptoms of depression and anxiety, quality of life, trust in medical professionals, and perceived quality of care. The study will include 100 patients aged 18 and older with advanced cancer referred to the ESC team, excluding those with cognitive impairment or already referred to community palliative care services."
219,"GPT4 Correct Assistant: This is a pragmatic, randomized controlled clinical trial investigating the effect of direct-from-blood bacterial testing on antibiotic administration and clinical outcomes in patients with bloodstream infections, sepsis, and bacteremia. Patients are randomized to receive either usual care (blood cultures) or usual care plus direct-from-blood testing using the T2Bacteria® Panel. The primary outcome measure is time to last dose of intravenous vancomycin, and the secondary outcome measure is time to last dose of systemic anti-pseudomonal beta-lactam antibiotic."
220,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effect of temperature-elevating armbaths on participants with arterial hypertension. The study is a randomized-controlled trial, with 50 participants randomized into either an intervention group or a waitlist group. The intervention group performs the armbaths on 5 of 7 days per week for 8 weeks. The primary outcome measure is blood pressure, measured at 8 weeks. Secondary outcome measures include health-related quality of life, sleep quality, heart rate, adverse events, and medication changes at 8 weeks and 6 months."
221,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of acupuncture on perceived stress and health in military service members and veterans. The study will use a parallel assignment design with a randomized allocation. Participants will be assigned to either an experimental group receiving both manual standardized stress acupuncture (MSSA) and mindfulness-based stress reduction (MBSR) or an active comparator group receiving only MBSR. The primary outcome measure is the Perceived Stress Scale (PSS), measured at baseline, two weeks post-intervention, and four weeks post-intervention. Secondary outcome measures include the Insomnia Severity Index, the Short Form (SF) Health Survey, and journal log entries."
222,"GPT4 Correct Assistant: This clinical trial aims to determine the prevalence of persistent COVID-19 in Punta Arenas, Magallanes, and the Chilean Antarctic Region. The study will include adults aged 18-100 years with at least one positive SARS-CoV-2 RT-qPCR test between July 2022 and July 2023. The primary outcome measure is the prevalence of persistent COVID-19 in the cohort, with a 13-month time frame. Secondary outcome measures include sociodemographic data, psychological profiles, sleep quality and disorders, psychosocial exposures, standard laboratory parameters, inflammatory biomarkers, immunological repertoire, flow cytometry immunophenotyping, and function of the musculoskeletal system."
223,"GPT4 Correct Assistant: This clinical trial is a multicenter randomized controlled trial comparing two methods of managing post-dural puncture headache (PDPH) in obstetric patients: resiting epidural catheter and intrathecal catheter placement. The primary outcome measure is PDPH incidence at 24 hours from the dural puncture. Secondary outcomes include PDPH intensity at 24 and 48 hours, quality of analgesia during labor, adverse events, chronic pain at 1 and 3 months, readmission to hospital, and patient satisfaction."
224,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of sectional matrix and circumferential matrix for reconstruction of proximal contact in Class 2 restorations. The study includes patients with good general health, aged between 18 and 60 years, with tooth decay and fully erupted occluding premolar and molar teeth. The primary outcome measure is the tightness of proximal contact immediately after the procedure, assessed using dental floss."
225,"GPT4 Correct Assistant: This clinical trial aims to evaluate the Santa Clara County Mental Health Service Pay for Performance Quality Improvement Initiative for high-utilizers of mental health services. The study compares the effectiveness and cost of a pay-for-performance (PFP) program versus usual care (UC) for individuals with a history of extensive utilization of 24-hour psychiatric services. The primary outcome measures are the total costs of 24-hour psychiatric services at 12, 24, and 36 months post-enrollment. Secondary outcome measures include total costs of specific psychiatric care services (e.g., Barbara Arons Pavilion Acute Inpatient Psychiatric Care, Emergency Psychiatric Services, etc.) at 12, 24, and 36 months post-enrollment."
226,"GPT4 Correct Assistant: This clinical trial aims to determine the clinical efficacy and cost-effectiveness of Culturally adapted Cognitive Behavioral Therapy (CaCBT) and Culturally adapted Family Intervention (CulFI) compared to Treatment as Usual (TAU) in reducing overall symptoms of psychosis in individuals with First Episode Psychosis (FEP) in Pakistan. The study will include 390 participants from psychiatric units of hospitals in ten centers across the country. Participants will be randomized into three groups: CaCBT + TAU, CulFI + TAU, or TAU alone. CaCBT and CulFI sessions will be conducted over 12 and 10 weeks, respectively, with each session lasting approximately 1 hour. The primary outcome measure is the Positive and Negative Syndrome Scale (PANSS), which will be assessed at baseline, months 3, 6, and 12. Secondary outcome measures include the Calgary Depression Scale for Schizophrenia, EuroQol-5 Dimensions, World Health Organization Disability Assessment Scale, Schedule for Assessment of Insight, Experience of Caregiving Inventory, Carer Well-Being and Support, Illness Perception Questionnaire, Generalized Anxiety Disorder, Patient Health Questionnaire (PHQ-9), Cognitive Behaviour Therapy Rating Scale, Cognitive Therapy for Psychosis Adherence Scale, The Psychosocial Treatment Compliance Scale (PTCS), Treatment Adherence Rating Scale, and Session Attendance Log."
227,"GPT4 Correct Assistant: The study is a phase 1/2 multi-center trial evaluating the safety and efficacy of IMPT-314, a CD19/20 bispecific chimeric antigen receptor (CAR) T cell therapy in participants with relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). The primary outcomes measured are incidence of dose-limiting toxicities (DLTs), investigator-assessed complete response rate, and the proportion of enrolled participants who receive the target dose. Secondary outcomes include overall response rate, duration of response, and overall survival. The study consists of two cohorts: CAR T experienced and CAR T naïve cohorts, each with three dose levels in the phase I part and one dose level in the phase II part."
228,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of Metabolic Syndrome (MetS) on cognitive performance and physical activity in middle-aged individuals. Participants are divided into two groups: the MetS group, consisting of diagnosed MetS individuals, and the control group, consisting of healthy individuals. The study measures various aspects of MetS, cognitive performance, and physical activity levels. The primary outcome measures include waist circumference, blood pressure, triglyceride, HDL-C, fasting plasma levels, MetS severity score, Montreal Cognitive Assessment, Stroop Test TBAG Form, Mini Mental State Examination, Visual Reaction Test, International Physical Activity Questionnaire Short-Form, and pedometer. The study aims to provide insight into the impact of MetS on cognitive performance and physical activity in middle-aged individuals."
229,"GPT4 Correct Assistant: This clinical trial aims to test the effectiveness of two brief digital interventions in increasing COVID-19 vaccination among individuals with anxiety or depression. The interventions include attitudinal inoculation, cognitive-behavioral therapy-informed intervention, and conventional public health messaging. Participants will be randomly assigned to one of the three intervention arms, and the primary outcome measure is self-reported receipt of a COVID vaccine dose at 4 weeks post-intervention."
230,"GPT4 Correct Assistant: This study aims to examine the effects of binaural beat music on sleep quality, heart rate variability, and depression in older people with poor sleep quality in a long-term care institution. The experimental group listens to binaural beat music for 12 sessions, while the control group listens to familiar music without binaural beats. The primary outcome measures include the Pittsburgh Sleep Quality Index (PSQI) and heart rate variability (HRV), while the secondary outcome measure is the Geriatric Depression Scale (GDS). The study is a randomized controlled trial with a parallel assignment design."
231,"GPT4 Correct Assistant: This study aims to evaluate the implementation of a Personalised Follow-up Pathway for head and neck cancer patients. The study will explore the acceptability of the pathway for both patients and service providers, as well as its safety and sustainability. The primary outcome measures include acceptability of the pathway for patients and service providers, and safety of the pathway within head and neck cancer. Secondary outcome measures include patient and service provider experience within the pathway, and the sustainability of the pathway. The study will involve semi-structured interviews, cross-sectional patient surveys, and qualitative interviews with a Patient and Public Involvement (PPI) group."
232,"GPT4 Correct Assistant: This is a randomized clinical trial comparing the effects of intrathecal bupivacaine-dexmedetomidine, intrathecal bupivacaine-neostigmine, and bupivacaine alone in elective Caesarean sections. The study includes ASA physical status I and II patients aged 18-40 years, with exclusion criteria including cardiac diseases, severe hypertension, coagulopathy, and inability to communicate. The primary outcome measure is the time from the end of intrathecal injection to the achievement of a bilateral sensory block at T10."
233,"GPT4 Correct Assistant: This is a randomized clinical study evaluating the performance of an air-polishing device with erythritol in preventing white spot lesions (WSLs) and gingivitis among patients undergoing multi-bracketed fixed orthodontic treatment. The study involves 60 participants aged between 12 and 16 years, and lasts for 3 years. The participants are randomly assigned to either the air-polishing device group or the conventional ultrasonic device group. The primary outcomes measured are the appearance of WSLs and inflammatory lesions during orthodontic treatment. Secondary outcomes include changes in clinical parameters, patient acceptance, tooth sensitivity, total bacterial counts, counts of periodontal pathogens, inflammatory markers in gingival crevicular fluid, and total treatment time."
234,"GPT4 Correct Assistant: The Atrial Fibrillation Driver Study is a pilot project aiming to obtain and analyze tissue from patients undergoing cardiothoracic surgery. The study will include up to 10 patients, with the aim of assessing the feasibility of the analysis and obtaining samples with different degrees of fibrosis. The primary outcome measures are histological analysis and molecular analysis, with a one-year time frame."
235,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of integrated and isolated resisted exercise on strength, power, and endurance in gym beginners. The study involves two groups: one undergoing integrated resisted training (INT) and the other undergoing isolated resisted training (ISO). The primary outcome measures are endurance (measured by sit-up test), power (measured by vertical jump test), and strength (measured by 1RM maximum). The study duration is 8 weeks, with participants undergoing exercises that progress in intensity and resistance over time."
236,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of Play Based Therapy and Functional Communication Training in children with speech-language delay. The study includes participants aged 2 to 6 years with speech and language developmental delay and excludes those with syndromes like Down syndrome, Treacher Collins syndrome, Hunter syndrome, Williams syndrome, and Kabuki syndrome. The intervention is designed as a randomized, parallel assignment with single masking. The primary outcome measure is the change from baseline in the Speech Questionnaire at the 3rd month. The study will determine which therapy is more effective in improving speech and language abilities in children with delay."
237,"GPT4 Correct Assistant: The Horyzons: Implementation and Integration in Clinical Practice study aims to assess the barriers and facilitators of integrating the digital intervention Horyzons in outpatient mental health clinics in North Carolina, which provide care to individuals with schizophrenia spectrum and other unspecified psychotic disorders. The study involves 20 clinicians and/or peer specialists and 50 individuals with first episode psychosis (FEP). The intervention consists of a digital platform, Horyzons, which offers therapeutic content and a moderated online community for clients to use for 12 months as part of their clinical care. The study aims to evaluate client engagement with Horyzons, attrition as part of clinical care, and changes in clients' psychological measures across the 12-month intervention."
238,GPT4 Correct Assistant: This study aims to investigate inflammatory and anti-inflammatory gene expressions in liver transplant patients before and after the operation. The researchers will measure the expression levels of specific genes and biochemical parameters in peripheral blood samples from patients. The primary outcome measure is the biochemical parameters of all subjects in the control and transplantation groups before surgery. The secondary outcome measures are the gene expression parameters before and after surgery. The study will help identify biomarkers with high predictive value for rejection and infection after liver transplantation.
239,"GPT4 Correct Assistant: This clinical trial aims to test the safety, tolerability, and pharmacokinetics of intravitreal single rising doses and multiple doses of BI 771716 in patients with geographic atrophy secondary to age-related macular degeneration. The trial involves four experimental groups: low dose, medium dose, high dose, and multiple doses of BI 771716. The primary outcome measures are the occurrence of ocular dose limiting events and drug-related adverse events. Secondary outcome measures include ocular adverse events, maximum serum concentration of BI 771716, area under the concentration-time curve, and time from dosing to maximum serum concentration."
240,"GPT4 Correct Assistant: This clinical trial, titled ""Furosemide-induced Diuresis With Matched Dehydration Compared to Standard Diuretic Therapy in Patients With Acute Heart Failure and Overt Fluid Overload,"" aims to compare the effectiveness of standard diuretic therapy with furosemide-induced diuresis and matched dehydration using the RenalGuard device in patients with acute decompensated heart failure and overt fluid overload. The study includes participants aged 18 and older with certain inclusion and exclusion criteria. The primary outcome measure is daily serum creatinine measurement during study treatment for assessment of acute kidney injury occurrence. Secondary outcome measures include daily weight decrease during study treatment."
241,"GPT4 Correct Assistant: This clinical trial aims to determine the feasibility, acceptability, and effectiveness of a self-guided mindfulness-based intervention in pediatric patients with idiopathic chest pain. The study is designed as a pilot study, with participants randomly assigned to either the standard of care control group or the mindfulness-based intervention group. The primary outcome measures include feasibility, acceptability, and intervention adherence, while the secondary outcome measures focus on pain coping strategies, perceived stress, patient quality of life, chest pain episode frequency, and chest pain episode intensity."
242,"GPT4 Correct Assistant: This is a four-arm, double-blind, non-inferiority trial examining the safety and immunogenicity of concomitant administration of the Novavax vaccine and a 20-valent pneumococcal conjugate vaccine in adults aged 60 years or older. The study compares three intervention groups: NVX plus placebo, PCV20 plus placebo, and NVX plus PCV20, with a placebo arm as the control. The primary outcome measure is antibody levels assessed at day 28. The trial aims to evaluate the immunogenicity and safety of these vaccines when administered concomitantly."
243,"GPT4 Correct Assistant: This clinical trial aims to investigate the safety and efficacy of combining anti-PD-L1 immune checkpoint inhibitor Durvalumab with TLR-3 agonist Rintatolimod in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) who have completed standard chemotherapy (FOLFIRINOX). The primary objective of the phase Ib study is to determine the recommended phase II dose (RP2D) of the combination therapy, while the primary objective of the phase II study is to determine the clinical benefit rate of the combination therapy. Secondary objectives include exploring the immunogenic effect of the therapy on the circulating immune profile, progression-free survival (PFS), and overall survival (OS)."
244,"GPT4 Correct Assistant: This clinical trial aims to evaluate the prophylactic effects of the flavonoid diosmin on delayed-onset muscle soreness (DOMS) in female athletes from a women's five-a-side soccer team in Brazil. The study is a randomized, double-blinded, and placebo-controlled trial, with 40 female athletes participating. Participants will undergo an intense dynamic exercise protocol, and will be randomly assigned to either a control group receiving placebo or an intervention group receiving diosmin supplementation. The primary outcome measure is muscle soreness, while secondary outcome measures include muscle tissue damage, oxidative stress, and recovery of muscle function. The study aims to determine if diosmin supplementation can reduce muscle pain, systemic levels of total creatine phosphokinase, and oxidative stress induced by intense dynamic exercise, and improve the reduction in muscular performance and impairment of balance."
245,"GPT4 Correct Assistant: This clinical trial aims to investigate the predictive factors for treatment success of Intrathecal Baclofen (ITB) therapy in children with cerebral palsy (CP). The study is a prospective observational study conducted over a period of 4.5 years using the Netherlands CP register. The primary research question is to determine the short- (3 months), medium- (1 year), and long-term (2 years) effects of ITB on personal treatment goals in children with CP. Secondary objectives include identifying factors associated with treatment success and the association between the effect on personal treatment goals and spasticity and/or dystonia. The study will include 67 to 90 children with CP who start ITB treatment under the age of 16. Outcome measures include goal attainment scaling (GAS), range of motion, spasticity, dystonia, scoliosis, selectivity, functional strength, gait analysis, and questionnaires on activities and participation."
246,"GPT4 Correct Assistant: The study aims to investigate the impact of vitamin D supplementation on the development of gestational diabetes mellitus (GDM) among high-risk pregnant women. Pregnant women with low vitamin D levels (<30 ng/mL) at 7-11 weeks of gestation will be randomly assigned to receive either vitamin D3 supplementation (200,000 IU/week) for 4-6 weeks or a placebo. The primary outcome measure is the incidence of GDM based on the International Association of Diabetes and Pregnancy Study Groups Criteria after a 75g oral glucose tolerance test (OGTT)."
247,"GPT4 Correct Assistant: The PERFORMANCE III study is a prospective, multicenter, single-arm, open-label trial evaluating the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in patients at elevated risk for adverse events following carotid endarterectomy. The Neuroguard IEP Direct System is a 3-in-1 carotid stent delivery system consisting of an angioplasty balloon, an integrated embolic protection device, and a nitinol self-expanding stent loaded over the balloon and constrained by an outer sheath. The primary endpoint is a composite 30-day rate of Major Adverse Events (MAE), defined as the cumulative incidence of all stroke, myocardial infarction (MI) and death within 30 days of the index procedure."
248,"GPT4 Correct Assistant: This study is a pilot trial designed to test the feasibility and safety of a novel Nordic Walking (NW) activity program for community-dwelling older adults at risk of falling or experiencing fear of falling. The study aims to determine the distribution and effect sizes of outcomes to inform future sample size calculations and explore participants' perspectives of the intervention. The study will be conducted in two stages. Stage One will involve a two-arm, parallel, single-blind, randomized controlled pilot trial with 40 older adults randomly assigned to either a 10-week NW intervention group or a control group receiving regular phone calls. Outcome measures will include feasibility and safety data, as well as effectiveness outcomes using measures such as the Timed Up and Go (TUG) test, Stay Independent Falls Risk Assessment Tool, Falls Efficacy Scale-International (FES-I), Activities-Specific Balance Confidence Scale, and the Four-Square Step Test (FSST). Stage Two will involve qualitative interviews with all participants in the intervention group to gather feedback on the acceptability, perceived value, barriers, and facilitators of participating."
249,"GPT4 Correct Assistant: This study aims to assess the feasibility, usability, and acceptability of an online intervention program (IP) for sexual and gender minority (SGM) adolescents experiencing depression and anxiety. The program is designed to provide education, support, and guidance to help SGM adolescents navigate mental health challenges in a safe and affirming environment. The study will enroll 160 participants, who will be randomly assigned to one of 16 groups. Each group will receive a different intervention, which will vary in content and length. Participants will be assessed at baseline and at one-month follow-up on various outcomes, including feasibility measures (IP use proportion, IP use days, IP use time), usability (System Usability Scale), acceptability of the intervention, help-seeking intention from counselor or therapist, help-seeking intention from multiple sources, perceived need for treatment, social support, anxiety, depression, mental health stigma, antidepressant outcome expectations, barriers to seeking help, depression and anxiety knowledge, expectation of rejection due to SGM status, confidentiality concerns, receipt of any mental health treatment in the past four weeks, and physical and mental health status."
250,"GPT4 Correct Assistant: The study aims to investigate the application of propofol mixed with remifentanil in fiber colonoscopy for controlled sedation and analgesia. The trial includes two groups: the experimental group receiving controlled analgesia/sedation (PCAS) with a self-control pump, and the active comparator group receiving intravenous combined anesthesia. The primary outcome measure is the auditory evoked potential (AEPI) recorded at various time points before, during, and after the examination. Secondary outcome measures include the time from surgery to OAA/S score reaching 5 and Aldrete score reaching 9."
251,"GPT4 Correct Assistant: This is a prospective, observational, confirmatory clinical study to predict the chronicization of radiation-induced acute intestinal injury in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy (NCRT) and total mesorectal excision (TME). The study will assess 200 patients who develop radiation-induced intestinal injury during NCRT or within 1 month. The primary outcome is the area under the curve (AUC) of the chronicization of radiation-induced intestinal injury predicted by the prediction model. The secondary outcomes are the accuracy, precision, specificity, and sensitivity of the prediction model. The study will follow up on the occurrence and progression of radiation-induced intestinal injury within 1 year after TME."
252,"GPT4 Correct Assistant: This is a Phase I clinical trial to evaluate the safety and tolerability of the Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells) in individuals aged 18 years and above. The study will randomize participants into two groups: one group will receive the vaccine, while the other will receive a placebo. The primary outcome measure is the incidence of adverse events within 12 months after vaccination. The secondary outcome measure is the geometric mean titer of SARS-CoV-2 neutralizing antibody 14 days after vaccination."
253,"GPT4 Correct Assistant: The study ""Evaluation of the Safety and Performance of ENDOMATIC SEPIOLA Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation"" aims to assess the safety and performance of the SEPIOLA System in patients with atrial fibrillation. The study participants must have a calculated CHA2DS2-VASc score of 2 or greater and be non-eligible or have an appropriate rationale to seek a non-pharmacologic alternative to chronic oral anticoagulants. The study is an open-label, single-group assignment, and the intervention is the implantation of the SEPIOLA device into the left atrial appendage. The primary outcome measure is the device and investigational procedure-related serious adverse events, and the secondary outcome measure is the confirmation of functional LAA closure at 45 days."
254,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of Motivational Interviewing (MI) for patients with acute psychosis. The study will compare MI with supportive conversations as a control group. The primary outcome measures are changes in therapeutic alliance and treatment adherence. Secondary outcome measures include changes in symptom severity, motivation for psychotherapy, and self-efficacy. The study will enroll 80 participants aged 18-65 with a diagnosis of psychosis."
255,"GPT4 Correct Assistant: This study aims to investigate the application of chromosomal instability (CIN) in the early diagnosis of biliary tract carcinoma using a new method called BileCAD. The study will analyze bile samples from gallbladder cancer and cholangiocarcinoma patients and control groups to compare the specificity and sensitivity of BileCAD test for diagnosing biliary tract carcinoma to other modalities, such as pathological diagnosis. The primary outcomes measured are the sensitivity and specificity of bile sample analysis by BileCAD, while the secondary outcomes include the consistency of BileCAD microbial analysis results with clinical microbial culture results and the sensitivity of different types and locations of malignant tumors."
256,GPT4 Correct Assistant: This clinical trial aims to evaluate the success of lumbar plexus block applied in lower extremity orthopedic surgeries using Near Infrared Spectroscopy (NIRS). NIRS is used to measure tissue oxygenation. The study includes participants aged 18-90 with specific conditions and exclusion criteria. The study uses a single group assignment model and measures regional oxygen saturation (rSO2) and sensory block level as primary outcomes. Secondary outcomes include blood pressure values and fingertip SO2 measured by pulse oximetry.
257,"GPT4 Correct Assistant: This clinical trial aims to evaluate the use of a digital platform for supporting the clinical effectiveness and integration of task-shared delivery of the COPSI (Community care for People with Schizophrenia in India) program in primary care. The study seeks to determine if a novel digital platform can enhance the clinical effectiveness and integration of an evidence-based psychosocial rehabilitation intervention for patients with schizophrenia in primary care settings in India. The primary outcome measure is the Indian Disability Evaluation and Assessment Scale (IDEAS), while secondary outcome measures include the Positive and Negative Syndrome Scale (PANSS), Generalized Anxiety Disorder Assessment-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), and Clinical Global Impression-Schizophrenia (CGI-SCH) Scale."
258,"GPT4 Correct Assistant: The study aims to investigate the characteristics of cytokine response in patients with temporomandibular disorders treated with occlusal splint therapy. Participants with myalgia, arthralgia, headache attributed to TMP, and painful disc displacement will be included. The intervention is the use of a stabilization occlusal splint made of hard acrylate resin. The primary outcome measures are the changes in cytokine levels in circulating blood and gingival crevicular fluid after the therapy. Secondary outcome measures include changes in pain-free opening, maximum unassisted and assisted opening, pain intensity and disability, oral health-related quality of life, perceived stress levels, jaw function limitation, depressed mood, anxious feelings and behavior, and physical symptoms. The study will be conducted over a period of three months."
259,"GPT4 Correct Assistant: This clinical trial aims to evaluate the feasibility, acceptability, and effects of digital training on the knowledge, fidelity, and treatment entry and retention of Community Reinforcement And Family Training (CRAFT) for addiction professionals working with families affected by Opioid Use Disorder (OUD). The study will test three levels of digital training: digital tutorial only, digital tutorial plus training materials, and digital tutorial plus training materials plus feedback and coaching. The primary outcome measure is CRAFT procedure fidelity, while secondary outcome measures include CRAFT knowledge, program implementation potential, and new treatment entry."
260,"GPT4 Correct Assistant: The Regional Scintigraphic DPD Uptake in Cardiac Transthyretin Amyloidosis study aims to describe the pattern of regional myocardial distribution of 3,3-diphosphono-1,2-propanedicarboxylic acid (DPD) SPECT uptake among patients with hereditary and wild-type cardiac transthyretin amyloidosis. The study will also investigate the clinical, biochemical, and echocardiographic profiles of these patients, including left ventricle longitudinal strain profile. The study is a prospective multi-center observational study, and participants will undergo TTR gene sequencing to assess the presence of pathogenic variants associated with ATTRm. The primary outcome measure is the comparison of regional left ventricle 99mTc-DPD uptake among patients with hereditary and wild-type cardiac transthyretin amyloidosis."
261,"GPT4 Correct Assistant: This clinical trial aims to investigate the early diagnosis, prognosis, and prevention of post-COVID syndrome in children during the pandemic of the new coronavirus infection COVID-19. The study will focus on children aged 6 to 18 years and will involve laboratory tests, questionnaires, and physical examinations. The primary outcome measure is the number of participants with post-COVID syndrome."
262,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of treadmill perturbation training for fall prevention after total knee replacement. The study will recruit 378 participants who are scheduled for primary unilateral total knee arthroplasty and can commit to four additional study visits. Participants will be randomized into two groups: the training group, who will undergo treadmill-based perturbation training, and the education group, who will receive fall prevention educational materials. The primary outcome measures are post-training trunk angle, post-training trunk angular velocity, and fall rate during the first year after surgery."
263,"GPT4 Correct Assistant: This clinical trial aims to evaluate the safety, tolerability, and efficacy of the combination of cadonilimab and nab-paclitaxel in patients with persistent, recurrent, or metastatic cervical cancer who have previously been treated with immune checkpoint inhibitors. The primary objective is to determine the objective response rate of cadonilimab in combination with nab-paclitaxel in these patients. Secondary objectives include evaluating the duration of response, disease control rate, time to response, progression-free survival, overall survival, and incidence of adverse events. Additionally, the study aims to explore potential predictive biomarkers of the efficacy of the combination therapy in tumor tissue and peripheral blood samples."
264,"GPT4 Correct Assistant: The study aims to assess the visual performance of the trifocal Hanita Lenses Intensity SL IOL in comparison to the trifocal Alcon PanOptix IOL in bilaterally implanted patients with age-related cataracts. This single-center, prospective, randomized, unblinded, controlled study will include approximately 58 patients and will have a maximum of 10 study visits over a period of 3-7 months. The primary study endpoint is to investigate whether the binocular distance-corrected visual acuity achieved with the study lens for the distance, intermediate, and near ranges is not statistically significantly inferior to the parameters achieved with the control lens."
265,"GPT4 Correct Assistant: This clinical trial is a retrospective, observational, single-centre cohort database analysis investigating the haemodynamic effects of low-dose spinal anaesthesia for hip fracture surgery. The study aims to determine if lower doses of spinal anaesthesia are linked with a lower rate of low blood pressure during surgery and if prevalence and/or depth+duration of hypotension are correlated with outcomes (survival, length of inpatient stay) after hip fracture repair. Participants are adults (over 18 years) who have sustained a unilateral hip fracture and received surgery under low dose spinal anaesthesia (1.3 mls 0.5% hyperbaric bupivacaine) after fascia iliaca block + sedation between 3rd March, 2017 and 1st January, 2020 at the Princess Royal Hospital, Hayward's Heath (E Sussex)."
266,"GPT4 Correct Assistant: The COVID-19 Transmission and Morbidity in Malawi clinical trial aims to investigate the hypothesis that malaria and intestinal parasitic diseases may result in enhanced or tolerogenic innate immune responses, decreasing the risk of symptomatic COVID-19. The trial will enroll up to 200 symptomatic individuals (index cases), their household contacts (anticipated 700), and up to 600 vaccinees. The study will measure the risk of asymptomatic infection among contacts who acquire infection, the duration of neutralizing antibody responses, and the change in frequencies of classical (CD14+CD16-) monocytes and markers of activation/inflammation with and without stimulation by toll-like receptor (TLR) and retinoic acid-inducible gene I (RIG-I) like receptors (RLR) ligands. Secondary outcomes include the probability of infections in a household, duration of COVID-19 symptoms, reinfection rates, and breakthrough infection rates."
267,"GPT4 Correct Assistant: The study aims to investigate the effect of hot-cold application to the bladder on postoperative urinary retention in orthopedic surgery patients. This is a single-blind randomized controlled trial with parallel assignment. Participants aged 18 or older who have undergone orthopedic surgery and have no urinary catheter inserted during the perioperative process are eligible. The experimental group will receive hot-cold application to the bladder, while the control group will receive routine clinical care. The primary outcome measure is the prevention of postoperative urinary retention during the first 6 hours of the postoperative period."
268,"GPT4 Correct Assistant: The study aims to evaluate the sensitivity and specificity of a deep-learning integrated model based on high concentration (370 mgI/ml) Iopromide-enhanced pancreatic CT obtained within 14 days after the first onset of symptoms for quantitative prediction of the first recurrence of acute pancreatitis in a 12-month follow-up period. The sample size is calculated to be 694 participants, with a dropout rate of 20%. The primary outcome measures the sensitivity and specificity of the model in predicting the first recurrence of acute pancreatitis in 12 months. Secondary outcomes include the total number of subjects who developed the first recurrence of acute pancreatitis within 3, 6, and 12 months, and the sensitivity and specificity of the model in predicting overall recurrence of acute pancreatitis in 3 and 6 months follow-up period. The study also evaluates the image quality of Iopromide-enhanced pancreatic CT images obtained within 14 days after onset of symptoms and the sensitivity and specificity of the model determined by radiomics features extracted from images with high-quality scores."
269,"GPT4 Correct Assistant: This clinical trial, titled ""CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea,"" aims to study the effect of continuous positive airway pressure (CPAP) treatment on polycythemia in patients with obstructive sleep apnea. The study includes participants aged 18-80 with a diagnosis of polycythemia (hematocrit > 49% in men and > 48% in women) and moderate to severe sleep apnea (apnea-hypopnea index > 15). Participants are randomly assigned to either the CPAP treatment group or the control group, receiving conventional pharmacological treatment. The primary outcome measure is the change in hematocrit from baseline to 12 months. Secondary outcome measures include changes in hemoglobin, health-related quality of life, relationship between hypoxic burden and hemoglobin and hematocrit, change in sleepiness assessed by Epworth scale, and relationship between night time below SaO2 90% (T90) and oxygen desaturation index (ODI) and hematocrit."
270,"GPT4 Correct Assistant: This clinical trial aims to compare the vaginal axis on MRI in alternative apical prolapse surgeries to sacrocolpopexy. The study will include patients undergoing lateral mesh suspension, pectopexy, and sacrospinous ligament fixation procedures for apical prolapse correction. The primary outcomes will be measured at four months after the operation, including vaginal axis, vaginal distances, prolapse symptoms, and quality of life measures. This study is designed to assess the effectiveness of alternative apical prolapse surgeries and provide valuable information for future treatments."
271,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a simulation teaching method in electronic fetal monitoring management for midwifery students. The study includes 68 participants, divided into an experimental group that receives simulation training and a control group that receives theory training. The primary outcome measures include information evaluation forms, student satisfaction and self-confidence scales, and a self-efficacy scale in monitoring and management of electronic fetal monitoring. Secondary outcome measures include a simulation design scale. The trial is designed as a parallel assignment, randomized study with no masking."
272,"GPT4 Correct Assistant: The study, ""Outcome and Predictors of Mortality of Patients on Prolonged Mechanical Ventilation in Critically Ill Patients: a Multicenter Retrospective Cohort Study,"" aims to investigate the outcomes and predictors of mortality in critically ill patients on prolonged mechanical ventilation. The study is conducted in Dessie Comprehensive Specialized Hospital from August 2023 to January 2024. The intervention is mechanical ventilation, and the primary outcome measure is the clinical outcome of the patients at the time of discharge. The study will use a retrospective cohort design and analyze data using SPSS version 22 software."
273,"GPT4 Correct Assistant: The clinical trial aims to compare the efficacy and safety of two bleeding reduction approaches in patients undergoing percutaneous coronary intervention (PCI): 1) DAPT de-escalation (switching from prasugrel or ticagrelor to clopidogrel while maintaining aspirin) and 2) potent P2Y12 inhibitor monotherapy (maintaining prasugrel or ticagrelor and dropping aspirin). The primary outcome measure is thrombus formation, determined by the area under the curve (AUC) measured by T-TAS, over a 30-day period."
274,"GPT4 Correct Assistant: This clinical trial investigates the age-dependent effects of egg intake on high-density lipoprotein (HDL) and immune profiles. The study includes participants aged 18-30 and 60-70 years old, who consume whole eggs, egg whites, or egg yolks daily for four weeks in a crossover assignment. The primary outcome measure is the change in serum concentration of large HDL particles between diet periods."
275,"GPT4 Correct Assistant: This clinical trial focuses on evaluating the effectiveness of a patient-driven augmented reality-based rehabilitation system, MyoTrain AR, in improving upper limb amputee outcomes. Participants with trans-radial unilateral limb loss are randomly assigned to either the experimental or control group. The experimental group undergoes functional task training using the MyoTrain AR system, while the control group performs motor imagery exercises. The primary outcome measures are GaMA Cup Transfer Task mean completion time and mean relative grasp duration, assessed on Day 35. Secondary outcome measures include Assessment of Capacity for Myoelectric Controls (ACMC), GaMA Cup Transfer Task completion rate, and wrist activation."
276,"GPT4 Correct Assistant: This is a prospective double-blinded randomized controlled trial studying the use of gastric electric pacemaker as a treatment for postoperative ileus following extensive surgery. The study includes patients over 18 years of age undergoing elective cytoreductive surgery with or without heated intraperitoneal chemotherapy due to colorectal or appendiceal cancer or with peritoneal metastases or pseudomyxoma peritonei. The intervention involves the use of a gastric electric pacemaker, and the primary outcome measure is the time from surgery till the first stool. Secondary outcome measures include whole gut and regional transit times, length of hospital stay, medical and surgical complications, need for surgical or radiological interventions, re-hospitalization within 30 days, time till initiation of postoperative systemic adjuvant chemotherapy, and 90-day mortality."
277,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of aromatherapy, music therapy, and a combination of both on pain, anxiety, and vital parameters in patients with cancer. The study is designed as a randomized controlled trial and includes four groups: music group, aromatherapy group, music and aromatherapy group, and control group. The music group listens to specially composed music with headphones for 20 minutes for three consecutive days, while the aromatherapy group uses 5% lavender oil with a diffuser for 15-20 minutes. The music and aromatherapy group receives music with headphones and aromatherapy inhaler for three consecutive days. The primary outcome measures include Visual Analog Scale (VAS), Facial Anxiety Scale (FAS), Distress Thermometer, and Edmonton Symptom Diagnostic Scale (ESAS)."
278,"GPT4 Correct Assistant: The Somatosensation Device Trial is a study investigating the effectiveness of the Somatosensation Device in enhancing feedback in lower extremities for individuals with amputation or neuropathy. Participants must be aged between 18 and 65 years with a below-knee amputation or neuropathy in their lower limbs. The study is non-randomized with a crossover assignment and is open-label. Participants will undergo functional gait assessment, 10-meter walk test, Mini-BESTest, Activities Specific Balance Confidence Scale, and Vestibular Disorders Activities of Daily Living Scale as primary and secondary outcome measures."
279,"GPT4 Correct Assistant: This is a decentralized clinical trial investigating the use of the OtoBand device in treating vertigo symptoms in real-world settings. The study aims to enroll up to 108 participants, divided into Moderate or Worse (MoW) and Quality of Life (QoL) groups. Participants will use either the experimental OtoBand device or a sham device for up to 49 days, completing questionnaires throughout the study. The primary outcomes measured are changes in vertigo severity and quality of life scores. The study seeks to determine the effectiveness of the OtoBand in providing temporary relief to vertigo symptoms."
280,"GPT4 Correct Assistant: This is a randomized controlled trial investigating the effect of OMNi-BiOTiC® Active, a multistrain probiotic, on the incidence and duration of upper respiratory tract infections (URTI) in older people. Participants must be 65 years or older and able to eat independently. The study lasts for 12 weeks, with participants receiving either the probiotic or a placebo. The primary outcome measure is the incidence of URTI, while secondary outcome measures include the duration of URTI, changes in serum concentrations of various blood cells, and changes in serum immunoglobulin A (IgA) concentration."
281,"GPT4 Correct Assistant: This study aims to compare the effectiveness of Gong's and Kaltenborn mobilization techniques in treating Adhesive Capsulitis (frozen shoulder) by assessing pain, range of motion, and functional mobility. Participants aged 40-60 with idiopathic Adhesive Capsulitis will be randomly assigned to either Group A (Gong's mobilization) or Group B (Kaltenborn mobilization). Both groups will receive routine physical therapy, including electrical muscle stimulation with heat therapy. The study will use the Numeric Pain Rating Scale, Shoulder Pain & Disability Index, and goniometry to measure outcomes. The study duration is nine months, with data collection points at baseline, the end of 1.5 weeks, and the conclusion of the 3rd week."
282,"GPT4 Correct Assistant: This clinical trial is a phase 3, open-label, randomized, controlled study examining the efficacy of disitamab vedotin in combination with pembrolizumab versus chemotherapy in subjects with previously untreated locally advanced or metastatic urothelial carcinoma that expresses HER2. The primary outcomes measured are progression-free survival (PFS) and overall survival (OS). The study includes participants aged 18 and older, with inclusion and exclusion criteria based on cancer type, prior treatment, and medical history. The study plans to measure PFS and OS for approximately 3 and 5 years, respectively, with secondary outcomes including objective response rate, duration of response, control rate, and various quality of life and adverse event measures."
283,"GPT4 Correct Assistant: This clinical trial aims to study the effect of lactoferrin versus placebo in improving clinical outcomes in ICU patients. The study is a double-blinded, randomized controlled trial, with a sample size of 650 patients. Patients will be randomly assigned to either the lactoferrin group or the placebo group. The primary outcome measure is 28-day mortality rate, and secondary outcome measures include the incidence of hypersensitivity reactions, need for invasive mechanical ventilation, and duration of ICU stay. The study will be conducted in Mansoura University Hospital, and the results will be published in peer-reviewed journals."
284,"GPT4 Correct Assistant: This is a 10-week randomized double-blinded crossover trial investigating the efficacy of BiOkuris® chitin-glucan based formulation (BK003) versus placebo in patients with Crohn's disease in remission and IBS-like symptoms. The study includes participants aged 18 to 75 years, and primary outcomes measure the subject's global assessment of relief responder rate at week 4 after randomization. Secondary outcomes include individual symptoms, stool consistency and dyschesia, stool number, IBS-related quality of life, anxiety and depression, serum CRp & fecal calprotectin, and adverse events."
285,"GPT4 Correct Assistant: The study aims to develop a novel biomarker, virus-host chimera DNA (vh-DNA), for response and prognosis prediction in HBV-related hepatocellular carcinoma (HCC) patients undergoing radiotherapy. The investigators hypothesize that HBV vh-DNA could accurately diagnose residual tumor by 6-12 months earlier than contemporary images and predict early recurrence/metastasis, thus allowing early intervention of salvage therapies. The study will analyze Capture-NGS analysis, Vh-DNA specific PCR, and serial changes of serum vh-DNA copies to determine the efficacy of this novel biomarker."
286,"GPT4 Correct Assistant: The study aims to develop an online individual intervention program to help women with breast cancer make sense of their experiences and improve their psychological health. The program, called the Meaning-Centered Coping Program, is based on the Meaning-Making Model and principles of meaning therapy. The study includes a total of 44 participants, who are randomly assigned to either the intervention group or the control group. The intervention group undergoes the Meaning-Centered Coping Program, while the control group does not receive any intervention. The program consists of eight individual sessions, each lasting approximately 60 minutes. The primary outcome measures include the Meaning in Life Questionnaire, Posttraumatic Growth Inventory-X, Stress Appraisal Measure, Global Meaning Violations Scale, Impact of Event Scale-Revised, Acceptance and Action Scale-II, and Hospital Anxiety and Depression Scale. The study aims to test the effectiveness of the program in improving psychological health and well-being for women with breast cancer."
287,"GPT4 Correct Assistant: This clinical trial aims to study the nutritional intake, nutritional status, and physical activity level in people who have undergone a major dysvascular lower limb amputation. The study will assess various outcomes, including nutritional intake, diet quality, nutritional status, muscle mass, muscle strength, body mass index, physical activity level, mortality, wound healing, quality of life, K-level, and physical functioning. The trial will follow participants for up to nine months post-amputation."
288,"GPT4 Correct Assistant: The study aims to evaluate the feasibility of a remote clinical trial in patients with diabetes and albuminuria. Participants will be randomly assigned to one of three treatment groups based on their albuminuria response after receiving empagliflozin for three weeks. The primary outcome measures include participants' perspectives toward the feasibility of participating in a remote trial, number and percentage of urine collections not received at the laboratory or unable to be analyzed, number and percentage of missed blood pressure measurements, number and percentage of missed body weight measurements, and treatment adherence measured by pill count and medication concentration in urine samples. Secondary outcome measures include individual UACR response to empagliflozin, individual systolic blood pressure response to empagliflozin, individual body weight response to empagliflozin, individual eGFR response to empagliflozin, individual fasting plasma glucose response to empagliflozin, and additive treatment effects of finerenone on UACR, systolic blood pressure, body weight, eGFR, and fasting plasma glucose."
289,"GPT4 Correct Assistant: The study aims to test the effectiveness of high-intensity interval training on physical fitness, skills, and tactical performance in college ice hockey players. The study is divided into an experimental group and a control group, with both groups undergoing 12 weeks of training. The experimental group undergoes high-intensity interval training, while the control group undergoes traditional on-ice training. The study measures the maximum oxygen uptake performance, endurance performance, power performance, agility and skill performance, and tactical performance of the participants."
290,"GPT4 Correct Assistant: The study aims to investigate the effects of Chlorhexidine (CHX) mouthwash on the oral microbiome, salivary pellicle, and vascular function in individuals with dental erosion. The study is a double-blind, randomized, crossover trial with two groups: healthy controls and people with dental erosion. Participants will undergo 15 visits over 15 weeks for sample collection and measurements. The primary outcome measures include identification of salivary proteins via SDS-PAGE Electrophoresis, Microbiome diversity using DNA extraction and 16s ribosomal RNA analysis, blood pressure measurement, endothelial function test, and flow-mediated dilation of the brachial artery. The secondary outcome measures include nitrate and nitrite in saliva and plasma via Ozone-based chemiluminescence and oxidative stress markers and redox-related molecules via ELISA."
291,"GPT4 Correct Assistant: The study aims to explore if a Pain and Coordination Plan (PAC-plan) for patients after accidental injury can reduce opioid use and improve quality of life. The PAC-plan consists of an opioid management plan upon discharge from the hospital, an appointment with the participant's regular GP within 2-4 weeks after discharge, and an opportunity for increased collaboration between GP and hospital specialists. The study is designed as a prospective randomized controlled trial and will recruit patients from the Division of orthopaedic surgery, Oslo University Hospital, Norway. The primary outcome is oral morphine equivalent (OMEQ) consumption 6 weeks after discharge, with secondary outcomes including OMEQ 52 weeks after discharge, registry-based OMEQ, pain, health-related quality of life (HRQoL), and other patient-reported outcome measures (PROMs) at 6 and 52 weeks."
292,"GPT4 Correct Assistant: This is a cluster randomized controlled cohort study comparing guided versus standard antiplatelet therapy in intracranial aneurysm intervention with stents. The study includes patients with unruptured intracranial aneurysms who received intracranial stenting and standard dual antiplatelet therapy for at least 5 days before stent implantation. The study measures ischemic events, including ischemic stroke, transient ischemic stroke (TIA), and stent thrombosis, 30 days after stent implantation. The experimental group uses a guided antiplatelet regimen based on LTA testing, while the control group continues the center's original antiplatelet regimen."
293,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between bone mineral density, gross motor function, and quality of life in children with cerebral palsy. The study will include 75 children aged 7-10 years, classified into two groups based on their gross motor function classification system (GMFCS) levels. The primary outcome measures are bone mineral density assessed by dual-energy X-ray absorptiometry (DXA) scans, gross motor function measured using the gross motor function measurement scale (GMFM), and quality of life assessed using the Quality of Life Questionnaire for Children (CP QOL-Child). The study aims to explore the correlation between these factors and their implications for intervention strategies in children with cerebral palsy."
294,"GPT4 Correct Assistant: This clinical trial aims to investigate the dopaminergic mechanisms of gating working memory, learning, and motivation using a pharmaco-fMRI study. Healthy volunteers between 18 and 45 years of age with right-handedness are eligible for participation. The study involves the administration of sulpiride (400 mg) and placebo to participants in a within-subjects, double-blind, randomized design. The primary outcomes measured include reaction time and accuracy during working memory gating tasks, BOLD-response during selective working memory gating, and cognitive effort investment during Simon and perceptual decision-making tasks. Secondary outcomes include eye-blink rate, working memory capacity assessed by Operation Span and Digit Span tests, and various psychological questionnaires."
295,"GPT4 Correct Assistant: This clinical trial, named HYGEF (Hypertension in high school students: Genetic and Environmental Factors), aims to determine the prevalence of obesity and hypertension in a cohort of adolescents, investigate the link between specific gene polymorphisms and hypertension, and explore whether urine Na+/K+ excretion and urinary markers of inflammation and oxidative stress are linked to hypertension and cardiovascular risk in participants with selected genotypes. The study will be conducted in high schools across Italy, targeting adolescents aged 13 to 19 years old. Participants will undergo blood pressure measurements, weight and height assessments, and provide urine and saliva samples for genetic analysis. The study aims to establish a link between specific gene polymorphisms of Adducins and EO-related genes with selected phenotypes, such as hypertension, Na+ and K+ intake."
296,"GPT4 Correct Assistant: The EPigenetic Consequences in Children of Intravenous vs Volatile Anaesthesia for Surgery (EPIVA) trial aims to investigate the effects of different types of anaesthesia on epigenetic changes in children undergoing surgery. The study is a randomized, clinical, feasibility trial that compares two anaesthetic maintenance approaches: intravenous (total intravenous anaesthesia, TIVA) and inhalational. Participants undergoing hypospadias surgery are randomized to one of the two groups. Blood samples are collected before and after surgery to analyze epigenetic changes. The primary objective is to assess the feasibility of conducting a larger study on anaesthesia and surgery in relation to epigenetic changes in children."
297,"GPT4 Correct Assistant: This clinical trial aims to investigate whether additional markers can improve laboratory diagnostics in patients with hypothyroidism receiving levothyroxine, in whom TSH cannot be used as a reflection of thyroid hormone status. The study will assess TSH concentration, fT4 concentration, fT3 concentration, and the fT3/fT4 ratio in various groups of hypothyroid patients and healthy controls. The primary outcome measures are TSH concentration, fT4 concentration, and fT3 concentration, while the secondary outcome measures include TT4 concentration, TT3 concentration, rT3 concentration, SHBG, acylcarnitine(s) (profile), and amino acids."
298,"GPT4 Correct Assistant: The study aims to implement Palliative NonOperative Management (PNOM) in all Dutch hospitals for a select group of frail elderly patients with limited life expectancy who have sustained a hip fracture. The primary objective is to provide the best care for these patients in the last phase of their life through shared decision-making. The study includes a multicenter prospective cohort design and various methods such as interviews, educational module development, and website design. The target population includes frail elderly individuals aged 70 or older with limited life expectancy, malnutrition, mobility issues, or severe comorbidities."
299,"GPT4 Correct Assistant: This clinical trial aims to generate proof-of-concept for using a physiological clinical target volume (CTV) for radiotherapy treatment planning in patients with brain tumours, specifically IDH-wildtype glioblastoma. The study will extend the clinical standard MRI session with advanced MRI techniques that assess oxygenation status and cell proliferation to generate a physiological CTV. The primary outcome measures are volume and location analysis of physiological and standard CTVs, while the secondary outcome measures are pattern-of-failure analysis of the physiological and standard CTVs. The study will include 10 patients aged 18 years or older, diagnosed with IDH-wildtype glioblastoma, and the intervention is an extension of the MRI scan time with advanced MRI techniques."
300,"GPT4 Correct Assistant: This clinical trial aims to study the acceptance and effectiveness of SARS-CoV-2 vaccination in Systemic Sclerosis (SSc) patients treated by Autologous Hematopoietic Stem Cell Transplantation (AHSCT). The trial will compare the cumulative incidence of asymptomatic or symptomatic COVID-19 infection in AHSCT and non-AHSCT SSc patients up to 18 months. Secondary outcomes include the proportion of patients refusing vaccination, cumulative incidence of symptomatic COVID-19 infection, time of onset of first COVID-19 infection, severity of symptomatic COVID-19, and the proportion of patients with at least one grade 3 adverse event after COVID-19 vaccination. Additionally, the trial will assess the humoral response in SSc patients treated by AHSCT and controls after mRNA vaccination."
301,"GPT4 Correct Assistant: The study aims to assess the effectiveness of the Chez NICU Home (CNH+) intervention, which is an eHealth platform designed to support parents of infants in the Neonatal Intensive Care Unit (NICU) through increased parental presence and education. The study will be conducted in four Canadian NICUs and will involve 360 families. The primary outcome measures are changes in parental self-efficacy, parental stress, parental perceived-readiness for infant discharge, and parental perceived family-centered care. Secondary outcome measures include changes in parental depression, parental perceived NICU-specific stressors, parental perceived amount of family-centered care, infant weight growth, infant head growth, infant length of stay in the NICU, amount of provision of mothers' own breast milk for their infant, receipt of breast milk at infant discharge, amount of time for the infant to reach full enteral feeds, incidence of mortality, incidence of necrotizing enterocolitis, incidence of late-onset sepsis, incidence of chronic lung disease, incidence of retinopathy of prematurity, incidence of severe brain injury, incidence of treated Patent Ductus Arteriosus, incidence of air leak, duration of respiratory support, duration of oxygen supplementation, duration of total parenteral nutrition, duration of hypoxic ischemic encephalopathy, number of days with a central venous line in situ, number of central line-associated bloodstream infections, infant neurological examination score at 18 months corrected gestational age, infant hearing assessment score at 18 months corrected gestational age, infant vision assessment score at 18 months corrected gestational age, infant development score at 18 months corrected gestational age, number of Chez NICU Home educational modules completed at 6 months after discharge, number of Chez NICU Home educational modules viewed at 6 months after discharge, amount of time spent on the Chez NICU Home platform at 6 months after discharge, number of text messages received by parents at 6 months after discharge, number of virtual communication tools used by parents at 6 months after discharge, and number of parents who enroll in CNH+ when offered."
302,"GPT4 Correct Assistant: This clinical trial investigates the effects of physical activity on physical fitness parameters, functional fitness age, and quality of life in women at risk of osteoporosis. The study includes women aged 54-75 years who are at medium-high risk of osteoporosis, as assessed by the Osteoporosis Self-Assessment Tool for Women (OST). Participants are randomized into two groups: an experimental group that participates in the Otago Exercise Program and moderate-intensity walking exercise, and a control group with no intervention. The primary outcome measures include lower extremity strength, upper extremity strength, aerobic endurance, upper extremity flexibility, agility, and quality of life. The study aims to determine if the Otago Exercise Program can improve these parameters and potentially reduce the risk of osteoporosis in post-menopausal women."
303,"GPT4 Correct Assistant: This study aims to determine if a digital-based diet quality intervention is feasible and effective for adolescents with overweight or obesity. It is a two-arm pilot randomized controlled trial, with 14 adolescents aged 14-17 years participating. Participants will be randomized to either usual care or a nutrition intervention with personal goals, meal timing, nutrition skills, and home food environment intervention components delivered through text messaging. The primary outcome measure is the change in overall Healthy Eating Index (HEI) 2020 score, while secondary outcome measures include change in urinary Na and K."
304,"GPT4 Correct Assistant: The study aims to analyze the incidence of postoperative complications such as cerebral hyperperfusion (CH) within one month and identify the risk factors of CH. It involves enrolling 400 patients with carotid artery stenosis, who will undergo carotid artery stenting. The study will use multi-parameter characteristics based on cerebral autoregulation to predict cerebral hyperperfusion syndrome after carotid artery stenting. The primary outcome measure is postoperative CH, defined as a more than 100% increase in MCA mean velocity within 48 hours after carotid artery stent. The secondary outcome measures include cerebral hyperperfusion syndrome and major stroke within one month post-operation."
305,"GPT4 Correct Assistant: This clinical trial aims to test the effects of an expressive writing (EW) intervention for informal caregivers of persons diagnosed with cancer. The intervention consists of four group-based expressive writing sessions delivered via videoconference. The study will examine the effects of the intervention on emotional, social, and physical well-being among caregivers, as well as identify potential moderators of benefit. The primary outcome measures include psychological distress, quality of life, and caregiver-specific quality of life. Secondary outcome measures include depression and perceived stress."
306,"GPT4 Correct Assistant: This is a prospective, randomized, controlled single-surgeon trial investigating the use of intravenous tranexamic acid (IV TXA) in patients undergoing gender affirming mastectomy at the University of California San Francisco. The trial aims to determine the effects of IV TXA on postoperative bleeding, hematoma, seroma, drain output, and time to drain removal. Patients aged 18 or older who meet WPATH guidelines for gender affirming mastectomy and have ASA I-III are eligible to participate. Participants are randomly assigned to either the experimental group receiving IV TXA or the control group not receiving IV TXA. The primary outcomes are the presence of hematoma, seroma, and drain output, and time to drain removal. The secondary outcomes are thromboembolic events and wound complications."
307,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of smell training (ST) and trigeminal nerve stimulation (TNS) on COVID-related persistent smell loss. The study includes three groups: active ST, placebo ST, and active TNS plus active ST. The primary outcomes measured are changes in psychophysical olfactory function, perceived intensity and hedonic perception of odorants, olfactory-related quality of life, and impact of olfactory loss. Secondary outcomes include changes in long COVID symptoms, sustained attention, cognitive function, mood state, sleep quality, excessive daytime sleepiness, symptoms of depression, and symptoms of anxiety."
308,"GPT4 Correct Assistant: The study aims to evaluate the clinical effect of Tiaoshen acupuncture on primary insomnia. Participants are randomly assigned to either the acupuncture group or the placebo acupuncture group. The primary outcome measure is the Pittsburgh Sleep Quality Index (PSQI) score, which assesses sleep quality before and after treatment. Secondary outcome measures include the Fatigue Scale-14, Epworth Sleepiness Scale, Self-Rating Anxiety Scale, Self-Rating Depression Scale, polysomnography, and heart rate variability. The study will analyze the changes in these measures to determine the effectiveness of Tiaoshen acupuncture in treating primary insomnia."
309,"GPT4 Correct Assistant: This clinical trial aims to determine the efficacy of shorter chemotherapy regimens with or without anthracene drugs for early-stage triple-negative breast cancer (TNBC) patients. The primary objective is to compare breast cancer event-free survival (BC-EFS) between patients randomized to receive either taxane-platinum-anthracycline-cyclophosphamide-pembrolizumab (Arm I) or taxane-platinum-pembrolizumab (Arm II). Secondary objectives include comparing pathologic complete response (pCR) rates, residual cancer burden (RCB) rates, distant relapse-free survival (DRFS), overall survival (OS), relapse-free survival (RFS), and safety and tolerability between the two arms. Additionally, patient-reported outcomes, including fatigue and physical function, will be assessed."
310,"GPT4 Correct Assistant: The study aims to evaluate a one-year version of the Parent-Child Assistance Program (PCAP) for pregnant or postpartum individuals who have used substances during their current or most recent pregnancy. The intervention provides mothers with a case manager who helps them set goals, provides practical assistance, serves as a role model, and offers emotional support and encouragement. The case manager connects mothers to community resources and recovery supports tailored to their needs and goals. The study will measure the proportion of target children not placed in foster care, mother's abstinence from drugs and/or alcohol, and other outcomes related to housing, employment, education, and criminal justice involvement."
311,"GPT4 Correct Assistant: This clinical trial is a comparative study evaluating the Tomey OA-2000, Tomey CASIA2, and LenStar LS900 devices for optical measurement in subjects with normal eyes, cataract, and special eyes (aphakic or pseudophakic). The primary outcome measures are agreement between the test devices and the predicate device, precision of the test devices, and safety of the test devices. The study aims to measure the accuracy and reliability of these devices in different cohorts and assess their safety."
312,"GPT4 Correct Assistant: This study is a phase III, interventional, multicenter, open-label, randomized trial comparing the efficacy of Rituximab plus Zanubrutinib versus Rituximab monotherapy in previously untreated patients with splenic marginal zone lymphoma (SMZL). The primary outcome measure is progression-free survival (PFS) rate at 3 years. The study aims to determine if the combination of Rituximab and Zanubrutinib results in an improvement in PFS compared to Rituximab monotherapy."
313,"GPT4 Correct Assistant: This study aims to compare the efficacy of perioperative US-guided serratus anterior plane block (SAPB) versus thoracic epidural (TEA) in adult patients undergoing thoracotomy for malignancy resection. The primary outcome is postoperative total morphine requirement within 24 hours. Secondary outcomes include intraoperative fentanyl requirement, time to the first analgesia requested by the patient, postoperative pain, length of hospital stay, and patient satisfaction score. The study is a randomized, controlled, double-blinded trial with 74 participants (37 in each group)."
314,"GPT4 Correct Assistant: This study aims to enhance parent/caregiver engagement in the Pediatric Intensive Care Unit (PICU) through the use of a PICU Journal intervention. The study will include parents/caregivers of children hospitalized in the PICU who have not had prior experience with their child(ren) being admitted to the PICU. The primary outcome measures include parent/caregiver reported stress level, care engagement level, depression and anxiety symptoms, impact of events, and use and satisfaction with the PICU journal. The study will collect data at three time points: time one (T1) between 24 and 72 hours of the child's admission, time two (T2) peri-discharge, and time three (T3) three months post-discharge."
315,"GPT4 Correct Assistant: This clinical trial aims to test the Design Thinking (DT) methodology for engaging Hispanic and Latino families of autistic children in research. The study compares DT and Focus Groups (FG) to determine which method is better at engaging stakeholders and understanding the facilitators and barriers to accessing therapy for autistic children. The long-term objective is to improve the functional skills and health of Hispanic/Latino autistic children and their families by improving access to an occupational therapy intervention. The trial uses a randomized mixed methods design and measures stakeholder engagement, acceptability, and feasibility of the adapted intervention for the Hispanic/Latino population."
316,"GPT4 Correct Assistant: This clinical trial aims to evaluate harm reduction products as a second line intervention for adult smokers who do not quit with nicotine replacement therapy (NRT). Participants aged 22-65 who smoke at least 10 cigarettes a day will be randomized into one of six groups: NRT responders who switch to Nicoderm, Nicorette 4Mg Chewing Gum, or Nicorette Lozenge Product; NRT non-responders who prefer nicotine pouches will be switched to either a nicotine pouch or remain on NRT; NRT non-responders who prefer electronic cigarettes will be switched to BIDI e-cigarette or remain on NRT. The primary outcome measure is the change in smoke exposure for NRT non-responders, while secondary outcome measures include smoking abstinence rates for NRT non-responders."
317,"GPT4 Correct Assistant: This study aims to evaluate the effectiveness of the flipped learning model on nursing students' asepsis knowledge and learning skills. The experimental group will receive flipped education model training, while the control group will receive normal course education. The study will be conducted with first-year students of Bilecik Şeyh Edebali University Nursing Department. The study will measure the effect of the flipped learning model on the course success of nursing students."
318,"GPT4 Correct Assistant: This clinical trial aims to evaluate the ability of Epitel's™ Remote EEG Monitoring System (REMI™) to record electroencephalography (EEG) of seizure events in an ambulatory setting for extended periods (14 - 28 days). The study focuses on patients with a history of seizures, a minimum reported seizure rate of one every two weeks, and who are prescribed an ambulatory EEG study as part of routine care. The primary outcome measure is the identification of ictal events in fourteen (14) days, while the secondary outcome measure is the identification of extended seizure activity over twenty-eight (28) days."
319,"GPT4 Correct Assistant: The study aims to compare the effects of a Multi-Component Training (MCT) programme versus a Continuous Cardiovascular Training (CVT) programme on blood pressure levels in adult hypertensive subjects. The study will involve a controlled, randomised, longitudinal, and prospective clinical trial, with three intervention groups: MCT, CVT, and a control group. The MCT programme will involve two main training units per session per day, focusing on strength work and cardiovascular training. The CVT programme will involve a single main training unit per session per day, with exclusive cardiovascular training. The study will measure changes in blood pressure, mean blood pressure, pulse pressure, dual product, and baseline heart rate from baseline at week 12. Secondary outcome measures include changes in weight, skeletal muscle mass, body fat mass, body mass index, body fat percentage, visceral fat, phase angle, waist circumference, total cholesterol, high-density lipoprotein, low-density lipoprotein, triglycerides, glucose, manual handgrip strength, upper body strength, and lower body strength from baseline at week 12."
320,"GPT4 Correct Assistant: This clinical trial aims to study the observance of preoperative fasting time before and after a sensitization campaign on preoperative fasting guidelines. The study includes adult participants undergoing a surgical procedure, excluding already intubated patients, redo surgeries, and specific medical conditions. The primary outcome measure is the duration of liquid and solid fasting time before surgery. Secondary outcome measures include preoperative anxiety, discomfort, thirst, hunger, nausea, vomiting, patient satisfaction, post-operative quality of recovery, length of stay, and post-operative surgical complications. The study compares the observance of fasting time in participants who undergo preoperative fasting as standard care with those who undergo fasting after a sensitization campaign."
321,"GPT4 Correct Assistant: The study ""Mentoring to be Active: Peer Mentoring to Mitigate Obesity and Extreme Obesity in Rural Appalachian Children"" aims to test the effects of the Mentored Planning to be Active + Family intervention on physical activity outcomes and health outcomes among rural Appalachian 7th/8th grade children suffering from overweight and obesity. It is a community-based randomized controlled trial targeting 7th grade students in rural Appalachia, with half receiving MPBA+F and the other half receiving self-guided (usual care) modules. The long-term goal is to reduce the high rates of overweight, obesity, and type 2 diabetes in Appalachia youth through effective, sustainable interventions."
322,"GPT4 Correct Assistant: This clinical trial investigates the effects of virtual reality animation and ice massage on labor pain, duration of labor, and satisfaction in primiparous and singleton pregnancies. The study includes participants aged 18-35 with a cervical dilatation of 0-3 cm. The experimental groups receive either ice massage or virtual reality animation for 20 minutes during labor, while the control group receives standard care. The primary outcomes measured are labor pain using Visual Analogue Scale (VAS), labor duration, and birth satisfaction using Birth Satisfaction Scale - Revised (BSS-R)."
323,"GPT4 Correct Assistant: This clinical trial aims to study the epidemiology of Cytomegalovirus (CMV) disease in pediatric and adult liver transplant recipients in China. The study includes participants aged ≤18 years in the children group and >18 years in the adults group, who have received their first orthotopic liver transplant within 10 days prior to the study. The primary outcome measure is clinically significant CMV reactivation or CMV disease observed within 12 months of transplantation. The study follows participants for 22 months after the liver transplantation or until the participant's death, loss to follow-up, or withdrawal from the study."
324,"GPT4 Correct Assistant: This clinical trial aims to study the effectiveness of Prism Adaptation Therapy (PAT) for right brain stroke rehabilitation in patients with spatial neglect. The study will identify patients who are the best candidates for PAT using a biomarker-based algorithm. The primary outcome measure is spatial neglect type, while the secondary outcome measures include functional independence and severity of spatial neglect. The study will involve 180 participants, including 120 with spatial neglect and 60 without."
325,GPT4 Correct Assistant: The study aims to analyze blood samples from glioma-affected patients to detect and quantify circulating tumor DNA (ctDNA). The investigators will use liquid biopsy as a diagnostic tool and analyze the ctDNA through a ddPCR. The primary outcome measure is the detection of ctDNA in blood samples. The study is designed as a pilot study with an open-label intervention.
326,"GPT4 Correct Assistant: This is a clinical trial studying the effects of zimberelimab and quemliclustat in combination with chemotherapy for patients with borderline resectable and locally advanced pancreatic adenocarcinoma. The primary objectives are to evaluate the safety, resection rate for patients with borderline resectable pancreatic cancer (BPRC), and progression-free survival for patients with locally advanced pancreatic cancer (LAPC). Secondary objectives include estimating efficacy, pathologic complete response rate, and overall survival. The study involves treatment with zimberelimab, quemliclustat, and chemotherapy, and participants will undergo various tests and procedures throughout the trial."
327,"GPT4 Correct Assistant: The study aims to investigate the effect of probiotics (MIYAIRI 588) on depression syndrome and the risk factors of cardiovascular disease in hemodialysis patients. Adults aged 20 years or older undergoing hemodialysis are eligible for participation. The study is a randomized, parallel assignment, open-label trial with two arms: experimental (intervention) and control (no intervention). Participants in the experimental arm receive MIYAIRI 588 at a dose of 1g/package with each meal, three packages per day, for three months. The primary outcome measure is the change in depression score, assessed using the Beck Depression Inventory Chinese version 2.0. The study will measure the change in depression score from baseline at three months."
328,"GPT4 Correct Assistant: The StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE) is a clinical trial aimed at testing the feasibility and acceptability of integrated Cognitive Motivational Enhancement Therapy (CM-PST) for young adults with Alcohol Use Disorder (AUD). The study has two phases: K99 Phase and R00 Phase. In the K99 Phase, 20 participants will receive 8 sessions of CM-PST via videoconferences over 12 weeks, while in the R00 Phase, 84 participants will be randomly assigned to either CM-PST or CM-only control group. The primary outcome measure is alcohol abstinence, assessed through blood alcohol content monitoring for up to 6 months. Secondary outcome measures include changes in AUD severity, alcohol-related negative consequences, alcohol use, drug use, reasons for drinking, and affect."
329,"GPT4 Correct Assistant: This is a phase 2, randomized, open-label study comparing the efficacy of a triplet therapy (encorafenib, binimetinib, pembrolizumab) versus a doublet/control therapy (nivolumab and ipilimumab) in patients with advanced melanoma. The study aims to measure the primary outcome of objective response rate in each treatment arm. Participants must have metastatic or unresectable locally advanced BRAF V600E/K-mutant melanoma that progressed during or after prior treatment in the adjuvant or first-line metastatic setting, with an approved anti-PD-1 monotherapy (pembrolizumab or nivolumab). Approximately 150 participants will be randomized in a 1:1 ratio to the triplet or the doublet/control therapy."
330,"GPT4 Correct Assistant: This clinical trial study aims to investigate the effect of high fidelity and virtual reality-based simulation applications on simulation-based learning, reflective thinking, and therapeutic communication skills in undergraduate nursing students. The study will be conducted at Hacettepe University Faculty of Nursing and will involve 68 students, divided into two groups: one receiving high fidelity simulation and the other receiving high fidelity and virtual reality-based simulation. The primary outcome measures include the Simulation-Based Learning Scale, Reflective Thinking Skills for Problem Solving Scale, and Therapeutic Communication Skills Scale."
331,"GPT4 Correct Assistant: The study aims to compare the effectiveness of a newly developed air trap (Emboless) with the standard air trap (F5008) in reducing microemboli of air during hemodialysis. The study is a randomized clinical trial with a crossover design, where chronic hemodialysis patients are randomized to perform two series of hemodialysis, one with each type of air trap. The primary outcome measure is the reduction of air microemboli contamination, measured using an ultrasound GAMPT 200 device. The study aims to enroll a maximum of 30 patients, with each patient performing two series of each two different sets of air traps, resulting in a total of 120 dialyses."
332,"GPT4 Correct Assistant: The study aims to determine the influence of repetitive transcranial magnetic stimulation (theta burst stimulation) on movement among individuals with and without a concussion history, with the goal of preventing injury through improved injury risk biomechanics. The study uses a single-blinded cross-over design, with participants completing two testing sessions separated by at least 7 days. The primary outcome measures are reaction time, knee flexion angle, knee abduction angle, hip flexion angle, hip adduction angle, trunk flexion angle, and trunk lateral bending angle. Secondary outcome measures include the NASA Task Load Index and the Tampa Scale of Kinesiophobia 11."
333,"GPT4 Correct Assistant: The study, titled ""Extended Pancreatic Neck Transection Versus Conventional Pancreatic Neck Transection During Laparoscopic Pancreaticoduodenectomy (LPDEXCEPT): a Multicenter Randomized Controlled Trial,"" aims to compare the effectiveness of extended pancreatic neck transection during laparoscopic pancreaticoduodenectomy with conventional pancreatic neck transection. The study includes patients with benign or resectable malignant tumors of the lower common bile duct, Vater ampulla, head or uncinate process of the pancreas, aged between 18 and 80 years. The primary outcome measure is the incidence of clinically relevant pancreatic fistula at three months postoperatively. Secondary outcome measures include the location of the pancreatic duct in the pancreatic transverse section, surgical performance of pancreaticojejunostomy, postoperative morbidity, and postoperative mortality."
334,"GPT4 Correct Assistant: This study aims to investigate the effects of traditional concurrent training and concurrent training consisting of strength training combined with dance classes on functional performance, cognitive function, and quality of life in older adults. The participants are aged between 65 and 75, do not have a history of competitive sports, and are not suffering from any musculoskeletal or neurological diseases. The study is a randomized controlled clinical trial with a primary purpose of prevention. The primary outcome measures include changes in dynamic balance, cognitive function, and self-reported quality of life, while the secondary outcome measures include changes in static balance, seat to stand capacity, stairs climb capacity, leg strength, leg power, hand grip strength, cardiorespiratory capacity, quadriceps muscle thickness, affectivity with the intervention, lipid profile, and depressive symptoms."
335,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of a Virtual Reality (VR)-based sensory stimulation intervention in preventing delirium in Intensive Care Units (ICUs). The study includes ICU patients aged 18-90 years who have not been diagnosed with dementia, delirium, acute psychiatric illness, end-stage cancer, or have severe hearing impairment. Participants are randomly assigned to either the experimental group, receiving VR-based sensory stimulation, or the control group, receiving usual care. The primary outcome measures are delirium incidence, duration, and severity, while secondary outcome measures include patients' psychological well-being, clinical outcomes, quality of life, independence, and cognitive function."
336,"GPT4 Correct Assistant: The clinical trial, titled ""Outcome of Surgical Fixation of Multiple Fractured Ribs at Sohag University Hospital,"" aims to study the effectiveness of surgical rib fixation in patients with multiple fractured ribs. The trial is designed as a randomized, parallel assignment, open-label study with a primary purpose of treatment. The intervention group receives surgical rib fixation, while the control group undergoes conservative management. The primary outcomes measured are the need and duration of mechanical ventilation and the severity of thoracic pain using a pain scale from 0 to 10."
337,"GPT4 Correct Assistant: This clinical trial is titled ""A Comparison of Acute Psychobiological Responses to Laboratory Stress Tests."" The study aims to compare the acute psychobiological responses to the Mannheim Multicomponent Stress Test (MMST) and the Trier Social Stress Test (TSST) in healthy, recreationally active men and women aged 18-35 years. The primary outcome measure is the change in saliva cortisol, while secondary outcome measures include state anxiety inventory (STAI-S) response, heart rate, and salivary alpha amylase (sAA). Participants are randomly assigned to either the MMST or TSST group, with stratified block randomization based on sex and trait anxiety."
338,"GPT4 Correct Assistant: The DELI_NAFLD study is a placebo-controlled, randomized clinical trial investigating the efficacy and safety of postbiotic and metabiotic supplementation in adults with non-alcoholic fatty liver disease (NAFLD). The study aims to assess short-term hepatic fat content, transaminases activity, biochemical hepatic steatosis indices, and chronic systemic inflammatory markers. Participants receive a twice-daily oral dose of postbiotics (cell lysate and DNA fragments of the probiotic strain L. rhamnosus DV - NRRLB-68023) or placebo for three months. The primary outcomes measure changes in hepatic fat content using magnetic resonance proton density fat fraction (MRI-PDFF) and ultrasonography. Secondary outcomes include changes in hepatic steatosis index (HSI), ALT, AST, GGT, liver stiffness (LS), TyG index, hs-CRP, total cholesterol (TC), triglycerides (TG), LDL-C, VLDL-C, HDL-C, waist circumference, BMI, body fat percentage, and visceral fat content."
339,"GPT4 Correct Assistant: The study aims to examine the effectiveness of Virtual Reality (VR) as an adjuvant therapy for sickle cell vaso-occlusive crisis (VOC) in pediatric emergency departments. The trial will compare two arms: a control arm with a retrospective chart review of patients with sickle cell VOC, and a trial arm with a prospective, convenience sampling of patients who will receive VR in addition to standard medical therapy. The primary outcomes measured are pain scores, patient disposition, length of stay in the emergency department, and time to emergency department disposition."
340,"GPT4 Correct Assistant: The study aims to investigate the efficacy of a web-based empowerment program for secondary cardiovascular prevention in patients post-acute myocardial infarction (AMI). The intervention consists of personalized, agreed, multidisciplinary, and blended educational, motivational, and coaching actions through a web-based interaction with the prevention team. The primary outcome measures include changes in BMI, systolic and diastolic blood pressure, LDL-cholesterol levels, glycemia levels, and glycosylated hemoglobin in diabetic patients at 12 months. Secondary outcome measures include lifestyle changes, adherence to a heart-friendly diet, smoking reduction or cessation, self-efficacy, health locus of control, and cardioprotective treatment adherence. The study plans to measure the long-term maintenance of controlled levels of risk factors at 48 months."
341,"GPT4 Correct Assistant: The study aims to investigate the accuracy of pocket-sized ultrasound (PsUS) in diagnosing pediatric elbow fractures. It consists of a feasibility phase and an active phase, both conducted in an urban pediatric emergency department. The feasibility phase involves training study providers in performing PsUS exams on children aged 1-16 years old with isolated acute elbow pain, while the active phase recruits children with the same condition to compare the initial test performance characteristics of PsUS to standard radiography. The primary outcome measure is the accuracy of PsUS elbow exams compared to X-ray or bedside nursemaid reduction. The study aims to determine the acceptability of the PsUS study training for obtaining adequate elbow images and compare the initial test performance characteristics of PsUS performed by bedside physicians to standard radiography in the diagnosis of pediatric elbow fractures."
342,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of two different orthoses, toe separator orthosis and dynamic orthosis, on individuals with hallux valgus, a painful condition affecting the big toe. The study includes participants aged 18-65 with mild to moderate hallux valgus deformity. The primary outcome measures are hallux valgus angle and plantar pressure. Secondary outcome measures include the Manchester-Oxford Foot Questionnaire, which assesses the functional and social effects of hallux valgus on walking, standing, and quality of life, and orthosis satisfaction."
343,"GPT4 Correct Assistant: The Prospective Evaluation of Speech Function Through Patient- and Parent-response Outcome Measurements in Velopharyngeal Insufficiency is a study evaluating the speech function of children with isolated or combined cleft palate due to velopharyngeal insufficiency. The intervention is a pharyngeal flap procedure, and the primary outcome measures are the patient response outcome measurement CLEFT-Q and the parent-response outcome measurement Intelligibility in Context Scale. The study aims to assess the change in speech function preoperatively and 1 year postoperatively."
344,"GPT4 Correct Assistant: This study aims to investigate the efficacy of probiotics for the treatment of alcohol use disorder among adult males, comparing the results with placebo and acceptance and commitment therapy (ACT) in a randomized controlled trial. The study will involve 120 participants, with 40 participants in each group (probiotics, placebo, and ACT). The primary outcome measures are the differences in severity of alcohol dependence, severity of alcohol withdrawal, and alcohol craving at four time points (baseline, 8 weeks, 12 weeks, and 24 weeks after the intervention). Secondary outcome measures include changes in depression, anxiety, serum pro-inflammatory cytokines, EEG monitoring, and gut microbiota composition. The study will follow an intention-to-treat analysis approach for the primary and secondary outcomes."
345,"GPT4 Correct Assistant: This is a randomized controlled trial comparing barbed absorbable suture with standard absorbable suture for vaginal cuff closure after total laparoscopic hysterectomy. The primary outcomes measured are vaginal cuff dehiscence at 30 and 90 days after surgery. Secondary outcomes include vaginal cuff complications, hospital stay, operative time, intraoperative blood loss, 30-day post-surgical morbidity, quality of life index, and sexual function at 90 days after surgery."
346,"GPT4 Correct Assistant: This clinical trial aims to test a new neurobiological model of gambling addiction, focusing on two opposite brain phenotypes in gambling addiction: striatal hyper-reactivity to reward combined with amygdala hypo-reactivity to emotional stimuli, and striatal hypo-reactivity to reward combined with amygdala hyper-reactivity to emotional stimuli. The study will involve 60 gamblers and 60 healthy controls, aged between 18 and 65. The primary outcome measures are striatal BOLD response to reward outcomes and amygdala BOLD response to emotional stimuli. The secondary outcome measures are the correlation between emotional states and gambling behavior in everyday life, measured using Ecological Momentary Assessment on participants' smartphones."
347,"GPT4 Correct Assistant: This clinical trial is a randomized controlled prospective study comparing 2D 4K and 3D HD laparoscopic imaging systems in bariatric surgery. Patients with a BMI greater than 35 and aged 18 or older are eligible for participation. The primary outcome measure is operation time, while secondary outcome measures include intraoperative and postoperative complications, and the workload of the operating surgeon. The study aims to determine the effectiveness and safety of using 2D 4K and 3D HD laparoscopic imaging systems in gastric bypass surgery."
348,"GPT4 Correct Assistant: This is a single-center, prospective, single-arm study to evaluate the efficacy and safety of Huaier granule in patients with stage I primary ovarian fallopian tube cancer after peritoneal cancer. The study includes patients aged 18 years or older with FIGO II-IV stage primary ovarian cancer, peritoneal, or fallopian tube cancer who are not suitable for chemotherapy or unwilling to receive it. The primary outcome measure is 1-year progression-free survival rate. Secondary outcome measures include progression-free survival, overall survival rate, quality of life score, pain score, and rates of adverse events and serious adverse events."
349,"GPT4 Correct Assistant: This study aims to assess the prevalence of Small Intestinal Bacterial Overgrowth (SIBO) in critically ill mechanically ventilated ICU patients and investigate its effects on ventilator-associated pneumonia, ICU length of stay, and all-cause in-hospital mortality rate. The study uses a modified hydrogen breath test for SIBO diagnosis. The primary outcome measure is the prevalence of SIBO, while secondary outcome measures include VAP, ICU LOS, and all-cause in-hospital mortality."
350,"GPT4 Correct Assistant: The study aims to investigate the presence of exercise-induced hypoalgesia (EIH) in patients after total knee arthroplasty (TKA) and whether it changes with exercise intensity. It is a randomized, single-blinded study with two groups: low-intensity exercises (LIE) and high-intensity exercises (HIE). The study measures the change in pain severity using a Visual Analog Scale and pressure pain thresholds using a handheld pressure algometer. The study includes patients aged 18-65 who have undergone primary unilateral total knee replacement surgery and are hospitalized for at least seven days. The intervention lasts for five days during the hospitalization period."
351,"GPT4 Correct Assistant: The Nigerian Breast Cancer Risk-Reduction Study aims to investigate the effects of risk assessment and counselling on adherence to risk reduction recommendations among female relatives of breast cancer patients in Southwestern Nigeria. The study includes women aged 20-75 who are first-degree relatives of breast cancer patients and have not previously been exposed to breast cancer risk assessment and counselling. Participants are randomly assigned to either standard care or standard care plus risk assessment and counselling. The primary outcomes measured are adherence to breast screening and lifestyle risk reduction recommendations at six months. Secondary outcomes include perception of familial breast cancer risk, knowledge of familial breast cancer risk, and knowledge, attitude, and perception towards genetic testing and breast cancer aetiology."
352,"GPT4 Correct Assistant: This study aims to investigate the interaction of CYP2B6 genotype and efavirenz on the metabolism, pharmacokinetics, and pharmacodynamics of methadone and tizanidine in healthy volunteers. The study will enroll normal metabolizers, intermediate metabolizers, and poor metabolizers of CYP2B6 genotype. Participants will receive a single dose of methadone and tizanidine at baseline (control) and after 16 days of pretreatment with efavirenz (600 mg/day). The primary outcomes will be the treatment-to-control ratios of the area under the time concentration curve to infinity (AUC0-∞) of S- and R-methadone and tizanidine."
353,"GPT4 Correct Assistant: This clinical trial aims to evaluate serum magnesium levels in type 2 diabetes mellitus patients. The study includes female participants aged 30 years and above, excluding those with renal failure, type I diabetes, acute pancreatitis, hyperthyroidism, hyperparathyroidism, malignancies, loop/thiazide diuretics, Mg supplement, and Mg containing antacids use. The primary outcome measure is the percentage of magnesium evaluated over a 1-year period."
354,"GPT4 Correct Assistant: This clinical trial investigates the effect of Ophiochepalus striatus extract on serum IGF-1 and IL-6 levels in elderly patients with sarcopenia. The study includes participants aged 60 years and above, with sarcopenia diagnosed using AWGS criteria. The intervention involves administering Ophiochepalus striatus extract or placebo to participants for 14 days. The primary outcome measures are IGF-1 and IL-6 serum levels, while secondary outcome measures include SARC-F Score, muscle mass, muscle strength, and physical performance."
355,"GPT4 Correct Assistant: This study aims to evaluate the feasibility of using the 2Morrow Chronic Pain Self-Management Program, a mobile app, as a digital therapeutic for patients with chronic pain. The study is a 2-arm randomized control feasibility study, with one arm receiving the mobile app in addition to treatment as usual, and the other arm receiving treatment as usual alone. The primary outcome measure is the PROMIS Pain Interference Scale - Short Form 6b, and secondary outcome measures include the Patient Health Questionnaire 9 (PHQ-9) and Generalized Anxiety Disorder 7 (GAD-7). The study will enroll participants aged 18 years and older with a diagnosis of chronic pain, and will measure outcomes at baseline, 1 month, 3 months, and 6 months after enrollment."
356,"GPT4 Correct Assistant: The Stentless Florence Robotic Intracorporeal Neobladder (FloRIN) clinical trial is a study designed to compare the effectiveness of stentless and stented Florence robotic Intra Corporeal Neobladder configurations in patients with diagnosed bladder cancer. The trial includes two participant groups: the experimental group, which undergoes stentless FloRIN, and the active comparator group, which undergoes stented FloRIN. The primary outcome measure is the rate of mid-term complications within six months, while the secondary outcome measure is the rate of perioperative complications within seven days."
357,"GPT4 Correct Assistant: The study aims to compare the effects of different storage conditions on removable retainers, specifically wet and dry storage. The primary outcome measure is the microbial colony counts of removable retainers in wet and dry storage conditions. Secondary outcome measures include surface roughness, colour stability, compressive strength, and OHRQoL (Oral Health-Related Quality of Life) of participants storing their retainers in dry and wet conditions. The study involves 24 participants who will be randomly assigned to four groups: Hawley retainers in dry storage condition, Hawley retainers in wet storage condition, Vacuum-formed retainers in dry storage condition, and Vacuum-formed retainers in wet storage condition. The study will measure the outcomes at baseline, 3 months (T1), and 6 months (T2)."
358,"GPT4 Correct Assistant: The study aims to test the feasibility of a new model of continuity of nutrition care for older adults diagnosed with malnutrition. The model involves cross-referrals and data transfer between acute care hospitals and community meal provision organizations, with the goal of increasing referrals, improving food security, and enhancing quality of life. The study will use a stepped wedge cluster-randomized trial design, with all sites starting in the control condition and then implementing the new model in a staggered approach. The primary outcomes measured include quality of life, sustainability, and changes in the percent of patients receiving nutrition care and meals."
359,"GPT4 Correct Assistant: This clinical trial aims to investigate the hemodynamic effects of modulating circulating ketone bodies with 1,3-butanediol in patients with chronic heart failure (NYHA class II-III) and left ventricular ejection fraction (LVEF) <40%. Participants will be randomly assigned to receive either 1,3-butanediol or a placebo, with the primary outcome measure being cardiac output, measured by left ventricular outflow tract velocity-time integral (LVOT VTI) and heart rate (HR), over a 6-hour period. Secondary outcome measures include stroke volume, heart rate, LVEF, changes in circulating 3-hydroxybutyrate (3-OHB), and changes in free fatty acids (FFA)."
360,"GPT4 Correct Assistant: This clinical trial, titled ""Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty,"" aims to investigate the efficacy of subpectoral bupivacaine in managing pain during and after adolescent reduction mammaplasty surgery. The study will randomize participants into either the study group, receiving subpectoral bupivacaine, or the control group, receiving saline. The primary outcome measure is post-operative pain score, while secondary outcome measures include narcotic use, length of stay in the post-anesthesia care unit, return to full activity, and demographics. The study will enroll female patients aged 13-21 undergoing bilateral reduction mammaplasty at Connecticut Children's between 1/1/2022-12/31/2025."
361,GPT4 Correct Assistant: This clinical trial aims to evaluate the radiobiological effects of skin toxicities in breast cancer patients receiving pencil beam scanning proton therapy with the Spot Delete technique. The study will compare the extent of skin reactions in patients using this technique to historical data from patients who underwent regular proton therapy without the technique. Digital photographs of the treatment area will be taken to assess radiation dermatitis using the Common Terminology Criteria for Adverse Events (CTCAE) ver. 5.0 and the Radiation Dermatitis Severity (RDS) scoring system. The study will measure the reduction in radiation dermatitis and investigate the relationship between the linear energy transfer (LET) of the proton beam and skin reactions.
362,"GPT4 Correct Assistant: This is a multicenter, non-inferiority, randomized controlled trial comparing the effectiveness of generic cetrorelix acetate and reference cetrorelix acetate for ovarian stimulation using a gonadotropin-releasing hormone (GnRH) antagonist protocol in women undergoing in vitro fertilization (IVF). The study includes women aged 20-42 who have not been treated for hydrosalpinges, endometriosis, recurrent spontaneous miscarriage, endometrial pathology, uterine malformations, endocrine diseases, or other systemic diseases. The primary outcome measure is the cumulative live birth rate through study completion, an average of 18 months."
363,"GPT4 Correct Assistant: This clinical trial aims to evaluate the safety and tolerability of combining peposertib and low-dose pegylated liposomal doxorubicin in patients with advanced sarcoma. The primary objectives are to determine the recommended phase 2 dose (RP2D) and identify the maximal tolerated dose (MTD) of the combined treatment. Secondary objectives include assessing the pharmacokinetics of the drugs, estimating the objective response rate and progression-free survival in patients with leiomyosarcoma treated with the combination, and testing hypotheses related to the susceptibility of soft tissue sarcomas with homologous recombination deficiency to the treatment."
364,"GPT4 Correct Assistant: The study aims to examine the implementation strategy and benefits of a free online Zoom t'ai chi and qigong gentle movement and meditation program in reducing back pain and improving sleep and quality of life among those with chronic back pain. The study will use a prospective, randomized controlled trial design with two groups: a t'ai chi and qigong exercise (treatment) group and a waitlist control group. The primary outcome measure is the change in Oswestry Disability Index (ODI) 3 months after intervention. Secondary outcome measures include changes in visual analog scale (VAS) back and leg pain, SF-36, Short Form Health Survey questionnaire, and Pittsburgh Sleep Quality Index."
365,"GPT4 Correct Assistant: The EMBOL-AF study is a multicenter, international, observational study designed as a retrospective registry to investigate the characteristics of systemic arterial embolic events after treatment of atrial fibrillation by catheter ablation. The primary objectives are to study the acute clinical profile, symptoms, signs, and results of image techniques of stroke/TIA associated with AFAbl, the acute therapeutic management of these events, and the sequelae and clinical consequences at 3 months of follow-up. The secondary objectives are to study whether the risk of stroke/TIA is more frequently associated with any AFAbl technique, whether the severity of stroke/TIA is associated to any specific AFAbl technique, whether other measures associated with AFAbl procedures have any impact on the incidence and severity of stroke/TIA, and to assess the incidence, management, and outcomes of embolic events (particularly stroke and TIA) after AFAbl. The study will include patients who have undergone catheter AFAbl and have experienced stroke/TIA after the procedure."
366,"GPT4 Correct Assistant: This clinical trial aims to evaluate patient-reported outcome measures (PROMs) during accelerating the en-masse retraction of upper anterior teeth using a low-intensity direct electrical current. The study will involve patients with class II malocclusion, division 1, aged between 17 and 25 years. Participants will be randomly assigned to either an experimental group using electrical stimulation or a control group using traditional retraction. The primary outcome measures are the perception of pain and discomfort, assessed using a visual analog scale. Secondary outcome measures include perception of burning, swelling, chewing ability, speech ability, analgesic consumption, patient satisfaction, ease of the procedure, the possibility of repeating the procedure, and recommendation of the procedure to a friend."
367,"GPT4 Correct Assistant: This is a single-site, non-randomized prospective observational study of men with prostate cancer to evaluate whether baseline plasma Amyloid-beta 42/40 (Aβ42/40) ratio is associated with cognitive decline in men upon starting ADT. The study also aims to evaluate whether ADT is associated with a decline in plasma Aβ42/40 ratio and whether intensified ADT (iADT) receipt is associated with greater cognitive decline compared to ADT. The primary outcome measures include the proportion of participants with cognitive decline, mean cognitive decline, and proportion of participants with cognitive impairment after ADT. Secondary outcome measures include change in mean plasma Aβ42/40 ratio, mean cognition score, and mean study partner-reported cognition score."
368,"GPT4 Correct Assistant: The High-dose Cephalexin for Cellulitis (HI-DOCC) trial aims to compare the effectiveness of high-dose (1000 mg QID) and standard-dose (500 mg QID) cephalexin in treating non-purulent cellulitis in adult patients. The study is a multicenter, parallel-arm, double-blind, randomized trial, with a total of 446 patients (223 per group) included. The primary outcome measure is oral antibiotic treatment failure within 7 days. Secondary outcomes include clinical cure, clinical response, unplanned healthcare visits, unplanned hospitalization, adverse events, antibiotic intolerance, antibiotic allergy, medication adherence, and health-related quality of life. The trial aims to determine if high-dose cephalexin is superior to standard-dose cephalexin in treating cellulitis, which could potentially reduce unnecessary IV antibiotic use, hospitalization, and costs."
369,"GPT4 Correct Assistant: This study aims to determine the Turkish validity and reliability of the Health Literacy Scale for Acute Complications of Type 1 Diabetes for Children (8-12 years) and to provide a diabetes health literacy box game to 8-12 school age children diagnosed with Type 1 diabetes. The study is conducted in two stages to evaluate the effect of educational games on acute complications of diabetes and health literacy in children. The experimental group participates in three meetings, playing the diabetes health literacy board game, while the control group fills data collection forms and receives the board game after all data is collected. The study measures the validity and reliability of the Health Literacy Scale for Acute Complications of Type 1 Diabetes for Children (8-12 Years) in Turkish and evaluates the health literacy of children with Type 1 diabetes (8-12 years) using the Literacy Scale for Acute Complications of Diabetes for Children with Type 1 Diabetes (8-12 years) scale."
370,"GPT4 Correct Assistant: This is a randomized controlled clinical trial comparing biofilm accumulation on the surface of zirconia vs. titanium implants in patients with implant infection. The study will be conducted in the Master of Oral Surgery and Implantology of the Faculty of Dentistry of the Complutense University of Madrid. The primary outcome measure is the total amount of biofilm on implants placed prior to crown placement, at 6 months and 1 year after final crown placement. The study will include 30 participants, with 15 in each group (zirconia and titanium implants)."
371,"GPT4 Correct Assistant: The study ""Scentsational Smiles: The Impact of Aromatherapy on Alleviating Dental Anxiety in Children"" aims to investigate the effects of aromatherapy on dental anxiety in children aged 6-9 years. The intervention groups are rosemary and lemongrass oil, which the children inhale for 3 minutes before dental anesthesia and extraction. The primary outcome measures include pulse rate, oxygen saturation, blood pressure, and pain level using the Wong-Baker Scale."
372,"GPT4 Correct Assistant: This clinical trial investigates the effect of puzzles on nursing students' learning concepts related to vital signs. The study uses a randomized controlled trial design with first-year nursing students from Bilecik Şeyh Edebali University Nursing Department. The experimental group will use puzzles for two weeks, while the control group will receive normal education. The primary outcome measure is students' knowledge test successes, which will be assessed after five weeks."
373,"GPT4 Correct Assistant: This study aims to determine the effect of a motivational interview-based online intervention program on smartphone addiction and sleep quality levels in nursing students. The intervention group will participate in a motivational interviewing and training program based on the Transtheoretic Model, while the control group will receive no intervention. The primary outcome measures are the Smartphone Addiction Scale Short Form (SAS-SF) and the Pittsburgh Sleep Quality Index (PSQI). The study will assess the effectiveness of the motivational interviewing and training program in improving smartphone addiction and sleep quality among nursing students."
374,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of Potassium-titanyl Phosphate (KTP) Laser alone versus KTP Laser combined with Ivermectin 1% cream in treating facial rosacea. The study is a randomized split-face trial with a primary outcome measure of relative decrease of erythema on the side treated with KTP laser and ivermectin 1% cream compared to laser alone, assessed by Normalized Erythema Index (NEI) at 16 weeks. Secondary outcome measures include assessment of erythema by Skin Redness Index (SRI) and Clinical Erythema Assessment (CEA), clinical improvement of skin lesions by Physician Global Assessment (PGA), patient satisfaction by Visual Analogue Scale (VAS), change in telangiectasia severity by telangiectasia grading scale (TGS), and reduction in papules, papulopustules, face swelling, redness, and purpura as assessed by the patient."
375,"GPT4 Correct Assistant: The study aims to investigate cerebral glucose metabolism in patients with neurodegenerative diseases and head trauma using FDG PET scans. It includes participants aged 18 years and above, with a diagnosis of neurodegenerative disease. The primary outcome measure is the measurement of brain areas with hypo or hyper regional metabolism using FDG PET scans. The study will analyze the distribution pattern of the FDG tracer to identify regions of altered brain function specific for each clinical condition. The study will continue for 4 years."
376,"GPT4 Correct Assistant: The COVID-19 ANtibody Responses in Cystic Fibrosis (CAR-CF) study is a prospective, longitudinal cohort study that aims to investigate SARS-CoV-2 seroprevalence changes over time and its clinical impact on people with Cystic Fibrosis (pwCF). The study will be conducted over a 3-year period, enrolling pediatric and adult pwCF from participating CF centers. Participants will donate blood samples at their routine clinic visits, and serum from these samples will be tested for SARS-CoV-2 antibodies. The study will also collect clinical data from patient health records and analyze seroprevalence and antibody levels according to natural infection and vaccination status."
377,"GPT4 Correct Assistant: The study aims to evaluate the use and reproducibility of duplex ultrasound to provide indices of left common iliac vein (CIV) diameter in patients with unexplained left leg swelling, potentially aiding in the diagnosis of May-Thurner Syndrome (MTS). The study is a non-randomized, open-label trial that includes two participant groups: symptomatic (with unexplained left leg swelling) and asymptomatic (without left leg swelling). The primary outcome measure is the left CIV diameter, and the secondary outcome measure is the inter- and intra-operator variation of the diameter measurement using duplex ultrasound. The study is designed to assess the diagnostic utility of duplex ultrasound in the context of MTS and to determine the reproducibility of the measurements."
378,"GPT4 Correct Assistant: This clinical trial aims to study the health-related quality of life of patients with symptomatic convergence insufficiency. The study includes participants aged 8-15 years old with myopia and convergence insufficiency. The intervention consists of behavioral visual training in the hospital for the training group, while the control group does not receive visual training. The primary outcome measures are changes in EuroQol five dimensions questionnaire (EQ-5D-5L) score and Short Form 6D (SF-6D) questionnaire score at 3 months compared to baseline."
379,"GPT4 Correct Assistant: The Sentinel Lymph Node Mapping and Detection With Indocyanine Green and Spy-Phi Handheld Camera Technology in Early-Stage Vulvar Cancer (PILOT) trial aims to compare the detection rate of sentinel lymph nodes using Indocyanine green (ICG) dye versus blue dye in patients with early-stage vulvar cancer. The study will measure the primary outcome of detection rates at the patient level and the hemi-pelvis level, as well as secondary outcomes of sensitivity, specificity, and negative predictive value. The trial will enroll patients aged 18 or older with early-stage squamous cell carcinoma of the vulva without suspicious lymph nodes at palpation or imaging."
380,"GPT4 Correct Assistant: This is a crossover, experimental, randomized, double-blind trial aiming to compare the effects of different neuromuscular electrical stimulation (NMES) protocols on evoked torque, muscle fatigue, sensory discomfort, and peripheral oxygen extraction in the triceps surae muscle. The study includes healthy participants aged 18-40 years who are physically active and meet specific eligibility criteria. The trial consists of five sessions with a seven-day gap between them, where participants undergo various NMES protocols, including Russian current, Aussie current, and pulsed current with 500 µs and 200 µs phases. Primary outcome measures include submaximal and maximum voluntary isometric contractions of the triceps surae, while secondary outcome measures include sensory discomfort, electromyographic signals, and peripheral oxygen extraction."
381,"GPT4 Correct Assistant: This clinical trial investigates the metabolic effects of a four-week lactate-ketone ester supplementation in participants with obesity. The study is a randomized, double-masked, crossover trial, with participants receiving either the lactate-ketone ester supplement or a placebo. The primary outcome measure is insulin sensitivity, while secondary outcome measures include differences in lipolysis rate, body weight and composition, gastric emptying rate, cardiac output, left ventricular ejection fraction, tricuspid annular plane systolic excursion, global longitudinal strain, mitral inflow velocities, mitral plane velocities in the lateral mitral annulus, global work index, changes in blood concentrations of various metabolic markers, mood, anxiety, supplement tolerability, and control of eating."
382,"GPT4 Correct Assistant: This study aims to explore the impact of FitnessGenes' platform on NHS staff's health and wellbeing. The 6-week study will involve participants completing a pre-trial questionnaire, DNA test, and feedback questionnaires at various time points. The primary outcome measure is the 5-Item World Health Organisation Well-being Index (WHO-5), which will be assessed at baseline, 3 weeks after receiving genetic results, and at a 3-month follow-up. The study aims to evaluate changes in subjects' well-being and the effectiveness of personalized insights and recommendations using genetic and lifestyle data."
383,"GPT4 Correct Assistant: This study aims to identify volatile organic compounds (VOCs) in breath samples as a diagnostic tool for invasive pulmonary aspergillosis (IPA) in patients with acute myeloid leukemia (AML) or those who are planned to undergo hematopoietic stem cells transplantation (HCT). The study is a prospective longitudinal study involving patients aged 18 years or older with a new diagnosis of AML or planned HCT, who have a chest CT performed within 30 days from sampling. Breath samples will be collected for VOC analysis at baseline and at the time of IPA diagnosis. The primary outcome measure is the diagnosis of IPA, defined according to the updated EORTC criteria. The study seeks to identify VOC profiles predictive of IPA in breath samples, with the potential application of this diagnostic tool in the early detection and management of IPA in immunocompromised patients."
384,"GPT4 Correct Assistant: This clinical trial is titled ""Psoas Tenotomy Under Ultrasound"" and is designed to study the effectiveness of a new ultrasound-guided ilio-psoas tendon tenotomy technique in treating hip injuries. The study includes patients 18 years and older with an indication for psoas tenotomy for ilio-psoas conflict after total hip replacement. The primary outcome measure is the success rate of the new technique, which will be assessed by the disappearance of the ilio-psoas conflict after surgery. Secondary outcome measures include pain experienced by the patient, Oxford Hip Score, Harris Hip Score, Postel and Merle Aubigne score, technical difficulty of the surgical procedure, operative time, installation time, total blood loss, length of hospital stay, scarring after surgery, quality of life, patient satisfaction with the results, subjective value of the hip, forgotten hip sensation, and the Forgotten Hip score. The trial also evaluates early and late surgical complications and the rate of patients requiring rehabilitation."
385,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of different local anesthetic volumes for thoracic paravertebral block (TPVB) in post-thoracotomy analgesia. The trial participants, aged between 18 and 80 years, undergoing elective thoracotomy surgery, are randomly assigned to receive TPVB with 20 ml, 25 ml, or 30 ml of 0.25% bupivacaine under real-time ultrasound guidance. The primary outcome measures are pain scores assessed at various time points after surgery, while morphine consumption is the secondary outcome measure."
386,"GPT4 Correct Assistant: This clinical trial aims to investigate the role of muscle vibration in improving the sense of fatigue in patients with Multiple Sclerosis (MS). The study is an interventional type, where eligible subjects undergo intensive multidisciplinary training for 4 weeks, with an additional vibration treatment in the experimental group. The primary outcomes measured are changes in mobility and postural control, while secondary outcomes include changes in fatigue and quality of life. The study will compare the results of the experimental group with a control group that undergoes traditional rehabilitation treatment without the application of vibrations."
387,"GPT4 Correct Assistant: The study aims to estimate the maximum tolerated dose (MTD) of osimertinib, cetuximab, and tucatinib in participants with EGFR-mutant non-small cell lung cancer (NSCLC) who have acquired resistance to EGFR-tyrosine kinase inhibitor (TKI). The secondary objectives include evaluating the toxicities of the combination and obtaining preliminary assessments of anti-tumor activity. The study is a dose-escalation study of tucatinib and cetuximab, with patients receiving osimertinib, tucatinib, and cetuximab in cycles of 28 days. The study is designed for participants with Stage IV or recurrent/metastatic histologically confirmed NSCLC with specific EGFR mutations. The primary outcome measure is dose-limiting toxicity, while secondary outcome measures include incidence of adverse events, objective response rate, and progression-free survival."
388,"GPT4 Correct Assistant: This clinical trial aims to study the diagnostic efficacy of transbronchial cryobiopsy compared to traditional transbronchial lung biopsy in monitoring complications of lung transplantation. The study includes participants aged 18-65 who have undergone lung transplantation and have unexplained pulmonary function decline, acute/chronic clinical lung injury, or new pulmonary infiltrates. The primary outcome measure is the diagnostic yield of transbronchial cryobiopsy for diagnosing lung transplantation rejection, compared to traditional transbronchial lung biopsy. Secondary outcome measures include the incidence of complications, biopsy sample area, number of alveoli and blood vessels in the biopsy sample, and the percentage of lung parenchyma without artifacts in the biopsy sample."
389,GPT4 Correct Assistant: This is a study investigating selective fetal growth restriction (sFGR) in monochorionic twins. The study aims to improve outcome prediction at the time of sFGR diagnosis and explore the potential benefits of additional ultrasound parameters to enhance the accuracy of the classification system. It will also examine the impact of sFGR on parental mental health and parent-to-infant attachment. The study will follow participants for two years after birth to assess neurodevelopment and examine histological placental examinations for better understanding of the pathophysiology.
390,"GPT4 Correct Assistant: The TransHealthGUIDE study aims to assess the effectiveness of an interactive educational digital platform in reducing suicidal ideation and improving mental health outcomes in gender-diverse youth aged 15-25 years and their caregivers. The study will randomize participants into immediate access or deferred access groups, with both groups receiving usual care. The primary outcome measure is suicidal ideation, while secondary measures include depression, anxiety, perceived family acceptance, and self-harm. The study will follow participants for 12 months, with assessments conducted every 3 months."
391,"GPT4 Correct Assistant: This clinical trial aims to phenotype patients with alcohol and cannabis use disorders using the Addictions Neuroclinical Assessment. The study includes two participant groups: AUD (Alcohol Use Disorder) and CUD (Cannabis Use Disorder). The intervention is Cognitive Behavioral Therapy (CBT) for 12 weeks, with additional motivational enhancement therapy for the CUD group. The primary outcome measures include changes in binge drinking days, cannabis use frequency, average drinks per day, amount of cannabis used per week, and self-reported alcohol and cannabis cravings. Secondary outcome measures include retention in treatment, changes in depressive and anxiety symptoms, and quality of life."
392,"GPT4 Correct Assistant: The study aims to investigate the impact of positive, neutral, and negative expectation speech on pain intensity in patients with chronic low back pain (CLBP) undergoing spinal manipulative therapy (SMT). This is an exploratory randomized clinical trial with a blinded assessor. Participants will be randomly assigned to one of three groups: positive expectation, neutral expectation, or negative expectation. Each group will watch a short video delivering their assigned message regarding SMT and then receive one session of SMT. The primary outcome measure is pain intensity assessed using the Numeric Pain Rating Scale (NPRS). Secondary outcome measures include global perceived effect of improvement, patient expectations regarding SMT, and perception of empathy in the therapeutic encounter."
393,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of transcranial focused ultrasound (tFUS) on fronto-striatal resting state functional connectivity in healthy individuals. The study includes two participant groups: one receiving active tFUS and another receiving sham tFUS. The primary outcome measure is resting state functional connectivity between the stimulation target (Nucleus Accumbens) and connected areas, including the prefrontal cortex, hippocampus, amygdala, and sensory areas of the brain. The study is designed as a parallel assignment with randomized allocation and single masking."
394,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of semaglutide on intracranial blood flow and brain-barrier permeability in patients with type-2 diabetes. The study is a randomized, double-blind, and placebo-controlled trial, with participants randomized to receive either semaglutide or a placebo for one year. The primary outcomes measured are intracranial blood flow and blood-brain barrier permeability. The study aims to determine if semaglutide can improve intracranial blood flow condition and reduce blood-brain barrier permeability, potentially leading to stroke reduction in type-2 diabetic patients."
395,"GPT4 Correct Assistant: This retrospective cross-sectional study aims to investigate the prevalence or occurrence of upper gastrointestinal diseases in patients younger than 50 years old who underwent simultaneous gastroscopy and colonoscopy. The study includes patients with normal colonoscopy examinations and those with colorectal polyps. The primary outcome measures include the prevalence of various upper gastrointestinal diseases such as Helicobacter pylori, atrophic gastritis/intestinal metaplasia, reflux esophagitis, Barrett's esophagus, peptic ulcer, gastric polyps, low-grade intraepithelial neoplasia (LGIN), and high-grade intraepithelial neoplasia (HGIN)."
396,"GPT4 Correct Assistant: The study aims to compare the outcomes of the screw tent pole technique and the autogenous bone block technique for augmentation of atrophied anterior maxilla. The primary objective is to assess bone gain, and the secondary objective is to evaluate bone quality. The study is a randomized clinical trial with a parallel group design and a 1:1 allocation ratio. The participants are systemically healthy patients with atrophied anterior maxilla, aged 18 or older. The primary outcome measure is the amount of bone gain before and after 6 months of the surgical procedure, and the secondary outcome measure is bone quality evaluation through bone core biopsy after 6 months post-operative."
397,GPT4 Correct Assistant: This clinical trial aims to evaluate the CD4/CD8+ Interferon Gamma Release Assay (IGRA) as a diagnostic test for monitoring anti-tuberculosis treatment. The study includes participants with pulmonary tuberculosis and healthy subjects. The primary outcome measures the correlation between changes in IFN-γ response in the first antigen tube (TB1) and the newly added antigen tube (TB2) with the reference standard of treatment response (culture conversion) in smear-positive and smear-negative/culture-positive pulmonary TB cases at various time points.
398,"GPT4 Correct Assistant: The study aims to evaluate the accuracy of brain response to mechanical and radiofrequency stimuli in humans. It will assess the effect of stimulation intensity on signal parameters, such as EP latency and amplitude, and explore the relationship between these parameters and psychophysical results. The study will be conducted in two experimental settings, using radiofrequency and pinprick stimuli, and will include participants aged 18-60 who are willing and able to comply with the experiment's instructions. The primary outcome measures are the latency and amplitude of EPs evoked by RF and pinprick stimuli, while the secondary outcome measures include changes in responses to somatosensory stimuli with pinprick thresholds and conduction velocity in radiofrequency stimuli."
399,"GPT4 Correct Assistant: The study aims to characterize the biomechanical coupling of the brain and skull in human volunteers with and without a history of traumatic brain injury (TBI) using magnetic resonance elastography (MRE). The study will include 25 mild TBI patients with a history of acute TME (TME+), 25 TME-patients (mild TBI patients without TME), and 25 healthy controls. The study will determine if local shear strain measures within the cortex during MRE are altered in TME+ subjects. The study endpoints are the completion of the MRE visit for each volunteer, and the MRE data will be used to characterize the skull-brain interface using the amplitudes and temporal delays of translation and rotation across the interface."
400,"GPT4 Correct Assistant: The study aims to investigate the impact of home blood pressure monitoring in addition to pharmacist care compared to usual care on blood pressure control in women with elevated blood pressure. The study is a randomized controlled trial with a 24-week intervention period and a final follow-up at 52 weeks. Participants are randomly assigned to either the experimental group, which receives home blood pressure monitoring and enhanced pharmacist care, or the active comparator group, which receives usual pharmacist care. The primary outcome measure is the difference in change in systolic blood pressure between the two groups. Secondary outcome measures include proportion of patients at their blood pressure target, percentage of home blood pressure readings recorded, adherence to medications, changes to antihypertensive medication regimen, lifestyle changes, and patient satisfaction with pharmacist care."
401,"GPT4 Correct Assistant: The study, titled ""Moderate Alcohol Consumption and Heart Function in Patients With a Recent Myocardial Infarction: a Multicentre Randomized Controlled Trial,"" aims to investigate the effects of moderate alcohol consumption on heart function in patients who have recently experienced a myocardial infarction. The trial includes participants aged 18 and older who have been hospitalized for acute ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI) within 365 days prior to screening. Participants are randomly assigned to either moderate alcohol consumption (1 standard unit a day for 12 months) or abstinence (no alcohol beverages for 12 months). The primary outcome measure is the change in left ventricular ejection fraction between the baseline visit and the 12-month visit."
402,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy and safety of lactulose for bowel preparation in patients with inflammatory bowel disease (IBD). The study includes patients aged between 16-75 years who require a colonoscopy. Participants are randomly assigned to either take lactulose or 3L-polyethylene glycol for bowel preparation. The primary outcome measures are effective preparation rate, incidence of adverse events, and taste score evaluated by patients. Secondary outcome measures include the effects of bowel preparation drugs on liver function and serum electrolyte."
403,"GPT4 Correct Assistant: This study aims to understand the sleep status and quality of life of older adults at risk of metabolic syndrome in the community and explore the effect of aromatherapy on improving sleep quality and quality of life. It is a longitudinal study with a prospective randomized control design, involving 64 elderly participants from two community bases in Hsinchu City. The experimental group receives aromatherapy using lavender essential oil, while the control group receives a placebo, sweet almond oil. The study measures the quality of sleep and quality of life of the participants using various questionnaires, with results expected to show better outcomes for the experimental group."
404,"GPT4 Correct Assistant: The study is a randomized controlled clinical trial comparing the effectiveness of soft tissue augmentation with a free connective tissue graft (CTG) and a collagen matrix (Fibro-Gide) in patients with soft tissue thickness deficiency in the distal part of the lower jaw. The trial included 32 patients, randomly assigned to either the CTG group (n=16) or the collagen matrix group (n=16). The primary outcome measure was the amount of soft tissue thickness gain at 90 days post-surgery, and secondary outcome measures included the amount of soft tissue thickness gain at 180 days, pain severity, collateral edema, analgesic consumption, quality of life, attached mucosa measurement, and soft tissue aesthetics."
405,"GPT4 Correct Assistant: This clinical trial, titled ""Evaluation of Ultrasound Sonography Intraoral Guided Injection of Botulinum Toxin in Masseter Muscle,"" aims to evaluate the effectiveness of intraoral trigger point injections by Botox for treating myofascial pain. The study includes participants aged 18-60 of both sexes, with definite diagnoses of myofascial pain and no history of invasive procedures in the related masseter muscle. The study is designed as a randomized, parallel assignment, single-masked trial with two arms: transcutaneous injection and intraoral injection. The primary outcome measure is the pain score on a 10-point visual analogue scale (VAS) at 6 weeks post-injection, while the secondary outcome measure is the OHIP-14 scale at the same time frame."
406,"GPT4 Correct Assistant: The OptimizeD study aims to determine the optimal treatment for patients with moderate to severe depression in primary care settings in low-resource settings. The study involves 510 patients aged 18-99, randomly assigned to either the Healthy Activity Program (HAP) or antidepressant medication (fluoxetine). The primary outcome measure is depression severity, assessed using the Patient Health Questionnaire-9 (PHQ-9). Secondary outcome measures include cost-effectiveness, depression remission, Generalized Anxiety Disorder Assessment (GAD-7), WHO Disability Assessment Schedule II (WHODAS-II), Minimal Clinically Important Difference (MCID), and World Health Organization Well-Being Index (WHO-5)."
407,"GPT4 Correct Assistant: The ILLUMINA-1 study is a clinical trial investigating the pulmonary immune cell-microbiome interactions in patients with acute respiratory distress syndrome (ARDS). The trial aims to explore immune cell populations, their function and differentiation, and the lung microbiome in both none-to-mild and moderate-to-severe ARDS patients. The study will collect data through bronchoalveolar lavage, blood samples, oral and nasal swabs, and electronic health records. The primary outcome measures are lung microbiome and lymphocyte populations. Secondary outcome measures include cell differential counts, trans-compartmental fluxes, auto-antibodies against type I interferons, white blood cell counts, cytokines, and number and characterizations of respiratory pathogens and microorganisms."
408,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of 3D printed insoles versus prefabricated insoles in flatfoot subjects. The study will recruit healthy adults with flexible flat feet and randomly assign them to either wear 3D printed insoles or prefabricated insoles. Subjective feedback will be collected at week 0 and week 4, and statistical analysis will be used to determine if there is a significant difference in the responses of the two groups. The primary outcome measures include Visual Analog Scale for pain assessment at weeks 0 and 4, and Quebec User Evaluation of Satisfaction with Assistive Technology questionnaire at week 4."
409,GPT4 Correct Assistant: This cross-sectional study investigates the pulmonary ventilation function between patients with primary and recurrent incisional hernia. Patients with abdominal incisional hernia and complete CT imagings and pulmonary function test data were included in the study. The primary outcome was recurrence after repair. The study aimed to analyze the pulmonary ventilation function as the main observation index and compare the pulmonary ventilation dysfunction between the primary and recurrent groups.
410,"GPT4 Correct Assistant: This clinical trial aims to determine the frequency and mapping of unstable coronary plaques in patients at intermediate and high risk of coronary artery disease, as well as their evolution under treatment. The study uses a 18F-Na PET scan to diagnose and monitor coronary plaque instability. The primary outcome measures include calcium score variation, coro-scanner plaque size and density variations, coro-scanner morphological aspect variations, coro-scanner variations in terms of stenosis diameter, and 18F-Na PET scan binding and intensity variations. Secondary outcome measures include the effectiveness of the primary cardiovascular prevention strategy, comparison of symptom evolution between study cohort and historical cohort, and the rate of occurrence of cardiovascular events of interest."
411,"GPT4 Correct Assistant: The White Matter Hyperintensity Shape and Glymphatics study aims to investigate the association of WMH shape with abnormalities in small vessel morphology, and the association between WMH shape and cognition/other cerebral small vessel disease markers. The study is a cross-sectional design conducted at Leiden University Medical Center and Alrijne Hospital Leiden, including patients over 65 years of age. The study utilizes 3T and 7T MRI scans, neuropsychological assessments, and general baseline data to analyze the associations. The primary outcome measures include WMH shape, brain clearance, perivascular space volume, and WMH subtypes."
412,"GPT4 Correct Assistant: The study aims to evaluate the clinical auxiliary value of an Intelligent Endoscopic Diagnosis System developed and verified based on deep learning in the endoscopic diagnosis of esophagogastric junctional adenocarcinoma. The study includes patients aged 18 and above with pathologically confirmed esophageal gastric junction adenocarcinoma or clear benign manifestations. The primary outcomes measured are sensitivity, specificity, negative predictive value, positive predictive value, and accuracy."
413,"GPT4 Correct Assistant: This is a Phase III clinical study evaluating the efficacy and safety of FRSW107, a recombinant human coagulation factor VII-Fc fusion protein, in pediatric patients with severe hemophilia A. The study aims to determine the annual bleeding rate, joint bleeding rate, and safety profile of FRSW107 in this patient population. Participants must be between 1 and 12 years old, have a confirmed diagnosis of severe hemophilia A, and have a history of treatment with coagulation factor VI. The primary outcome measure is the annual bleeding rate during the treatment period, while secondary outcome measures include annual joint bleeding rate, frequency and severity of adverse events, and incidence of positive FVIII inhibitor."
414,"GPT4 Correct Assistant: The study aims to assess differences in acceptability and feasibility of music therapy sessions played live versus a recording at a palliative care ward. Participants will undergo music therapy and complete questionnaires, while autonomic response markers will be measured using a commercially available tracker. The primary outcome measure is intervention-specific acceptability, while secondary outcomes include subjective quality of life, symptom severity, anxiety and depression levels, and autonomic response markers."
415,"GPT4 Correct Assistant: This clinical trial investigates the effect of reusing operative supplies on cataract surgery and its impact on climate change. The study compares two groups: one where the surgeon changes the gown and glove between each case, and another where the surgeon changes only the glove. The primary outcome measure is the rate of postoperative complications, specifically endophthalmitis, over a six-month period. The trial aims to determine if reusing supplies can reduce financial costs and environmental waste while maintaining patient safety."
416,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of deep transcranial magnetic stimulation (dTMS) targeting the anterior cingulate cortex (ACC) in the treatment of anorexia nervosa (AN). The study is a randomized controlled trial with a parallel assignment and double masking, where participants are divided into either the dTMS treatment group or the pseudo-stimulation group. The primary outcome measure is body mass index (BMI), and secondary outcome measures include eating disorder examination questionnaire (EDE-Q6.0), eating disorder inventory (EDI-II), Beck depression inventory (BDI), and Beck anxiety inventory (BAI). The study will provide insights into the potential of ACC-targeted dTMS as a novel intervention for AN."
417,"GPT4 Correct Assistant: This clinical trial aims to assess the acceptability of expanded newborn screening to parents in France with or without genetics in the first line. The study involves various participant groups, including parents of newborns, parents of children aged 1 week to 3 years, and parents of children diagnosed later based on clinical signs for diseases not included in the French newborn screening list but included in the lists of other countries. The study uses a combination of self-administered questionnaires and semi-structured interviews to measure parental acceptability of expanded newborn screening and explore parental representations on the extension of newborn screening. The primary outcome measure is a mixed matrix of parental acceptability dimensions of expanded newborn screening, with secondary outcome measures including parental acceptability scores, typology of parental acceptability scores, and parent opinions on newborn screening for specific diseases. The study is expected to provide insights into the acceptability of expanded newborn screening and the use of genetic testing in newborn screening."
418,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of T'ai Chi and Qigong Rehabilitation in treating low back pain. The study is a randomized trial with parallel assignment and an open-label design. Participants are aged 18 or older and have experienced low back pain for at least 6 weeks. The intervention consists of a 12-week, twice-per-week t'ai chi and qigong gentle movement and meditation program, while the control group receives usual care. The primary outcome measure is the change in the Oswestry Disability Index 3 months after intervention, and secondary outcome measures include changes in visual analogue scale (VAS) for low back pain, VAS leg pain, SF-36 Short Form Health Survey questionnaire, and 9-Item Pittsburgh Sleep Quality Index."
419,"GPT4 Correct Assistant: This observational study aims to assess the safety and efficacy of CD19-directed CAR T cell therapy in people living with HIV (PLWH) who have been diagnosed with B-cell lymphoid malignancies. The study includes participants aged 18 years and older, who have a documented history of HIV infection and have received CD19-directed CAR T cell therapy for acute lymphoblastic leukemia, diffuse large B-cell lymphoma, high-grade B-cell lymphoma, transformed follicular lymphoma, or primary mediastinal B-cell lymphoma. The primary outcome measure is the rate of toxicities related to CAR19 therapy, while secondary outcome measures include changes in CD4 count, absolute lymphocyte count, HIV viral load, and overall response."
420,"GPT4 Correct Assistant: The Prospective Evaluation of AI R&D Tool for Patient Stratification - Mechanism of Action Evaluation in Triple Negative Breast Cancer (PEAR-MET) is a UK-based observational study aiming to discover novel predictive biomarkers to guide treatment decision-making and improve progression-free survival (PFS) and overall survival (OS) in patients with advanced triple negative breast cancer (TNBC). Patients undergo a mandatory biopsy and blood collection before starting their next line of therapy. The research sample is run on Pear Bio's test, while the patient receives therapy as per their physician's choice. Treatment response data is collected at multiple timepoints to analyze the study's secondary and tertiary objectives. The study uses Pear Bio's organ-on-a-chip technology to provide a physiological 3D environment for drug dosing experiments and to test immunotherapies. The primary outcome measure is to establish a functional dose of each commonly used FDA-approved therapeutic or combination of therapies. Secondary outcome measures include complete response rate correlation accuracy, PFS prediction accuracy, and OS prediction accuracy."
421,"GPT4 Correct Assistant: The clinical trial, titled ""Delayed Elective Surgery in Inflammatory Bowel Disease - a Health Economic Analysis Including Quality of Life,"" aims to study the effects of delayed surgery on the health economy and quality of life in patients with Inflammatory Bowel Disease (IBD). The study includes two participant groups: those waiting for surgery and those who have undergone surgery. The primary outcome measure is the impact on health economy and quality of life when surgery is delayed, with a focus on patients with IBD. Secondary outcome measures include socioeconomic differences in delayed surgery and the effects of waiting for surgery on complications and failures. The study is planned to be completed by 2026."
422,"GPT4 Correct Assistant: The clinical trial aims to study the role of myeloid-derived suppressor cells (MDSCs) and cancer stem cells in non-small cell lung cancer (NSCLC) and their cross-talks. The study will assess the non-immunological pro-tumor functions of MDSC isolated from lung cancer patients. The trial will include patients with lung carcinoma surgically treated by surgery only, and the primary outcome measure will be a comparative analysis of the modifications of phenotype and functions of lung cancer cell lines when exposed to MDSC extracted from patient tumor tissue."
423,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of substituting unsweetened sparkling water for sugar-sweetened beverages (SSB) on sweetness perception and physiological measures of glycemia in adolescents at risk for diabetes. The study involves participants aged 10-21 years who are overweight or obese and high consumers of SSB. The intervention is the replacement of SSB with unsweetened sparkling water, and the primary outcome measures are changes in 2-hour glucose concentration, dietary consumption of SSB and sparkling water, insulin sensitivity, and glycemic variability. Secondary outcome measures include changes in flavor perception of beverage sweetness, blood pressure, blood triglycerides, and waist circumference. The study is designed as a prospective, before and after, cohort study with an open-label intervention."
424,"GPT4 Correct Assistant: This study is a randomized, monocentric, double-blinded, prospective trial to evaluate early wound healing after the utilization of Novosyn® Quick and Monosyn® Quick suture materials in resective periodontal surgery. The study includes adult patients undergoing resective periodontal surgery, excluding emergency surgeries, pregnant or breastfeeding patients, and patients with hypersensitivity or allergy to the suture material. The primary outcome measure is the early wound healing score (EHS) evaluated in patients 10 ± 5 days postoperatively. Secondary outcome measures include various postoperative complications and patient satisfaction."
425,"GPT4 Correct Assistant: This is a small, unicentric, randomized, controlled clinical study investigating the use of Coenzyme I for injection in the treatment of sudden sensorineural hearing loss. Patients aged 18 years and older with sudden deafness were included in the study. Participants were randomly divided into an experimental group, which received conventional treatment plus Coenzyme I for injection, and a control group, which received conventional treatment only. The primary outcome measures were pure tone average (PTA) and speech recognition rate, while secondary outcome measures included tinnitus handicap inventory, tinnitus visual analogue scale, and severity of ear fullness. The study collected data at baseline, and at 3, 7, 14, 30, and 90 days after treatment."
426,"GPT4 Correct Assistant: The study aims to transfer the genetic newborn screening for cystinosis and primary hyperoxaluria to other laboratories and to establish the scientific basis for screening these diseases. The study investigates whether the inclusion of these diseases into general newborn screening is recommended. The study includes newborns whose parents wish to participate in the pilot project and have provided informed consent. The screening is performed using molecular genetic methods, and the detection rate is expected to be above 95% for both diseases. The study's primary outcome measures include the number of newborns with confirmed diagnoses of cystinosis and primary hyperoxaluria, as well as the number of newborns with heterozygous mutations."
427,GPT4 Correct Assistant: This is a randomized controlled trial investigating the effect of negative pressure drainage on reducing surgical site infections in patients undergoing abdominal surgery. The study is double-blinded and participants are randomized into two groups: those with negative pressure drainage in their surgical wounds and those without. The primary outcome measures are the rates of surgical site infections at various post-operative time points. Secondary outcome measures include length of hospital stay and quality of life scores.
428,"GPT4 Correct Assistant: This study aims to compare the immune modulation effects of palbociclib, ribociclib, and abemaciclib with letrozole in neoadjuvant treatment for ER+/HER2- early breast cancer. The study will collect tumor tissue, blood, and stool samples before treatment, after 2 weeks of treatment, and after 12 weeks of treatment at the time of surgery. The immune modulation effects will be compared between the three treatment groups through breast tumor RNAseq analysis. The primary outcome measure is the expression of immune-related signature change after different CDK4/6 inhibitor treatments by RNAseq."
429,"GPT4 Correct Assistant: The Caring for Caregivers and People Living With Dementia Under Home-Based Primary Care trial aims to develop and test the feasibility of implementing the Dementia Care Quality at Home intervention in two HBPC practices. The intervention includes a standardized assessment tool, seven modules to optimize the well-being of PLWD and their caregivers, and a team-based case conference approach. The study measures feasibility, acceptability, and fidelity of the intervention for both caregivers and practices."
430,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of resistance training and flexibility training on self-efficacy, symptoms, and maternal quality of life in postpartum depression. The study includes 36 postpartum females aged 20-40, divided into two groups: one receiving resistance training and the other receiving flexibility training. The primary outcome measures are exercise self-efficacy, Epidemiological studies Depression scale, and MAPP-QOL (Maternal Postpartum Quality Life Questionnaire). The study is designed as a randomized, parallel assignment, single-masked trial with an intervention period of 8 weeks."
431,"GPT4 Correct Assistant: This clinical trial, titled ""Surface Hardness and Wear Resistance of Prefabricated and CAD/CAM Milled Artificial Teeth: A Cross-over Clinical Study,"" aims to investigate the surface hardness and wear resistance of prefabricated and CAD/CAM milled artificial teeth in completely edentulous patients. The study is designed as a randomized, crossover assignment with an open-label design. Participants will be randomly assigned to either a prefabricated artificial teeth group or a CAD/CAM milled artificial teeth group. Both groups will undergo surface hardness tests and wear resistance measurements at the time of insertion and after 6 months of use. The primary outcomes measured will be the wear resistance of denture teeth and the surface hardness of the denture artificial teeth."
432,"GPT4 Correct Assistant: The ARIADNE trial is a randomized, parallel-assignment study for patients with HER2-positive breast cancer. The experimental arm includes treatment with trastuzumab deruxtecan (T-DXd), while the active comparator arm uses standard treatment (TCHP or PCHP). The study aims to determine the pathologic complete response (pCR) of HER2-enriched patients and the event-free survival (EFS) among other secondary outcomes. The trial will enroll eligible patients and randomly assign them to either the experimental or active comparator arm. The study will measure the primary outcome, pCR of HER2-enriched patients, and various secondary outcomes, such as EFS, biomarkers, and overall survival. The trial aims to provide valuable insights into the efficacy of trastuzumab deruxtecan in treating HER2-positive breast cancer patients."
433,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of intraoperative use of intravenous anesthetic propofol and inhaled anesthetic sevoflurane on the prognosis of patients undergoing surgery for primary brain, liver, lung, and ovarian cancer tumors and investigate its mechanism of action. The study will measure overall survival, presence of disease progression, postoperative complications, and Karnofsky performance status score. Participants will be randomly assigned to either the propofol group or the sevoflurane group, with different anesthesia administration methods."
434,"GPT4 Correct Assistant: The ""Take Care! - Dissemination Von Bewegungsbezogener Gesundheitskompetenz in Der Pflegeausbildung"" clinical trial aims to examine the effects of promoting physical activity-related health competence (PAHCO) in vocational education of nursing care. The study is a cluster-randomized controlled trial (cRCT) with 16 schools in Bavaria, Germany. The trial includes three intervention groups and a control group. The intervention groups involve cooperative planning for promoting PAHCO, expert-based intervention by physical activity specialists, and expert-based intervention by teachers. The control group receives regular education and health promotion. The primary outcome measures include physical activity-related health competence, psychological movement quality, and quality physical activity. Secondary outcome measures include general health status, work ability, musculoskeletal complaints, and physical job stress in nursing."
435,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of a Diosmin/Hespiridin combination on clinical outcomes in patients with Polycystic Ovary Syndrome (PCOS). The study includes a total of three arms: 1) Metformin + Combined oral contraceptive (standard therapy), 2) Diosmin/Hespiridin + Combined oral contraceptive, and 3) Diosmin/Hespiridin + Metformin + Combined oral contraceptive combination. The primary outcomes measured are improvement of inflammation and improvement of glycemic index, while secondary outcomes include improvement of PCOS status levels and improvement of patient's quality of life. The study duration is 4 months."
436,"GPT4 Correct Assistant: The study aims to develop a fluorescent visualization system for non-visible lung cancer nodules to improve lung cancer detection and treatment during minimally invasive surgery. The investigators propose using Cetuximab-IRDye800 as an optimal tracker during minimally invasive lung surgical procedures. The study will determine the optimal time window and dose of the tracker, and assess the tracker's ability to detect neoplastic localization in lymph nodes and lung parenchyma not predictable pre-operatively."
437,"GPT4 Correct Assistant: The SPARROW trial is a multicenter, randomized controlled trial that aims to evaluate the additional value of pre-emptive antibiotic treatment on clinically relevant organ/space surgical site infections (OSIs) in patients undergoing pancreatoduodenectomy with a high risk for contaminated bile. The study compares perioperative versus pre-emptive antibiotic treatment during five postoperative days after pancreatoduodenectomy in patients with a high risk for contaminated bile. The primary endpoint is the rate of clinically relevant organ/space surgical site infection (OSI) between patients with perioperative versus prolonged antibiotic prophylaxis within 90 days after surgery. Secondary endpoints include various complications, reinterventions, ICU admission, length of hospital stay, readmission, and in-hospital and 90-day mortality."
438,GPT4 Correct Assistant: This is a Phase 2 basket trial investigating the efficacy of a combination of oral sotorasib and intravenous panitumumab in patients with advanced solid tumors carrying the KRAS G12C mutation. The primary outcome measure is the objective response rate based on RECIST v1.1.
439,"GPT4 Correct Assistant: This clinical trial investigates the use of a novel volume-stable collagen matrix (VCMX) in treating single gingival recession associated with non-carious cervical lesion partially restored. The study is a randomized clinical trial with two arms: 1) Partial restoration with coronally advanced flap (CAF) and 2) Partial restoration with CAF and VCMX. The primary outcome measure is recession reduction, and secondary outcome measures include dentine hypersensitivity, patient-centered esthetic evaluation, oral health impact profile, patient discomfort, number of analgesics, percentage of complete combined defect coverage, modification of the root coverage esthetic score, and clinical parameters. The study includes participants aged 20-60 years who are systemically healthy and have no signs of active periodontal disease."
440,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of different nutritional support modes based on nutritional risk screening on the postoperative nutritional status of patients with gastrointestinal cancer. The study includes 302 patients with gastrointestinal tumors admitted to the First Hospital of Shanxi Medical University. Patients are divided into an intervention group (NRS2002 ≥ 3 and PG = SGA ≥ 4) and a control group (NRS2002 < 3 or PG = SGA < 4) based on nutritional risk screening results. The intervention group receives a dietary supplement and conventional nutritional intervention, while the control group receives conventional nutritional intervention only. The primary outcome measures are nutritional risk screening 2002 and patient-generated subjective nutrition assessment. Secondary outcome measures include dietary energy and protein intake, nutrient energy and protein intake, prealbumin, albumin, hemoglobin, BMI, fat-free body weight, grip strength, and walking time."
441,"GPT4 Correct Assistant: This clinical trial, titled ""Effect of the Abutment-Prosthesis Connection on Marginal Bone Loss and Gingival Sealing Around Dental Implants,"" aims to investigate the impact of the Connect® abutment-prosthesis connection on marginal bone loss and gingival sealing around dental implants. The study includes participants aged between 18 and 75 years, with various jaw conditions requiring multiple implants. The trial is designed as a randomized, parallel assignment study with a single masking, comparing the Connect® abutment-prosthesis connection with a conventional multi-unit abutment-prosthesis connection. The primary outcome measure is the peri-implant marginal bone level measured by standardized periapical radiography at one year. Secondary outcome measures include the relative abundance of microbial species in the peri-implant sulcus evaluated by next-generation sequencing methods and the concentration of pro-inflammatory markers in the peri-implant sulcus evaluated by multiplex techniques methods, also at one year."
442,GPT4 Correct Assistant: This clinical trial aims to assess the clinical feasibility of a wearable ultrasound patch for monitoring blood flow in the brain compared to a conventional transcranial Doppler probe. The study includes 60 participants with varying physiological parameters. The primary outcome measure is the agreement between the two devices in measuring blood flow spectrum of different arterial segments. The study will last for 1.5 years.
443,"GPT4 Correct Assistant: This clinical trial aims to evaluate the clearance rate of uremic toxins using hemodiafiltration with endogenous reinfusion (HFR) in maintenance hemodialysis patients. The study includes participants aged 18-75 years with a history of maintenance hemodialysis for at least 3 months. The primary outcome measures are the concentrations of β2-microglobulin (β2-MG), indoxyl sulfate, and λ-free light chain (λFLC) before and after HFR. Secondary outcome measures include single-compartment urea clearance index (spKt/V), Urea Reduction Ratio, and other middle molecules and macromolecular uremic toxins. The study is designed as a single-group assignment with an open-label model."
444,"GPT4 Correct Assistant: This is a clinical trial investigating the effect of multi-kinase inhibitors (including sorafenib, lenvatinib, and donafenib) in combination with bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma (HCC) at high risk of recurrence after liver transplantation. The study aims to determine the one-year recurrence-free survival rate and other outcomes such as recurrence-free survival duration, overall survival, and graft survival. Participants must be between 18 and 75 years of age and have undergone liver transplantation within 4 to 8 weeks prior to enrollment. The study compares the efficacy and safety of the drug combination with no adjuvant therapy."
445,"GPT4 Correct Assistant: The Psychosocial Transitional Group Pragmatic Trial is a study conducted at a free-standing rehabilitation hospital in Toronto, Canada, with inpatients who have experienced limb loss. The goal of the study is to evaluate the effectiveness of a weekly supportive-expressive group therapy (SEGT) intervention in improving mental health outcomes, specifically anxiety and depression, compared to treatment as usual (TAU). The study includes 130 participants, with 65 assigned to SEGT and 65 to TAU. The SEGT approach fosters mutual support, promotes openness, and emotional expression, and has been modified to address the needs of limb loss inpatients. The primary outcomes measured are changes in Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder 7-Item (GAD-7) scores. Secondary outcomes include changes in Post-Traumatic Stress Disorder Checklist-5 (PCL-5) and Generalized Self-Efficacy Scale (GSE) scores."
446,"GPT4 Correct Assistant: The Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D) study is an open-label randomized controlled trial designed to investigate the effects of 20% human albumin infusions on coagulation parameters in patients with decompensated cirrhosis of the liver. The study will include patients aged 18-70 years with decompensated cirrhosis and serum albumin levels ≤ 2.5 g/dl. The primary outcome measures are changes in clotting time, clot formation time, and maximum clot formation in both groups at 1 week. Secondary outcome measures include changes in inflammatory parameters, endothelial dysfunction, pulmonary function, renal function, and adverse effects of human albumin solution. The study will also assess the change in albuminome in both groups and the duration of hospital stay and mortality at 28 days."
447,"GPT4 Correct Assistant: This prospective study aims to evaluate the significance of MRD (minimal residual disease) monitoring in patients with potentially resectable stage III non-small cell lung cancer (NSCLC) without EGFR/ALK mutation. The study involves 65 patients who underwent neoadjuvant therapy and were followed up for 2 years. Patients were either in the complete resection group or the concurrent radio-chemotherapy group, receiving immunotherapy alone or chemotherapy combined with immunotherapy. The primary outcome measure is disease-free survival (DFS) using RECIST, while secondary outcome measures include overall survival (OS), prediction of recurrence by positive MRD, pCR rate of MRD-negative patients, negative MRD rate in pCR patients, and 2-year DFS of ctDNA-negative patients in the operation group and inoperable group."
448,"GPT4 Correct Assistant: This is a single-center prospective cohort study comparing the effectiveness of ciprofol and propofol for sedation in hypotensive ICU patients. The study includes participants aged 18 and older, who require sedation for comfort, safety, and facilitation of life support measures. The primary outcome measure is the proportion of patients meeting the RASS sedation score within 24 hours. Secondary outcome measures include dosages of propofol or ciprofol, dosages of norepinephrine, duration of mechanical ventilation, incidence of adverse events, ICU length of stay, and mortality rate."
449,"GPT4 Correct Assistant: The NECO2 trial is a pilot study evaluating the effectiveness of laparoscopy with CO2 insufflation in premature infants with ulcerative necrotizing enterocolitis (ECUN) requiring surgical treatment. The study is a randomized, controlled trial with two parallel arms: laparoscopy + laparotomy and laparotomy alone. The primary outcome measure is the blood C-reactive protein level between Day 0 and Day 2 postoperatively. Secondary outcomes include postoperative inflammatory response, mortality, morbidity, and other clinical parameters. The study aims to assess the short-term evolution of premature infants with ECUN and the tolerance of laparoscopy."
450,"GPT4 Correct Assistant: This is a randomized controlled trial comparing intense pulsed light and diode laser for hair removal in the axilla region for women. The study includes four treatment sessions, with a follow-up at 30 days and six months after the end of treatment. The primary outcome measures are hair count and global aesthetic improvement scale. Secondary outcome measures include hair thickness, pain score, quality of life, satisfaction level score, and self-esteem scale."
451,"GPT4 Correct Assistant: The PRecisiOn Medicine In StrokeE (PROMISE-BD-100) study aims to assess the evolution of plasma brain-derived tau (BD-tau) levels in 100 patients with acute ischemic stroke. The study will measure BD-tau levels every hour from admission to 48 hours after stroke onset. The primary outcome is the characterization of the evolution of BD-tau levels, including the time point when they start to rise, the type of rise, and until when they continue to rise. Secondary outcomes include 90-day functional outcome, infarct progression, and other measures of brain injury and complications."
452,"GPT4 Correct Assistant: This clinical trial aims to investigate the use of artificial intelligence (AI) in accelerating the learning curve for mastering contrast-enhanced ultrasound of thyroid nodules. The study includes patients with thyroid nodules who underwent conventional ultrasound, contrast-enhanced ultrasound, and fine-needle aspiration biopsy. The primary outcome measures include the area under the curve from the receiver operating characteristic curve analysis and the number of cases and case time assessed by the faculty responsible for the training program. The study will use AI to assist radiologists in extracting ultrasound features of thyroid nodules in a training set, an internal test set, and an external test set."
453,"GPT4 Correct Assistant: The study aims to investigate the use of AI-powered artificial vision for visual prostheses in patients with blindness. Participants will be implanted with a visual prosthesis (e.g., Argus II, Cortivis) and will undergo psychophysical testing to assess their ability to perform simple perceptual and behavioral tasks using different stimulus encoding methods. The study will measure the effect of stimulation strategy on phosphene shape, pattern discrimination accuracy, and scene understanding performance. The primary outcome measures are phosphene shape, pattern discrimination accuracy, and scene understanding performance, which will be assessed through participant drawings, verbal responses, and eye-tracking equipment."
454,"GPT4 Correct Assistant: This clinical trial investigates the surveillance of regional nodal basins in patients with primary high-risk cutaneous squamous cell carcinoma of the head and neck. The study aims to assess the number of participants with nodal metastasis and compare it with historical controls. Participants are divided into three groups based on the stage of their cancer. The primary outcome measure is the number of participants with nodal metastasis, and the secondary outcome measures include the number of participants with local recurrence of squamous cell carcinoma, disease-specific death, and overall survival rate. The study uses ultrasound surveillance every 6 months and regular visits every 3 months for a duration of 2 years."
455,"GPT4 Correct Assistant: This clinical trial is aimed at studying the salivary biomarkers of gastroesophageal reflux (GER) in infants. It is a non-randomized, parallel assignment study with an open-label design. The trial includes two participant groups: cases with GER or GERD symptoms and controls who are healthy infants. The study measures the prevalence of GERD in infants with symptoms of gastroesophageal reflux and investigates the biochemical profile of saliva samples collected from healthy, GER, and GERD patients. The trial aims to develop non-invasive diagnostic strategies and detect personalized therapeutic treatments for GER in infants."
456,"GPT4 Correct Assistant: The Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18) study aims to compare the effects of Empagliflozin and Dulaglutide on liver fat fraction in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). The study is a prospective open-label observational study conducted in Greece, involving three groups: Empagliflozin group, Dulaglutide group, and Control group. The primary outcome measure is the change in liver fat fraction after 52 weeks of treatment. Secondary outcome measures include changes in HbA1c, BMI, Fatty Liver Index, Fibrosis-4 Index, Aspartate Aminotransferase to Platelet ratio Index, and NAFLD Fibrosis Score."
457,"GPT4 Correct Assistant: This clinical trial aims to assess the feasibility of surgical exposure of palatally impacted upper canines using an open-eruption technique with a surgical template, in comparison to the conventional free-hand method. The study includes 20 patients in each group, and the primary outcome measures are the success of the intervention and the success of the open eruption technique. The secondary outcome measures include surplus costs of surgical planning, duration of the surgical intervention, postoperative pain, and intra- and postoperative complications."
458,"GPT4 Correct Assistant: The CAVEAT trial aims to determine the feasibility of administering the manualized brief psychotherapy Clinician Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) to violence-exposed mothers and their young children (ages 1-5 years) in an ambulatory care center of a Swiss public hospital. CAVEAT is a combination of four evidence-based psychotherapy models for parents, infants, and young children. The study will assess the feasibility of recruitment procedures, adherence to treatment, and the appropriateness of evaluation measures. There is no control group or intervention in this pilot feasibility study."
459,"GPT4 Correct Assistant: This study aims to reduce the risk of Type 2 diabetes (T2D) and pre-diabetes in Asian women and their children with a history of gestational diabetes (GDM) in Singapore. It is a 1-year randomized controlled trial with a 3-year follow-up period, assessing the efficacy of a holistic lifestyle digital intervention focusing on diet, physical activity, sleep, and mental well-being. The intervention includes virtual coaching sessions, an Oura ring for activity tracking, and the HAPPY App for health promotion and data display. The primary outcome is the incidence of T2D confirmed by a 2-hr 75g Oral Glucose Tolerance Test (OGTT) over a 4-year period. Secondary outcomes involve changes in cardiometabolic variables, women's body composition, mental well-being, and the health and well-being of their children."
460,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of dry heat and dry cold application on pain, anxiety, and fear levels in school-age children before blood sample collection. The study involves three groups: control, dry heat application, and dry cold application. The primary outcome measure is the Wong Baker Faces Pain Rating Scale, and the secondary outcome measures are the Child Fear Scale, Child Anxiety Scale, and Medical Procedures Fear Inventory."
461,"GPT4 Correct Assistant: The trial aims to evaluate the safety profile of chemoreduction with intra-arterial melphalan, followed by ruthenium brachytherapy, for patients with choroidal melanoma who would otherwise need enucleation due to tumor size. The study enrolls patients with a diagnosis of choroidal melanoma with a thickness equal to or greater than 8 mm. The intervention includes intra-arterial administration of 7.5 mg of melphalan, followed by ruthenium brachytherapy after 4±1 weeks. The primary outcome measure is the determination of treatment safety through electroretinography (ERG) exams at baseline, 1, 3, and 6 months after the intervention. Secondary outcome measures include reduction of tumor size, best corrected visual acuity, signs of intraocular inflammation, treatment-related adverse events, and globe salvage rate."
462,"GPT4 Correct Assistant: The Trauma Registry in Villavicencio, Colombia is an observational retrospective trial aiming to analyze the incidence of trauma in a general hospital. The study includes patients admitted to the emergency ward due to trauma, with no age or sex restrictions. The primary outcome measure is the number of patients dead within 28 days or at discharge. Secondary outcome measures include hospital length of stay, need for ICU, ICU length of stay, need for mechanical ventilation, and length of mechanical ventilation. The study aims to provide essential information on the severity, mechanisms, type of population affected, immediate or consequential care delivered, and outcomes of trauma patients."
463,GPT4 Correct Assistant: The LSS-NIPT trial is a study for older adult veterans with Lumbar Spinal Stenosis. The intervention is Non-Invasive Postural Therapy (NIPT) which includes the use of DME and training to maintain flexion posture for six weeks. The study aims to measure the change in mobility by actigraph at Week 6 compared to baseline. Participants must be between 60 and 80 years old and have a diagnosis of Lumbar Spinal Stenosis as the cause of their symptoms.
464,"GPT4 Correct Assistant: This study is a pilot study assessing the effects of self-administered nitrous oxide (SANO) on urodynamic study (UDS) parameters in participants scheduled for UDS. The study aims to determine the effects of SANO on bladder capacity, intra-UDS pain, intra-UDS anxiety, post void residual, maximum flow rate, detrusor overactivity, and detrusor pressure at maximum flow. Participants will be randomized to receive SANO or oxygen during the two UDS runs, with the order of interventions being either SANO first, followed by oxygen, or oxygen first, followed by SANO. The study is designed to be supportive care and is a crossover assignment with triple masking."
465,"GPT4 Correct Assistant: This clinical trial, titled ""Adverse Childhood Experiences, AdaPtatiOn and Breast Cancer,"" aims to investigate the relationship between adverse childhood experiences (ACEs), attachment styles, resilience, and quality of life in breast cancer patients in remission. The study includes women aged 18 and above who have had breast cancer and are in remission. The primary outcome measure is the quality of life assessed using the Short Form Survey 12 (SF-12 scale). Secondary outcome measures include fear of recurrence, fatigue, anxiety and depression, attachment, adverse childhood experiences, resilience, and RMSSD values. The study utilizes genetic measures, including biological and epigenetic assessments, to explore gene expression variations related to vulnerability/protection and the relationship between self-reported measures and epigenetic biomarkers."
466,"GPT4 Correct Assistant: This clinical trial aims to assess the real-world effectiveness of the Discovery™ AI-assisted polyp detector system during screening colonoscopy and compare the results between expert and non-expert endoscopists. The trial includes participants aged 45-89, with a focus on measuring adenoma detection rate (ADR), polyp detection rate (PDR), and diagnostic performance of the AI-assisted system. The study uses a crossover design with two intervention groups: HD-colonoscopy with AI-assisted polyp detector followed by HD-colonoscopy, and AI-assisted colonoscopy followed by HD-colonoscopy. The trial's primary outcome measures are ADR and PDR, while the secondary outcome measure is adenoma miss rate (AMR)."
467,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness and tolerability of a low glycemic index (LGI) diet in pregnant individuals with epilepsy. The study will enroll 21 participants, who will be divided into an intervention group (LGI diet) and a control group (standard diet). The primary outcome measures are diet tolerability, seizure frequency, gut bacteria composition, and metabolite alterations. The study aims to explore the potential benefits of the LGI diet in managing epilepsy during pregnancy and its impact on both mother and baby's health."
468,"GPT4 Correct Assistant: This study aims to investigate the feasibility of using mesothelin-targeted CAR-T cells as a neo-adjuvant treatment in patients with resectable pancreatic cancers. The research hypothesis is that EUS-guided injection of MSLN targeted CAR-T cells into pancreatic cancer can induce a tumor response, improve the rate of R0 resection, and translate into better patient survival. The study will measure primary and secondary outcomes such as pathologic response, radiological response, rate of R0 surgical resection, serious adverse events, and disease-free and overall survival."
469,"GPT4 Correct Assistant: The clinical trial aims to assess the efficacy of a decision support system (DSS) and a machine learning web application in promoting adherence to oral anticancer treatments among 100 metastatic breast cancer (MBC) patients over a three-month period. The DSS, named TREAT, is a web-based solution designed to assist patients in managing their oral treatment and enhancing adherence through evidence-based education. The machine learning web application focuses on predicting patients' risk factors for adherence, considering physical status, comorbid conditions, and short- and long-term side effects. The trial also aims to identify clinical, psychological, and quality of life predictors of adherence and evaluate their impact on the machine learning model."
470,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effects of weight bearing exercises with and without Jaffrey's core stability exercise training on dynamic balance and trunk muscle strength in children with Down Syndrome. The study includes children aged 4-10 years who can stand and walk, with a maximum of 4 weeks of intervention. The primary outcome measures are Pediatric Balance Scale and Trunk Control Measurement Scale."
471,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of melatonin, as a dietary supplement, on glycemic parameters, cardiovascular disease risk factors, bone metabolism markers, and quality of life in peritoneal dialysis patients. The study is a randomized, parallel assignment, quadruple-masked trial, comparing melatonin (5 mg) and placebo interventions. The primary outcome measures include serum concentrations of lipoprotein-a, malondialdehyde, high sensitivity c-reactive protein, soluble intercellular adhesion molecule-1, fasting glucose, pentosidine, carboxy-methyl lysine, procollagen 1 intact N-terminal propeptide, osteoprotegerin, tartrate-resistant acid phosphatase 5b, receptor activator of nuclear factor kappa-Β ligand, systolic and diastolic blood pressure, triglyceride, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Secondary outcome measures include serum concentrations of albumin, calcium, phosphorous, and intact parathyroid hormone. The study will last for 10 weeks."
472,"GPT4 Correct Assistant: The clinical trial is titled ""Optimization Strategy to Predict and Individualize Oxygen Delivery During Cardiac Surgery Under Cardiopulmonary Bypass."" It aims to study the effects of cardiopulmonary bypass (CPB) on patients undergoing elective cardiac surgery. The trial includes patients aged 18 to 100 years and excludes pregnant or breastfeeding individuals, off-pump cardiac surgery, and emergency surgeries. The primary outcome measure is the values of DO2 calculated with the CONNECT software, while the secondary outcome measures include the incidence of postoperative acute kidney injury, postoperative delirium, and vital status up to 28 days postoperative. The trial uses non-heparin-coated bypass circuits with an integrated phosphorylcholine-coated oxygenation system."
473,"GPT4 Correct Assistant: This clinical trial aims to investigate the changes in lumbar region temperature during auricular acupressure at the kidney point in healthy volunteers. The study participants will be randomly divided into two groups: one receiving auricular acupressure (AA) followed by sham auricular acupressure (SA) (AA-SA group), and the other group receiving SA followed by AA (SA-AA group). The primary outcome measures are the changes in temperature of the left and right lumbar regions during the procedure. The secondary outcome measure is the proportion of auricular acupuncture side effects."
474,"GPT4 Correct Assistant: The study aims to compare the effects of three different strategies of mean arterial pressure management during cardiopulmonary bypass (CPB) in patients undergoing cardiac surgery. The three strategies are: standard MAP (50-60 mmHg), high MAP (70-80 mmHg), and patient-tailored MAP (comparable to the patient's pre-operative MAP). The primary outcome measure is the peak serum lactate level during CPB, which will be compared among the three groups. Secondary outcomes include the area under the curve of serum lactate values during CPB, number of cases with serum lactate peak > 3 mmol/l during CPB, evaluation of intraoperative cerebral perfusion, intraoperative pulmonary perfusion, evaluation of postoperative low cardiac output syndrome, postoperative left ventricular ejection fraction, evaluation of pulmonary injury, postoperative acute kidney injury, postoperative gastrointestinal ischemia, hepatic function and coagulation indexes, evaluation of neurological dysfunction, in-hospital mortality, and mortality at 30 days after surgery."
475,"GPT4 Correct Assistant: This is a prospective observational study investigating the acute and subacute effects of furosemide on hemodynamics and pulmonary congestion in patients with acute heart failure. Participants receive 80 mg of furosemide via IV, and measurements of blood pressure, oxygen saturation, pulmonary fluid content, and ultrasound examination of heart and lungs are taken at various time points. The primary outcome measure is the change in pulmonary fluid content after furosemide administration, as measured by remote dielectric sensing (ReDS)."
476,"GPT4 Correct Assistant: This is a randomized controlled trial for university students with binge drinking behavior. The study aims to test a smartphone application for prevention. Participants are between 18 and 25 years old, with a history of binge drinking. The intervention includes blood microsampling for the measure of Phosphatidylethanol (PEth). The primary outcome measure is the change of the number of standard drinks per week over 30 months. Secondary outcome measures include changes in PEth concentration at various time points."
477,"GPT4 Correct Assistant: This clinical trial aims to evaluate the potential benefit of nitazoxanide in patients with type 2 diabetes mellitus. The study includes 35 patients in each group, with one group receiving the drug nitazoxanide in addition to their current treatment, while the other group receives only their current treatment. The primary outcome measure is glycemic control, assessed through fasting blood glucose and glycated hemoglobin levels. Secondary outcomes include insulin resistance, lipid profile, and serum levels of A-kinase anchoring protein 1 and asprosin. The study duration is 12 weeks."
478,"GPT4 Correct Assistant: This clinical trial aims to investigate clinical risk factors of autism and explore the changes in gut microbiome in Egyptian autistic children, aged 3-9 years, and their possible correlation with clinical outcomes and disease severity. The study will not involve any intervention and will collect stool samples for intestinal microbiome investigation and fecal metabolome analysis. The primary outcome measure is autism clinical risk factors, while the secondary outcome measures are intestinal microbiome and metabolome analysis."
479,"GPT4 Correct Assistant: This study aims to develop an internet-based self-help money management program to improve financial self-efficacy and its associated outcomes among adults with severe mental illness. The program will consist of 4 weekly modules and will be compared to a waitlist control group. The primary outcomes measured include change in financial self-efficacy, financial behaviour, financial attitude, and financial well-being. Secondary outcomes include psychological wellbeing, anxiety symptoms, depressive symptoms, and quality of life."
480,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of Startle Adjuvant Rehabilitation Therapy (START) in enhancing upper extremity function post-stroke. The study will be conducted in two phases: Aim 1, which evaluates the capacity of START to enhance training outcomes in individuals with stroke, and Aim 2, which assesses the generalizability of START training to untrained tasks. The primary outcomes measured will be changes in EMG onset, EMG amplitude, movement onset, and movement linearity during a functional reaching task. Secondary outcomes include retention in functional reaching task scores and skill transfer to untrained tasks. The trial will involve participants aged 18 to 99 years with a history of stroke and upper extremity impairment."
481,"GPT4 Correct Assistant: This clinical trial investigates the effects of endoscopic lung volume reduction on diaphragm function and conformation in patients with COPD. The intervention involves the insertion of endobronchial valves, and the study measures transdiaphragmatic pressure and diaphragmatic conformation before and 3 months after the intervention. The study is a prospective, single-group assignment, and open-label trial."
482,"GPT4 Correct Assistant: This is a randomized clinical trial examining the clinical performance of dual- and light-cure bulk-fill resin composites in Class II restorations over a two-year period. Participants must be between 21 and 50 years old with at least three permanent molars and premolars requiring Class II restorations due to primary carious lesions. The study compares the esthetic, functional, and biological properties of three different bulk-fill resin composites: Fill-Up, QuiXfil, and Tetric N-Ceram Bulk Fill. The primary outcome measures are assessed from baseline to the 2-year follow-up."
483,"GPT4 Correct Assistant: The NET RETREAT study is a phase II clinical trial comparing the effect of 177Lu-DOTATATE versus everolimus in patients with metastatic/unresectable midgut neuroendocrine tumors who have progressed following previous peptide receptor radionuclide therapy (PRRT). The primary objective is to evaluate the effect of these treatments on progression-free survival (PFS), while secondary objectives include evaluating the toxicity and safety of the treatments, the effect on overall response rate (ORR), overall survival (OS), post progression survival (PPS), time to second objective disease progression (PFS2), and patient quality of life. Patients are randomized to receive either 177Lu-DOTATATE or everolimus, with treatment continuing until disease progression or unacceptable toxicities."
484,"GPT4 Correct Assistant: The study aims to compare the effects of McKenzie extension exercises program and Mulligan techniques on chronic unilateral radicular low back pain. Patients aged 28-50 years with lumbar radiculopathy will be included, while those with fracture, trauma, inflammatory disorder, acute disc bulge, and lumbar instability will be excluded. Participants will be divided into two groups, with each group receiving either Mulligan techniques with manual traction or McKenzie extension exercises with manual traction for four weeks. Primary outcome measures include pain reduction (Numeric Pain Rating Scale), disability (Oswestry Disability Scale), and lumbar range of motion. The results will be analyzed using SPSS 29."
485,"GPT4 Correct Assistant: This is a Phase 2, multicenter, long-term, open-label extension trial evaluating the safety, tolerability, and efficacy of subcutaneous doses of TransCon CNP administered once weekly in children and adolescents with Achondroplasia. The study includes participants aged 3-15 years who have completed a previous clinical trial with TransCon CNP. The primary outcomes measured are safety and tolerability, while secondary outcomes include height Z-scores and annualized growth velocity. The trial is designed to assess the long-term effects of TransCon CNP treatment in this population."
486,"GPT4 Correct Assistant: This observational study aims to explore the impact of illness perceptions and coping strategies on the quality of life of patients with paroxysmal atrial fibrillation (PAF). The study includes participants aged 18-75 years who are able to read and write in Chinese. The primary outcome measure is the 12-item Short Form Health Survey (SF-12) which assesses physical and mental well-being. The study uses correlation and mediation analyses to examine the mediating effects of self-efficacy, coping, depression, and anxiety on the quality of life of patients with PAF."
487,"GPT4 Correct Assistant: The LORENA trial is a study investigating the use of transanal local excision for organ preservation in early rectal cancer without adjuvant treatment. The study aims to assess the primary outcome of the success rate of patients with no need for total mesorectal excision after follow-up. Secondary outcomes include postoperative complication rate, radicality of resection, histological poor outcome predictor rate, and radical rescue surgery specimen quality. The study includes patients with clinical staging cT1N0M0 rectal cancer, aged 18 or older, who undergo local excision as surgical treatment."
488,"GPT4 Correct Assistant: This study aims to evaluate the impact of different surgical strategies on outcomes in patients undergoing surgery for Type A Aortic Dissection (TAAD) and to investigate outcome predictors. The study includes four surgical intervention arms and measures primary outcomes such as operative mortality, rate of mesenteric ischemia, rate of permanent neurologic deficit, and rate of composite of Major Adverse Events within 30 days. Secondary outcomes include rate of transient neurologic deficit, rate of spinal cord injury, rate of acute kidney injury, rate of perioperative bleeding, and rate of reoperation for bleeding, among others. The study seeks to better understand the determinants of outcome in patients undergoing surgery for TAAD and to aid in the design of service delivery and improve outcomes for surviving patients."
489,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of virtual reality on academic stress and academic performance in physiotherapy and nursing students. The study consists of three groups: an experimental group that uses virtual reality to simulate exam experiences, an active comparator group that uses traditional guided visualization, and a control group with no intervention. The primary outcomes measured are intra-group and between-group changes in academic stress and perceived stress from the last month. Secondary outcomes include between-group differences in stress levels, blood pressure, maximal heart rate, and salivary cortisol levels just before exams. Additionally, between-group differences in exam qualifications will be considered."
490,"GPT4 Correct Assistant: This study compares the use of remimazolam and propofol as induction agents for morbid obesity patients undergoing laparoscopic sleeve gastrectomy. The primary outcome measure is the rate of hypotension event during anesthesia induction. Both experimental and control groups require 40 subjects each, considering a dropout rate of 10%. The study is designed as a randomized parallel assignment with single masking."
491,"GPT4 Correct Assistant: This study aims to determine the objective response rate, duration of response, progression-free survival, and overall survival of the drug combination of darolutamide, leuprolide acetate, and exemestane in patients with recurrent ovarian granulosa cell tumors. The study will also explore biomarkers predictive of response to the drug combination and elucidate the toxicities associated with the treatment. Patients will receive exemestane and darolutamide orally and leuprolide acetate intramuscularly, with cycles repeating every 28 days. The primary outcome measure is the objective response rate, with secondary outcomes including duration of response, progression-free survival, overall survival, and incidence of adverse events."
492,"GPT4 Correct Assistant: This study aims to evaluate the safety and effectiveness of combining chemotherapy (cisplatin and gemcitabine) with an anti-PD1 immune checkpoint inhibitor (nivolumab) in children, adolescents, and young adults with nasopharyngeal carcinoma (NPC). The primary objective is to determine the rate of Common Terminology Criteria for Adverse Events (CTCAE) grade 3 or higher immune-related adverse events (irAEs) during induction chemoimmunotherapy (CIT). Secondary objectives include estimating 2-year event-free survival (EFS), objective response rate (ORR), and feasibility of the induction regimen. The study also explores various exploratory objectives, such as estimating 5-year EFS and overall survival, comparing response assessed by FDG PET versus MRI, and evaluating treatment outcomes and quality of life."
493,"GPT4 Correct Assistant: This study is an observational cohort study investigating the effects of Elexacaftor/Ivacaftor/Tezacaftor (ETI) on gastrointestinal (GI) function, lung structure and function, and liver endpoints in children with cystic fibrosis aged 6 to 11 years. The study uses MRI to measure these endpoints and aims to determine if these measures are changed before and after starting ETI. The study is divided into a pilot phase and a main phase, with the pilot phase involving three children with CF and three healthy age and gender matched controls undergoing MRI scanning. If successful, the main phase will recruit 12 additional children with CF who will undergo the scanning protocol before starting ETI and then return for repeat scans approximately 6 months after starting ETI. The primary outcome measure is delta small bowel water (DeltaSBW), and secondary outcome measures include small bowel water content, liver volume, liver elastography, and lung ventilation."
494,"GPT4 Correct Assistant: This study aims to evaluate the analgesic efficacy and safety of caudal methylprednisolone in pediatric patients undergoing hypospadias surgical repair, compared to caudal dexamethasone. The primary outcome measure is the duration of analgesia, and secondary outcome measures include the severity of postoperative pain according to the FLACC score and side effects. The study is a randomized, double-blind, controlled bi-center study with participants aged 1 to 6 years."
495,"GPT4 Correct Assistant: This study is a prospective, randomized pilot trial evaluating the addition of hemodiafiltration (HDF) to ex-vivo lung perfusion (EVLP) and its impact on the regeneration of marginal donor lungs. The primary outcome measure is the suitability for transplantation of the lungs after 6 hours of EVLP with HDF. Secondary outcome measures include survival, length of mechanical ventilation, length of ICU stay, length of hospital stay, and lung function parameters at various time points post-transplantation."
496,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of white noise and multisensory stimulation in retinopathy examination on premature infants. The study participants are randomly assigned to three groups: the control group, the white noise group, and the multisensory stimulation group. The outcomes measured include physiological responses, behavioral indicators, and examination success rate. The findings of this study have the potential to contribute to the development of effective and well-tolerated retinopathy examination protocols for premature infants."
497,"GPT4 Correct Assistant: The study titled ""A Modified Calculation Formula for Meibomian Gland Grading"" aims to investigate Meibomian Gland Dysfunction in participants aged 18 to 80, with both sexes eligible for participation. The study involves two participant groups, one using the previous calculation formula and the other using a modified calculation formula. The primary outcome measures are the area of the Meibomian Glands (MGs) and the whole eyelids, as well as the WTW distance of the cornea. The study accepts healthy volunteers and measures these outcomes at baseline."
498,"GPT4 Correct Assistant: This is a randomized, single-blind clinical trial aimed at preventing oral mucositis in head and neck cancer patients undergoing radiotherapy. The study compares the efficacy of a zinc gluconate spray and a sodium bicarbonate rinse in reducing oral mucositis. The primary outcome measure is the presence of oral mucositis one week after the end of radiotherapy, while secondary outcome measures include the time of onset and severity of oral mucositis. The study includes patients aged 18 and above with head and neck cancer, who are able to self-apply the treatment."
499,"GPT4 Correct Assistant: This study is a cross-sectional clinical trial aimed at determining the predictive ability of a panel of biomarkers in saliva for healthy and periodontally affected subjects. The study includes participants diagnosed as periodontally healthy, gingivitis, treated periodontitis (stable/unstable), periodontitis stages I & II, or periodontitis stages III and IV. The primary outcome measure is the combination of salivary biomarkers, including C-reactive protein (CRP), triggering receptor expressed on myeloid cells-1 (TREM-1), interleukin (IL)-1beta, metalloproteinase (MMP)-8, IL-10, IL-6, monocyte chemoattractant protein-1 (MCP-1), Macrophage Inflammatory Protein-1 Alpha (MIP-1), interferon-gamma (IFN-gamma), osteoprotegerine (OPG), Receptor activator of nuclear factor kappa B ligand (RANKL), and Tumor Necrosis Factor-Alpha (TNF-alpha). Secondary outcome measures include age, gender, HbA1c, Finn-risk, blood pressure, patient's temperature, habits, plaque index, bleeding on probing, suppuration on probing, probing depth, recession, radiographic bone loss, and microbiological analyses."
500,"GPT4 Correct Assistant: This study aims to compare the effectiveness of a dual-hormone artificial pancreas system with a single-hormone system in adults with type 1 diabetes. The dual-hormone system uses insulin and glucagon for glucose control, while the single-hormone system uses insulin with rescue carbohydrate recommendations. The primary objectives are to evaluate the time spent below the target glucose range and the occurrence of hypoglycemic events. The study will involve 15 participants in a randomized crossover interventional design, with each participant undergoing two inpatient studies comparing the dual-hormone and single-hormone configurations."
501,"GPT4 Correct Assistant: This study aims to determine the effect of white noise, heart sound, and music on reducing neonatal pain during heel lance in infants. The study uses a randomized controlled experimental design with a sample of 84 infants with a gestational age of 28-42 weeks. The infants are exposed to white noise, heart sounds, or the music that the mother listened to most frequently during pregnancy for 10 minutes before, during, and 20 minutes after the procedure. The pain of the infants is measured using the Neonatal Infant Acute Pain Assessment Scale (NIAPAS), and the duration of the procedure and crying time are evaluated."
502,"GPT4 Correct Assistant: This clinical trial study aims to compare two training and supervision processes for facilitators of Caregiver Skills Training (CST). One group will receive training and supervision remotely, while the other group will receive face-to-face training and supervision. Both groups will undergo 15 hours of training, followed by 12 weeks of supervision. The study will measure the changes in caregiver skills and knowledge, parenting stress, and child adaptive behavior at baseline and week 12. The primary outcome measure is the change in caregiver skills and knowledge, while secondary outcome measures include parenting stress, Vineland Adaptive Behavior Scales, Social Communication Checklist, and Caregiver Diary scores."
503,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of transcranial electrical stimulation (TES) in addition to strengthening exercises for the functional recovery of subjects with subacromial pain syndrome. It is a randomized clinical trial with an experimental group receiving TES and a control group receiving a sham TES. The primary outcomes measured are changes in Pain and disability Index (SPADI), Western Ontario Rotator cuff (WORC) scale, Visual Analogic scale for shoulder pain intensity, and shoulder pain pressure threshold. Secondary outcomes include changes in shoulder muscle strength, active range of movement, joint position sense, head forward posture, scapulohumeral rhythm, scapulothoracic muscle activation, and primary motor cortex activity."
504,"GPT4 Correct Assistant: This study aimed to retrospectively determine any association between hyperbaric oxygen therapy (HBOT) and change in verbal scores in children with autism spectrum disorder (ASD). Children aged 2 to 17 years, diagnosed with ASD, who completed a verbal test every six months, and received applied behavioral analysis at Oxford Recovery Center were screened for inclusion. Some of these children had elected to receive HBOT (at least 40 sessions for 60 minutes at 2.0 ATA). The primary outcome measures were the verbal scores of children with ASD who underwent hyperbaric oxygen therapy and compared to those who did not, using age-appropriate assessments. The secondary outcome measure was the number of participants with hyperbaric oxygen treatment-related adverse events."
505,"GPT4 Correct Assistant: This is a comparative, randomized, double-blinded study investigating the analgesic efficacy of ultrasound-guided adductor canal block versus 4-in-1 block in patients undergoing knee surgeries. The primary outcome measures are postoperative pain scores at 6, 12, 18, and 24 hours postoperative. Secondary outcomes include changes in blood pressure and heart rate, as well as postoperative opioid requirements. The study includes both sexes, aged between 20-60 years, undergoing knee surgeries under neuroaxial anesthesia."
506,"GPT4 Correct Assistant: This clinical trial aims to determine if immediate lymphatic reconstruction (ILR) can reduce the risk of arm lymphedema in breast cancer patients after axillary lymph node dissection. The study is a prospective randomized controlled trial comparing ILR with non-ILR groups. Female patients aged between 20 and 75 with unilateral breast cancer and going to receive axillary lymph node dissection are eligible for participation. The primary outcome measure is the occurrence of arm lymphedema within two years, while secondary outcome measures include drainage amount, seroma or lymphocele occurrence, patient reported outcome measures by LYMPH-Q Upper Extremity Module, and subclinical lymphedema occurrence within two years."
507,"GPT4 Correct Assistant: This study aims to assess the cosmetic and functional outcomes in patients with hand burns who have received releasing incisions as part of their treatment. The study includes adult patients with acute burns on one or both hands, excluding those who refuse participation or have less than a month of follow-up or die within the first month. The primary outcome measures include functional recovery, healing time, scar quality, and burn visual analog scale (VAS) scores at 3 and 6 months. The study will follow participants for an average of 6 months."
508,"GPT4 Correct Assistant: The Stanford Plant-based Educational Study: Providers Learning About Nutrition Together (PLANT) is a randomized, delayed intervention trial testing a 6-week multimodal Whole-Food Plant-Based Diet (WFPBD) educational program for providers at Stanford in any department. The study aims to assess the change in diet quality, mindset about WFPBD, and motivation/confidence to adopt and prescribe a WFPBD to patients. The intervention includes interactive didactic sessions, cooking classes, and weekly emails with suggested resources and activities. The study includes both healthy and unhealthy participants and measures the change in diet quality, mindset, and motivation/confidence over a 6-week period."
509,"GPT4 Correct Assistant: This clinical trial aims to validate a questionnaire called ""Patient Reported Outcome (PRO) Survivorship Concerns"" for breast cancer patients in early stages. The study will include 80 representative patients during the transcultural adaptability phase, and more patients will be included during the validation phase (at least 280). The primary outcome measure is the translation and validation of the PRO questionnaire, which evaluates survival problems, concerns about patient care, screening, symptom management, family and genetic issues, and fear of disease recurrence. The study will measure the levels of agreement between two assessments using the Interclass Correlation Coefficient (ICC) model 3.1. The study will last for 6 months."
510,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of the Connecting and Reflecting Experience (CARE) Program, a 12-session mentalizing-focused parenting group therapy, for postpartum depression, postpartum anxiety, parenting stress, and parent-child relationships. The study includes participants who are birthing parents of infants aged 3-12 months, experiencing moderate to high levels of depression and/or anxiety symptoms in the postpartum period, and receiving postpartum OB/GYN or mental health services at Montefiore Medical Center. The primary outcome measures are changes in postpartum anxiety, postpartum depression, and parenting stress scores from baseline to post-treatment. Secondary outcome measures include change in parental reflective functioning, parent-infant bonding, treatment acceptability, feasibility, and infant temperament."
511,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of electroencephalography-based neurofeedback (EEG-NFB) training on cognitive function in healthy young men. The study involves 50 male students, randomly assigned to either a training group (TR) that undergoes 3 weeks of EEG-NFB training or a control group (CO) that does not undergo training. The primary outcome measures are performance times in various psychological tests, including the Trail Making Test (TMT) and Stroop Test (ST), which assess cognitive processing speed, executive function, selective attention, and inhibition. The study will use the Shapiro-Wilk test, Wilcoxon signed-rank test, Student's t-test, Mann-Whitney test, and Cohen effect size to analyze the data."
512,"GPT4 Correct Assistant: The study ""Radial Versus Femoral Access For Thrombectomy in Patients With Acute Basilar Artery Occlusion"" aims to compare the effectiveness of endovascular recanalization via radial approach and femoral approach in patients with acute ischemic stroke due to basilar artery occlusion. The primary outcome measure is favorable neurological function (mRS score ≤ 3) at 90 days post-operation."
513,"GPT4 Correct Assistant: The BUNDLE study is a prospective mixed-methods study aimed at integrating community doulas into prenatal care for Black/African American pregnant individuals in Southeastern Wisconsin. The study has three aims: 1) to develop an integrated prenatal care model with medical providers and community doulas, 2) to compare the effectiveness of the integrated model to standard prenatal care in improving healthcare engagement and trust and reducing adverse maternal outcomes, and 3) to disseminate findings and pursue opportunities for systems- and policy-level change. The study will randomize 412 Black/AA pregnant individuals to either BUNDLE or standard prenatal care and measure primary and secondary outcomes related to healthcare engagement, trust, perceived discrimination, stress, depression, cesarean birth, unplanned healthcare utilization, severe maternal morbidity, and breastfeeding initiation."
514,"GPT4 Correct Assistant: This clinical trial, titled ""QUILT-3.100: Phase 1 Open-Label Study to Evaluate Safety And Determine The Maximum Tolerated Dose of IBRX-042 In Subjects With HPV-Associated Tumors,"" is designed to evaluate the safety and determine the maximum tolerated dose of IBRX-042 in subjects with HPV-associated tumors. The study involves up to 60 subjects who will receive at least one dose of IBRX-042 by injection once every three weeks for a total of three injections. The primary outcome measure is to determine the maximum tolerated dose of IBRX-042, while secondary outcome measures include determining the safety profile and reactogenicity of IBRX-042 and examining HPV-specific humoral and cellular immune responses."
515,"GPT4 Correct Assistant: This study is a 3-arm randomized controlled trial that investigates the effects of connective tissue massage, classical massage, and a standardized physiotherapy program on pain, functional status, and quality of life in patients with chronic non-specific low back pain. The study includes 30 participants randomly divided into three groups, with each group receiving treatment for 4 consecutive weeks. The primary outcome measures include the Visual Analog Scale (VAS) for pain intensity, Modified Schober Test (MST) for lumbar mobility, Sit and Reach Test (SRT) for trunk mobility, Back Pain Functional Scale (BPFS) for functional activities, Roland Morris Disability Questionnaire (RMDQ) for functional status, and Short Form-36 Questionnaire (SF-36) for quality of life."
516,GPT4 Correct Assistant: This clinical trial aims to compare the clinical outcomes of cataract surgery with OMNI canaloplasty alone versus OMNI canaloplasty and Hydrus stent. The study will involve 80 participants aged 18 or older with mild to moderate open-angle glaucoma. The primary outcome measure is the change in unmedicated intraocular pressure from baseline to 12 months. Secondary outcome measures include the reduction in the number of medications needed to control intraocular pressure and the percentage of patients with a greater than 20% reduction in intraocular pressure from baseline.
517,"GPT4 Correct Assistant: This study is a comparative, open-label, randomized trial designed to evaluate the efficacy and safety of Dorzotimol eye drops, 20 mg/mL + 5 mg/mL, and Cosopt eye drops, 20 mg/mL + 5 mg/mL, in patients with primary open-angle glaucoma. The primary efficacy endpoint is mean intraocular pressure (IOP) change from baseline at week 12. Secondary endpoints include IOP reduction rate to the target level of ≤ 18 mm Hg, IOP reduction rate greater than 20%, and IOP reduction rate greater than 30%. The study found that Dorzotimol eye drops were noninferior to Cosopt eye drops in terms of efficacy and safety parameters, with no statistically significant intergroup differences observed for any efficacy criteria tested. The efficacy differences between the test and reference product by the primary criterion did not exceed the noninferiority margin of 1.5 mm Hg."
518,"GPT4 Correct Assistant: This study, titled ""Text Messaging to Improve Adherence To Repeat Colonoscopy In The VA: A Pilot Study,"" aims to assess the effectiveness of text messaging in improving adherence to repeat colonoscopy appointments among patients at a Veterans Affairs (VA) hospital. The study will randomly assign participants to either receive a series of instructional and motivational text messages before and during their colonoscopy procedure or to receive no intervention. The primary outcome measure is the National Annie Colonoscopy Survey Score, which assesses participant satisfaction with the text intervention. Secondary outcome measures include the percentage of participants who attend their scheduled colonoscopy appointment and the percentage of participants with adequate bowel preparation at their appointment. The study includes patients aged 45-85 with a history of colonoscopy and is open to both sexes."
519,"GPT4 Correct Assistant: The study aims to compare the efficacy of hysteroscopy and endouterine aspiration in the management of trophoblastic retention after early miscarriage. It is a prospective, multicenter, randomized, open-label, two-arm, parallel therapeutic clinical trial. The primary outcome measure is uterine vacuity at 6 weeks after surgery, assessed by endovaginal pelvic ultrasound. Secondary outcomes include the rate of complications, use of second-line surgical management, synechiae, and fertility at 2 years after surgery."
520,"GPT4 Correct Assistant: The study, titled ""On-line Crowdsourcing of Multi-Timescale Inference Strategies,"" aims to investigate human inference using online testing. The primary purpose of the study is basic science, and the intervention model is single group assignment with an open-label design. Participants must be adult Prolific participants with a 95% approval rating, a minimum score of 80% on a pre-test, fluent in English, and residing in the US. The study involves three blocks of trials: short-term inference, long-term inference, and multi-timescale inference. The primary outcome measure is binary behavioral decision responses, collected through task completion on each trial."
521,"GPT4 Correct Assistant: This study is an N-of-1 trial investigating the effectiveness and safety of lemborexant, a new class of medication for insomnia, in adults with early-onset dementia and insomnia. The trial will use an 8-week treatment sequence of lemborexant 5mg and 10mg alternating with placebo. The primary outcomes measured will be total sleep time, sleep onset latency, wake time after sleep onset, number of awakenings, and quality of sleep. Secondary outcomes will include presence and severity of adverse drug reactions and patient drop-out due to ADRs."
522,"GPT4 Correct Assistant: This is a prospective, double-blind, randomized, multicenter clinical trial comparing the efficacy of Sinomenine and Glucocorticoid in treating early knee osteoarthritis. Participants aged 40-70 with bilateral knee pain and Kellgren and Lawrence grade 2 or 3 knee osteoarthritis are eligible. The primary outcome measures are the total WOMAC score and tibial cartilage volume at 24 months after the first injection, while the secondary outcome measures are the change in time from baseline in the Timed Up and Go (TUG) test and the change in time spent at 20m walking time from baseline."
523,"GPT4 Correct Assistant: This study aims to determine the effect of breathing exercises applied with virtual reality glasses on dyspnea, anxiety, and quality of life in COPD patients. The study is designed as a single-blind pre-test post-test parallel group randomized controlled experimental design, with 48 patients divided into experimental and control groups. The experimental group will undergo breathing exercises with virtual reality glasses for eight weeks, while the control group will receive routine treatment and care. The study will measure oxygen saturation, respiratory rate, forced vital capacity, volume of air exhaled in 1 second of forced expiration, peak expiratory flow rate, FEV1/FVC, COPD Evaluation Test, Modified Medical Research Council Dyspnea Scale, Hospital Anxiety and Depression Scale, St George Respiratory Questionnaire, and Virtual Reality Experience Evaluation Form."
524,"GPT4 Correct Assistant: This clinical trial aims to study the cardiovascular health in Black women through a biobehavioral approach. The study involves an observational group of Black women aged 18-49 years who will undergo lab-based assessments of vascular health and a 10-day free-living monitoring period with mobile and wearable devices. The primary outcome measures include macrovascular function, arterial stiffness, and blood flow measurements. The secondary outcome measure is physical activity level assessed via a wrist-worn accelerometer."
525,"GPT4 Correct Assistant: The study aims to evaluate the efficacy and safety of RCN3028 in treating drug-induced moderate to severe vasomotor symptoms in breast cancer patients. The study is a randomized, placebo-controlled, double-blind, parallel, phase 2 study with two groups: one receiving a placebo and the other receiving 0.8 mg RCN3028. The primary outcome measures are the mean change in frequency and severity of moderate to severe VMS from baseline to weeks 4 and 12. Secondary outcome measures include quality of life, responder rates, time to onset of efficacy, and subject and physician global assessments. The study will enroll female breast cancer patients aged 20 to 80 years who have completed chemotherapy and radiotherapy and are on a stable dose of tamoxifen or aromatase inhibitors for at least 8 weeks at baseline."
526,"GPT4 Correct Assistant: This retrospective cohort study aims to investigate if higher doses of tranexamic acid are associated with a lower incidence of post-operative delirium after cardiac surgery. The study will analyze data from patients who underwent elective or in-house urgent cardiac surgery at RPH between 05/2018 and 08/2022. The primary outcome measure is the Richmond Agitation Sedation Score up to 48 hours after surgery, and the secondary outcome measure is 30-day mortality."
527,"GPT4 Correct Assistant: The study aims to compare the effects of myofascial decompression therapy and positional release therapy on pain, range of motion, and functional disability in patients with chronic non-specific neck pain. The study includes patients aged 25 to 50 years with mild to moderate neck pain for at least three months. The primary outcome measures are the Numerical Rating Scale (NPRS) for pain intensity and the Neck Disability Index (NDI) for functional disability, both measured at the sixth week. Secondary outcome measures include range of motion (flexion, extension, side flexion, and rotation) of the cervical spine."
528,"GPT4 Correct Assistant: This is a randomized parallel-controlled study comparing the Dumpling suture method and the Traditional suture method for ileostomy in rectal anterior resection surgery with specimen extraction via stoma. The study aims to measure the complication rate of stoma, stoma DET (Discoloration, Erosion, and Tissue overgrowth) score, stoma pain score, and quality of life scale score for patients with stoma at day 30 after surgery. Participants must be aged between 18 and 100 years, with no serious systemic infection or immunosuppression, and expected survival time greater than 6 months."
529,GPT4 Correct Assistant: This clinical trial aims to investigate the progression in cognitive abilities and associated Activities of Daily Living (ADL) impairment in Parkinson's disease patients. The study includes a detailed neuropsychological test battery and assessments of cognitive and motor instrumental activities of daily living function. The primary outcome measure is the diagnosis of Parkinson's disease dementia (PDD) or Level II diagnosis of mild cognitive impairment in Parkinson's disease (PD-MCI). Secondary outcome measures include comparison of instrumental activities of daily living (IADL) function and follow-up scores in global cognition and cognitive domain performance.
530,"GPT4 Correct Assistant: This clinical trial aims to determine the median effective dose of rocuronium for the prevention of myofibrillation caused by the injection of succinylcholine. Participants aged 18 to 80 are eligible, with those aged 18 to 44, 45 to 59, and 60 to 80 forming different groups. The intervention is an advanced intravenous injection of rocuronium before succinylcholine injection, with the dose adjusted based on the patient's myofibrillation level. The primary outcome measure is the appearance of myofibrillation, measured as a positive or negative reaction on average within 45 seconds."
531,"GPT4 Correct Assistant: The study aims to investigate the effects of dietary phospholipids on measures of human brain health and psychological wellbeing. Participants aged 25-49 years will receive either 12 weeks of dietary supplement containing phospholipids or a placebo. The primary outcome measure is the cognitive domain factor score, assessed at baseline and after 6 and 12 weeks of intervention. Secondary outcome measures include mood, perceived stress, sleep quality, levels of fatigue, physical symptoms, and general health and wellbeing. Blood plasma phospholipid profiles will also be measured pre and post intervention."
532,"GPT4 Correct Assistant: This clinical trial, titled ""Presence of Environmental Pollutants in Human Carotid Atherosclerotic Plaques and Their Relationship With the Plaque Phenotype and Clinical Outcomes,"" aims to investigate the presence of environmental pollutants in human carotid atherosclerotic plaques and their association with plaque phenotype and clinical outcomes. The study will enroll 300 consecutive patients with asymptomatic carotid stenosis undergoing carotid endarterectomy. The primary outcome measure is the incidence of a composite of myocardial infarction, stroke, and all-cause mortality in patients with polluted vs non-polluted plaques. Secondary outcome measures include the incidence of the composite outcome according to terciles of pollutants burden."
533,"GPT4 Correct Assistant: This clinical trial is titled ""Transarterial Radioembolization (TARE) in COlorectal MEtastasis of Liver"" and aims to evaluate the effectiveness and safety of Therasphere device in patients with colorectal cancer liver metastases. The study includes participants aged 18 and above, and follows them for at least 6 months after radioembolization. The primary outcome measure is the comparison of mean effective tumor doses in patients with or without response to radioembolization, while the secondary outcome measure is the investigation of dose-response and dose-toxicity relationships after transarterial radioembolization."
534,"GPT4 Correct Assistant: This clinical trial aims to evaluate the clinical performance of chemically cured conventional glass ionomer after light-emitting diode (LED) radiant heat enhancement. Eighteen healthy patients with 36-second molar teeth will be selected, and each patient will have two oclusso-mesial cavities. The first tooth will be restored with chemically cured conventional glass ionomer without any enhancement (M1 group), while the second tooth will be restored by chemically cured conventional GICs enhanced with radiant heat (LED) (M2 group). The clinical performance of biological and functional properties will be assessed using Federation Dentaire International (FDI) criteria at three time points: immediately after restoration, six months later, and after 12 months."
535,"GPT4 Correct Assistant: FAPO-X is an interventional study conducted at the Heart Institute of the Clinics Hospital of the Medical School of the University of São Paulo. The study aims to develop and validate an assisted digital telemonitoring platform for patients with postoperative atrial fibrillation (POAF) using wearables. The study involved six phases, including outpatient preoperative care, hospitalization, surgical phase, postoperative care, 30-day telemonitoring, and an outpatient visit at InCor. The experimental group used the SAMSUNGTM Galaxy Watch5 smartwatch for remote monitoring, while the control group followed standard care protocols. The study measured rehospitalization rate, scheduled consultations, extra occurrences, technological adherence, treatment adherence, and use of the mobile application by patients."
536,GPT4 Correct Assistant: The study aims to test the adoption of HSMonitor solutions by healthcare professionals and patients to improve hypertension management. It is a randomized controlled trial where patients with hypertension will be randomized to either one of two digital solutions (HSmartBPM or HyperHealth) or standard care. The study's primary outcome measures are changes in systolic and diastolic blood pressure at 2 and 6 months. Secondary outcome measures include user satisfaction measured with a Visual Analog Scale (VAS).
537,"GPT4 Correct Assistant: The Liver Care Trial is a randomized controlled study aimed at screening for liver disease in individuals attending treatment for alcohol use disorder. The study includes participants aged 18-110 years, both male and female, and excludes those who do not speak Danish or English and have severe liver disease. The primary outcome measure is alcohol abstinence or light consumption (≤ 10 units/week) in the last 30 days, assessed 6 months after randomization. The intervention group receives a liver stiffness measurement using Transient Elastography, blood sampling, and a leaflet on alcohol-related disease, while the control group receives an invitation to screening by blood sampling with Fib-4. The study aims to assess the effectiveness of the intervention in promoting alcohol abstinence or light consumption in individuals with alcohol use disorder."
538,"GPT4 Correct Assistant: This study aims to assess the value of trio exome sequencing in diagnosing specific non-syndromic language and learning disorders. Participants must be aged 3 to 40 years, have severe learning disorders, and not have undergone genetic testing before. The study involves blood sampling, consultation for results delivery, and a study on humanities and social sciences. The primary outcome measure is the identification of a genetic cause defined by the presence of at least one ACMG class 4 or 5 variant."
539,"GPT4 Correct Assistant: The Five Days for Health (FDH) study is a small group-based lifestyle modification program aimed at promoting weight loss in adults with overweight or obesity. The program involves five days of education, nutrition, daily physical activity, and psychological support in a group setting. Follow-up continues with additional educational lectures, support, and weight measurements at one month, three months, six months, and one year. The primary outcome measure is weight loss, and secondary outcome measures include changes in body composition and metabolic parameters."
540,"GPT4 Correct Assistant: This clinical trial is investigating the safety and efficacy of Bio-008 in patients with advanced solid tumors. The study includes six dose groups, ranging from 0.3mg/kg to 40mg/kg of Bio-008. The primary outcome measures are adverse events, severe adverse events, incidence of dose limiting toxicity, maximum tolerated dose, and objective response rate. Secondary outcome measures include area under plasma concentration vs time curve, peak plasma concentration, time to maximum observed plasma concentration, terminal elimination half life, immunogenicity, disease control rate, duration of response, and progression free survival."
541,"GPT4 Correct Assistant: The study aims to determine the effect of different music (rainstick and The Happiest Baby) on the pain and comfort levels of premature infants during retinopathy examination. The study is a stratified randomized controlled experimental type study with triple masking. The primary outcome measure is the Premature Infant Pain Profile (PIPP) score. The secondary outcome measure is the Baby Information Form. The study includes premature infants with a gestational age of 34 weeks or less and a birth weight of 2000 grams or less, who are undergoing their first retinopathy examination."
542,"GPT4 Correct Assistant: This clinical trial aims to assess the safety and efficacy of sovateltide in patients with acute cerebral ischemic stroke. The study is a multicentric, randomized, double-blind, parallel, placebo-controlled phase III study conducted in the United States, Canada, United Kingdom, and Europe. The primary outcome measure is the proportion of patients with a good outcome (modified Rankin Scale score of 0-2) at day 90 post-randomization. Secondary outcome measures include excellent outcome, improvement in functional and overall clinical outcomes, quality of life, recurrent stroke, and mortality."
543,"GPT4 Correct Assistant: This is an ambispective cohort study investigating the outcome and influencing factors in patients with Borderline Personality Disorder (BPD). The study includes participants aged 12 and above, with a diagnosis of BPD based on ICD-10 (F60.3). Exclusion criteria include comorbidity with severe physical disease, neurological diseases such as epilepsy, and mental retardation. The primary outcome measure is the remission rate of BPD, while secondary outcome measures include social disability and quality of life. Patients are followed up every 6 months for a total of 2 years."
544,"GPT4 Correct Assistant: This clinical trial aims to assess the management of evaporative dry eye (EDE) using intense pulsed light (IPL) in combination with diquafosol ophthalmic solution. Participants with a diagnosis of dry eye disease will be randomly assigned to one of three groups: IPL+, IPL, or DQS. The IPL+ group will receive IPL treatment and DQS eye drops, while the IPL group will receive IPL treatment alone, and the DQS group will receive DQS eye drops alone. The primary outcomes measured are non-invasive tear break-up time (NIBUT) and Ocular Surface Disease Index (OSDI). Secondary outcomes include fluorescein and lissamine conjunctival and cornea staining (CFS), meibomian gland function and secretion quality, Tear Film Lipid Layer Score (TFLL), tear meniscus height (TMH), and conjunctival hyperemia (RS score)."
545,"GPT4 Correct Assistant: This study aims to compare the effectiveness of Cognitive-Behavioral Therapy (CBT) and Mindfulness-Based Therapy (MBT) for autistic adults with co-occurring anxiety and/or depressive disorders. The primary outcome measure is the change in anxiety and depression symptoms assessed using the Patient Health Questionnaire Anxiety-Depression Scale (PHQ-ADS). Secondary outcome measures include changes in mental health, psychiatric diagnosis, quality of life, well-being, self-acceptance, functional impairment, disability, potential negative effects of intervention, intervention services satisfaction, and intervention therapist and therapy satisfaction. The study will enroll participants aged 18 years and older who meet the inclusion and exclusion criteria."
546,"GPT4 Correct Assistant: The Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1) trial is a study evaluating the efficacy and safety of methotrexate in patients with immune related arthritis or arthralgias. The primary outcome measure is the proportion of patients who discontinue prednisone by 12 weeks without recurrence of grade 2 or higher irAA. Secondary outcome measures include total steroid usage, development of immune related adverse events other than irAA, adverse events, re-initiation of immune checkpoint inhibitor therapy, and progression free survival. The study includes patients aged 18 years or older with a history of hydroxychloroquine treatment or enrolled in IMPACT 2.0 who develop recurrent grade ≥ 2 irAA or remain on glucocorticoids for irAA at 3 months. Patients receive methotrexate 20 mg PO weekly for 12 weeks, with folic acid 1 mg PO daily for as long as methotrexate is given, and prednisone starting at 20 mg PO daily for 8 weeks tapering dose."
547,"GPT4 Correct Assistant: This study aims to compare the effects of general and regional anesthesia on sleep quality in patients undergoing total hip arthroplasty. The participants will be randomly assigned to either general or regional anesthesia. Sleep quality will be assessed using the PIRS-20 (Pittsburgh Insomnia Rating Scale) before and after surgery. Additionally, anxiety and pain levels will be evaluated using the STAI (State Trait Anxiety Inventory) and VAS (Visual Analogue Scale), respectively. The study seeks to determine if regional anesthesia is more advantageous in eliminating postoperative sleep disorders and improving sleep quality for patients undergoing total hip arthroplasty."
548,"GPT4 Correct Assistant: The study aims to assess the change in disease activity in adult Japanese participants with episodic migraine using oral Atogepant tablets. The trial is a Phase 2/3, multicenter, randomized, double-blind, placebo-controlled study with an active treatment extension. The primary outcome measure is the change from baseline in mean monthly migraine days. Participants will be randomized to receive Atogepant dose A, B, or C, or placebo for 12 weeks, followed by re-randomization for another 12 weeks. The study aims to measure the efficacy, safety, and tolerability of Atogepant for the prevention of migraine in Japanese subjects with episodic migraine."
549,"GPT4 Correct Assistant: This is a Phase 2, randomized, double-blind, controlled, single-site trial evaluating the safety and efficacy of Efgartigimod Alfa-Fcab in patients with Guillain-Barré Syndrome (GBS). The study includes two arms: one receiving Efgartigimod Alfa-Fcab and the other receiving the active comparator Intravenous Immunoglobulin (IVIg). The primary outcome measure is the Guillain-Barre Syndrome Disability Scale (GBS-DS) at 12 weeks, with additional secondary outcome measures at 4, 24, and 48 weeks."
550,"GPT4 Correct Assistant: This is a phase 2b, double-blind, randomized, placebo-controlled trial to evaluate the safety and efficacy of oral PF-07817883 in non-hospitalized symptomatic adults with COVID-19. Participants will be assigned to one of four groups: low, medium, or high doses of PF-07817883 or a placebo. The primary outcome measure is the change from baseline in SARS-CoV-2 RNA level from day 5. Secondary outcome measures include adverse events, serious adverse events, clinically significant abnormal laboratory values, and discontinuations due to adverse events."
551,"GPT4 Correct Assistant: This study is a prospective cohort study investigating the therapeutic effect of adding letrozole to the protocol of combined treatment of cesarean scar pregnancy (CSP). The study compares two treatment groups: MTX monotherapy and MTX + letrozole add-on, followed by hysteroscopic evacuation of products of conception (POC). The primary outcome measures are blood loss during the procedure, blood loss volume during the procedure, and conversion rate from hysteroscopy to laparoscopy or laparotomy due to hemorrhage. Secondary outcome measures include the effects of treatment on bone marrow function, liver function, and kidney function."
552,"GPT4 Correct Assistant: The BLEED study is a feasibility pilot study examining the use of red blood cell concentrates from organ donors for liver transplant recipients. The study includes adult patients receiving a liver transplant from deceased donors at Fondazione Policlinico A. Gemelli IRCCS. The primary outcome measure is the number and percentage of liver transplant recipients who receive donor RBC concentrates for intraoperative transfusion support during liver transplant. Secondary outcome measures include blood product need and graft failure rate. The study is designed as a single-group assignment, open-label trial."
553,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of sublingual versus subcutaneous allergen immunotherapy in patients with bronchial asthma. Fifty patients received sublingual immunotherapy and another fifty received subcutaneous immunotherapy. Serum IgE and sputum eosinophil levels were measured before and after 6, 12, and 18 months of treatment. The study's primary outcome measures are total IgE and sputum eosinophil levels at different time points."
554,"GPT4 Correct Assistant: This study aims to determine the minimum number of contrast-enhanced stereotactic biopsy (CESB)-guided tissue samples needed for a reliable diagnosis in women with recombined-only lesions (ROLs) observed during a regular contrast-enhanced mammography (CEM) examination. The study is a prospective, single-center, observational cohort study where participants undergo CESB, and tissue samples are collected in six separate cassettes in a chronological order. The primary study aim is to calculate the cumulative diagnostic yield per specimen, which will help define the minimum number of biopsies required for a reliable diagnosis using CESB. Secondary outcomes include general parameters of the biopsy procedure, such as patient characteristics, histopathological results, pain experienced during the procedure, and complication rates."
555,"GPT4 Correct Assistant: This clinical trial aims to compare the effects of concentric quadriceps strengthening and facilitatory kinesiotaping on gait parameters in individuals with knee osteoarthritis. The study includes adults aged 50-60 with knee OA for at least 6 months. Participants are randomly assigned to either group A (concentric muscle training) or group B (facilitatory kinesiotaping). The primary outcome measures are temporo-spatial gait parameters, assessed using a mobile app, and the secondary outcome measures include the Numeric Pain Rating Score, Functional Status (WOMAC Questionnaire), and strength measured using a handheld dynamometer. The study duration is 6 weeks."
556,"GPT4 Correct Assistant: The Family Therapy Training and Implementation Platform (FTTIP) Supplement Study aims to collect qualitative data to complement the parent study's quantitative data, focusing on the experiences of trainees and agency leaders with the platform. The study involves 20 therapists and 16 agency leaders, who will participate in qualitative interviews to gather their perceptions and experiences about learning and practicing specific competencies from the platform and their unique experiences related to implementation of the Evidenced Based Treatment, delivery of competencies learned, and the application of EBT in a real-world context. The study measures therapist and agency leader experiences through interviews at two time points."
557,"GPT4 Correct Assistant: This clinical study aims to investigate the analgesic effect of a freshly manufactured 35kDa Hyaluronan fragment (HA35) on herpes zoster pain and shoulder, neck, back, and temporal pain. The HA35 is prepared by mixing hyaluronidase injection extracted from bovine testis and Hyaluronan injection at room temperature for 20 minutes. The study includes 26 patients with shoulder, neck, back, and temporal pain and 10 patients with herpes zoster pain. The intervention involves injecting 100 mg Hyaluronan at the pain point or where the nerve trunk is innervated by the pain point. The primary outcome measure is the pain scores of all patients before and after treatment, measured using a pain scale from 0 to 10."
558,"GPT4 Correct Assistant: This is a randomized clinical trial investigating the effectiveness of hysteroscopic septoplasty using different modalities for the treatment of septate uterus, recurrent pregnancy loss, and subfertility. The study includes two groups: one undergoing the procedure with scissors and saline as the distending medium, and the other undergoing the procedure with resectoscope, monopolar energy, and glycine 1.5% as the distension medium. The primary outcome measures are operative time, fluid deficit, operative and post-operative complications, and need for second intervention. Secondary outcome measures include pregnancy rate and live birth rate."
559,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a breathing control technique, cardiac coherence, on long COVID symptoms at the Reunion University Hospital. The study includes patients aged 18 and over with a diagnosis of long COVID according to the WHO definition. The intervention group will receive complementary respiratory training to cardiac coherence for six months in addition to usual care, while the control group will follow usual care procedures. The primary outcome measure is the reduction in symptomatology using the Long COVID Symptom Tool scale at six months. Secondary outcome measures include the decrease of overall and specific symptoms (fatigue, dyspnea, anxiety, depression, cognitive disorders, and post-traumatic stress disorder) over time."
560,GPT4 Correct Assistant: This single-center cohort study aims to investigate the cardiovascular complications of Ibrutinib therapy. The study includes patients aged 18 and over with an indication for Ibrutinib treatment for hematologic reasons. The intervention includes ophthalmological examination and blood tests to assess biomarkers related to cardiovascular complications. The primary outcome measure is the rate of patients developing atrial fibrillation (AF) within 12 months after the introduction of Ibrutinib.
561,"GPT4 Correct Assistant: The study aims to evaluate the effect of bicarbonate profiling in dialysis fluid on phosphate removal during hemodialysis and blood pH. It is a non-randomized trial involving 20 chronic hemodialysis patients. The study compares three different bicarbonate interventions: constant Dbic of 35 mmol/L, Dbic of 35 mmol/L for the first two hours and 30 mmol/L for the second two hours, and Dbic of 30 mmol/L for the first two hours and 35 mmol/L for the remainder of the treatment. The primary outcome measure is the blood phosphorus concentration change in hemodialysis patients, and the secondary outcome measure is maintaining the acid-base balance in accordance with applicable recommendations. The study duration is four weeks."
562,"GPT4 Correct Assistant: This clinical trial aims to evaluate the potential effectiveness of a multimodal intervention for treating unipolar depression, combining Transcranial Direct Current Stimulation (tDCS) with metacognitive therapy (MCT). The study is a randomized, double-blind design with three arms of treatment: tDCS alone, MCT alone, and tDCS followed by MCT. The primary outcome measure is the change in the Hamilton Depression Rating Scale during follow-up. The study also explores the TMS-EEG correlates of change in depressive symptomatology in a subgroup of patients."
563,"GPT4 Correct Assistant: This clinical trial studies the efficacy and safety of proton pump inhibitor (Lansoprazole) in patients with moderate gastrointestinal bleeding risk and coronary artery disease who underwent percutaneous coronary angioplasty and are on dual antiplatelet drugs. The trial aims to compare gastrointestinal and cardiovascular events in these patients while using Lansoprazole. Participants are randomly assigned to either the gastric acid secretion inhibitor group or the non-dose group. The primary outcome measure is the occurrence of upper gastrointestinal clinical complex, and the secondary outcome measure is the occurrence of a cardiovascular clinical complex."
564,"GPT4 Correct Assistant: This clinical trial aims to study the influence of hot and cold cognition on prospective memory in HIV+ patients. The study includes participants who are HIV+ and healthy controls. The primary outcome measure is prospective memory in HIV+ patients and healthy subjects, assessed through the Memory for Intentions Screening Test (MIST). Secondary outcome measures include the influence of global cognitive performance on prospective memory, assessed through the Montreal Cognitive Assessment (MOCA), and the influence of hot and cold cognition on prospective memory, assessed through the Interpersonal Reactivity Index (IRI) and the Modified Five Point Test, respectively."
565,"GPT4 Correct Assistant: This clinical trial aims to determine the effects of vertical sitting versus supine lying traction on pain, range of motion, and function in patients with chronic radicular low back pain. The study includes participants aged between 20-50 years with a history of low back pain for at least 3 months. The intervention consists of continuous mechanical traction applied in two positions: vertical sitting and supine lying. The primary outcome measures are the Oswestry Disability Index and Numeric Pain Rating Scale, both assessed at the 12th week follow-up. The study aims to help physiotherapists determine the best possible position for applying traction in patients with radicular low back pain and develop an optimal traction treatment protocol for chronic radicular low back pain."
566,"GPT4 Correct Assistant: The study, titled ""Dry Needling vs Lasertherapy in Greater Trochanteric Pain Syndrome (GTPS): Randomized Clinical Trial,"" aims to assess the effectiveness of dry needling and lasertherapy in treating lateral hip pain caused by trochanteric bursitis. The study includes participants aged 35 to 60, and the intervention period is 6 weeks, twice a week. The primary outcome measure is the change in pain intensity using the Visual Analog Pain Scale (VAS), with assessments before treatment, immediately after treatment, and 12 weeks post-treatment. Secondary outcome measures include changes in hip function, lower limb function, and quality of life using the VISA-G questionnaire and functional tests such as the Timed Up and Go Test (TUG) and 30-second Sit to Stand Test (SL30)."
567,"GPT4 Correct Assistant: This clinical trial aims to investigate the diagnostic accuracy of a rapid technique for detecting intestinal anti-transglutaminase antibodies in patients undergoing esophagogastroduodenoscopy (EGD) for suspected celiac disease (CD) or other gastrointestinal conditions. The study will compare the sensitivity and specificity of the EMA assay and rapid anti-TG2 test on mechanically lysed intestinal biopsies to the reference standard of serology and histopathology. The study will also assess the concordance of the EMA assay and rapid anti-TG2 test with Culture-EMA results. The target population includes patients aged 1 to 22 years with various gastrointestinal conditions, excluding those with bleeding disorders or fulfilling the new ESPGHAN Guidelines for diagnosing CD."
568,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of cognitive-behavioral therapy (CBT) on insomnia in nurses with post-COVID-19 condition. The study includes nurses aged 20-65 years, both male and female, who have not had sleep apnea, narcolepsy, pregnancy, seizure, or pacemaker. Participants are randomly assigned to either receive 6 weeks of CBT or continue with usual care. The primary outcomes measured are insomnia severity, sleep quality, and sleep efficiency, while secondary outcomes include anxiety, depression, and health-related quality of life. The study follows participants for 20 weeks."
569,"GPT4 Correct Assistant: The RAPID AFib Pilot Trial is a pilot study designed to evaluate the acceptability of the Risk Assessment and Personal Preference to Improve Decisions in Atrial Fibrillation (RAPID AFib) decision aid for stroke prevention in patients with atrial fibrillation. The study aims to determine if the RAPID AFib decision aid is acceptable for both patients and clinicians and leads to more effective shared decision-making than standard care among patients with atrial fibrillation who are considering oral anticoagulation. The study is a prospective, randomized pilot study with two arms: intervention and control. The intervention group receives a web-based decision aid, while the control group receives only web-based information. The primary outcome measure is the 9-Item Shared Decision Making Questionnaire (SDM-Q-9: patient version), measured immediately after the clinic visit."
570,"GPT4 Correct Assistant: A Phase I clinical trial is being conducted to study the safety, tolerability, pharmacokinetics, and pharmacodynamics of a new medicine, NNC0491-6075, in healthy participants and those with high levels of fat in the blood (dyslipidaemia). The study is divided into three parts: Part A involves single ascending dose cohorts in healthy participants and dyslipidaemia participants, Part B involves multiple ascending dose cohorts in dyslipidaemia participants, and Part C involves single ascending dose cohorts in healthy Japanese participants. The primary outcome measures are the number of treatment-emergent adverse events (TEAEs) in each part. Secondary outcome measures include pharmacokinetic parameters such as AUC0-∞, Cmax, t½, and tmax."
571,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficiency of high-flow nasal cannula (HFNC) versus noninvasive ventilation (NIV) in patients with acute type 2 respiratory failure. The study includes 50 patients in each group, with one group receiving HFNC and the other receiving NIV as ventilatory support. The primary outcome measure is the failure of improvement of pH, while the secondary outcome measures are mortality during ICU stay and ICU stay duration. The trial uses various devices and interventions for each group, and the patients' responses are monitored and followed up on."
572,"GPT4 Correct Assistant: This study aims to implement a digital-first care delivery model for heart failure patients in Uganda. Participants with a clinical diagnosis of New York Heart Association (NYHA) Class II-III heart failure and access to a mobile phone will be included. The intervention consists of an enhanced heart failure clinical care (Core-HF) plus a digital health intervention (Medly Uganda), which is a patient-facing mobile health application designed to improve self-care among patients with heart failure. The study will measure the change in self-care of heart failure index (SCHFI) and clinical effectiveness, which is the number of participants with mortality and heart failure hospitalization. Secondary outcomes include participant fidelity to self-care, facility fidelity to implementation strategy, and other health-related outcomes. The study will run for 36 months."
573,"GPT4 Correct Assistant: This clinical trial is a comparative pharmacokinetic study of ibuprofen and diphenhydramine hydrochloride modified-release tablets in healthy adults under fasting conditions. The trial aims to compare the bioequivalence of the compound ibuprofen polyrelease tablet (each containing ibuprofen 400 mg and diphenhydramine hydrochloride 50 mg) with Motrin IB (ibuprofen tablets USP 200 mg) and BENADRYL (diphenhydramine hydrochloride tablets 25 mg). The primary outcome measures are the area under the curve from time zero to the time of the last quantifiable plasma concentration of the period (AUC0-last) and area under the curve from time zero to infinity (AUC0-inf). The secondary outcome measures include peak concentration at each treatment period (Cmax,tp), peak concentration of the first dosing (Cmax), time to reach peak concentration of the first dosing (Tmax), terminal half-life (T1/2), and mean residence time (MRT)."
574,"GPT4 Correct Assistant: The study, titled ""Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients,"" is a multicenter, prospective observational study aimed at investigating the effects of apalutamide on patients with metastatic hormone-sensitive prostate cancer (mHSPC). The study includes male participants aged 18 years or older with a confirmed diagnosis of adenocarcinoma of the prostate. The primary outcome measure is the undetectable prostate-specific antigen (PSA) rate in mHSPC patients receiving apalutamide. Secondary outcome measures include the impact of apalutamide on fatigue, cognitive function, and health-related quality of life, as assessed using patient-reported questionnaires. The study is expected to run from August 2023 to April 2027."
575,GPT4 Correct Assistant: This clinical trial aims to demonstrate the hair and scalp benefits of Duobrii (0.045% Tazarotene/0.01% Halobetasol Lotion) in treating scalp psoriasis. The study includes male and female participants aged 18 or older with moderate to severe scalp psoriasis. Participants will apply Duobrii lotion to their scalp once daily for 12 weeks. The primary outcomes measured are improvement in hair growth and reduction in scalp itch due to the treatment.
576,"GPT4 Correct Assistant: This trial is a phase I/II study evaluating the safety, tolerability, and efficacy of the combination of idasanutlin and selinexor in children with progressive/relapsed atypical teratoid/rhabdoid tumors (AT/RT) or malignant rhabdoid tumors (MRT), or synchronous/metachronous AT/RT and MRT. The primary objective is to determine the maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of the combination treatment. Secondary objectives include assessing objective response rate, progression-free survival, and overall survival."
577,"GPT4 Correct Assistant: This is a comparative study investigating the effectiveness of radial and capitate shortening in treating Kienbock's disease, a condition characterized by avascular necrosis of the lunate. Participants aged 18-65 with stages II & III of the disease are eligible. The study employs a randomized, parallel assignment design with an open-label model. The primary outcome measure is the Modified Mayo Wrist Score, assessed after one year."
578,"GPT4 Correct Assistant: The study aims to assess the impact of a 4-week multimodal prehabilitation program on functional capacity, nutritional status, and patient-reported health-related quality of life in patients with pancreatic or periampullary cancer undergoing surgery. The program includes exercise training, nutritional therapy, and anxiety reduction techniques. The study is a randomized controlled trial with participants randomized into either the intervention group (multimodal prehabilitation) or the control group (usual care). The primary outcome measure is the Comprehensive Complication Index (CCI) at 90 days after surgery. Secondary outcome measures include time to patient functional recovery, length of stay, bioimpedance analysis-derived body composition, computed tomography-derived body composition, and generic and disease-specific health-related quality of life."
579,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of dual task exercise training in children with cerebral palsy. The study includes children aged 5-12 years with hemiplegic, monoplegic, unilaterally affected, or diplegic cerebral palsy, who are at GMFCS level 1 or 2. The intervention group receives conventional rehabilitation plus dual task exercise training, while the control group receives only conventional rehabilitation. The primary outcomes measured are changes in Pediatric Balance Scale, Timed Up and Go Test, One Leg Standing Test, 3-Meter Backward Walk Test, and 6 Meter Walk Test at 12 weeks. The study also assesses the impact of the intervention on quality of life using the Generic Children's Health-Related Quality of Life Questionnaire."
580,"GPT4 Correct Assistant: The study, titled ""Active Surveillance of Influenza Virus Zoonotic Transmission Events: a Pilot Study in Belgium,"" aims to investigate the transmission of influenza viruses between animals and humans. The study focuses on various groups, including avian influenza outbreak farms, poultry farm sentinel network, wild bird/life rehabilitation centre sentinel network, and pig industry veterinarian sentinel network. Participants will perform self-sampling with nasopharyngeal swabs and provide blood samples for testing. The primary outcome measure is the number of sentinel participants and outbreak participants positive for a non-seasonal influenza virus, while the secondary outcome measure is the number of outbreak participants with seroconversion against a non-seasonal influenza virus. The study is open to people aged 18 and above, with no gender restrictions."
581,"GPT4 Correct Assistant: This clinical trial study uses a longitudinal, within-person design with two parallel conditions: a 6-week canine therapy intervention and treatment as usual. The study focuses on youth in a full-time residential treatment facility in Lawrence Hall, assessing the impact of a canine-assisted therapy program on emotion regulation, behavioral disorder, and self-esteem. The primary outcome measures include emotional Stroop, change in emotional Stroop, Flanker Task, change in Flanker Task, Rosenberg Self-Esteem Scale, and change in Rosenberg Self-Esteem Scale. Secondary outcome measures include attendance and attrition, change in positive affect, significant event report, and change in attitudes towards pets."
582,"GPT4 Correct Assistant: This study aims to explore the effect of myofascial release in addition to foot core exercises on young adults with asymptomatic flexible pes planus. The study will be carried out with a randomized controlled prospective study design, involving two groups of young adults with flexible pes planus. One group will be applied an exercise program including only foot core exercises, while the other group will be applied self myofascial release with foam rollers, in addition to foot core exercises. The study will measure changes in balance, flexibility, power, and gait after a 6-week program."
583,"GPT4 Correct Assistant: This clinical trial aims to investigate whether arm training can reduce pain when inserting a peripheral venous catheter in patients undergoing chemotherapy. The study is randomized, with one group receiving an 8-week daily arm training program and the other group receiving normal care. The primary outcome measures are the level of pain as measured by the Numeric Rating Scale (1-10) at baseline, five weeks, and eight weeks of training/control. Secondary outcome measures include vein status assessed via ultrasound at the same time points. The study includes patients aged 18 years or older who are undergoing neoadjuvant or adjuvant chemotherapy via intravenous peripheral venous cannula."
584,GPT4 Correct Assistant: The study aims to investigate the differences in decidual leukocyte subpopulations and activation markers between women with miscarriage of either a trisomy 16 conceptus (47XY+16 or 47XX+16) compared with a chromosomally normal male conceptus (46XY). The intervention is ultrasound-guided manual vacuum aspiration (USG-MVA) for managing miscarriage or termination of pregnancy in the first trimester. The primary outcome measures are histopathologic diagnosis of chorionic villi and immunohistochemistry staining of maternal decidua.
585,"GPT4 Correct Assistant: This trial aims to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamic properties of Lu AF28996 in Japanese adults with Parkinson's disease. Participants must be diagnosed with idiopathic PD, have well-recognizable and predictable motor fluctuations, and be currently receiving stable levodopa therapy. The study will measure the number of participants with treatment-emergent adverse events (TEAEs), area under the plasma concentration-time curve from zero to last quantifiable concentration (AUC0-tlast) of Lu AF28996, area under the plasma concentration-time curve from zero to 24 hours post-dose (AUC0-24h) of Lu AF28996, maximum observed plasma concentration (Cmax) of Lu AF28996, and oral clearance (CL/F) of Lu AF28996."
586,"GPT4 Correct Assistant: The study aims to determine the cost-effectiveness of the seasonal influenza vaccination in Bangladesh. The study targets high-risk groups, including children aged six months to eight years, pregnant women, elderly aged 60 years and above, and adults with chronic diseases. The study will collect data on the vaccination acceptability, cost-effectiveness, and required capacity for a facility-based seasonal influenza vaccination program. The primary outcome measures include influenza vaccine acceptability and incremental cost-effectiveness ratios (ICERs). The study will also collect secondary data on perceived susceptibility and severity, perceived barriers and benefits, and required capacity related to vaccine doses, self-injection equipment, and storage capacity."
587,"GPT4 Correct Assistant: The SUSPECT Italian Prospective Study is a clinical trial focused on evaluating the performance characteristics and technical outcomes of Single-Use Duodenoscopes in patients with gastrointestinal tract diseases. The study includes participants aged 18 years or older who are scheduled for clinically indicated ERCP or other duodenoscope-based procedures. The primary outcome measures are technical performance and procedural performance, both assessed over a 24-month period."
588,"GPT4 Correct Assistant: This study is a feasibility trial examining the effectiveness of a hybrid pulmonary rehabilitation program for patients with chronic respiratory disease. The program combines in-person sessions with technology-enabled remote sessions using the Active+me REMOTE App. The study aims to assess patient uptake, adherence, and outcomes of the hybrid program compared to a standard pulmonary rehabilitation program. The trial will also explore the feasibility of integrating the hybrid program into routine practice and gather qualitative feedback from both patients and healthcare staff."
589,"GPT4 Correct Assistant: This is an observational study in Japan that aims to describe the baseline demographics and clinical characteristics of patients who received EVUSHELD as pre-exposure prophylaxis against SARS-CoV-2 infection/COVID-19. The study will follow patients for up to 6 months after the first administration of EVUSHELD. The primary outcome measure is the demographics and clinical characteristics of patients received Evusheld as PrEP. Secondary outcome measures include medically attended COVID-19, COVID-19 hospitalization, in-hospital mortality due to COVID-19, and all-cause mortality."
590,"GPT4 Correct Assistant: This study is a Phase 4 multicenter, randomized, double-blind trial assessing the safety and efficacy of subcutaneously injected risankizumab in adult participants with genital or scalp psoriasis. The study includes two groups: Study G for participants with moderate to severe genital psoriasis and Study S for participants with moderate to severe scalp psoriasis. The primary outcome measures are the percentage of participants with achievement of static Physician Global Assessment of Genitalia (sPGA-G) of 0 or 1 for Study G and percentage of participants with achievement of Scalp Investigator Global Assessment (IGA) of 0 or 1 for Study S at week 16. Secondary outcome measures include various scores and improvements related to psoriasis symptoms and quality of life."
591,"GPT4 Correct Assistant: The Prevalence of the Linburg-Comstock Variation in Patients With Symptomatic Thumb CMC Arthritis is a descriptive cross-sectional study aiming to determine the prevalence of the Linburg-Comstock Variation (LCV) in patients with thumb CMC arthritis. The study will include 500 male and female patients aged 35-89 years, who will be recruited through convenience sampling. The intervention is a clinical examination for LCV, which will be performed by the recruiting physicians during the patients' regular office visits. The primary outcome measure is a positive or negative clinical exam for LCV. No control group is included, and there are no risks to patients enrolled in the study. The study will be conducted at the Bone and Joint Center and satellite offices in Albany, Guilderland, Clifton Park, Malta, Saratoga, Schenectady, and Catskill for up to two years."
592,"GPT4 Correct Assistant: This is a Phase 3, multicenter, 12-week, double-blind, placebo-controlled study to evaluate the safety and efficacy of Atogepant for the preventive treatment of episodic migraine in pediatric subjects aged 6-17 years. The primary outcome measure is change from baseline in mean monthly migraine days, while secondary outcome measures include change from baseline in mean monthly headache days, mean monthly acute medication use days, percentage of participants who achieve at least a 50% reduction in average of monthly migraine days, change from baseline in the Pediatric Quality of Life Inventory (PedsQL) total score, and change from baseline in the Pediatric Migraine Disability Assessment (PedMIDAS) total score."
593,"GPT4 Correct Assistant: This clinical trial investigates the effects of targeted touchscreen training on patients with Parkinson's disease (PD) after two weeks of training. The study aims to examine the learning potential of PD patients using a tablet-based touchscreen training program. The experimental group will practice the Swipe Slide Pattern (SSP) task for two weeks, while the control group will not receive any intervention. The primary outcome measures are average slide duration and performance accuracy. Secondary outcomes include retention effects after four weeks, consolidation effects of two weeks of training, and transfer towards an untrained task. The study will include 36 PD patients, randomized into experimental or control groups."
594,"GPT4 Correct Assistant: This study investigates the effect of intensified tactile contact between a mother and newborn, in the form of Shantali massage, on the emotional transformation of women after physiological delivery. The study used a non-randomized quasi-experimental design, with the experimental group receiving the intervention and the control group receiving no intervention. Participants underwent four standardized psychological questionnaires to measure their emotional state before and after the 12-week observation period. The results aimed to provide insights into the direction of the mother's emotional transformation and potentially inform future treatments for postpartum blues, depression, and psychosis."
595,"GPT4 Correct Assistant: This clinical trial aims to study the effectiveness of the combination of Paclitaxel, Bevacizumab, and Atezolizumab in treating patients with advanced non-small cell lung cancer (NSCLC) who have progressed after treatment with immunotherapy and chemotherapy. The primary outcome measure is progression-free survival at 6 months, determined by an independent reviewer. Secondary outcome measures include overall survival, objective response rate, time until definitive health-related quality of life score deterioration, and incidence, nature, and severity of adverse events."
596,"GPT4 Correct Assistant: This is a pilot prospective cohort study examining the role of osteopathic manipulative treatment (OMT) in managing persistent post-COVID-19 symptoms. The study includes participants aged 18 years and above, with at least one symptom of post-COVID-19 that has persisted for at least 4 weeks after diagnosis. The primary outcome measures are patient recruitment rate and data completion rate, while secondary outcome measures include neurocognitive and psychological symptoms, physical symptoms, global health, and return to work status. OMT is provided at the discretion of the treating physician and based on the patient's response to previous treatments. The study aims to assess the feasibility of the study design and the impact of OMT on the symptoms of post-COVID-19."
597,GPT4 Correct Assistant: This pilot study aims to prospectively compare the Indocyanine Green (ICG) microangiography and conventional angiography in patients with severe frostbite. The primary outcome measure is the assessment of angiography and ICG microangiography imaging demonstrating ischemic tissue present in severe frostbite scored by Hennepin Frostbite Score. The secondary outcome measure is the safety of indocyanine green when delivered in close association with contrast dye (used in conventional angiography) measured by the number of adverse events.
598,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of a multidisciplinary approach in the Perioperative Geriatrics Unit on the functional status of patients aged 70 and over who have undergone surgery for colorectal cancer. The study compares two groups: a control group receiving classical management in the digestive surgery department and a GPOU group receiving specialized geriatric care. The primary outcome measure is the change in functional status as measured by the Instrumental Activities of Daily Living (IADL) score at months 3 and 6. Secondary outcomes include changes in basic functional status, patient motor ability, patient satisfaction, length of hospital stay, medical complications, surgical complications, destination on discharge, patient weight, quality of life, and overall survival."
599,"GPT4 Correct Assistant: This clinical trial aims to investigate the safety and efficacy of using 64Cu-DOTA Pembrolizumab for imaging metastatic solid tumors in patients receiving stereotactic body radiation therapy (SBRT). The primary objectives are to describe toxicities of 64Cu-DOTA-pembrolizumab (64CDP) positron emission tomography (PET) and to identify changes in 64CDP uptake in radiated metastatic lesions pre- and post-SBRT. The study includes patients with metastatic disease from a solid-tumor malignancy currently being treated with single-agent pembrolizumab, who have been referred for SBRT for consolidative local therapy or for oligo resistant/progressive disease. The trial will measure dose limiting toxicities, changes in 64CDP uptake, and incidence of adverse events."
600,"GPT4 Correct Assistant: This clinical trial is a follow-up study designed to assess the safety of participants who received the RSVPreF3 maternal vaccine or controls from previous RSV MAT studies during any pregnancy conceived post-vaccination/control. The study includes participants from various countries and considers both retrospective and prospective data. The primary outcomes measured are the percentage of maternal participants reporting pregnancy outcomes and pregnancy-related adverse events from Day 1 up to Day 42 post-delivery of the first pregnancy conceived within 2 years post-vaccination. Secondary outcomes include the percentage of maternal and infant participants reporting various adverse events and outcomes, as well as the percentage of participants reporting these events stratified by selected risk factors."
601,"GPT4 Correct Assistant: The study is a cross-sectional pilot study examining the use of 19F MRI in healthy children and children with mild cystic fibrosis lung disease. The intervention is a combination product of inhaled perfluoropropane during MRI procedures. The primary outcomes measured are participation rate, completion rate, parental acceptability score, and child acceptability score. Secondary outcomes include MRI-defined ventilation defect parameters and MRI-defined fraction of lung volume with slow gas washout time in both healthy participants and participants with cystic fibrosis."
602,"GPT4 Correct Assistant: This study aims to compare the effects of open and closed chain exercises on pain, function, and balance in athletes with patellofemoral pain syndrome. The study will be conducted in Pakistan sports board Lahore, Model town Sports Club Lahore, and Sheikh Zaid Hospital, Lahore. Participants will be randomly assigned to either open or closed chain exercise groups, and will undergo treatment for 6 weeks. The study will measure pain using the Numerical Pain Rating Scale (NPRS), function using the Lower Extremity Functional Scale (LEFS), and balance using the Y balance test."
603,"GPT4 Correct Assistant: This study aims to investigate the effects of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet on oxidative stress, inflammation, and neurodegenerative risk biomarkers in American football players. The MIND diet is rich in antioxidants and anti-inflammatory properties, which may improve oxidative stress, inflammation, and neurodegenerative risk biomarkers. The study will include 30 American football players, with 15 in each group, and will last for nine weeks. The primary outcome measures include tau protein, NfL, S100B protein, BDNF, telomere, zonulin, NOX2, 8-OHdG, F2-isoprostanes, hs-CRP, IL-6, and TNF-α. The secondary outcome measures include sleep quality score, quality of life score, and dietary inflammatory index score."
604,"GPT4 Correct Assistant: This clinical trial, titled ""Left Bundle Branch Area Pacing in Heart Failure Patients With Ejection Fraction Below Normal,"" aims to investigate the effectiveness of left bundle branch area pacing (LBBAP) in heart failure patients with ejection fraction below normal. The study includes patients with mid-range (mildly reduced) ejection fraction and heart failure with reduced ejection fraction. The primary outcome measures are the acute success rate of LBBAP and acute complications related to the procedures. Secondary outcome measures include the incidence of acute procedure-related complications, repeat procedures, pacemaker upgrades, heart failure hospitalizations, cardiovascular death, and all-cause death at one year. The study uses left bundle branch area pacing as the intervention, locating the ventricular lead into the interventricular septum to capture left bundle branch areas."
605,"GPT4 Correct Assistant: The clinical trial is a Phase 1a, randomized, double-blind, placebo-controlled study investigating the safety, tolerability, and pharmacokinetics of CSX-1004 injection in healthy adults aged 18 to 50 years. CSX-1004 is a recombinant human immunoglobulin G (IgG) 1λ monoclonal antibody specific for fentanyl and structurally related fentanyl analogs. The study will measure treatment-emergent adverse events, clinical laboratory assessments, vital signs, electrocardiogram variables, physical examination, and infusion site examination. The primary outcome measures will be assessed for 5 months, while secondary outcome measures (Cmax, AUCinf, AUClast, Tmax, and t1/2) will be evaluated for 4 months."
606,"GPT4 Correct Assistant: This clinical trial is a prospective cohort study titled ""Joint Aspiration in Dysfunctional Hip, Knee or Shoulder Prostheses (JAD-Pro)."" The study aims to evaluate the diagnostic accuracy of joint fluid aspiration (JFA) in patients with dysfunctional joint prostheses, either due to chronic infection or implant failure. The primary outcome measure is the bacteriological concordance between JFA and perioperative samples. Patients aged 18 or older with a hip, knee, or shoulder joint prosthesis and who require joint fluid aspiration for any reason are eligible for the study. Exclusion criteria include acute prosthesis infection with less than one-month symptoms' duration, antibiotic therapy between preoperative JFA and intraoperative samples, and pregnancy or breastfeeding."
607,"GPT4 Correct Assistant: This clinical trial aims to study the quantitation and spatial registration of airways dysfunction using dynamic 19F MRI in patients with cystic fibrosis. The study participants must be 18-99 years old, non-smokers, and diagnosed with cystic fibrosis. The primary outcome measures are changes in ventilation defect parameters and forced expiratory volume over 14 and 365 days. The study uses a combination product of 19F MRI and inhalation of a biologically inert contrast gas, perfluoropropane, at every visit."
608,"GPT4 Correct Assistant: This is a randomized, open, single-dose, two-sequence, two-cycle, double-cross design bioequivalence trial of fasting single oral STI-1558 capsule in healthy Chinese subjects. The study aims to compare the maximum observed concentration (Cmax), Area Under the Curve (AUC), and other pharmacokinetic parameters of two different formulations of STI-1558 (test preparation and reference preparation) in healthy adult subjects. The trial will enroll 32 eligible subjects who will be randomly assigned to either the TR group or RT group. The trial drug STI-1558 should be taken with approximately 240 ml of water after fasting overnight for at least 10 hours. The study will evaluate the relative bioavailability of the two formulations of STI-1558."
609,"GPT4 Correct Assistant: This randomized controlled trial investigates the effectiveness of detaching the breathing circuit on the rate of double-lumen endotracheal tube malposition after postural change in patients undergoing thoracic surgery. The study includes patients aged 18-65 years who require a left-sided double-lumen endobronchial tube. Participants are randomly assigned to either the experimental arm (disengagement of the breathing circuit) or the control arm (connect the breathing circuit). The primary outcome measure is the malposition rate of the double-lumen endobronchial tube immediately after a change in body position. Secondary outcome measures include effects of lung collapse, blood oxygen saturation, and PACU length of stay."
610,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of personalized comprehensive diabetes support for families of children with newly diagnosed type 1 diabetes. The study includes children aged 16 years or younger with a stable living situation. The intervention is a personalized comprehensive diabetes support provided for 6 months following the diagnosis. The primary outcome measures are Diabetes Distress Scale and Problem Areas in Diabetes (PAID) scores, which will be assessed at 24 months."
611,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy of telemedicine monitoring in the management of depression in patients with major depressive disorder (MDD) after hospitalization in medicine or surgery. The study is a randomized multicenter clinical trial with two parallel arms, comparing usual care (UC) to usual care plus telemedicine monitoring (UC-plus). Patients are followed for 3 years, with the primary endpoint being the treatment response rate at 6 months after inclusion. Telemedicine sessions are semi-standardized and include evaluation of medication tolerance and efficacy, assessment of depressive symptoms, identification of daily difficulties, and provision of personalized advice and treatment recommendations. Secondary endpoints include incremental cost-utility ratio, quality of life scores, number of relapse episodes, medication compliance, integration into a psychiatric care pathway, and feasibility and satisfaction of telemedicine tools. The study aims to optimize secondary prevention by maintaining treatment adherence and reducing costs attributed to depression."
612,GPT4 Correct Assistant: The study aims to develop an AI algorithm that can differentiate between benign and malignant soft tissue masses using artificial intelligence (AI) and quantitative MR images. Patients with a soft tissue mass undergoing MRI as part of their standard care are eligible for participation. The study will measure the diagnostic accuracy of the AI algorithms for distinguishing between benign and malignant soft tissue lesions and the classification accuracy of AI algorithms for classifying malignant lesions into their pathological grade.
613,"GPT4 Correct Assistant: This is a randomized controlled clinical trial aimed at comparing the effectiveness of microneedling alone versus microneedling with hyaluronic acid in increasing gingival thickness in patients with thin gingival phenotype. The study will be conducted over a period of 24 months, and a total of 20 patients with thin gingival phenotypes will be recruited. The primary outcome measure is the measurement of gingival thickness at baseline, 1 month, 6 months, and 9 months."
614,"GPT4 Correct Assistant: This clinical trial is a multicenter, randomized controlled trial investigating the effects of preoperative immunonutrition on patients undergoing elective colorectal surgery for neoplasm. The study aims to assess the impact of the dietary supplement Oral Impact Nestle and placebo on surgical outcomes, including surgical site infections, anastomotic leakage, length of stay, and inflammatory infiltration in adipose tissues. The trial includes participants aged 20-85 with primary colorectal neoplasms eligible for elective surgery and excludes those with emergency surgery, major intraoperative complications, and certain chronic diseases. The intervention is administered for 10 days prior to surgery, and outcomes are measured up to 30 days after surgery and at tissue analysis, usually 1 month after surgery."
615,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact and potential additional benefits of adding an oculomotor therapy treatment to a manual therapy protocol of the cervical region in patients with migraine. The study includes participants aged 18-65 with migraine symptoms, excluding those receiving preventive physiotherapy treatment, with certain medical conditions, or unable to communicate in Spanish. The intervention consists of a control group receiving cervical treatment and exercises for 6 weeks and an experimental group receiving both cervical treatment and oculomotor treatment with specific exercises for 6 weeks. The primary outcome measure is the change in the impact of migraine using the Headache Impact Test (HIT-6) Questionnaire at baseline, 6 weeks, and 3 months after intervention. Secondary outcome measures include changes in pain, disability, depression, anxiety, sleep quality, kinesiophobia, catastrophizing, central sensitization, neck disability, head repositioning, deep cervical flexors strength, ocular movement, ocular movement with head variation, range of movement, and quality of life."
616,"GPT4 Correct Assistant: The CRATOS clinical trial aims to evaluate the Cratos™ Branch Stent Graft System in treating descending aorta lesions, such as aortic dissection, intramural hematoma, and penetrating aortic ulcer. The study includes participants aged 18 and above with thoracic aortic pathology requiring surgical repair. The primary outcome measure is 30-day all-cause mortality. The intervention is the use of the Cratos™ Stent Graft in a TEVAR (thoracic endovascular repair) procedure."
617,"GPT4 Correct Assistant: This study aims to compare the depth of lumbar plexus, image quality, and presence of vessels between the Trident and Shamrock techniques for ultrasound-guided lumbar plexus block (BPLE). Adults with an indication for lumbar echography are eligible, excluding those with a history of spine surgery or spinal malformation. The study measures the projection of line C on the costiform processes, depth of lumbar plexus, image quality, and presence of vessels. The results will provide insights into the most favorable approach for ultrasound-guided lumbar plexus block."
618,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of standardized pre-operative pelvic floor physical therapy (PFPT) in reducing stress urinary incontinence (SUI) and improving patient quality of life following Holmium Laser Enucleation of the Prostate (HoLEP). The study will be a prospective randomized trial, comparing patients who start PFPT before surgery (Group A) with those who start PFPT after surgery (Group B). The primary outcome measure is the time to continence, and secondary outcome measures include uroflow, post-void residual, international prostate symptom score, operative time, length of stay, catheter duration, infectious complications, emergency room visits, and other related parameters."
619,"GPT4 Correct Assistant: The DETECT-IP study is a randomized trial designed to evaluate the effectiveness of a Clinical Decision Support System (CDSS) in reducing adverse drug events in older hospital patients. The study involves two groups: one that receives CDSS intervention and another that does not. The primary outcome measure is the number of adverse drug events such as acute renal failure and/or hyperkalemia in older hospitalized patients. Secondary outcome measures include the presence of an adverse event related to the intervention, therapeutic adaptations implemented in case of acute renal failure or hyperkalemia, relevance of CDSS alerts, number of pharmaceutical interventions accepted, changes in ADEs prevention/management work process induced by the introduction of alerts, and cost-effectiveness of the pharmaceutical intervention."
620,"GPT4 Correct Assistant: The study ""Mesenteric Bacterial Translocation in Evolved Crohn's Disease"" aims to investigate the differences in bacterial taxa proportions and abundance, as well as bacterial profile function, between the mesentery, ileal tissue, and blood of Crohn's disease (CD) patients with and without early post-surgical disease recurrence. The study also aims to perform an association analysis of genetic variants related to innate immunity and the bacterial microbiome profile of CD patients. Participants are CD patients requiring surgical treatment (ileocecal resection) and a control group of patients requiring an ileocecal resection for a cause other than CD. The study measures the primary and secondary outcomes at the time of surgery inclusion."
621,"GPT4 Correct Assistant: This clinical trial, titled ""Effect of Injection Site on the Relative Bioavailability of a Single Dose of LY3437943 in Healthy Participants With a High Body Mass Index,"" aims to study the pharmacokinetics of LY3437943 in healthy participants with a high body mass index (BMI between 27.0 and 45.0 kg/m²). The study is designed as a randomized, parallel assignment, open-label trial with two intervention groups: LY3437943 administered subcutaneously (SC) in either thigh, upper arm, or abdomen, and LY3437943 administered intravenously (IV). The primary outcome measures are the area under the plasma concentration versus time curve from zero to infinity (AUC[0-∞]) and maximum concentration (Cmax) of LY3437943. The study is open to both males and females aged between 18 and 70 years who are nonchildbearing and agreeable to receiving study treatment by injections."
622,"GPT4 Correct Assistant: This clinical trial, titled ""A Research Registry on Aggressive PitNETs,"" aims to study aggressive pituitary tumors in adult patients. The primary outcome measure is the characterization of aggressiveness of pituitary tumors by transcriptome analysis, which will be predictive of prognosis. The study will follow participants for three years."
623,"GPT4 Correct Assistant: The OPTI study is a randomized pilot study investigating the feasibility of a lower starting dose of oral anticancer drugs in older adults, with the aim of improving treatment tolerability while maintaining the same benefits. The trial includes 30 patients aged 65 or older, starting treatment with one of five anti-cancer tablet drugs. The study has two groups: a control group receiving standard doses and an intervention group starting with lower doses, which would be increased every two weeks if tolerated. The primary outcome measure is the feasibility of the approach, while secondary outcomes include overall treatment utility, progression-free survival, overall survival, quality of life, safety, hospital care use, and pharmacokinetic parameters."
624,"GPT4 Correct Assistant: The study, titled ""Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma: a Prospective, Multicenter, Randomized Controlled Study (PRECAM-R), aims to evaluate the pathologic complete response (pCR) rate following short-course radiation then Envafolimab Plus CAPEOX in patients with MSS locally advanced rectal adenocarcinoma. The study includes two arms: experimental and control. The experimental arm receives neoadjuvant chemoradiotherapy combined with immunotherapy and total mesorectal excision (TME surgery) with Envafolimab, while the control arm receives neoadjuvant chemoradiotherapy and TME surgery without Envafolimab. The primary outcome measure is the pCR rate, and secondary outcome measures include tumor regression grade, overall survival (OS), progression-free survival (PFS), treatment-related adverse events (TRAEs), surgical complications, and quality of life (QoL)."
625,"GPT4 Correct Assistant: This is a two-stage clinical trial to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of Levilimab when administered at repeated intravenous or subcutaneous doses in subjects with active rheumatoid arthritis resistant to methotrexate monotherapy. The primary outcome measure is the proportion of subjects with low activity of rheumatoid arthritis (DAS28-ESR <3.2) at Week 24 of the study in each treatment group."
626,"GPT4 Correct Assistant: This is a randomized, double-blind, crossover clinical trial investigating the efficacy of White Kidney Bean on oral glucose tolerance test in healthy adults aged 25-45 years. The trial consists of two phases, each lasting one day, with a 72-hour washout period between them. Participants receive either the White Kidney Bean product or a placebo in each phase. The primary outcome measure is the change in blood glucose level in mmol/L based on the Oral Glucose Tolerance Test (OGTT) after intervention. The secondary outcome measure is the change in fasting blood glucose level in mmol/L based on the OGTT after intervention."
627,"GPT4 Correct Assistant: The ""IMPlementation of Evidence Based Facility and Community Interventions to Reduce the Treatment Gap for depRESSion"" clinical trial aims to evaluate the effectiveness of community interventions and a Healthy Activity Program (HAP) in reducing the treatment gap for depression among adults aged 18 and above. The study is designed as a randomized controlled trial with parallel assignment and single masking. Participants are allocated to either the experimental group (community model) or the active comparator group (facility model). The experimental group receives community intervention strategies and HAP, while the active comparator group receives HAP alone. The primary outcome measure is the Patient Health Questionnaire-9 (PHQ-9) score at three months post-recruitment. Secondary outcome measures include sustained effectiveness, remission, response to treatment, client service receipt inventory, WHO Disability Assessment Schedule (WHODAS 2.0), costs of receiving HAP intervention, system-level costs of delivering interventions, depression awareness, perceived social support, treatment completion, and behavioral activation."
628,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of low-intensity blood flow restriction training in normoxia and hypoxia conditions on muscle strength, thickness, catecholamine, and inflammatory responses in physically active adults. Participants will be randomly assigned to one of five groups: low-intensity normoxia, high-intensity normoxia, low-intensity normoxia with blood flow restriction, low-intensity hypoxia, or low-intensity hypoxia with blood flow restriction. The study measures primary outcomes such as force output, one-repetition maximum, maximum number of repetitions, countermovement jump height, countermovement jump power output, catecholamine response, muscle stiffness, and muscle thickness. Secondary outcomes include perception of pain, perception of effort, and blood pressure."
629,"GPT4 Correct Assistant: This is a Phase II multicenter clinical trial investigating the efficacy of subcutaneous mosunetuzumab monotherapy in patients with follicular lymphoma with early relapse in the Nordic countries. The primary objective is to assess progression-free survival 2 years after the initiation of 2nd line treatment in these patients. Mosunetuzumab is a new, bispecific, T-cell engaging antibody with high response rates and long response duration in B-cell lymphoma patients with multiple relapses or lack of response to standard salvage regimens."
630,"GPT4 Correct Assistant: This clinical trial aims to test the safety and effectiveness of combining PLX2853 and trametinib in the treatment of advanced uveal melanoma. The study has two primary objectives: determining the maximum tolerated dose (MTD) and recommended phase II dose, and evaluating whether the combination of PLX2853 and trametinib demonstrates clinical activity in advanced uveal melanoma. Secondary objectives include evaluating overall response rate, progression-free survival, overall survival, and adverse event profile associated with the combination of PLX2853 and trametinib. Additionally, the pharmacokinetic profile of the combination will be evaluated."
631,"GPT4 Correct Assistant: The ASCERTAIN study is a 2-arm, multicentre, phase IV, randomised, open-label trial designed to evaluate the implementation and utility of a primary care model in patients with Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD-risk equivalents and elevated LDL-C. The study aims to assess the effectiveness of a new model of care compared to usual care in patients who have not reached their LDL-target. Participants will receive maximally tolerated statin and/or ezetimibe therapy with or without other LDL-C lowering therapies as per the treating physician's discretion. The primary clinical question of interest is the effectiveness of a new model of care implementation strategy compared to usual care in patients who have not reached their LDL-target. The study includes male and female participants ≥18 years of age with a history of ASCVD (coronary heart disease, ischaemic cerebrovascular disease, or peripheral arterial disease) or ASCVD-risk equivalents who have elevated LDL-C (≥1.8 mmol/L). A total of approximately 600 participants will be included in the study and will be randomised in a 1:1 ratio at approximately 20 sites across Australia."
632,"GPT4 Correct Assistant: This randomized, controlled, single-blinded study was conducted at Al-Azhar University Hospital to compare the efficacy of ultrasound-guided erector spinae block, thoracic para-vertebral block, and quadratus lamborum block in patients undergoing elective open renal surgeries under general anesthesia. The study enrolled 48 patients aged 21-65 years and measured total morphine requirements 24 hours postoperatively."
633,"GPT4 Correct Assistant: This study aims to evaluate and describe musculoskeletal health in adult haematological cancer survivors, focusing on the prevalence of musculoskeletal conditions, sarcopenia, and frailty, as well as quality of life and musculoskeletal function-related quality of life. The study will use questionnaires and semi-structured interviews to gather data from survivors at various time points post-treatment. The study will also assess risk factors associated with poor musculoskeletal health."
634,"GPT4 Correct Assistant: This is a Phase 2 basket study examining the efficacy of disitamab vedotin, a drug given intravenously every two weeks, in treating various types of solid tumors that express HER2. The study includes four cohorts: head and neck squamous cell carcinoma, non-small cell lung cancer, ovarian cancer, and endometrial cancer. The primary outcome measure is the confirmed objective response rate per RECIST v1.1, assessed by the investigator, with a time frame of approximately three years. Secondary outcome measures include the number of participants with adverse events, laboratories abnormalities, dose alterations due to AEs, confirmed disease control rate, duration of response, duration of progression free survival, overall survival, and pharmacokinetic parameters."
635,"GPT4 Correct Assistant: This clinical trial aims to assess the feasibility and acceptability of neurocognitive assessments and in-vehicle sensor deployment in older ICU survivors with risk factors for ICU-acquired cognitive impairment. The study aims to determine the relationship between neurocognitive assessments and driving behavior and safety in older ICU survivors and conduct stakeholder advisory panels to evaluate priorities and data presentation needs for driving assessments in older ICU survivors. The trial will enroll a cohort of 24 older ICU survivors and collect data on driving time, depression, executive function, attention, working memory, processing speed, and health-related quality of life."
636,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a brief Acceptance and Commitment Therapy (ACT) workshop for women with obesity. The study will recruit 70 participants, with 35 receiving the ACT workshop and 35 serving as a waitlist control. The primary outcomes measured will be changes in psychological flexibility, distress tolerance, and valued living at 1 week and 1 month post-intervention. Secondary outcomes include changes in weight self-stigma, body image, emotional eating, physical activity, diet quality, and body weight."
637,"GPT4 Correct Assistant: This is a clinical research study focused on gastrointestinal stromal tumor (GIST) patients at high risk of recurrence. The study aims to evaluate the value of minimal residual disease (MRD) detection in monitoring postoperative recurrence of high-risk GIST, investigate the effect of drug holiday treatment based on MRD detection on disease recurrence and patient survival, and explore whether it can delay the occurrence of drug-resistant mutations. The study includes patients who have been treated with imatinib for 3 years after surgery and have achieved disease control. The primary outcome measures are progression-free survival, drug re-use rate, and drug retreatment response rate. Secondary outcome measures include overall survival, genetic mutation profiling of ctDNA-MRD, and comparison of MRD versus imaging examination."
638,"GPT4 Correct Assistant: This study is a randomized control trial aiming to compare the effects of Dohsa hou exercises on functional mobility in children with Down syndrome. Participants aged 6 to 12 years old with Down syndrome and meeting inclusion and exclusion criteria will be divided into two groups. One group will receive standard treatment protocol, while the other group will receive Dohsa hou therapy. The study will measure the trunk impairment scale and Time Up and Go Test to assess balance and coordination. The study duration is 6 weeks."
639,"GPT4 Correct Assistant: The Supporting Physical Literacy at School and Home (SPLASH) Study aims to increase children's physical activity (PA) through a multilevel, comprehensive physical literacy (PL)-focused program that reaches children both at school and at home. The study uses a 2-arm, group randomized controlled trial (RCT) with 400 3rd-5th grade students from low-income schools, who are either given the multilevel Rising New York Road Runners (RNYRR) program or a delayed-intervention control. The study measures the impact of the RNYRR program on children's PL and PA (total daily volume and moderate-to-vigorous PA (MVPA)) over one school year. The study also examines whether RNYRR program effects on children's PL and PA differ by sex or weight status, and whether changes in PL and PL subdomains mediate changes in daily total PA volume or MVPA."
640,"GPT4 Correct Assistant: This is a Phase III clinical trial investigating the efficacy and safety of BI 456906, a drug administered subcutaneously, compared to a placebo in Japanese patients with obesity. The primary outcomes measured are the percentage change in body weight from baseline to week 76, and achievement of body weight reduction ≥5% from baseline to week 76. Secondary outcomes include various measures of body weight, blood pressure, and eating behavior."
641,"GPT4 Correct Assistant: The study, titled ""Ultrasound Evaluation of Gastric Volume in Pediatric Patients Undergoing Adenotonsillectomy Surgery: a Prospective Cohort Study,"" aims to evaluate the pre- and postoperative gastric volume in children undergoing tonsillectomy and/or adenoidectomy using ultrasound. This study seeks to determine if the accumulation of blood and fluid in the stomach after these surgeries increases the risk of aspiration. The study will include patients aged 1-18 who are undergoing the surgeries at Istanbul University. The primary outcome measure is gastric volume, while secondary outcome measures include the cross-sectional area of the gastric volume, postoperative presence and severity of postoperative nausea and vomiting (PONV), blood volume in the suction system, and duration of surgery."
642,"GPT4 Correct Assistant: The study aims to investigate the effect of pituitrin on patients with pulmonary hypertension undergoing cardiac surgery. The study is a randomized controlled trial, with participants divided into two groups: the pituitrin group and the normal saline group. The primary outcome measure is a composite endpoint of mortality or severe postoperative complications within 30 days after cardiac surgery. Secondary outcome measures include incidence of postoperative infection, septic shock, duration of mechanical ventilation, postoperative pulmonary complications, time to achieve hemodynamic stability, use of dobutamine or other vasoactive drugs, incidence of digital ischemia, acute mesenteric ischemia, gastrointestinal complications, incidence of acute myocardial infarction, new onset tachyarrhythmia, water poisoning, vasodilative shock, incidence of pulmonary embolism, low cardiac output syndrome, acute respiratory distress syndrome, delirium, need for renal replacement therapy, need for hemodialysis, incidence of readmission to ICU, length of ICU stay, length of hospital stay, levels of serum antidiuretic hormone in patients, levels of copeptin in patients, and secondary endotracheal intubation."
643,"GPT4 Correct Assistant: The study aims to evaluate the feasibility and safety of home initiation of noninvasive positive pressure ventilation (NiPPV) in children with medical complexity (CMC) compared to usual care, which is in-hospital polysomnography (PSG) laboratory-based initiation. The study will use remote telemonitoring for home NiPPV initiation, which may improve patient and family empowerment and optimize NiPPV use. Home initiation of NiPPV has been associated with increased survival and improved health-related quality of life in CMC. The study will measure recruitment and retention rates, adherence to NiPPV, psychological scales, and caregiver reported sense of mastery. The results of this study will help determine if a larger-scale trial is warranted."
644,"GPT4 Correct Assistant: This is a single-blind randomized clinical trial investigating the effects of dry needling on vertical jump performance in female athletes with latent myofascial trigger points in the gastrocnemius muscle. The study includes two groups: an intervention group receiving dry needling and a control group. The primary outcome measure is counter movement jump performance, measured at various time points after the intervention."
645,"GPT4 Correct Assistant: This clinical trial aims to investigate the clinical features of refractory gastrointestinal Henoch-Schönlein purpura (HSP) and the clinical outcome of mycophenolate mofetil (MMF) in these patients. The study includes participants aged 3 to 18 years old who meet the diagnostic criteria for HSP involving the digestive tract and have a refractory gastrointestinal type HSP. The intervention is MMF, and the primary outcome measure is the incidence of abdominal pain, hematemesis, and bloody stools. The study is designed as an open-label, single-group assignment trial."
646,"GPT4 Correct Assistant: This clinical trial aims to investigate the safety, feasibility, and efficacy of adjunctive, midline prefrontal, lower intensity, shorter session, EEG-enhanced, repetitive transcranial magnetic stimulation (eTMS) for the treatment of Chronic Trauma and Stressor-Related Disorders (TSRD) in Veterans. The study will enroll a total of 300 participants, divided into an initial cohort of 30 and a subsequent cohort of 270. The primary outcome measures are the number of participants with device-related serious adverse events and the rate of participants completing 80% of scheduled visits. Secondary outcome measures include the mean change in Veterans RAND 36-item health survey (VR-36) mental component scores."
647,"GPT4 Correct Assistant: This is a retrospective study investigating the efficacy of combined radiotherapy and EGFR-TKI treatment in patients with stage III EGFR mutant lung cancer. The primary metric for measuring effectiveness is progression-free survival (PFS). Eligible participants are those diagnosed with lung cancer, with EGFR mutation, in stages IIIA-IIIC, who have not undergone surgery or chemotherapy. The study involves two arms: one receiving RT+C (radiotherapy and targeted therapy), and the other receiving RT+TKI (radiotherapy and EGFR-TKI). The study measures PFS over a 2-year period."
648,"GPT4 Correct Assistant: This clinical trial, titled ""Identifying the Microorganisms Responsible for Acute Head and Neck Infections,"" aims to study head and neck infections caused by Streptococci in individuals over 18 years old. The study will analyze samples from Northampton General Hospital and exclude samples from other National Health Service (NHS) hospitals, infections from other body areas, non-streptococcal infections, and participants who choose not to participate. The primary outcome measure is the identification of Streptococci species using DNA analysis and biochemical testing. Secondary outcome measures include patient characteristics, clinical outcomes, and common traits in acute head and neck infections. The study will be conducted over a 4-year period."
649,"GPT4 Correct Assistant: This clinical trial investigated the effectiveness of functional magnetic stimulation and pelvic floor muscle training on pelvic floor muscle function, urinary incontinence symptoms, and quality of life in women with stress urinary incontinence. The study included 48 women aged 29-49 who had experienced stress urinary incontinence for at least 4 weeks. Participants were randomly divided into two groups: one group underwent functional magnetic stimulation, and the other group participated in a pelvic floor muscle training program. The study used the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and Incontinence Impact Questionnaire-Short Form (IIQ-7) to assess urinary incontinence symptoms and their impact on quality of life. Pelvic floor muscle strength and endurance were assessed using a Pelvexiser perineometer. The study found that both functional magnetic stimulation and pelvic floor muscle training were effective in improving urinary incontinence symptoms and quality of life in women with stress urinary incontinence."
650,"GPT4 Correct Assistant: This clinical trial aims to optimize the selection and treatment outcomes of biologic therapies for psoriatic arthritis (PsA) and seronegative rheumatoid arthritis (RA) patients. It focuses on the role of ultrasonographic and tissue biomarkers in patient selection. The study includes various intervention groups, such as PsO patients at risk of PsA development, naive to treatment PsA, TNF-inhibitor resistant PsA, and c-DMARDs resistant RA. The primary outcome measures are minimal disease activity status achievement, PsA development, and remission maintenance. The study is designed to generate a comprehensive cellular and molecular atlas of PsA using CITE-Seq and spatial transcriptomics of synovium."
651,"GPT4 Correct Assistant: This clinical trial aims to investigate the use of artificial tears (methylcellulose) in preventing nasolacrimal duct obstruction in patients treated with radioactive iodine for thyroid cancer. The study includes participants aged 18 or older and randomly assigns them to either the experimental arm, which receives artificial tears, or the control arm, which receives no intervention. The primary outcome measure is the incidence of post-radiotherapy nasolacrimal duct obstruction within two years."
652,"GPT4 Correct Assistant: This clinical trial, titled ""A Decentralized Phase II Randomized Controlled Trial of Atorvastatin in Resected High-Risk Melanoma,"" aims to compare recurrence-free survival (RFS) of patients with high-risk melanoma treated with atorvastatin to placebo. The trial includes two arms: Arm I, where participants receive placebo, and Arm II, where participants receive atorvastatin. The study measures RFS, distant metastasis-free survival (DMFS), and overall survival (OS) as primary and secondary outcomes. Participants must be aged 18 or older, have a diagnosis of stage IIA cutaneous melanoma, and have not been previously treated for melanoma beyond complete surgical resection. The study plans to enroll 260 participants and follow them for up to 5 years."
653,"GPT4 Correct Assistant: The ACHIEVE (Advancing Community and Clinical Care for Childbirth-related Hypertension Through Implementation, Engagement, and Valuing Equity) initiative aims to improve maternal health outcomes for pregnant individuals with high blood pressure by implementing the Severe Hypertension During Pregnancy and Postpartum Period Safety Bundle (HTN bundle). The study will test the impact of three implementation strategies (training, coaching, facilitation) in 20 outpatient clinics in central North Carolina. The intervention will be compared to usual clinic care for severe hypertension. The study will measure the normalized percentage of achieving the highest possible scores for blood pressure measurement technique, documentation of delivery of patient education on hypertension, recognition and response to simulated episodes of severe hypertension, and recognition and response to actual episodes of severe hypertension."
654,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of scalable, tailored text-messaging programs for alcohol use among older adults. It focuses on gain and loss framing of behavior change goals. The study involves 150 older adults with hazardous drinking who will be randomized to one of three conditions: loss-framed messaging, gain-framed messaging, or a combination of both. The primary outcome measures are the weekly sum of standard drinks and the weekly sum of heavy drinking days. The study will run for 16 weeks, with assessments at baseline, week 4, week 8, and week 16."
655,"GPT4 Correct Assistant: This clinical trial is designed to evaluate the safety and effectiveness of 18F-Fluselenamyl, a new radiotracer, for PET imaging in detecting Alzheimer's disease. The study includes two participant groups: healthy participants and those with mild cognitive impairment due to Alzheimer's dementia. Participants will receive an intravenous injection of the radiotracer and undergo PET/CT scans. The primary outcome measures are the biodistribution, kinetics, and human dosimetry of the radiotracer, as well as the sensitivity of the radiotracer to image Amyloid beta in participants with mild cognitive impairment. The study aims to determine the safety of the tracer and assess its potential use in Alzheimer's disease diagnosis."
656,"GPT4 Correct Assistant: This clinical trial investigates the long-term effects of Transcranial Magnetic Stimulation (TMS) in individuals with Primary Progressive Aphasia (PPA). The study includes two groups: one receiving active TMS with language therapy, and another receiving sham TMS with language therapy. The primary outcome measure is changes in brain metabolism as measured by FDG-PET imaging at 0 and 6 months. Secondary outcome measures include changes in spontaneous language, language assessment tests, daily-living activities, and neuropsychiatric symptoms at 0, 3, and 6 months. The study aims to determine the effectiveness of TMS in improving language function and quality of life in individuals with PPA."
657,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of methylprednisolone on cognitive deficits in patients with post-COVID-19 syndrome (PCS) with suspected autoimmune involvement. It is a randomized, double-blind, placebo-controlled trial evaluating the effects of methylprednisolone versus placebo in patients with PCS and cognitive deficits. The study spans 52 weeks, and participants will be stratified based on age, sex, and cognitive screening. The intervention group will receive approximately 1mg/kg body weight oral methylprednisolone once daily for 6 weeks, followed by an additional 6 weeks of open treatment with methylprednisolone after a 6-weeks treatment pause. The primary outcome measure is improvement in memory satisfaction as measured by the Multifactorial Memory Questionnaire (MMQ) in patients with PCS treated with methylprednisolone compared with placebo. The trial has the potential to benefit individuals with post-COVID-19 syndrome (PCS) by exploring the effects of methylprednisolone on cognitive impairment and fatigue, and may provide crucial insights into PCS's pathophysiological processes, leading to the development of more effective therapies and improved patient outcomes."
658,"GPT4 Correct Assistant: This clinical trial aims to analyze the aetiological factors of malnutrition, specifically focusing on inflammation and oral intake. The study involves a dietary supplement rich in omega-3 and olive oil polyphenols as the intervention. Participants are followed for 3 consecutive months, and the primary outcome measures include blood biochemistry data such as albumin, prealbumin, C-reactive protein, ferritin, neutrophils, lymphocytes, and platelets. Secondary outcome measures encompass bioelectrical impedance data, functional parameters, oral intake, and malnutrition diagnosis using the GLIM criteria."
659,"GPT4 Correct Assistant: This is a clinical trial investigating the effects of financial support for healthy food and free home delivery on glycosylated hemoglobin levels and other patient-reported outcomes in food-insecure high-risk adults with Type 2 diabetes. Participants are randomized into two groups: an intervention group receiving financial support for healthy food items and free home delivery, and a control group receiving only free home delivery. The primary outcome measure is the 6-month change in glycosylated hemoglobin level. Secondary outcome measures include 12-month change in glycosylated hemoglobin level, percentage of participants with glycosylated hemoglobin <7.5%, all-cause hospitalizations or emergency department visits, change in self-reported level of food security, nutrition security, dietary habits, diabetes-related quality of life, and readiness to change."
660,"GPT4 Correct Assistant: The study is a four-arm, double-blind, randomized controlled clinical trial evaluating the solvent evaporation time of universal adhesives in the quality of cervical lesions restorations. It compares two experimental groups (one using an alcohol- and water-based solvent universal adhesive with evaporation for 25 seconds and another using an acetone-based universal solvent adhesive with evaporation for 25 seconds) with two control groups (one using an alcohol- and water-based solvent adhesive with evaporation for 5 seconds and another using an acetone-based universal solvent adhesive with evaporation for 5 seconds). The primary outcome measure is the retention of restorations measured by World Dental Federation (FDI) criteria at 24 months. Secondary outcome measures include marginal adaptation and marginal staining of restorations."
661,"GPT4 Correct Assistant: This study is a Phase II/III trial evaluating the immunogenicity and safety of SWIM816 vaccines for SARS-CoV-2 compared to a Pfizer Bivalent vaccine in previously vaccinated individuals. The trial includes two stages: Phase II, which involves two groups of 100 subjects each receiving either SWIM816 or SW-BIC-213 vaccines, and Phase III, which includes two groups of 300 subjects each receiving either SWIM816 or Pfizer Bivalent vaccine. The primary outcome measures are immunogenicity, measured by GMTs of SARS-CoV-2 Omicron and related strain neutralizing antibody levels for SWIM816, and non-inferiority of neutralizing antibody response in terms of geometric mean titers (GMT) of COVID-19 mRNA vaccine(SWIM816) compared with mRNA COVID-19 vaccine(Pfizer Bivalent vaccine) 14 days post dose."
662,"GPT4 Correct Assistant: The Esbjerg Cohort is a cross-sectional study investigating the effects of ergonomic exposure and physical capacity on work ability and musculoskeletal pain in workers aged 55 to 70. The study population consists of 336 participants divided into 12 groups based on gender, age, and occupational group. The primary outcome measure is work ability assessed using the Work Ability Index (WAI) questionnaire. Secondary outcomes include height, weight, BMI, waist-to-hip ratio, blood pressure, pressure pain threshold, warm and cold detection threshold, heat and cold pain threshold, temporal summation, conditioned pain modulation, physical activity, musculoskeletal pain, and several strength and endurance tests. The study aims to provide insights into the consequences of high physical workload on the musculoskeletal system in the oldest group of workers, which can inform better treatment and counseling for this demographic and improve guidelines for optimizing work demands and physical capacity."
663,"GPT4 Correct Assistant: This is a phase I safety and feasibility study of cellular immunotherapy for extensive stage small cell neuroendocrine prostate cancer using autologous T cells lentivirally transduced to express L1CAM-specific chimeric antigen receptors. The study aims to evaluate the incidence of adverse events and dose-limiting toxicity rates, as well as assess objective response, radiographic progression-free survival, and overall survival. Participants must be 18 years or older, have a diagnosis of small cell neuroendocrine prostate cancer, and have metastatic or locally advanced and unresectable disease. The study involves lymphodepleting chemotherapy followed by autologous L1CAM-specific CAR+EGFRt+ T cell infusions. Participants undergo various imaging and blood tests throughout the study, with follow-up for up to 15 years after completion of treatment."
664,"GPT4 Correct Assistant: This study assesses the safety and efficacy of a new technique, Whipple over the splenic artery (WOTSA), as a treatment for pancreatic ductal adenocarcinoma (PDAC) which traditionally requires total pancreatectomy (TP). The study group comprised 40 consecutive patients who underwent WOTSA for PDAC, and their clinicopathological characteristics and survival were compared with those of a historical control group of 30 consecutive patients who underwent TP. The primary outcome measures were the measurement of the remnant pancreatic volume before and one week after the operation. Secondary outcome measures were the measurement of the remnant pancreatic volume and physiological parameters one month after the operation."
665,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of breastfeeding education given to fathers via WhatsApp messaging application on breastfeeding rates in the postpartum period. The study is designed as an experimental design with four groups, using a computer program for randomization and double-blind masking. The primary outcome measures include the Breastfeeding Support Scale and The Partner Breastfeeding Influence Scale, which will evaluate the fathers' support and influence on breastfeeding. The study includes participants who are mothers and fathers, aged 18 and above, with a baby at a gestational age of 37 weeks and above, weighing 2500 g and over, and living in the same house."
666,"GPT4 Correct Assistant: This study aims to investigate biomarker testing and treatment patterns among patients with PIK3CA mutation in advanced breast cancer. The study includes patients who have been newly diagnosed with advanced breast cancer between 2015 and 2020, have tested positive for the PIK3CA gene, and have not participated in specific clinical trials. The primary outcomes measure includes the number of patients with PIK3CA mutations, the time from first breast cancer diagnosis to first PIK3CA evaluation, and the type of biopsy. Secondary outcomes measure includes age at advanced breast cancer diagnosis, stage of diagnosis, and performance status of patients."
667,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of melatonin on sleep spindles in children with Autism Spectrum Disorder (ASD). The study includes participants aged 12-18 years, with both males and females eligible for participation. Participants must be able to understand and respond to questionnaires in English. Exclusion criteria include pregnancy, breastfeeding, substance abuse, certain medical conditions, and prior melatonin use or adverse reactions. The study uses an open-label design, with participants receiving 5mg melatonin gummies 30 minutes before bedtime for two consecutive nights. The primary outcome measure is the change in sleep spindle density during non-Rapid Eye Movement (NREM) sleep, measured using a portable EEG device over five nights of sleep. Secondary outcome measures include changes in sleep quality."
668,"GPT4 Correct Assistant: The DETERMINE trial (Treatment Arm 04: Trastuzumab in combination with pertuzumab for adult, teenage and paediatric patients with cancers with HER2 amplification or activating mutations) is a trial investigating the efficacy of trastuzumab and pertuzumab in combination for patients with rare cancers with HER2 amplification or activating mutations in adults, teenagers, and paediatric patients. The trial aims to enroll 30 evaluable patients and has primary outcome measures of objective response rate (OR) and durable clinical benefit (DCB). The trial also has secondary outcome measures of duration of response (DR), best percentage change in sum of target lesion/index lesion diameters (PCSD), time to treatment discontinuation (TTD), progression-free survival time (PFS), time to progression (TTP), growth modulation index (GMI), overall survival time (OS), occurrence of at least one Suspected Unexpected Serious Adverse Event (SUSAR), occurrence of at least one Grade 3, 4, or 5 trastuzumab and pertuzumab-related adverse event (AE), and quality of life measures."
669,"GPT4 Correct Assistant: This clinical trial aims to study the etiology of persistent velopharyngeal insufficiency in children with operated velopalatine cleft using analysis of velopharyngeal motor skills in static and dynamic MRI. The study includes children aged 7 to 12 years with isolated cleft lip and isolated velopalatal cleft without syndromic cleft or Pierre Robin sequence, who were operated with cheiloplasty or intravelar veloplasty at Amiens University Hospital. The study uses real-time MRI as an intervention and measures the ratio between the diameter of the pharynx at rest and during phonation, closure distance between the velar knee and the posterior pharyngeal wall, and distance between the velar knee and the posterior pharyngeal wall."
670,"GPT4 Correct Assistant: This study aims to investigate the effects of a remotely-delivered exercise training program on cognition and mobility in older adults with multiple sclerosis (MS). The study includes two intervention groups: the Aerobic and Resistance Exercise Program (GEMS program) and the Flexibility and Stretching Program (FLEX-MS program), both delivered via telerehabilitation. The primary outcome measures include cognitive function, physical function, lower-extremity function, functional mobility, walking endurance, and walking speed. Secondary outcome measures include physical activity level, exercise behavior, and vascular function. The study aims to determine the feasibility and efficacy of home-based exercise interventions for older adults with MS who have cognitive and walking impairments."
671,"GPT4 Correct Assistant: This is a pilot, non-interventional study aiming to measure the clinical and biological effects of using the oXiris hemofiltration membrane in critically ill patients with vasoplegic shock. The study will analyze the clearance of vasoactive metabolites, hemodynamic stabilization, and angiotensin metabolites in patients receiving oXiris hemofiltration with Prismaflex system, Phoxylium or Hémosol B0 dialysis solution, and anticoagulation with heparin, citrate, or none. The study will assess the 50% reduction in vasoactive score within 24 hours of initiation, evolution of vasoactive score within 72 hours, and the correlation between angiotensin metabolite concentrations and 90-day mortality."
672,"GPT4 Correct Assistant: The study aims to compare the efficacy of central urinary bladder dissection (Group A) and lateral urinary bladder dissection (Group B) during total laparoscopic hysterectomy in patients with previous cesarean section. The primary outcome measure is the rate of urinary bladder injury during dissection. Secondary outcome measures include operative time, amount of blood loss, and late urological complications. The study uses the Wolf laparoscopy tower as a device for laparoscopic surgery."
673,"GPT4 Correct Assistant: This is a 6-month observational study that aims to explore the association between the asthma microbiome and disease characteristics, severity, and treatment response. Participants will undergo various assessments, including validated symptom questionnaires, pulmonary function testing, and sample collection of blood, oral rinse, nasopharyngeal swab, exhaled breath condensate, stool, and induced sputum. The study will analyze the microbiome and host transcriptome profiling to determine if there is any association between asthma phenotype and microbiome signature, and if the microbiome signature can predict treatment response or resistance."
674,"GPT4 Correct Assistant: This study is a randomized controlled trial comparing the effects of split-body and full-body resistance training on strength and functional performance in amateur cricket players. It includes 28 participants, divided into two groups of 14, who will undergo either split-body or full-body resistance training for six weeks. The primary outcome measures are the bench press test, leg press test, and 30-second sit-to-stand test. The study aims to determine the most effective training method for enhancing performance in amateur cricket players."
675,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of training on breastfeeding given to fathers on breastfeeding, parent-baby bonding, and breastfeeding self-efficacy level. The study includes three groups: experimental group 1 (mothers and fathers receive training), experimental group 2 (only mothers receive training), and control group (no intervention). The primary outcome measures include the Breastfeeding Self-Efficacy Scale-short form, Mother to Infant Bonding Scale, Father Breastfeeding Self-Efficacy Scale Short Form, and Paternal-Infant Attachment Questionnaire. The study will follow participants for three months."
676,"GPT4 Correct Assistant: This is a randomized, double-blind controlled trial investigating the effects of Amway Bundle Combination of Products on Osteoarthritis and Sarcopenia. The trial includes four participant groups: Bundle Group 1 with Nutrilite Lifestyle, Bundle Group 2 without Nutrilite Lifestyle, Control Group 1, and Control Group 2 with Nutrilite Lifestyle. The study measures the change in Short Physical Performance Battery (SPPB) score from baseline to day 180, as well as changes in WOMAC Questionnaire Scores, Visual Analogue Scale/Score (VAS), Chalder Fatigue Scale (CFS), Fat and Muscle Portions measured by Inbody S10, Hand & Grip Strength measured by Jamar Smart Hand Dynamometer, and bone density measured by DXA Bone Densitometer from baseline to day 90 and day 180."
677,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of a Type 1 Hybrid Effectiveness-Implementation Trial of Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Family Planning Clinics for improving alcohol and drug use, access, and equity in care among reproductive-aged women. The study will be conducted in a large network of Family Planning Clinics with a diverse, primarily structurally disadvantaged population of reproductive-aged women. The primary outcomes include average drinks per drinking day, depression score, and fidelity to the SBIRT intervention. Secondary outcomes include anxiety score, days of alcohol use, days of drug use, incidence of condom nonuse, incidence of contraceptive nonuse, incidence of regretted/nonconsensual sex and sexual violence, NIDA ASSIST score, number of events of condom nonuse, number of events of contraceptive nonuse, number of events of regretted/nonconsensual sex and sexual violence, patients receiving referral, patients screened, quality of life score, STI incidence, unintended pregnancy, and well-being score."
678,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of herbal tea infusions on gut microbiome and blood lipid markers after 21 days of habitual consumption. The trial involves 150 adult participants with obesity or well-being issues who will be randomly assigned to one of three intervention groups: green tea control, senna herbal mix, or rhubarb root herbal mix. The study is double-blinded, with participants and researchers unaware of group allocation. The primary outcome measure is the change in total plasma cholesterol after 21 days. Secondary outcomes include changes in plasma high-density lipoprotein cholesterol, triglycerides, non-high-density lipoprotein cholesterol, and short-chain fatty acids concentrations in plasma. Additionally, the study will evaluate diet choices by measuring the Prime Diet Quality Score."
679,"GPT4 Correct Assistant: The study aims to investigate the effect of adding strengthening exercises for hip rotators and ankle muscles to knee exercises on pain, function, muscle strength, and knee proprioception in patients with knee osteoarthritis. Patients will be randomly allocated to either a control group receiving knee exercises or an experimental group receiving both knee and hip rotator/ankle muscle exercises. Measurements will be taken at baseline and after 4 weeks of treatment."
680,"GPT4 Correct Assistant: This clinical study aims to evaluate the safety and effectiveness of a Novabel bioabsorbable steroid-releasing stent for treating chronic sinusitis. The study includes participants aged 18 years or older, diagnosed with chronic sinusitis based on Chinese guidelines, who are scheduled for primary or revision bilateral endoscopic sinus surgery. The primary outcome measure is the non-reintervention rate within 30 days. Secondary outcome measures include Lund-Kennedy and Lund-Mackay scores, VAS scores for pain, sinus patency rate, and implantation success rate. The study is designed as a randomized, parallel assignment, double-masked trial with two arms: experimental (Novabel bioabsorbable steroid-releasing stent) and active comparator (marketed bioabsorbable steroid-releasing stent)."
681,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of providing cancer care closer to home for patients with multiple myeloma. The study is a non-randomized, parallel assignment trial with two arms: care transition and no care transition. The primary outcome measure is the proportion of eligible participants who successfully transfer to the provider at a satellite location. Secondary outcome measures include types of candidacy for care transfer, treatment burden, participant-provider interaction satisfaction, and financial toxicity. The study will also explore participant rationales for opting to transfer care or maintain care at their usual site through a sub-study."
682,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of virtual reality (VR) goggles as a distraction method to nitrous oxide in reducing pain and anxiety during pediatric dental procedures. The study includes children aged 4-12 years who require nitrous sedation for painful dental treatment. Participants will be randomly assigned to either a control group using nitrous oxide or a treatment group using VR goggles. The study will measure the effectiveness of VR in reducing pain and discomfort using the FLACC, Wong-Baker FACES, and Houpt Behavior scales. The primary outcome measures will be assessed at 12 months."
683,"GPT4 Correct Assistant: The study aims to identify patients with a high risk of recurrent colorectal lesions and design optimal intervals for surveillance colonoscopies using mutation and clinical-pathologic phenotype analysis. The study will involve 200 patients, and the primary outcome measure is the development and clinical utility of a new method to identify patients at risk of recurrent colorectal lesions and personalize their surveillance based on mutation burden and clinical-pathological phenotype. Secondary outcome measures include determination of the mutation profile and mutation burden in patients, clinical and histopathological evaluation and mutational profiling of all metachronous lesions found during the five-year surveillance period, and analysis of the similarity of the mutation profile of lesions found in the same or close areas of the colorectum."
684,"GPT4 Correct Assistant: The SAM Project, or Science Against Malnutrition Project, is a study focused on understanding and characterizing malnutrition through the identification of specific biomarkers. The study involves participants affected by malnutrition due to deficiency or excess, as well as sex- and age-matched healthy controls not affected by malnutrition or any pathology. The study uses data and sample collection, including clinical, anamnestic, and lifestyle data, as well as faecal, blood, and saliva samples. The primary outcome measures include the characterization of malnutrition, untargeted microRNA expression profiles in blood and saliva samples, plasmatic extracellular vesicles, metagenomic analysis of fecal and salivary samples, and metabolomic analysis of fecal samples. The study is expected to last for 36 months."
685,"GPT4 Correct Assistant: This clinical trial aims to study how people with Parkinson's disease manage their physical activity and exercise with varying levels of support from their communities and clinicians. The study will be conducted in two clinics in the Chicagoland area and will enroll participants in three groups: standard care, written exercise guidance by neurologists, and physical therapy. The primary outcome measure is minutes per day of moderate to vigorous physical activity, while the secondary outcome measure is steps per day. The study will utilize a remote therapeutic monitoring platform and commercial-grade activity trackers to track participants' physical activity and exercise throughout the 12-month study period."
686,"GPT4 Correct Assistant: The study aims to use multi-channel time-resolved functional near infrared spectroscopy (tr-fNIRS) to detect and prevent perioperative brain injury in adult patients undergoing elective shoulder surgery in the beach-chair position. The tr-fNIRS device will monitor cerebral oxygenation in multiple brain regions during surgery, assessing the impact of intraoperative hemodynamic parameters and cerebral autoregulation. The study will also explore the association between cerebral desaturation events and clinical outcomes such as stroke and delirium."
687,"GPT4 Correct Assistant: This clinical trial aims to evaluate the feasibility and safety of using Mechanical Insufflation-Exsufflation (MI-E) as a Cough Assist in critically ill adults receiving invasive ventilation. The intervention involves applying MI-E sessions twice a day for a maximum of 7 days. The study will assess the proportion of complete sessions of MI-E, safety outcomes, and the acceptability, appropriateness, and feasibility of the intervention. The primary outcome measure is the proportion of complete MI-E sessions, while secondary outcomes include incidence of pneumothorax, endotracheal tube obstruction, severe hypoxemia, severe hypotension, and severe hypertension. The study will also measure the acceptability, intervention appropriateness, feasibility of intervention, and time needed for MI-E."
688,"GPT4 Correct Assistant: The Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation (EVENT) is a multicenter, randomized, double-blind, placebo-controlled study designed to test the hypothesis that therapy with the SGLT2 inhibitor enavogliflozin for 18 months would improve clinical and echocardiographic outcomes in heart failure (HF) patients with functional tricuspid regurgitation (TR) and preserved left ventricular ejection fraction (LVEF). The primary outcome measure is a composite of cardiovascular death, hospitalization for HF, or worsening of TR during follow-up. Secondary outcome measures include all-cause death, cardiovascular clinical event, renal event, change of TR, and change of RV strain."
689,"GPT4 Correct Assistant: The trial, titled ""Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia A,"" aims to investigate the relationship between daily physical activity, measured by the Sensewear armband device, and pharmacokinetic variability of infused rec-FVIII concentrate in patients with severe hemophilia A. The study will enroll patients aged 12-60 years with severe hemophilia A under FVIII concentrates prophylaxis and will measure the association between physical activity and the area under the curve (AUC) PK parameter. The study will also explore whether and how daily physical activity affects the PK parameter."
690,"GPT4 Correct Assistant: The study, titled ""Critical Time Window for Rehabilitation After Incomplete Spinal Cord Injury: Early vs Late Locomotor Training,"" is a clinical trial aimed at examining the effects of different intervention timings on recovery outcomes for individuals with spinal cord injuries. The study participants are randomly assigned to one of four groups: early intervention, sub-acute intervention, chronic intervention, or standard of care. The primary outcome measure is the 10-meter walk test, while secondary outcome measures include the 6-minute walk test, Walking Index for spinal cord injury, and daily step counts."
691,"GPT4 Correct Assistant: The study aims to investigate the effect of education given according to the Health Promotion Model on premenstrual symptoms, emotional eating behavior, and perceived stress. The study is a pretest-posttest randomized controlled study with a total of 330 participants. The experimental group will receive training based on the Health Promotion Model using the Philips 66 technique, while the control group will not receive any training. The primary outcome measures include the Premenstrual Syndrome Scale, Eating Habits During the Premenstrual Period Form, Healthy Lifestyle Behaviors Scale, Emotional Eating Scale, and Perceived Stress Scale. The study seeks to determine if the training has a significant impact on the participants' symptoms, behaviors, and stress levels."
692,"GPT4 Correct Assistant: The AMP SCZ® Observational Study: PREDICT-DPACC is part of the Accelerating Medicines Partnership (AMP) program, aiming to develop a deep biomarker-informed functional characterization and longitudinal clinical profiling of participants at clinical high risk (CHR) for psychosis. The study works with two CHR research networks, the Psychosis-Risk Outcomes Network (ProNET) and the Trajectories and Predictors in the Clinical High Risk for Psychosis Population: Prediction Scientific Global Consortium (PRESCIENT). This is a non-interventional study examining clinical trajectories and predictors of outcomes in the CHR population, with assessments at baseline, 2 months post-baseline, and other time points. The primary outcome measure is conversion to psychosis, while secondary outcomes include remission and non-conversion/non-remission by the 24-month follow-up."
693,"GPT4 Correct Assistant: The study aims to evaluate the feasibility and acceptability of implementing the Problem Management Plus (PM+) intervention in Dutch prisons for individuals with elevated levels of psychological distress. This single-blind pilot randomized controlled trial (RCT) will include 60 Dutch-speaking adults aged 18 or older, imprisoned in Dutch prisons, and with at least 15 weeks remaining on their sentence. The PM+ intervention, a brief psychological intervention program, will be delivered by trained master students in clinical psychology and supervised by mental health care specialists. The study will measure factors such as PM+ fidelity, perceptions about PM+ from stakeholders, indicators of intervention delivery, retention rate of PM+ sessions, and recruitment and consent rates. Secondary outcomes will include preliminary indications of pre to post-effects on symptoms of depression and anxiety, self-identified problems, daily functioning, symptoms of trauma, and suicidality vulnerability."
694,"GPT4 Correct Assistant: This clinical trial is studying the effectiveness of Xevinapant, a drug, in combination with radiation therapy and chemotherapy (Carboplatin and Paclitaxel) for patients with head and neck cancer who are ineligible for Cisplatin. The trial aims to determine the best safe dose of Xevinapant when given with radiation and chemotherapy. The primary outcome measure is to determine the safe dose, while secondary outcome measures include progression-free survival, overall survival, locoregional failure, distant failure, and response rate."
695,"GPT4 Correct Assistant: A Phase 1, open-label study is being conducted to evaluate the pharmacokinetics, safety, and tolerability of ARV-471 (PF-07850327) as a single agent in Chinese participants with ER+/HER2- advanced breast cancer. The primary outcome measures are single dose Cmax (maximum plasma concentration) and single dose AUCtau (area under the concentration-time profile from time zero to time tau, the dosing interval). The secondary outcome measures include objective response rate, percentage of participants with clinical benefit, duration of objective response, presence or absence of blood biomarkers, notable ECG values, laboratory abnormalities, clinically significant change from baseline in vital signs, and adverse events."
696,"GPT4 Correct Assistant: The study is a Phase 2 clinical trial to assess the efficacy and safety of combining the PARP inhibitor olaparib with the PI3K inhibitor alpelisib in treating patients with metastatic breast cancer. The trial has four cohorts: Cohort 1, Cohort 2 (PARP-inhibitor naive), Cohort 2 (PARP-inhibitor resistant), and Cohort 3. The primary objective of Cohort 2 is to determine the progression-free survival (PFS) of BYL719 (alpelisib) and olaparib compared to olaparib alone. The primary objective of Cohort 3 is to determine the objective response rate (ORR) of BYL719 (alpelisib) and olaparib in patients with PARP-inhibitor resistant metastatic breast cancer. Secondary objectives include assessing PFS, overall survival (OS), clinical benefit rate (CBR), and safety. The study aims to explore the effect of PI3K mutations on ORR and PFS, and to assess correlates of response to olaparib and BYL719 (alpelisib) therapy."
697,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of Schema Therapy (ST) for patients with Treatment-Resistant Chronic Depression (CRTD) compared to Treatment as Usual (TAU). The study is a randomized controlled trial with an allocations ratio of 1:1. Patients will be randomly assigned to either receive ST or TAU for up to 30 sessions. The primary outcome measure is the change from baseline in depression symptoms on the Hamilton-6 Rating Scale for Depression at 12 months after baseline measurements. Secondary outcomes include changes in depression symptoms at 6 and 24 months, functional impairment, psychological well-being, personal recovery, reactions to anger, negative effects of treatment, and patient-defined problems. The study will also explore the potential mediators of treatment effect, such as changes in schema modes and early maladaptive schemas."
698,"GPT4 Correct Assistant: This is a prospective, multicenter, randomized, controlled, open-label, phase III, stepped wedge cluster randomized trial designed to evaluate the effectiveness of a paramedical protocol for ventilation in acute respiratory distress syndrome (ARDS) compared to usual care. The primary endpoint is a combination of mortality and the number of days without mechanical ventilation at 28 days. The experimental group receives ventilatory adjustments by nurses according to a pre-established care protocol, while the control group receives ventilator settings adjusted according to the center's usual practice. Secondary outcomes include measures of tidal volume ventilation, plateau pressure, positive end-expiratory pressure (PEEP), FiO2, oxygenation, number of days without mechanical ventilation, catecholamine, continuous sedation, duration of mechanical ventilation, occurrence of mechanically ventilated pneumothorax, duration of ARDS, duration of weaning from mechanical ventilation, number of participants with rescue therapy, rate of re-intubation, rate of use of non-invasive ventilation and curative high-flow oxygen therapy, tracheostomy rate, length of stay in intensive care and in hospital, and number of deaths in ICU and hospital."
699,"GPT4 Correct Assistant: The study, titled ""Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes,"" aims to test a culturally tailored engagement and retention intervention for Haitian immigrants living with HIV. The study is designed as a prospective, quasi-experimental single arm pilot with a sample of newly diagnosed or nonvirally suppressed Haitian immigrants with HIV drawn from two Federally Qualified Health Centers in Miami. The intervention is an adaptation of the iENGAGE intervention, culturally adapted for Haitian immigrants with HIV. The primary outcome measures are the change in Engagement in Care score over time and the change in HIV load measurement toward a target of less than 200 copies/ml."
700,"GPT4 Correct Assistant: The study is a randomized, non-blinded clinical trial comparing the effectiveness of three different root canal cleaning methods: passive ultrasonic irrigation (PUI), Endoclean device using hydraulic cavitation, and conventional root canal preparation. The primary objective is to test the effectiveness of the Endoclean device for root canal debridement up to a 12-month follow-up. Secondary objectives include testing the extended effectiveness and safety of the Endoclean device up to a 24-month follow-up. The study includes 109 participants, divided into three arms, where each group undergoes a different root canal cleaning method. The primary outcome measure is the successful healing of periapical lesions up to 12 months post-procedure, assessed using the periapical index score. Secondary outcome measures include safety endpoints and the long-term effectiveness of the Endoclean device up to 24 months post-procedure."
701,"GPT4 Correct Assistant: The FRACT-AI study aims to evaluate the impact of artificial intelligence (AI) on the diagnostic accuracy of frontline clinicians in detecting fractures on plain X-rays. Participants include emergency medicine doctors, trauma and orthopaedic surgeons, emergency nurse practitioners, physiotherapists, general radiologists, and radiographers. The study measures the performance of the Gleamer Boneview AI algorithm in terms of sensitivity, specificity, and area under the ROC curve. It also compares the performance of readers with and without AI assistance in terms of sensitivity, specificity, area under the ROC curve, and reader speed."
702,"GPT4 Correct Assistant: This clinical trial aims to investigate fine motor skills, hand grip strength, and anthropometric measurements in children with Specific Learning Disorders (SLD) compared to healthy children. The study will also examine the relationship between fine motor skills and quality of life and participation in activities at home, school, and community settings. Participants will be assessed using various tests, including the Bruininks-Oseretsky Test of Motor Proficiency-2, Purdue Pegboard Test, Hand Dynamometer, and Pinch Gauge. Additionally, the Participation and Environment Measurement Child & Youth and the Pediatric Quality of Life Inventory will be used to assess participation and quality of life."
703,"GPT4 Correct Assistant: The IM-ZBULLE Study is a multicenter, prospective, randomized, double-blind, controlled study comparing the efficacy of intramuscular injections of haloperidol decanoate using the Z-track and Airlock techniques versus the standard injection technique in adult patients with schizophrenia or related disorders. The primary outcome measure is pain reduction, assessed using a visual analogic scale, while secondary outcome measures include drug leakage reduction, impact of the injection, participant satisfaction, therapeutic alliance, and identification of levers and obstacles to changing practices among psychiatric nurses."
704,"GPT4 Correct Assistant: This study is a feasibility trial investigating the use of preoperative 5-day hypofractionated radiotherapy for primary soft tissue sarcoma. The primary outcome measure is the feasibility of 5-day HFRT, measured by the uptake rate of eligible patients who elect to participate in the trial. Secondary outcome measures include the rate of favorable pathologic response, local control, acute toxicity, and 1-year late HFRT toxicity."
705,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of pericapsular nerve group block (PENG block) combined with lateral femoral cutaneous nerve block (LFCN block) to patient-controlled analgesia (PCA) for postoperative pain relief after hip replacement surgery. The trial includes patients with American Society of Anesthesiologists (ASA) physical status I-III, aged 18-80 years. The primary outcome measures are the average visual analogue scale (VAS) scores at rest and on movement at different time points. The study also records side effects such as vomiting, nausea, itching, urinary retention, and respiratory failure."
706,"GPT4 Correct Assistant: This clinical trial, titled ""Study of Pelvic Organ Mobility by Dynamic MRI in Pelvic Endometriosis,"" aims to evaluate the mobility of pelvic organs in patients with endometriosis using dynamic MRI. The study includes two participant groups: those with pelvic endometriosis and those without. The primary outcome measure is the mean vertical displacement of the anterior wall of the vagina between rest and maximum pushing force during dynamic MRI. Secondary outcome measures include similar measurements on the cervix and posterior wall of the vagina, as well as the statistical association between patient symptoms and mean vertical displacement on the wall of each pelvic organ at the push effort during dynamic MRI. The study is designed to compare these measures between the two participant groups."
707,"GPT4 Correct Assistant: This study aims to provide up-to-date epidemiological evidence on the uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and its impact on influenza-related healthcare resource use in England during the 2012 to 2022 flu seasons. The study will use the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES) databases and will include participants aged 2 to 17 years. The primary outcome measures the uptake of influenza vaccination, while secondary outcomes include GP consultations, laboratory-confirmed influenza, APC episodes, A&E attendances, outpatient attendances, length of stay in APC, antibiotic prescriptions, and antiviral prescriptions associated with ILI. The study will provide insights for planning and evaluation of the childhood influenza vaccination program."
708,"GPT4 Correct Assistant: This is a pilot pre-post interventional trial to determine if reciting Tang poems can promote happiness in South Asian children in primary schools (Grades 1-2, age 6-9) in Hong Kong. The intervention involves three 1.5-hour sessions of Tang poem reciting and one session for participant performances, led by experienced instructors. The primary outcomes measured are the number of successful recited poems and change in happiness reported subjectively by students. Secondary outcomes include change in acculturation, ability in speaking Chinese, and attitude in Chinese learning."
709,"GPT4 Correct Assistant: This clinical trial aims to develop and test a comprehensive digital platform, Vira, for adolescents aged 13-18 years at high risk for suicide. The study will implement a pragmatic randomized controlled trial at an intensive outpatient service to compare the impact of using Vira versus treatment as usual control. The primary outcome measure is the Columbia Suicide Severity Rating Scale (C-SSRS) at 6 months, while secondary outcome measures include the Scale for Suicidal Ideation (SSI), Screen for Anxiety Related Emotional Disorders (SCARED), Risky Behavior Questionnaire for Adolescents (RBQ-A), Pittsburgh Sleep Quality Index (PSQI), Mood and Feelings Questionnaire (MFQ), and Anticipatory & Consummatory Interpersonal Pleasure Scale (ACIPS) at 3 and 6 months."
710,"GPT4 Correct Assistant: This clinical trial, titled ""Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian Rhythms,"" aims to study the effects of non-visual light on pupil response, circadian timing, and hormone levels in participants aged 18-85 years with normal physiology. The intervention includes pupillometry and light box exposure to different wavelengths and intensities of light. The primary outcome measures are pupil size, melatonin levels for circadian timing assessment, and melatonin levels for hormone response."
711,"GPT4 Correct Assistant: The study, ""Evaluation of Improving Parenting Skills Adult ADHD (IPSA): A New Parent Training Program for Parents With ADHD"", is a randomized controlled trial investigating the efficacy and feasibility of a new parent training program for parents with ADHD. The intervention group receives the Improving Parenting Skills adult ADHD (IPSA) program, which combines structured group-based skills training with individualized support. The control group receives continued routine services. The study focuses on primary and secondary outcomes, including parental self-efficacy, parental stress, household disorganization, and child behavior problems. The study aims to determine if participation in IPSA is associated with positive treatment outcomes in these areas."
712,"GPT4 Correct Assistant: The Substance Use and Health Risk Intervention (SUHRI) for Justice-involved Youth is a study examining the preliminary efficacy of an adapted intervention for youth aged 14 to 18 who are disposed to community supervision. The intervention is a technology-based application that addresses substance use and risky sex practices within the context of personal relationships. The study measures outcomes such as problem recognition, decision making, intention to reduce personal risk, service initiation, substance use, and sexual/STI health risk."
713,"GPT4 Correct Assistant: This is a phase II open-label, single-center, single-arm futility trial investigating the efficacy of remote ischemic conditioning (RIC) in preventing disability worsening in patients with Primary Progressive Multiple Sclerosis (PPMS). The intervention consists of daily RIC for 12 months using an electric auto-control device. The primary outcome measure is the worsening of disability, defined as a 20% or more increase in the timed 25-foot walk at 12 months follow-up compared to baseline. Secondary outcome measures include the Nine Hole Peg Test, MRI measure of remyelination, and SDMT (Single digit modalities test)."
714,"GPT4 Correct Assistant: The clinical trial ""Prothrombin Time Predicts Steroid Response in Severe Alcoholic Hepatitis"" aims to investigate the correlation between prothrombin time at diagnosis and response to steroid treatment in patients with severe alcoholic hepatitis. The study includes patients aged 18-70 with a clinical diagnosis of first episode of severe alcoholic hepatitis and no contraindications to corticosteroid therapy. The primary outcome measure is response to steroid treatment assessed with Lille score at day 7. Secondary outcome measures include death during hospitalization, early liver transplantation, and infection following steroid treatment."
715,"GPT4 Correct Assistant: This study is a randomized controlled trial comparing the effectiveness of functional task training versus functional therapy program on gross motor function, range of motion, and balance in children with cerebral palsy. The trial includes participants aged 6-12 years with GMFCS scores between 1-2. The intervention period is 8 weeks, and the primary outcome measures are goniometer for range of motion, Pediatric Balance Scale, and GMFM-88 for gross motor function. The trial aims to determine the comparative effects of the two interventions on the targeted outcomes."
716,"GPT4 Correct Assistant: This retrospective observational study aims to evaluate the prognostic value of neutrophil-lymphocyte ratio (NLR), absolute lymphocyte count (ALC), and thrombocyte-lymphocyte ratio (TLR) in predicting outcomes of tetralogy of Fallot (ToF) primary repair. The study includes patients with ToF who underwent primary repair between January 2020 and December 2022. The primary outcome measures are the number of patients requiring redosurgery, mortality, and complications. Secondary outcome measures include hospital length of stay and postoperative length of stay."
717,"GPT4 Correct Assistant: The study is a pilot randomized double-blind clinical trial assessing the effectiveness of patient-applied aqueous lidocaine via tampon as a pre-treatment prior to intra-uterine device (IUD) placement. Participants will apply either lidocaine or saline to a tampon and use it 1 hour before the procedure. The study measures procedure time, patient-reported pain level, patient-reported satisfaction with procedure, patient-reported interest in subsequent procedure, and provider-reported procedural difficulty. Eligible participants are females aged 18 to 54, willing to return for the procedure after completing virtual study consent, and requesting IUD insertion."
718,"GPT4 Correct Assistant: This is a low-risk, single-center, interventional study assessing the feasibility and acceptability of capillary screening for early staging of chronic metabolic, cardiovascular, and autoimmune diseases in the population of Cantalupo, a locality in the Municipality of Cerro Maggiore (Milan). Participants will undergo capillary blood sampling to test for blood glucose levels, cholesterol, and autoantibodies for type I diabetes and celiac disease. Blood pressure will also be measured. The study aims to determine the feasibility and acceptability of this public intervention and estimate the prevalence of identified diseases within the population."
719,"GPT4 Correct Assistant: The SMaRT Mom study is a randomized, parallel assignment intervention study designed to evaluate the effectiveness of the SMaRT Mom intervention in reducing smartphone addiction and improving breastfeeding experiences for mothers. The study includes participants aged 20-40 years with 3-6 months old infants who have a Smartphone Addiction Scale cut-off score of 31 or above. The intervention group will undergo the SMaRT Mom intervention for one week, while the control group will not receive any intervention. The study measures primary outcomes such as infant temperament and maternal self-efficacy, and secondary outcomes like breastfeeding as a rewarding experience, maternal attention towards the infant, changes in breastfeeding mothers' neural activity, and physiological responses."
720,"GPT4 Correct Assistant: This study aims to investigate the effectiveness of Low-Level Laser Therapy (LLLT) in treating Plantar Fasciitis. The study involves participants aged between 18 and 54 years, who have been diagnosed with Plantar Fasciitis by a healthcare provider. Participants are randomly assigned to one of two groups: the Usual Care with PBM Therapy group or the Usual Care with Sham PBM Therapy group. Both groups receive the intervention for 6 weeks, with 3 treatments per week. The primary outcome measures include the Demographic Information, Baseline Data Collection CRF, Foot and Ankle Ability Measure (FAAM), Pain Diary Defense and Veterans Pain Rating Scale (DVPRS), and plantar fascia thickness measured using ultrasound. The study aims to determine if LLLT is an effective treatment for Plantar Fasciitis, and to compare the outcomes between the two groups."
721,"GPT4 Correct Assistant: This clinical trial is a single-center, open, randomized, single-dose, completely repeated crossover bioequivalence study to evaluate the effects of Entacapone, Levodopa, and Carbidopa Tablets in the postprandial state in healthy Chinese subjects. The study includes 36 healthy subjects who are randomly assigned to two groups, either Test (T)-Reference (R) or Reference (R)-Test (T), with a washout period of at least 2 days between doses. The primary outcome measures are Peak Plasma Concentration (Cmax), Area under the plasma concentration versus time curve (AUC0-t), and Area under the plasma concentration versus time curve (AUC0-∞)."
722,"GPT4 Correct Assistant: This clinical trial aims to study the brain anatomy and function in healthy participants and patients with tremor, psychosis, and epilepsy using simultaneous EEG-fMRI at 7 Tesla and structural MRI at 7 Tesla. The primary outcome measures include contrast-to-noise ratio between thalamic nuclei in 7T structural MRI, Pearson correlation between thalamocortical brain regions in 7T functional MRI, and microstate duration in EEG acquired concurrently with 7T functional MRI. The study will provide valuable insights into the neuroimaging of brain anatomy and function in health and disease."
723,"GPT4 Correct Assistant: This study aims to investigate the effect of weight loss on hepcidin levels and iron status in subjects with obesity. The trial consists of two phases: Phase 1, a cross-sectional study comparing hepcidin levels, iron status, and inflammatory markers in individuals with and without obesity; and Phase 2, a randomized controlled clinical trial assessing the impact of weight loss on hepcidin levels, iron status, and inflammatory markers in obese individuals with iron deficiency. Participants will be assigned to one of two dietary intervention groups with a 60-day follow-up period, undergoing a calorie-restricted diet with either red meat or without red meat. Blood samples will be collected at baseline and after the intervention to determine various biochemical parameters and inflammatory markers."
724,"GPT4 Correct Assistant: The Non-invasive Electrophysiological Monitoring in High Risk Pregnancies at the Obstetric High Care (NIEM-O) study aims to evaluate the effectiveness of continuous antepartum electrophysiological monitoring using the Nemo Fetal Monitoring System (NFMS) in high-risk pregnancies. The study includes 1911 pregnant women aged 18 years and older with a singleton pregnancy between 23+0 and 32+0 weeks of gestation, requiring hospitalization at the Obstetric High Care (OHC) for maternal or fetal surveillance. The primary outcome measures include the incidence of perinatal mortality and major neonatal morbidity. The study aims to improve perinatal and maternal outcomes by introducing continuous antepartum electrophysiological monitoring."
725,"GPT4 Correct Assistant: This clinical trial aims to explore genetic susceptibility to severe infections, including various types of viral, bacterial, and fungal infections. The study will recruit a small cohort of patients with rare and severe infections and will involve blood sample drawing and skin biopsies. The primary outcome measures include identifying chromosomal regions associated with the disease, identifying candidate genes for genetic susceptibility to infectious diseases, and validating candidate genes as factors of susceptibility to infectious diseases."
726,"GPT4 Correct Assistant: This study investigates the prevalence, type, and risk factors of urinary incontinence (UI) in married women and its impact on their quality of life. The study includes women over 18 years of age who are married and willing to participate. The study involves a diagnostic test and measures the Incontinence Quality of Life as the primary outcome."
727,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of bone marrow aspirate concentrate (BMAC) and minimally manipulated adipose tissue (MM-AT) in the treatment of knee osteoarthritis. The study includes 204 patients with symptomatic unilateral knee OA, who will be randomly assigned to receive either a single intra-articular injection of BMAC or MM-AT. The primary outcome measure is the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) - Pain subscale at 6 months follow-up. Secondary outcome measures include various questionnaires and objective parameters assessing pain, stiffness, physical function, and quality of life."
728,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy and safety of CBD TPM capsules in adults for the reduction of insomnia severity. The study is a randomized, double-blind, placebo-controlled Phase III trial with three groups: placebo, 75mg CBD, and 150mg CBD. The primary outcome measures are the mean change from baseline in insomnia severity index (ISI) score and subject sleep efficiency (sSE) at 8 weeks."
729,"GPT4 Correct Assistant: This clinical trial aims to study the pattern of intestinal parasitic infection among cirrhotic patients at Sohag University Hospital. The study includes 100 cirrhotic patients with gastrointestinal (GI) complaints (cases group) and 100 patients with GI complaints but no comorbidity (control group). Both groups undergo stool analysis to detect the prevalence and pattern of intestinal parasitic infection. The study seeks to determine the most common risk factors of intestinal parasitic infection in cirrhotic patients and compare the findings between cirrhotic and non-cirrhotic patients with no comorbidity. The study's primary outcome measure is the pattern of intestinal parasitic infection among cirrhotic patients, with a duration of 12 months."
730,"GPT4 Correct Assistant: The REtinal Detachment Outcomes Study (REDOS) is a factorial, randomized controlled trial that aims to compare the outcomes of various treatments for rhegmatogenous retinal detachment. The primary outcome measure is single surgery anatomic success, and secondary outcome measures include pinhole visual acuity, best-corrected visual acuity, time to onset of RD recurrence, severity and number of complications, and quality of life questionnaire. The trial consists of four arms: Pars plana vitrectomy (PPV) with sulfur hexafluoride gas tamponade, PPV with scleral buckle and sulfur hexafluoride gas tamponade, PPV with perfluoropropane gas tamponade, and PPV with scleral buckle and perfluoropropane gas tamponade."
731,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of different concentrations of ropivacaine (0.25%, 0.5%, and 1%) on the onset and duration of ultrasound-guided ankle blocks in patients undergoing forefoot surgery. The study will be randomized, triple-blinded, and parallel-group interventional. The primary outcome is the difference in sensory block duration, while the secondary outcomes are the differences in onset time of the sensory block, postoperative pain scores, and opioid consumption. Participants will be aged between 18 and 65 years, and the study will measure these outcomes over a period of 48 hours, 72 hours, and one week, respectively."
732,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of compression stockings on the complaints, well-being, and sleep quality of pregnant women with Restless Legs Syndrome (RLS). The study includes pregnant women aged 18-40, with a gestational age of 27 weeks or more, and having a severity of 11 or above according to the RLS Severity Rating Scale. Participants are randomly assigned to either a compression stockings group or a placebo sock group, wearing the assigned socks for 3 weeks. The primary outcome measure is the change from baseline score at the end of 21 days on the RLS Severity Rating Scale. The secondary outcome measure is the change from baseline score at the end of 21 days on the Pittsburgh Sleep Quality Index."
733,"GPT4 Correct Assistant: This is a clinical trial for older adults aged 65 or more, who are able to perform daily physical activity independently but not regularly engaging in recreational sports or structured exercise. The study aims to test the efficacy of home-based strength and Tai-chi exercise snacking for improving physical function in Taiwanese and British older adults. The study will take place over approximately 3 months, with participants undergoing 5 assessments remotely. A subset of 60 participants will be assessed in person to validate the remote assessment and undergo more in-depth assessments. The intervention group will be given an exercise teaching video and written instructions on how to safely perform the exercise at home, while the control group will receive usual care. The primary outcome measure is the change in Short Physical Performance Battery (SPPB) between every 4 weeks. Secondary outcome measures include changes in 1RM of leg press, balance function, strength function, agility function, flexibility, quality of life and wellbeing, physical activity level, mental health, self-confidence for exercise, attitudes to exercise, acceptability of the intervention, general health, mental health and wellbeing, and quality of life."
734,"GPT4 Correct Assistant: This clinical trial aims to evaluate the role of pre-emptive caudal epidural analgesia for postoperative pain relief in lumbosacral surgeries and compare the effects of adding dexamethasone to ropivacaine. The trial is a randomized case control study, with participants allocated to either Group RD (caudal epidural injection with 0.25% ropivacaine 20 ml containing dexamethasone 8 mg) or Group R (caudal epidural injection with 0.25% ropivacaine 20 ml). The primary outcome measures are the Visual Analogue Scale scores at various time points postoperatively and the time of rescue analgesia."
735,"GPT4 Correct Assistant: This study aims to determine the effect of nursing care based on Kolcaba's comfort theory on the comfort, care satisfaction, and sleep quality of intensive care patients. The study is a randomized controlled experimental study with 80 participants (40 in each group), comparing standard care to care based on Kolcaba's comfort theory. The primary outcome measures include the General Comfort Scale, the Newcastle Satisfaction Scale, the Richard Campbell Sleep Scale, and the Comfort Behaviours Checklist. The study seeks to improve patient comfort, satisfaction, and sleep quality in the intensive care setting."
736,"GPT4 Correct Assistant: The P-KIDs CARE study aims to develop and pilot an intervention to address health systems delays in care for injured children in Tanzania. The study consists of three aims: Aim 1 involves formative research to inform the intervention's development, Aim 2 uses this data to develop the P-KIDs CARE intervention, and Aim 3 pilots the intervention in two study facilities. The primary outcome is mortality, with secondary outcomes including time to definitive care, disposition, and morbidity. The intervention includes the World Health Organization (WHO) Basic Emergency Care Course and a decision support tool integrating two evidence-based tools."
737,"GPT4 Correct Assistant: This preliminary study aims to evaluate the effectiveness of combining pelvic floor rehabilitation with postural re-education in women with stress urinary incontinence and chronic low back pain. The study includes two intervention groups: one with pelvic floor rehabilitation and postural re-education, and the other with pelvic floor rehabilitation and spinal mobilization, both combined with perineal exercises. The primary outcome measure is the change in International Consultation on Incontinence Questionnaire-Urinary Short Form (ICIQ-UI SF) scores from baseline, after 5 weeks of treatment, and 1 month after the end of training. Secondary outcome measures include changes in Pain Visual Analogue Scale (VAS) scores and Modified Oxford Scale (MOS) scores at the same time points."
738,"GPT4 Correct Assistant: The study aims to develop a pharmacodynamic model for propofol in older adults, as the administration of intravenous anesthetics in this population requires adequate titration to avoid deleterious effects. The model will use the pharmacokinetic parameters of the Eleveld model and new pharmacodynamic parameters derived from frontal EEG in a population older than 65 years. The study will include 30 participants, and the primary outcome measure is the performance error between the measured and predicted concentrations."
739,"GPT4 Correct Assistant: The study aims to compare the effectiveness of a very short-course (1 day) of antibiotics with a standard course (4-7 days) of antibiotics in patients with acute cholangitis after adequate biliary drainage. The primary outcome measure is the clinical cure rate by day 14 after endoscopic retrograde cholangiopancreatography (ERCP) without relapse by day 30. Secondary outcome measures include all-cause 90-day mortality, relapse of cholangitis within 90 days, rate of any other subsequent infection requiring antibiotic therapy within 90 days, rate of subsequent infections with multi-drug resistant bacteria or Clostridioides difficile within 90 days, rate of other adverse drug events within 14 days, length of intensive care and hospital stay for the initial episode of cholangitis, quality of life and health utility, and societal costs and cost-effectiveness/-utility."
740,"GPT4 Correct Assistant: This is a prospective randomized clinical double-blinded study investigating the effects of conventional versus ultrasound-guided lung recruitment maneuver in morbidly obese patients undergoing laparoscopic bariatric surgery. The primary outcome measure is the change in lung ultrasound score, with secondary outcomes being the incidence of atelectasis and intra-operative desaturation. The study will enroll 60 patients, randomly allocated into two groups: conventional lung recruitment (group C) and ultrasound-guided lung recruitment (group US). The results of this study aim to provide insights into the most effective lung recruitment maneuver for morbidly obese patients undergoing laparoscopic bariatric surgery."
741,"GPT4 Correct Assistant: The study is a prospective randomized open-label trial aimed at optimizing fractionation schedules for radiotherapy in the treatment of heel spurs. The primary goal is to determine if one-day irradiation (single fraction) is non-inferior to fractionated radiotherapy over a three-month period in terms of pain relief for heel spur patients. Patients are randomized into six groups based on the total dose of radiotherapy, with different groups receiving varying total doses in single fractions. The study will measure non-inferiority of single fraction radiotherapy of heel spur, comparison of different single fraction radiotherapy prescriptions, comparison of the need for reirradiation till 1 year after radiotherapy between fractionated vs. single fraction radiotherapy, and comparison of quality of life and VAS score at various time points between fractionated vs. single fraction radiotherapy and between different single fractions radiotherapy prescription."
742,"GPT4 Correct Assistant: The study aims to examine if a behavioral weight reduction program combined with Pain Neuroscience Education (PNE) and Cognition-Targeted Exercise Therapy (CTET) is superior to reduce pain at 12 months follow-up compared to PNE and CTET alone, in overweight or obese people with Chronic Low Back Pain (CLBP). The study will be conducted as a randomized controlled trial, with both interventions (experimental and control) organized equally. The experimental intervention will consist of a total of 18 treatment sessions distributed over 14 weeks, including both chronic-pain-focused interventions and a weight reduction intervention. The control intervention will consist of a total of 18 treatment sessions distributed over 14 weeks, including only the chronic-pain-focused interventions. The primary outcome measure is the Brief Pain Inventory - Average pain Intensity. Secondary outcome measures include other pain related outcomes, anthropometrics, energy balance related behavior, and health economics."
743,"GPT4 Correct Assistant: This is a randomized controlled trial comparing the clinical outcomes and efficacy of single versus double pyloromyotomy in gastric per-oral endoscopic myotomy (G-POEM) for the treatment of refractory and severe gastroparesis. The study includes patients with refractory gastroparesis based on GCSI > 2 and plans to follow up subjects at 3, 6, and 12 months after the procedure. The primary outcome measures include clinical success, GCSI scores, and technical success rate, while secondary outcome measures include total procedure time, adverse events, and recurrence of symptoms."
744,"GPT4 Correct Assistant: The study titled ""A Single Arm, Open-label Study of the Efficacy of Minayo Iron-rich Yeast Drink With SOD on Female Nutritional Anemia, Skin Condition and Qi-blood Deficiency Syndrome"" aims to investigate the effectiveness of Minayo Iron-rich Yeast Drink with SOD in treating female nutritional anemia, skin condition, and Qi-blood deficiency syndrome. The study includes female participants aged 18 to 35 with hemoglobin concentration levels below 110g/L. Participants will consume the Minayo Yeast Drink product daily for four weeks. The study measures the change in serum ferritin level, hemoglobin concentration level, Superoxide Dismutase (SOD) concentration level, and Glutathione (GSH) concentration level in blood. Additionally, skincare measurements will be taken using the Miravex Antera 3D imaging system."
745,"GPT4 Correct Assistant: The study aims to determine the effects of combining acute intermittent hypercapnic-hypoxia (AIHH) with transcutaneous spinal cord stimulation (tSCS) on cervical neural drive in individuals with chronic spinal cord injury (SCI). The study will be conducted in three phases: Phase 1 will involve baseline testing, Phase 2 will involve the active intervention (AIHH + tSCS), and Phase 3 will involve the control intervention (SHAM AIHH + SHAM tSCS). The study will also investigate the effects of single-session combined AIHH and tSCS on respiratory and upper extremity motor function in individuals with chronic SCI. The study will use a crossover design with randomization to ensure equal distribution of participants across the intervention groups. The primary outcome measures are change in respiratory cortical and spinal drive and change in upper extremity cortical and spinal drive during the intervention. Secondary outcome measures include change in maximum respiratory voluntary force production, change in airway occlusion pressure (P0.1), change in forced vital capacity, and change in upper extremity functional assessment. The study will also investigate the effects of the interventions on cardiovascular response. The study will use a combination of non-invasive and invasive neurophysiological techniques, including transcranial magnetic stimulation (TMS), cervical magnetic stimulation (CMS), surface electromyography (sEMG), and neuroplasticity measures. The study will enroll a total of 29 participants with chronic SCI, aged between 18 and 65 years, with a minimum of 20% impairment in maximal inspiratory or expiratory pressure generation. The study will exclude participants with uncontrolled cardiopulmonary disease, orthostatic hypotension, or other medical conditions that may interfere with the study procedures or confound the study endpoints. The study will be conducted over a period of 12 months."
746,"GPT4 Correct Assistant: This study aims to investigate the effects of anesthetic maintenance agents and vasopressors on cerebral hemodynamics and metabolism during adult surgery. The study participants will be randomized into one of four groups, receiving either propofol or sevoflurane as the anesthetic maintenance agent, and either phenylephrine or ephedrine as the vasopressor. The primary outcome measure is the cerebral metabolic rate of oxygen consumption (CMRO2) during surgery. The study will also explore the effects of these agents on cerebral hemodynamics and metabolism during induction."
747,"GPT4 Correct Assistant: The RaDiCo-IDMet (National Cohort on Imprinting Disorders and Their Metabolic Consequences) study aims to investigate the clinical, genetic, biological, and morphometric characteristics of patients with various imprinting disorders (IDs) such as Silver Russell Syndrome, Beckwith-Wiedemann Syndrome, and others. The study includes patients of both sexes and focuses on primary and secondary outcome measures. The primary outcomes are the clinical, genetic, biological, and morphometric characteristics of IDs in pediatric and adult patients. The secondary outcomes include the association between the metabolic phenotype of IDs patients and their biological profile, the prevalence of metabolic abnormalities, the risk for metabolic complications, the description of different therapeutic approaches, variations of quality-of-life scores, and the analysis of (epi)genetic mutations transmission in proband and relatives. The study is designed to follow patients for an average of 10 years."
748,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of unipolar and bipolar interlocking in treating humeral shaft fractures in adults. The study includes patients aged 18 or older with a humeral shaft fracture requiring surgical treatment with intramedullary nailing. The primary outcome measure is the proportion of patients with radiologically assessed bone healing at 12 months. The study is designed as a randomized, parallel assignment, open-label trial with two arms: unipolar interlocking group and bipolar interlocking group. Both groups will undergo questionnaires (EQ-5D-5L and SF-12) and CT scans at specific time points."
749,"GPT4 Correct Assistant: The EPI-MINN trial aims to investigate the effects of combining cognitive and social cognitive training with the Personalized Real-Time Intervention for Motivational Enhancement (PRIME) app on cognitive dysfunction and impaired motivation in individuals with early psychosis. The study will enroll participants aged 18-40 who are in good general health, fluent in spoken and written English, and have an estimated IQ of at least 70. Participants will be randomly assigned to either the experimental group, which receives cognitive and social cognitive training along with PRIME app use, or the active comparator group, which receives treatment as usual. The primary outcome measures include changes in Test My Brain scores, Dysfunctional Attitudes Scale-Defeatist Beliefs Subscale scores, and Quality of Life Scale-Abbreviated scores. The study aims to provide data-driven knowledge on factors contributing to 2-year treatment response trajectories in early psychosis and to optimize coordinated specialty care for improved clinical outcomes."
750,"GPT4 Correct Assistant: This clinical trial aims to assess the use of wearable fitness trackers in prehabilitation programs for patients with cancer. The study will investigate whether using fitness trackers to monitor heart rate zones during prescribed exercise can improve the levels of moderate intensity exercise achieved and enhance patient adherence to the program. The trial will also explore patient satisfaction with the use of fitness trackers in a prehabilitation setting. The primary outcome measure is the total number of minutes of moderate intensity exercise achieved by participants in the 8 weeks of follow-up. Secondary outcome measures include volume of physical activity, adherence, and patient feedback on the acceptability and usability of the fitness trackers."
751,"GPT4 Correct Assistant: The LA POPA Trial is a randomized, single-blinded, controlled trial comparing two minimally invasive treatments for pilonidal disease: pit-picking surgery alone and pit-picking surgery with Sinus Laser-assisted Closure (SiLaC). The primary outcome measure is the success rate of treatment defined by wound healing outcomes at 1 year. Secondary outcome measures include success rate at long-term follow-up, pain scores, patient-reported outcome measures, wound healing and complications, work rehabilitation, return to daily activities, recurrence rate, need for secondary or revision surgery, patient satisfaction, and quality of life."
752,"GPT4 Correct Assistant: This clinical trial aims to identify sociodemographic, personal characteristics, and patterns of illicit drug abuse in patients admitted for addiction treatment. The study will be conducted at Assiut University Hospital's Addiction Management Unit. Participants will undergo supportive psychotherapy, and data will be collected on sociodemographic characteristics, previous admissions/trials for detox, medical, psychological, social, financial, and legal aspects of addiction, adverse life events, and patterns of substance abuse. The primary outcome measures include identifying the sociodemographic characteristics, personality traits, and patterns of substance abuse among patients with substance use disorder."
753,"GPT4 Correct Assistant: This phase 2 single-arm study investigates the efficacy and safety of a combination of immune checkpoint inhibitors (Durvalumab and Tremelimumab) and radioembolisation for previously untreated metastatic hepatocellular carcinoma. The primary outcomes are best objective response and rate of abscopal effect, with secondary outcomes including progression-free survival, overall survival, incidence of treatment-related side effects, local control rate, and distant control rate."
754,"GPT4 Correct Assistant: This clinical trial is a phase II study assessing the efficacy of a neoadjuvant treatment regimen consisting of durvalumab, tremelimumab, gemcitabine, and cisplatin in patients with intrahepatic cholangiocarcinoma that is borderline resectable/resectable but with a high risk for recurrence. The primary outcome measure is the rate of conversion from unresectable to resectable after the treatment. Secondary outcome measures include overall survival, progression-free survival, and patient-reported outcomes, among others."
755,"GPT4 Correct Assistant: The study aims to establish the normal reference values of high-frequency ultrasound for the structure and blood flow of the extremities in Chinese Han adults, and explore its influencing factors. This multi-center study will help provide a quantitative reference for the early diagnosis, degree evaluation, and therapeutic effect observation of the extremity artery structure and blood flow. The intervention is high-frequency ultrasound examination of the extremity arteries, and the primary outcome measure is the intima thickness of the dorsalis pedis artery and proper palmar digital artery."
756,"GPT4 Correct Assistant: The study aims to evaluate the efficacy and safety of STERIFY GEL in treating periodontitis following scaling and root planing (SRP). The study involves participants with chronic periodontal disease, who will be randomly assigned to either receive STERIFY GEL treatment in addition to SRP or only SRP. The primary outcome measure is pocket depth, and secondary outcome measures include gingival recession, clinical attachment level, plaque index, bleeding index, furcations, grade of mobility, and quantification of bacterial contamination. The study is designed as a split-mouth, randomized, controlled trial."
757,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) and hippocampal training in improving memory recovery and PTSD symptoms in veterans with PTSD. The study will include 40 male veterans aged 25-60 with combat-associated PTSD and peritraumatic amnesia. Participants will be randomly assigned to receive either HBOT alone or HBOT and hippocampal training, which combines physical and cognitive training. The primary outcomes measured are changes in memory gaps and time to inaccessible memory surfacing. Secondary outcomes include changes in brain activity, cognitive performance, and memory test scores."
758,"GPT4 Correct Assistant: The study aims to investigate the use of 64Cu-DOTATATE PET/CT imaging for the diagnosis of cardiac sarcoidosis. It includes four groups of participants: those with suspected or confirmed cardiac sarcoidosis, those with myocarditis, those with neuroendocrine tumors, and a control group. The primary outcome measure is the proportion of patients with tracer uptake in the heart on 64Cu-DOTATATE PET/CT in patients with verified cardiac sarcoidosis and the proportion of patients without tracer uptake in the heart on 64Cu-DOTATATE PET/CT for patients with a neuroendocrine tumor without a history of inflammatory heart disease (the control group). Secondary outcome measures include rates of adverse outcomes and tracer uptake in patients with myocarditis."
759,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of probiotics on immunosuppressive-drug-associated diarrhea among renal transplant recipients. The study is a randomized, double-blinded, placebo-controlled, single-center pilot/exploratory trial. Participants will be randomly assigned to receive either probiotics (Florajen Digestion) or a placebo for six months. The primary outcome measures are reduction in immunosuppressive drugs-associated diarrhea, analysis of inflammatory biomarkers, and association between inflammatory markers and fecal microbiome. The study will enroll participants aged 18 to 80 years, with mild to severe diarrhea, who have been on adjusted and/or maintenance dose of immunosuppressive drugs."
760,"GPT4 Correct Assistant: This is a clinical trial to assess the efficacy of inhaled sevoflurane compared to current intravenous sedation practice for improving PaO2/FiO2 in ICU patients at high risk for ARDS. The trial is a randomized, stratified, parallel-group clinical trial with blinded outcome assessment and concealed allocation of patients. The primary outcome measure is the longitudinal evolution in the PaO2/FiO2 ratio within 5 days from randomization. Secondary outcome measures include progression to ARDS, rate of pneumonia, ventilator-free days to day 28, organ failure to day 5, mortality at day 28, length of ICU-stay up to 28 days, and various physiological and hemodynamic measures."
761,"GPT4 Correct Assistant: The study aims to investigate the outcomes of different treatment modalities for massive rotator cuff tendon tears. The study population includes patients aged between 50 to 80 years with a grade III tear according to the Davidson and Burkhart classification. The study is conducted at Tartu University Hospital Sports Traumatology Centre, and the treatment options include arthroscopic rotator cuff partial repair with superior capsular augmentation with LHBBT, arthroscopic partial repair, arthroscopic complete rotator cuff repair, and conservative treatment. The primary outcome measures are changes in shoulder strength and range of motion, while secondary outcomes include functional scores, pain scores, and integrity of surgically repaired rotator cuff tendons on MRI studies."
762,"GPT4 Correct Assistant: The IRIS Program is a study designed to optimize the treatment of injection-related infections for people who inject drugs in Hamilton, Ontario. The study offers a one-stop, low-barrier combined care model to address injection-related infections, substance use treatment, peer support, and care coordination/systems navigation. The primary outcome measure is the number of emergency department visits and hospital readmissions within 30 days of initial admission or program enrolment, while secondary outcome measures include treatment completion, hospital readmissions, emergency department visits, substance use treatment initiation or continuation, mortality rates, and program drop-out rates within specific timeframes. The study is open to participants aged 16 or older who have a confirmed or suspected injection-related infection and live in Hamilton, Ontario."
763,"GPT4 Correct Assistant: This is a randomized controlled trial comparing the use of a mobile app (CanImmunize) for surveillance of adverse events following influenza immunization to a web-based platform. The study aims to assess the usability of these two platforms in reporting adverse events after influenza vaccination. Participants who meet the inclusion criteria (speak English or French, have an active email address and telephone) are eligible to participate. The study includes both healthy volunteers and parents of children who have received the seasonal influenza vaccine. The primary outcome measure is usability, assessed through a user experience survey."
764,"GPT4 Correct Assistant: The study aims to investigate the relationship between peri-implantitis and COX-2 gene polymorphisms, as well as the levels of active matrix metalloproteinase 8 (MMP-8) in peri-implant tissues. The study will also identify the microbial profile associated with peri-implantitis using novel bacterial identification methods. The study is designed as a case-control study, with participants diagnosed with peri-implantitis and healthy controls. Saliva samples will be collected from both groups for genetic analysis, and active MMP-8 levels will be measured in peri-implant crevicular fluid samples. The microbial profile of peri-implantitis will be characterized using Next Generation Sequencing (NGS) techniques."
765,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of virtual reality on pain, anxiety, and patient comfort during trigger point injections. The study involves two groups: the experimental group, which will watch virtual reality videos during the procedure, and the control group, which will not use virtual reality. The primary outcome measures are state anxiety scale, general comfort scale, and visual analog scale for pain. The study will enroll participants aged 18-65, and both sexes are eligible."
766,"GPT4 Correct Assistant: The study titled ""Effect of Autonomic Dysfunction on Hemodynamic Instability During Per-oral Endoscopic Myotomy in Achalasia Patients: a Prospective Observational Study"" aims to investigate the impact of autonomic dysfunction on hemodynamic instability during per-oral endoscopic myotomy in patients with Achalasia. The study will include two participant groups: those with autonomic dysfunction and those with normal autonomic function. The primary outcome measure is the wobble of systolic arterial pressure during surgery. The study will be conducted at Gangnam Severance Hospital, and participants must be aged 19 or older."
767,"GPT4 Correct Assistant: This study evaluates the use of virtual reality (VR) glasses during inhaler treatment in children aged 2-5 years. The trial is designed as a prospective, single-blind, randomized, controlled study with three groups: VR audio-visual users (Roller Coasters, group 1), VR audio-visual users (Wild Dolphins, group 2), and those who did not use any additional equipment (group 3). The study aims to measure the change in the pain scoring system by using VR glasses to help with uncomfortable procedures for children during inhaler treatment."
768,"GPT4 Correct Assistant: This clinical trial aims to study the feasibility, acceptability, and effect of a transdiagnostic psychological treatment, the Unified Protocol (UP-C/A), for children and youth with anxiety disorders and/or depression in a primary care setting. The trial includes participants aged 7-17 years who have anxiety syndrome, obsessive-compulsive disorder, and/or depression according to the Diagnostic and Statistical Manual of Mental Disorders (DSM). The intervention consists of an 11-session group format for children and adolescents, along with parent training in a group format. The primary outcome measure is the Emotion Regulation Index for Children and Adolescents (ERICA), with secondary outcome measures including the Revised Children's Anxiety and Depression Scale (R-CADS), the Strengths and Difficulties Questionnaire (SDQ), the Kidscreen-10 Index, the Children's Global Assessment Scale (C-GAS), and the Client Satisfaction Questionnaire (CSQ-8). The study aims to evaluate the feasibility, acceptability, and treatment effects of the Unified Protocol for children and youth with anxiety disorders and/or depression and their parents."
769,"GPT4 Correct Assistant: The PALISA study aims to assess pain in premature infants undergoing Less-Invasive-Surfactant-Administration (LISA) by measuring skin conductance and video recording. The study includes preterm infants between 27 to 48 hours old, who require LISA. The primary outcome measures are median peaks per second at prespecified time points, and the secondary outcome measures include median Neonatal Pain, Agitation and Sedation Scale (N-PASS) at prespecified time points, and various physiological parameters. The study aims to understand the pain experienced by infants during LISA and to develop better pain management strategies."
770,"GPT4 Correct Assistant: This is a feasibility cluster randomised controlled trial in Nigeria studying the effectiveness of a home-based depression care program for older people delivered by lay providers. The study aims to compare the efficacy of a behavioral intervention (emhGAP-Age) with an active comparator (generic emhGAP-IG and psychoeducation). The primary outcome measure is depression remission, defined as a Patient Health Questionnaire (PHQ-9) score of < 6 at six months post trial entry. Participants must be aged 60 or over, with a PHQ-9 score of ≥11, and must not have severe co-morbidities or cognitive impairments."
771,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of augmented ACL integration via platelet-rich plasma (PrP) enriched collected autologous bone compared to standard ACL technique in reducing tunnel widening and improving graft-bone integration. The study is a prospective, single-center, single-blinded, 2-arm-parallel, randomized, controlled study with a 24-month follow-up. Participants are recruited from the Knee Surgery department at Schulthess Klinik when scheduled for ACL reconstruction. The study sample comprises 107 patients, allocated 1:1 on experimental and control arm. Outcome measures are taken at 0, 6, 12, and 24 months. The total study duration is 48 months, and the study duration per patient is 24 months."
772,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of high-flow oxygen preoxygenation during rapid sequence induction in infants and small children. The study will randomize patients into three groups: 1) face-mask preoxygenation, 2) high-flow nasal oxygen cannula preoxygenation, and 3) high-flow nasal oxygen cannula + face-mask preoxygenation. Primary outcomes include the impact of high-flow oxygen preoxygenation on oxygen saturation and heart rate during anaesthesia induction. Secondary outcomes include the safety of the rapid sequence induction protocol, Cormack-Lehane score, incidence of difficult airway management, number of intubation attempts, and episodes of regurgitation/aspiration."
773,"GPT4 Correct Assistant: This is a clinical trial to evaluate the long-term safety, tolerability, and effectiveness of the combination therapy of Pozelimab and Cemdisiran in adult patients with Paroxysmal Nocturnal Hemoglobinuria (PNH). The primary objective is to study the incidence, severity, and outcomes of treatment-emergent serious adverse events (SAEs) and treatment-emergent adverse events of special interest (AESIs) in patients receiving the study drug. Secondary objectives include maintaining adequate control of hemolysis, transfusion avoidance, and assessing fatigue and physical function scores."
774,"GPT4 Correct Assistant: This 24-week prospective study aims to examine user engagement predictors of health and fitness app uptake and subscription in the general population using WayBetter Inc.'s app, WayBetter. The primary objectives are to identify predictors of initial six-month subscription and subscription renewal rates at six months. The secondary objective is to characterize WayBetter app engagement over the first 24 weeks of app use. The study will include approximately 400 adult users (aged ≥18 years) who are new app users and have engaged in a 7-day free trial. The primary outcomes are rates of initial six-month subscription and subscription renewal rates at six months."
775,"GPT4 Correct Assistant: The study aims to compare the effects of aerobic exercises and Pilates exercises on depression and sleep quality in primigravida females during pregnancy. The study is a randomized clinical trial with 42 participants, divided into two groups: Group A receiving aerobic exercises and Group B receiving Pilates exercises. The primary outcome measures are the Center for Epidemiologic Studies Depression Scale (CES-D Scale) and the Pittsburgh Sleep Quality Index (PSQI). The study will last for 10 months, with data collected at baseline and after 8 weeks of treatment."
776,"GPT4 Correct Assistant: This study aimed to determine the effect of swaddling and inhaling mother's breast milk odour on the pain and comfort during the placement of peripheral intravenous catheter in term infants. A randomized controlled experimental study was conducted with 120 term infants, divided into four groups: swaddled, inhaling mother's breast milk odour, both swaddled and inhaling mother's breast milk odour, and a control group with no procedure. The pain and comfort levels of infants in the experimental and control groups were assessed before, during, and after the placement of peripheral intravenous catheter using Infant Descriptive Information Form, Neonatal Infant Pain Scale, and Neonatal Comfort Behaviour Scale."
777,"GPT4 Correct Assistant: This study aims to investigate the biological mechanism of psychotherapy for depression using functional Near-Infrared Spectroscopy (fNIRS). Patients with depression will be randomly assigned to one of three groups: medication therapy, interpersonal psychotherapy (IPT), or a combination of medication therapy and IPT. fNIRS assessments will be conducted to evaluate changes in brain function and determine the effectiveness of psychotherapy. The study will also use standardized psychological assessments to compare the effectiveness of fNIRS assessments and explore the differential efficacy of different treatment approaches."
778,"GPT4 Correct Assistant: This clinical trial, titled ""Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer,"" aims to assess the safety of 111In-panitumumab as a molecular imaging agent in patients with head and neck squamous cell carcinoma (HNSCC). The trial also aims to compare the sensitivity and specificity of identifying sentinel lymph nodes by systemic injection of 111In-panitumumab prior to surgery versus conventional local injection with an optical dye at the time of surgery. The trial involves the use of biological agents, imaging procedures, and surgical procedures. Participants must be aged 19 or older and have a confirmed diagnosis of squamous cell carcinoma of the head and neck. The primary outcome measure is the incidence of adverse events grade 2 or higher."
779,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy and mechanism of transcutaneous vagus nerve stimulation (tVNS) in the treatment of Generalized Anxiety Disorder (GAD). The study will include 100 participants with GAD who will be randomly assigned to either the medication-combined tVNS group or the medication-combined sham stimulation group. The primary outcome measure is the change in the Hamilton Anxiety Scale (HAS) scores at baseline and week 2 of treatment. Secondary outcome measures include changes in HAS scores at weeks 4, Hamilton Depression Scale (HAMD-17) scores at weeks 2 and 4, Generalized Anxiety Scale (GAS) scores at weeks 2 and 4, brain function indicators from baseline to the end of treatment, and the incidence of adverse events."
780,"GPT4 Correct Assistant: This clinical trial investigates the use of dacryoendoscopic-assisted laser dacryoplasty with silicone intubation (DLDI) for the treatment of nasolacrimal duct obstruction (NLDO). The study aims to report the results of DLDI for the management of NLDO and identify factors associated with DLDI failure. Participants are divided into three groups based on the site of obstruction: higher nasolacrimal duct obstruction, lower nasolacrimal duct obstruction, and nasolacrimal duct stenosis. The primary outcome measure is the cumulative success rate of DLDI within 2 years follow-up using the Kaplan-Meier estimator."
781,"GPT4 Correct Assistant: The clinical trial titled ""Immediate Effects of Proprioceptive Neuromuscular Facilitation With Lower Leg Kinesiotaping on Ankle Dorsiflexion, Gait and Functional Mobility in Patients With Chronic Stroke"" aims to investigate the immediate effects of lower leg kinesiotaping and proprioceptive neuromuscular facilitation with lower leg kinesiotaping on ankle dorsiflexion, gait, and functional mobility in patients with chronic stroke. The study involves three intervention groups: lower leg kinesiotaping, proprioceptive neuromuscular facilitation, and proprioceptive neuromuscular facilitation with lower leg kinesiotaping. The primary outcome measures include time up and go test, Barthel Index, Motor Assessment scale, and Dynamic gait index."
782,"GPT4 Correct Assistant: The study is designed as a mixed, multicentre, non-randomised, quasi-experimental, before-and-after, open, cross-sectional study, with control and experimental groups and comprising three phases. The study aims to develop and evaluate an algorithm for vascular access management in adult patients requiring at least one peripheral venous catheter. The study will assess the impact of the implementation of the A-DIVA Scale and the algorithm composed of the A-DIVA Scale and the new decision-making tree (the A-DIVA Tool) on practitioners' approaches to peripheral venous catheter placement and the quality of this placement. The study will also measure the acceptability and feasibility of using the A-DIVA Scale in isolation and in conjunction with the catheter placement algorithm."
783,"GPT4 Correct Assistant: This clinical trial aims to evaluate the STARgraft-3 device for hemodialysis access in patients with End Stage Renal Disease. The study will implant the STARgraft-3 shunt in the upper arm and assess its primary unassisted patency at 6 months post-implantation. Secondary outcomes include primary unassisted patency, assisted primary patency, secondary patency, frequency of interventions, blood flow rates in grafts, and safety outcomes at various time points post-implantation."
784,"GPT4 Correct Assistant: The Primary Care Online Emotion-regulation Treatment (POET) clinical trial aims to determine the clinical efficacy of a digital emotion regulation treatment in adolescents with mental health problems. Participants will be randomized to either the POET treatment or an active comparator. The primary outcome measure is the Clinical Global Impressions-Severity scale (CGI-S), assessing symptom severity. Secondary outcome measures include various scales assessing mental health, emotion regulation, and quality of life. The study will also investigate the cost-effectiveness and potential moderators of treatment outcomes."
785,"GPT4 Correct Assistant: The study, titled ""Impact of Hypofractionated Radiotherapy Strategy After Surgery of Skin Carcinomas in Older Patients (IMPACTE-01),"" aims to evaluate the comparative efficacy of two modalities of radiotherapy over surgery alone on local tumor control in older patients with non-melanoma skin cancer (NMSC). The study is a multicenter, randomized, open-labeled, comparative 3-arm phase III trial. Patients aged 70 years and older with a performance status of 0-3 and who have completed surgery for high-risk NMSC will be randomized into three arms: Arm A (surgery alone), Arm B (surgery + moderate hypofractionation), and Arm C (surgery + extreme hypofractionation). The primary endpoint is local tumor control at a 3-year follow-up. The study will also assess quality of life, acute and late toxicity, and overall survival."
786,"GPT4 Correct Assistant: The Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study aims to investigate colorectal cancer risks among older adults with prior polypectomy and evaluate the potential benefits of surveillance colonoscopy. The study will compare cumulative CRC risk after age 75 in a cohort of older adults with history of normal colonoscopy vs. colonoscopy with polypectomy prior to age 75. Additionally, the study will assess comparative effectiveness of exposure vs. no exposure to surveillance colonoscopy after age 75 for reducing CRC risk using a case-cohort design. Multi-stakeholder perspectives on CRC risk and surveillance outcomes will also be gathered to inform future use and VA policy regarding surveillance colonoscopy in older Veterans. The results of this study will help fill critical evidence gaps and inform guidelines within and outside VA, and serve as a model for leveraging VA data to address important population health challenges for the VA's growing older adult population."
787,"GPT4 Correct Assistant: The study aims to assess the effect of early bedside cycling exercises on selected physical and psychological outcomes in patients after heart valve surgery. It will include 50 patients diagnosed with valve heart disease and undergoing valve replacement or intervention. The patients will be randomly assigned to either the intervention group (bedside cycling) or the control group (routine physiotherapy). The primary outcomes measured include functional capacity, forced vital capacity, psychological status, activities of daily living and functional level, and quality of life. The study will also assess the incidence of adverse events and prothrombin international normalized ratio at one-month follow-up."
788,"GPT4 Correct Assistant: The Sloane Project is a molecular analysis study focused on non-invasive breast cancer and atypical breast hyperplasias. The study includes participants with Ductal Carcinoma in situ (DCIS), Lobular Carcinoma in situ (LCIS), and atypical hyperplasias. The primary outcome measure is the progression of breast disease from diagnosis to the end of 2016. The study is designed to analyze the molecular aspects of these conditions in females."
789,"GPT4 Correct Assistant: This clinical trial aims to evaluate the efficacy of Tirzepatide in the concurrent treatment of obesity and Type 1 Diabetes Mellitus. The trial includes participants aged 18-70 with a clinical diagnosis of T1DM for less than 12 months and a BMI of ≥30kg/m2. Participants will be randomized into two groups: one receiving insulin treatment only and the other receiving Tirzepatide in addition to insulin treatment. The primary outcome measure is the percent change in body weight over 32 weeks. Secondary outcome measures include changes in HbA1c, time in range, total daily insulin dose, insulin carbohydrate ratio, waist and neck circumference, blood pressure, mean glucose, time in hypoglycemia and hyperglycemia, and lipid parameters."
790,"GPT4 Correct Assistant: This clinical trial is titled ""Efficacy of Losartan in the Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients."" The study aims to determine the effectiveness of Losartan in preventing paclitaxel-induced peripheral neuropathy in breast cancer patients. The trial is a randomized parallel assignment study with a primary purpose of prevention. The intervention group will receive standard-of-care management for chemotherapy-induced nausea and vomiting plus losartan 100mg, while the control group will receive standard-of-care management alone. The primary outcome measures are the incidence of paclitaxel-induced peripheral neuropathy and the grade of neuropathy at 12 weeks. Secondary outcome measures include patient quality of life assessed by Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-NTX) and the level of nerve growth factor (NGF) in serum at 12 weeks."
791,"GPT4 Correct Assistant: This clinical trial investigates the effects of Ginkgo biloba ketone ester tablets on cognitive function in patients with type 2 diabetes and mild cognitive impairment. The study includes 370 participants, randomly assigned to either the experimental group (n=185) receiving Ginkgo biloba ketone ester tablets in addition to conventional hypoglycemic treatment, or the control group (n=185) receiving conventional hypoglycemic treatment alone. The primary outcome measure is cognitive function testing using the Alzheimer's Disease Assessment Scale-Cognitive section. The study also assesses memory function, daily living ability, functional evaluation, and attention. The intervention is administered for six months, and the results are expected to provide insights into the potential benefits of Ginkgo biloba ketone ester tablets in managing cognitive impairment in patients with diabetes."
792,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of two treatments, CsA+ATG+AVA and CsA+AVA, for the treatment of newly-diagnosed severe aplastic anemia (SAA) in elderly patients. The trial will randomize participants into two groups, with one group receiving CsA+ATG+AVA and the other receiving CsA+AVA. The primary outcome measure is the overall response rate at 6 months. Secondary outcome measures include complete response rate, relapse rate, and adverse event rate at 6 and 12 months."
793,"GPT4 Correct Assistant: This clinical trial aims to determine the sensitivity and specificity of zirconium Zr 89 panitumumab (89Zrpanitumumab) for detecting indeterminate metastatic lesions in head and neck squamous cell carcinoma. It will also compare the sensitivity and specificity of standard imaging modalities to 89Zr-panitumumab-PET/CT. The study involves patients receiving panitumumab, Zr 89 panitumumab, and undergoing PET/CT scans. The primary outcome measures are the sensitivity and specificity of 89Zr-panitumumab, while the secondary outcome measures are the comparison of these values to standard imaging modalities."
794,"GPT4 Correct Assistant: This is a prospective, open-label, multicenter, randomized controlled Phase III study examining the effect of prophylactic central neck dissection on the excellent response and recurrence-free survival of cN0 low-risk papillary thyroid cancer. The study includes patients aged 18-70 years with a thyroid nodule measuring 11-40 mm and a diagnosis of papillary thyroid carcinoma. The intervention group receives prophylactic central neck dissection, while the control group does not. The primary outcome measure is excellent response at 1 year, and the secondary outcome measure is recurrence-free survival at 1 and 2 years."
795,"GPT4 Correct Assistant: The Net Transition Initiative study aims to assess the efficacy of two next-generation nets, Veeralin LLIN and Interceptor G2 LLIN, in controlling malaria in Cote d'Ivoire. The study is a three-arm superiority, single-blinded, cluster-randomized trial, with a total of 33 villages and 50 children per cluster. The study compares the incidence of malaria cases between the intervention arms (Veeralin LLIN and Interceptor G2 LLIN) and the control arm (MAGNet LLIN). The primary outcome measure is malaria case incidence by malaria rapid diagnostic test HRP2/pLDH [pf/pan] over one year follow-up. Secondary outcome measures include malaria infection prevalence by RDT, vector density, and sporozoite rate in Anopheles."
796,"GPT4 Correct Assistant: The PRECISION Study aims to investigate the safety and efficacy of a 3-fraction prostate stereotactic body radiotherapy (SBRT) schedule with the RayPilot HypoCath image guidance system for the treatment of localized prostate cancer in men with low or intermediate risk disease. The study is a single-arm, 2-stage Phase II trial, with a total of 100 patients planned to be recruited. The primary outcomes are the rates of acute radiation oncology/toxicity grading (RTOG) and common terminology criteria for adverse events (CTCAE) urinary and bowel toxicity at 12 weeks post treatment. Secondary outcomes include late toxicity rates and quality of life measures."
797,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of Low-Level Laser (LLL) in reducing root resorption of the upper incisors during intrusion movement using mini-implants in adult patients with deep overbite. The study is a randomized controlled clinical trial with two arms: traditional orthodontic treatment and LLLT. Participants must be between 18 and 30 years old, with a deep overbite and normal or horizontal facial growth pattern. The primary outcome measures are change in root volume and change in root length."
798,"GPT4 Correct Assistant: The Italian Study on the Right Hemicolectomy aims to investigate the lymphadenectomy performed during right hemicolectomy surgery for colon cancer. A total of 788 patients were enrolled in the study, and the data collected included patient demographics, tumor stage, type of surgery, post-operative course, and presence of post-surgical complications. The primary outcome measure is the analysis of lymphadenectomy in relation to the radicality of surgical resection, and the secondary outcome measure is the study of vascular anatomical variability. The study aims to correlate a certain number of lymph nodes and their possible positivity with the surgical radicalness and the anatomical piece obtained."
799,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of Cawthorne Cooksey exercises on balance and quality of life in children with hearing deficits. The study involves children aged 7 to 12 years with sensorineural hearing deficits, who will be randomly assigned to either the experimental group (receiving Cawthorne Cooksey exercises and Swiss ball exercises) or the control group (receiving standard care). The primary outcome measure is the Pediatric Berg Balance Scale, assessed at 12 weeks. Secondary outcomes include the Four-step square test."
800,"GPT4 Correct Assistant: This study aims to explore the psychological impact on women with Gestational Trophoblastic Neoplasia (GTN) who have completed chemotherapy treatment. The study plans to conduct semi-structured telephone interviews with 20 participants who received chemotherapy. Thematic analysis will be used to identify common themes of psychological experiences, support received, and potential areas for improvement in patient care. This research aims to provide insights into the patient perspective and improve the care and support provided to these patients after their treatment."
801,"GPT4 Correct Assistant: This clinical trial aims to evaluate the utility of bone grafts in open wedge corrective osteotomy and plate fixation for patients with malunited distal radius fractures. The study will include two participant groups: one with bone grafting and one without. The primary outcome measures are complications during and after the operation, quality of life using the EQ-5D-5L questionnaire, and time to complete bone healing. Secondary outcome measures include subjective and objective functional outcomes and cost-effectiveness analysis. The study will follow participants for at least one year."
802,"GPT4 Correct Assistant: This study aims to examine the short-term effectiveness of a brief behavioral teacher training program for children with behavioral difficulties at school. The study is a two-arm randomized controlled trial with 120 elementary school teachers of children with behavioral difficulties. Teachers are randomly assigned to either three sessions of brief behavioral teacher training with practice as usual (experimental group) or practice as usual only (control group). The primary outcome measure is the severity of teacher-rated daily measured target behaviors in specific classroom situations. The study will also assess secondary outcomes, such as the number and severity of behavioral difficulties, teacher-reported impairment at school, teacher-student relationship quality, and teacher's sense of self-efficacy."
803,"GPT4 Correct Assistant: This study aims to assess the feasibility, acceptability, and usability of a tele-rehabilitation program combining immersive virtual reality exercises and therapeutic education for individuals with chronic non-specific neck pain. The intervention consists of a 6-week program, including 5 virtual reality sessions and 1 teleconsultation session per week, along with several brochures for therapeutic education. The study will measure the feasibility of the intervention through retention rate, adhesion, safety, implementation at home, and online consultations. Acceptability and usability will be assessed through satisfaction and usability questionnaires, respectively. Secondary outcomes include changes in range of motion, neck disability, pain intensity, kinesiophobia, illness perception, and global perceived effect."
804,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness of implementing a HABIT-ILE intervention at home for children with bilateral cerebral palsy, compared to the traditional HABIT-ILE camp intervention. The study will also explore the potential benefits of a follow-up HABIT-ILE intervention at home after the initial two-week therapy. The primary outcome measure is the change in Gross Motor Function (GMFM-66) score between baseline and follow-up assessments. Secondary outcome measures include changes in the Both Hand Assessment (BOHA), Box and Block Test (BBT), Six Minutes' Walk Test (6MWT), ABILHAND-Kids questionnaires, PEDI questionnaire, ACTIVLIM-CP Questionnaire, ABILOCO-Kids Questionnaire, Jebsen Hand Function Test, ESTIMILL-CP questionnaire, PILS-CP questionnaire, lower and upper limbs physical activity, functional goals assessed by the Canadian Occupational Performance Measure (COPM) questionnaire, 3D T1-weighted structural imaging, Fractional Anisotropy (Diffusion tensor imaging (DTI)), Resting-state functional magnetic resonance imaging (rs-fMRI), and Mean Diffusivity (Diffusion tensor imaging (DTI))."
805,"GPT4 Correct Assistant: This study, titled ""Digital Versus Speculum Exams in Preterm Prelabor Rupture of Membranes: A Randomized Controlled Trial,"" aims to compare the effectiveness of digital and speculum exams in patients with preterm prelabor rupture of membranes (PPROM). The study includes participants between 22 weeks 0 days gestation to 33 weeks 5 days gestation with PPROM. The primary outcome measure is pregnancy latency, and secondary outcome measures include various maternal and neonatal complications. The study is designed as a randomized controlled trial with parallel assignment and single masking."
806,"GPT4 Correct Assistant: The trial is a single-center, prospective, single-arm study designed to evaluate the overall survival rate of patients with liver cirrhosis and hepatocellular carcinoma (HCC) treated with sequential adult left lateral lobe liver transplantation (SALT). The study includes patients aged 18-75 with Child-Pugh A-B liver cirrhosis and HCC with hepatitis B virus infection who meet the up to seven criteria. Patients with main portal vein tumor thrombus, main vena cava tumor thrombus, common bile duct tumor thrombus, severe hepatic encephalopathy, pulmonary hypertension, special types of anatomical variations, extrahepatic tumor burden, cardiopulmonary disease, severe infection, cerebral vascular disease, or psychological/social conditions that interfere with the study are excluded. The primary outcome measure is overall survival (OS) at 3 years after the second liver resection, and the secondary outcome measure is disease-free survival (DFS) at 1, 3, 6, 12, 24, and 36 months post-transplant."
807,"GPT4 Correct Assistant: This clinical trial aims to establish the validity and reliability of a Dexterity Assessment Tool in patients with degenerative cervical myelopathy (DCM) and healthy populations. The tool measures finger dexterity using pressure sensor pads. The study includes participants aged 35-75 years, with or without neurological disorders. The primary outcome measures include dexterity measurements, correlation between the Dexterity Assessment Tool and the GRASSP-M tool, and inter-rater and test-retest reliability of the Dexterity Assessment Tool in healthy participants."
808,"GPT4 Correct Assistant: This is a non-interventional, single-center, multi-surgeon, observational study to evaluate the effect of intraocular lens (IOL) centration and tilt on visual performance in patients who have undergone Clareon® Vivity® IOL implantation. The study population includes individuals implanted with Clareon® Vivity® and Vivity® Toric IOLs. The primary outcome measure is monocular best-corrected distance visual acuity (BCDVA). Secondary outcome measures include decentration of IOL, tilt of IOL, monocular uncorrected distance visual acuity (UCDVA), monocular distance-corrected intermediate visual acuity (DCIVA), monocular uncorrected intermediate visual acuity (UCIVA), and manifest refraction/manifest refraction spherical equivalent (MRSE)."
809,"GPT4 Correct Assistant: The study aims to investigate the efficacy of ultrasound-guided serratus posterior superior interfascial plane block (SPSIPB) for postoperative analgesia management after mastectomy and axillary lymph node dissection surgery. The trial is a randomized, prospective, controlled study involving female patients aged 18-65 years. Patients are allocated to either the SPSIPB group or the control group. The primary outcome measure is the comparison of pain scores (Numerical Rating Scale) at postoperative 1 hour. Secondary outcome measures include the need for rescue analgesia, adverse events related to opioid use, and dermatomal coverage of SPSIPB in Group S."
810,"GPT4 Correct Assistant: This exploratory study aims to assess the clinical value of delayed ductal imaging using contrast-enhanced spectral mammography (CESM) in patients with pathological nipple discharge. The study includes females aged 18-65 with pathological nipple discharge, who have undergone routine iopromide 370 mgI/ml-enhanced ductography. Participants will undergo CESM 4-6 hours after their initial ductography, and the study will measure changes in imaging diagnosis, diagnostic accuracy, and diagnostic confidence of radiologists. The study seeks to optimize ductography techniques and provide a systematic description of the mammary duct structure in the Chinese population."
811,"GPT4 Correct Assistant: The clinical trial is a prospective study examining the association between postoperative dyslipidemia and organ rejection in heart transplant patients. Participants must be aged 18 or older, have a history of symptomatic heart failure for at least 6 months, and provide informed consent. The study measures blood lipid levels (TG, TC, HDL-C, LDL-C, ApoB) and graft/patient survival over a 4-year period, as well as left ventricular ejection fraction (LVEF) at rest determined by contrast echocardiography. Key terms associated with the study include heart transplantation, macrophages, fatty acid, PCSK9, and lipid metabolism."
812,"GPT4 Correct Assistant: This study is a prospective cohort study comparing the effectiveness of virtual pelvic floor physical therapy with a pelvic floor trainer (Pelex Upp) in treating stress urinary incontinence in women over 18 years old. Participants are randomized into one of three arms: Pelex Upp device only, Pelex Upp device plus pelvic floor physical therapy, or pelvic floor physical therapy only. The primary outcome measure is the change in stress urinary incontinence symptoms as measured by the ICIQ-UI SF questionnaire. The study duration is four weeks."
813,"GPT4 Correct Assistant: The study aims to improve attendance in Community Wise, a multi-level manualized behavioral intervention designed to decrease alcohol and substance misuse (ASM) frequency in low-income, predominantly African American communities. Funded by the National Institute for Minority Health Disparities (NIMHD), the intervention has shown positive results in reducing ASM, but low attendance rates need to be addressed. The study proposes a 23 full factorial experiment to identify strategies to improve attendance and test the feasibility and acceptability of the intervention among men and women with a history of substance use disorder (SUD) living in marginalized communities. Intervention delivery strategies include recruiting individuals under supervision, incentivizing intervention attendance, and delivering the intervention in an open group format. The study will impact public health by improving the potency of an optimized multi-level intervention adaptable to address different health inequities."
814,"GPT4 Correct Assistant: This clinical trial aims to compare the efficacy of interpectoral area block + serratus anterior area block (IPSA) with erector spinae block (ES) in minimally invasive cardiac surgery patients. The primary outcome measure is postoperative pain scores (NRS) up to 48 hours. Secondary outcome measures include opioid consumption, recovery criteria, intraoperative parameters, and CPOT score until extubation. The study is a randomized, double-blind, parallel assignment trial with participants randomly assigned to either the IPSA or ES group."
815,"GPT4 Correct Assistant: This is a randomized controlled trial investigating the efficacy of Botox injection and internal sphincterotomy in pain relief after hemorrhoidectomy. The study includes participants aged between 18 and 70 years with grade III and IV hemorrhoids who have failed conservative treatment. The study has three arms: Botox injection post hemorroidectomy, internal sphincterotomy, and hemorroidectomy alone (control group). The primary outcome measure is post-operative pain assessed using the visual analogue scale (VAS) at 2 weeks. The secondary outcome measure is the time taken to return to daily activities without complaint at 4-6 weeks."
816,"GPT4 Correct Assistant: The study aims to explore the clinical efficacy and safety of Fruquintinib as maintenance therapy for advanced colorectal cancer patients who achieve NED (No Evidence of Disease) after adjuvant chemotherapy. The study is a prospective, single-arm, phase II trial with participants receiving Fruquintinib maintenance treatment for six months or until tumor recurrence, metastasis, or intolerable drug toxicities occur within six months. The primary outcome measure is the 2-year recurrence and metastasis rate, and the secondary outcome measure is the 2-year disease-free survival rate."
817,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of methylphenidate (MPH) in treating posttraumatic stress disorder (PTSD) with associated neurocognitive complaints in Veterans. The study utilizes an aggregated N-of-1 randomized placebo-controlled trial design, with participants receiving sequential 4-week periods of MPH and placebo, in randomized order and separated by a 1-week washout, for a total of 20 weeks. The primary outcome measure is the PTSD Symptom Checklist for DSM-5 (PCL-5), with secondary measures including the Neuro-QoL Cognitive Function short form (NeuroQoL) and Symbol Digit Coding (SDC). The study aims to assess the efficacy of MPH compared to placebo for reducing PTSD and depression symptoms, the impact of MPH on neurocognitive functioning, and the baseline predictors of treatment response to MPH in this population."
818,"GPT4 Correct Assistant: This clinical trial aims to prospectively validate the capacity of CFRflow as a predictor of the presence of angina measured by SAQ7 in patients with INOCA at 3 months. Secondary objectives include identifying hemodynamic factors related to the persistence of angina at 3 and 12 months, identifying clinical factors related to the persistence of angina, establishing the prevalence of patients with coronary microvascular dysfunction within the cohort of INOCA patients, identifying predictors of major cardiovascular events at 12 months, validating the pathological value of MMR, and establishing the pathological value of AF measured in ml/min. The study also aims to evaluate the concordance between measures of the coronary microvascular function obtained by continuous thermodilution and bolus thermodilution, as well as their concordance with clinical characteristics."
819,"GPT4 Correct Assistant: This clinical trial aims to determine if the addition of ruxolitinib to tacrolimus and methotrexate as graft-versus-host disease (GVHD) prophylaxis is safe in pediatric and young adult patients with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation (HCT) from a matched donor. The trial consists of two segments: a safety lead-in segment and a phase II segment to evaluate the efficacy of the regimen. The primary outcome measures are the incidence of adverse events and GVHD-free and relapse-free rates at 1 year post-transplant. Secondary outcome measures include the cumulative incidence of acute and chronic GVHD, overall and progression-free survival, relapse/progression rate, and other safety and exploratory objectives."
820,"GPT4 Correct Assistant: This clinical trial aims to determine the effectiveness of a Temple Stay in improving the intestinal microbiome profile and symptoms of Irritable Bowel Syndrome (IBS) in patients aged 20-69. The study will observe patients before, during, and four weeks after a temple stay experience, which includes dietary regulation and stress control. The primary outcome measure is the Irritable Bowel Syndrome Symptom Score (IBS-SSS), and the secondary outcome measure is the fecal microbiome composition and diversity."
821,"GPT4 Correct Assistant: This clinical trial aims to assess asthma patients' and prescribers' willingness to change inhalers for environmental reasons. The study will also evaluate patient awareness of the climate impact of inhalers and the importance attributed to this issue. Participants will receive an educational intervention about the climate impact of inhalers, and the primary outcome measure is the proportion of participants who change their inhaler from Ventolin MDI to Bricanyl Turbuhaler within 30 days of the study visit. Secondary outcome measures include the rate of failure of the intervention, patients' awareness and willingness to change inhalers for environmental reasons, and prescribers' willingness to change inhalers for environmental reasons."
822,"GPT4 Correct Assistant: This study aims to evaluate the durability of endoscopic plications, weight loss outcomes, and improvements in obesity-related comorbidities for the combined hybrid argon plasma coagulation plus endoscopic sleeve gastroplasty (HAPC-ESG) procedure compared to traditional endoscopic sleeve gastroplasty. The investigators hypothesize that HAPC-ESG will provide greater durability of the gastroplasty construct than traditional ESG. The study is a single-center, randomized, single-blinded clinical trial involving adult patients with a BMI between 30 and 40 kg/m² who are seeking ESG at True You Weight Loss in Cary, NC. The primary outcome measure is the durability of plications and endoscopic sutures on repeat endoscopy at 6 months. Secondary outcome measures include weight loss, blood pressure, HbA1c percentage, quality of life, depression, eating behavior, and incidence of esophagitis."
823,"GPT4 Correct Assistant: The study aims to determine the effectiveness of cancer education based on the Health Belief Model on awareness levels and participation in screening among women with physical disabilities. The study includes two intervention groups: one receiving cancer awareness training based on the Health Belief Model, and the other receiving standard cancer education. The primary outcome measure is the Gynecological Cancers Awareness Scale, while the secondary outcome measure is the Champion's Health Belief Model Scale for Breast Cancer and Screening."
824,"GPT4 Correct Assistant: This systematic review assessed the effectiveness of neoadjuvant chemotherapy and Trastuzumab in achieving pathological complete response (pCR) in patients with HER2-positive breast cancer. The study included nine clinical trials with a total of 1,209 patients. The overall pCR rate was found to be 42%. The review examined the design of the trials, patient characteristics, disease staging, HER2 status, treatment regimens, and primary/secondary endpoints. The primary outcome of interest was the pCR rate, while other survival outcomes were not analyzed."
825,"GPT4 Correct Assistant: This study aims to assess the feasibility of a coach-led digital platform using an intelligent coaching assistant for promoting healthy lifestyles and preventing lifestyle-related diseases in an urban community. The platform provides educational content, health coaching, and data from wearable devices to residents of Athy, Ireland, for a 6-month period. The study will evaluate factors such as recruitment rates, engagement, and adherence, as well as the participants' experience with the platform through qualitative interviews. The primary outcome measures include reach, adoption, engagement, and experience of the platform, while secondary outcome measures focus on changes in perceived stress, wellbeing, and healthy lifestyle practices."
826,"GPT4 Correct Assistant: This is a randomized controlled clinical trial investigating the effects of Progressive Muscle Relaxation (PMR) and Deep Breathing Exercises (DBE) on dyspnea, fatigue, and quality of sleep in patients with COPD. The study consists of three arms: an experimental group receiving PMR, a DBE group, and a control group receiving no intervention. Participants in the PMR and DBE groups undergo 10-minute exercises three times a day for eight weeks, with weekly check-ins. The primary outcome measures are the COPD and Asthma Fatigue Scale, Dyspnea-12 Scale, and Pittsburgh Sleep Quality Index, all assessed at two weeks."
827,"GPT4 Correct Assistant: This clinical trial aims to evaluate the diagnostic accuracy of ultrasonic flow ratio (UFR) in assessing coronary artery lesions. The study includes participants with stable or unstable angina pectoris, or after the acute phase of myocardial infarction, aged 18 years or older. The primary outcome measures the sensitivity and specificity of UFR in predicting functionally significant coronary stenosis at the patient level, using FFR as the reference standard. Secondary outcomes include sensitivity and specificity of UFR in predicting functionally significant coronary stenosis at the vessel level, diagnostic accuracy of UFR in predicting functionally significant coronary stenosis at the patient level, and the area under the receiver-operating characteristic curve for UFR in coronary stenosis with FFR as the gold standard."
828,"GPT4 Correct Assistant: This randomized controlled trial aims to investigate the effect of Balint group activities on burnout and self-efficacy of nurse leaders in China. Nurse leaders in clinical departments who voluntarily participated and had not previously participated in Balint groups were randomly assigned to either the experimental group (Balint group) or the non-intervention group (non-Balint group). The primary outcome measures were the Maslach Burnout Inventory-Human Services Survey (MBI-HSS) subscales of emotional exhaustion and depersonalization, and the secondary outcome measure was the General Self-Efficacy Scale (GSES). The study assessed these measures at baseline and 3 months after the completion of Balint group activities for the experimental group."
829,"GPT4 Correct Assistant: This study aims to test non-pharmacological TCM-based treatments for cognitive impairment in people with long COVID symptoms through a randomized controlled trial. The study participants will be randomly assigned to one of four groups: acupuncture, TCM-based lifestyle management, acupuncture plus TCM-based lifestyle management, or a wait-list control group. The primary outcome measure is global cognitive function, with secondary measures including cardiopulmonary function, fatigue, health-related quality-of-life, psychological distress, neurocognitive functions, and neurobiological outcomes. The study will last for 12 weeks, with the intervention period being 8 weeks."
830,"GPT4 Correct Assistant: The myCare-102 clinical trial aims to assess the clinical utility and usability of Cellworks Singula™ and Cellworks Ventura™ reports in facilitating treatment decisions for pan-cancer patients. The study includes patients with cancer, relapsed cancer, or refractory cancer who have already received first-line therapy. The primary outcome measure is the surveyed view of the Cellworks Singula™ and Ventura™ reports. The study is expected to run for approximately 24 months."
831,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of Cognitive Stimulation Therapy (CST) on apathy, loneliness, anxiety, and activities of daily living in elderly individuals diagnosed with Alzheimer's disease. The study will be conducted in a single center with a pretest-posttest control group design. Participants will be randomly assigned to either the intervention group, receiving CST, or the control group, receiving no intervention. The intervention group will undergo 14 sessions of CST, each lasting 45-50 minutes, twice a week. The primary outcome measures include the levels of apathy, loneliness, anxiety, and activities of daily living in Alzheimer's patients after CST. The study is designed to determine the potential benefits of CST in improving cognitive, psychological, and social aspects in Alzheimer's patients."
832,"GPT4 Correct Assistant: This study is a prospective, parallel, two-arm (1:1), randomized controlled experimental study aiming to examine the effect of counselling and follow-up after education on the risks and prevention methods of breast cancer on early diagnosis behaviours and healthy lifestyle behaviours. The study population consists of female administrative staff working at Mersin University. The study will be conducted in two groups: the experimental group receiving counselling for 6 months after training and a reminder message via SMS every week, and the control group receiving only training. The primary outcome measures are early diagnosis behaviours, counselling, and healthy lifestyle behaviours."
833,"GPT4 Correct Assistant: The study aims to determine the effect of simulation-based postpartum hemorrhage management on the application skills, satisfaction, self-confidence, and self-efficacy-competences of Health Sciences University Hamidiye Health Sciences Faculty Midwifery Department 3rd year students. The study population consists of 82 3rd grade students who took the Risky Birth and Postpartum Period course. The intervention group (n:39) received practical training on postpartum hemorrhage assessment and management using a high-reality Gaumard Scientific brand, product code: S550.100 Noella simulator. The control group (n:39) received postpartum hemorrhage management practices on a standard adult patient model. The study measures student satisfaction and self-confidence using the Student Satisfaction and Self-Confidence Scale in Learning, self-efficacy using the Self-Efficacy Scale, and postpartum hemorrhage management skills using the Early Postpartum Hemorrhage Management Skill Assessment Form."
834,"GPT4 Correct Assistant: The clinical study aims to investigate the effect of mangrove sword bean food bars on the weight of older people in Cihanjuang Village, Sumedang District, West Java Province, Indonesia. Participants, aged 60-80, must be living in the village and affected by the landslide disaster. The study is non-randomized and parallel assignment, with the treatment group receiving 50g mangrove sword bean food bars daily for 15 days, while the control group receives 50g sword bean food bars daily for the same period. Both groups receive balanced nutrition education. The primary outcome measure is the weight change of participants over two weeks, while the secondary outcome measure is the change in balanced nutrition knowledge."
835,"GPT4 Correct Assistant: The pAIn-sense study aims to develop a novel telemonitoring system for pain patients, using advanced AI techniques and wearable sensing technology to collect biometric data. The system will monitor patients during normal activities while collecting physiological, psychosocial, and pain information to provide personalized treatments. The study will include participants with nociceptive and neuropathic pain, aged 18-80 years, and will measure pain levels, psychosocial components of pain experience, physiological components of pain, and psychological and clinical factors affecting pain."
836,"GPT4 Correct Assistant: This is a Phase 2a/b single-arm open-label study evaluating the safety and efficacy of intracystic administration of TARA-002 for the treatment of macrocystic and mixed cystic lymphatic malformations in participants between 6 months to less than 18 years of age. The study will measure the proportion of participants with clinical success after one treatment cycle of TARA-002, safety outcomes, durable response, clinical success by lymphatic malformation type, investigator assessment, quality of life, and other secondary outcomes."
837,"GPT4 Correct Assistant: This clinical trial investigates the efficacy and safety of Chiglitazar added to Glargine in patients with Type 2 Diabetes. The study includes 128 participants who are randomly assigned to either a group taking Chiglitazar sodium tablets 48mg/day or a group taking a placebo. The primary outcome measure is changes in HbA1C from baseline at 18 weeks of treatment. Secondary outcome measures include changes in daily dose of insulin, triglyceride, fasting blood glucose, and fasting C-Peptide from baseline."
838,"GPT4 Correct Assistant: The study aims to evaluate the robustness of the EarSwitch technology in detecting voluntary eardrum movements in people with assistive needs and gather information about how well they can perform voluntary eardrum movements. The study will involve four main parts: co-design questionnaires, EarSwitch insertion, ear rumbling test, and usability testing. The primary outcome measures include the F-score, Matthews correlation coefficient (MCC), the receiver operating characteristics (ROC) curve, and the Area Under the ROC curve (AUC). The secondary outcome measures focus on how accurately people with assistive technology needs can perform voluntary tensor tympani (TT) movements and the comfort and ease of use of the EarSwitch device."
839,"GPT4 Correct Assistant: This study aims to prospectively validate, implement in real-time, and assess the performance of an EHR-based pancreatic cancer risk model (PRISM) in predicting pancreatic ductal adenocarcinoma (PDAC) in a real-time clinical setting. The study will use a multi-center prospective cohort study design, deploying the PRISM within the TriNetX federated network database. The primary outcome measures include area under the receiver operating characteristic curve (AUROC) of PRISM for all groups stratified by age, sex, race, and geographical location at different time points (6 months, 1 year, 2 years, and 3 years). The study will also assess PRISM performance metrics of high-risk and medium-risk groups for direct screening and biomarker testing."
840,"GPT4 Correct Assistant: This study is a comparative trial examining the effectiveness of autologous adipose tissue graft with hyaline cartilage versus microfracture for the treatment of articular cartilage defects in patients with knee osteoarthritis. The study includes participants aged 18-60 with a single full-thickness symptomatic femoral condyles ulcer and varus deformity of the affected knee. The primary outcome measure is the clinical assessment of International Knee Documentation Committee (IKDC) scores at one year. The study uses a randomized, parallel assignment design with single masking, and includes three arms: cartilage regeneration with high tibial osteotomy, microfracture with high tibial osteotomy, and high tibial osteotomy alone."
841,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between exercise training and recovery strategies in improving physical performance and health indices. Participants will be randomized into one of three groups for 8 weeks: a control group with a standard exercise regimen, a lower exercise volume group, and an extended recovery group. Changes in health indices will be assessed through blood markers, body composition, and performance measurements at baseline, 4, and 8 weeks of the intervention."
842,"GPT4 Correct Assistant: This clinical trial aims to study the accuracy of quantifying phosphodiesterase 4B (PDE4B) in the human brain and determine if it is reduced in individuals with major depressive disorder (MDD). The primary objective is to determine if PDE4B is reduced in the brains of individuals with MDD experiencing a major depressive episode (MDE). The secondary objectives include determining the optimal scanning length and retest variability and reliability of [18F]PF-06445974, and assessing the correlation between clinical rating scales and PDE4B binding. The study uses PET imaging with the drug 18F-PF-06445974 and includes participants aged 18-70, both with and without MDD."
843,"GPT4 Correct Assistant: This clinical trial, titled ""3D Joint Space Evaluation in Knee Osteoarthritis: The Importance of Weight-bearing and Flexion,"" aims to evaluate the importance of weight-bearing and flexion in knee osteoarthritis using a diagnostic test: weight-bearing MRI. The study includes patients with symptomatic knee osteoarthritis aged 18 or older with a Kellgren-Lawrence grade of 2 or 3. The primary outcome measure is the medial joint space width, and the secondary outcome measure is the lateral joint space width. The study takes place over one hour."
844,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of i-BiSSkApp, an at-home surface electromyography (sEMG) biofeedback therapy tool, on swallowing safety and efficiency in patients with Parkinson's disease (PD). Dysphagia, or disordered swallowing, is prevalent in PD and can lead to aspiration pneumonia, a leading cause of death in the condition. Swallowing therapy has been effective in managing dysphagic symptoms, but lacks biofeedback and long-term therapeutic intervention at home. The i-BiSSkApp device provides at-home biofeedback for swallowing rehabilitation, potentially reducing hospitalizations and healthcare costs associated with dysphagia. The study will compare the impact of i-BiSSkApp with traditional behavioral swallowing therapy on swallowing outcomes in PD patients."
845,"GPT4 Correct Assistant: The Global Burden Estimation of Human Papillomavirus (GLOBE-HPV) study aims to estimate the point-prevalence of high-risk HPV (HR HPV) in low socio-economic populations and the incidence of persistent HPV infection in specific sub-populations across eight countries. The study will employ a harmonized protocol and will use standardized survey questionnaires and laboratory assays to generate comparable data. The study will utilize two approaches: cross-sectional surveys (CSS) to estimate HPV prevalence in sub-Saharan Africa and South Asia, and longitudinal studies (LS) to estimate the incidence of persistent HPV infection in sexually active girls and young women in geographically defined communities and special populations. The study will also conduct qualitative sub-studies in five selected countries to gain insights into the attitudes, beliefs, and behaviors related to HPV and cervical cancer."
846,"GPT4 Correct Assistant: This study aims to assess the efficacy of strategic memory training coupled with non-invasive brain stimulation techniques in healthy aging population and subjective cognitive decline patients. The intervention consists of a randomized, double-blind, parallel-assignment study, where participants are assigned to either an experimental group (strategic memory training + active tDCS) or a control group (strategic memory training + sham tDCS). The primary outcome measures include associative learning test scores, while secondary outcome measures involve list learning test scores and other memory-related tests. The study will follow up with participants at 1 month and 3 months after the end of the intervention program to investigate the preservation of any improvements and the impact on the evolution of cognitive decline."
847,"GPT4 Correct Assistant: The FIND-HF study aims to predict the risk of new onset heart failure using population-based nationwide electronic health records. It is an observational study with no intervention given. Participants must be aged 16 years or older with no history of heart failure and a minimum of one-year follow-up. The study will develop and validate a predictive model using Read codes and identify potential predictors such as sociodemographic variables, lifestyle factors, and more. The primary outcome measures will be assessed between 2nd Jan 1998 and 28 Feb 2022."
848,"GPT4 Correct Assistant: The study, titled ""Recommended Time to Resume Sexual Activity After Hysterectomy: Impact on Sexual Function (FSFI® Score) and Complication Rate ISHYS Study,"" aims to determine the impact of the recommended time between hysterectomy and resumption of sexual activity on sexual function using the FSFI® score. The study will include female patients aged 18 years and older who are receiving a conservative or non-conservative total hysterectomy for benign pathology. The participants will be randomly assigned to either resume sexual intercourse 4 weeks or 8 weeks after the hysterectomy. The primary endpoint is the FSFI® score, which will be assessed preoperatively and at 3 months after surgery. Secondary outcomes include postoperative complications and follow-up to the recommendation."
849,"GPT4 Correct Assistant: The study investigates the effects of testosterone on human skeletal muscle, specifically whether it possesses an epigenetic memory of testosterone. It involves sedentary males aged 55-70 with no known illnesses or conditions. Participants are randomly assigned to one of four groups: placebo, testosterone, resistance exercise training with placebo, or resistance exercise training with testosterone. The study measures changes in fat-free mass, skeletal muscle size and cross-sectional area, skeletal muscle fiber cross-sectional area, DNA methylation in skeletal muscle and blood, gene expression in skeletal muscle and blood, myonuclei, satellite cells, isometric muscle strength, dynamic muscle strength, and muscle force-velocity profiling."
850,"GPT4 Correct Assistant: This is a dengue sero-prevalence study conducted in the metropolitan area of Buenos Aires. A two-stage stratified design is used, with primary sampling units defined as the census sections of the 2010 National Census of Population, Households and Dwellings. The study aims to determine the seroprevalence of dengue fever and other flaviviruses in the population. All participants who consent will undergo a diagnostic test for dengue immunoglobulin G antibodies using ELISA. The primary outcome measure is the percentage of the population with immunoglobulin G antibodies against dengue fever, while secondary outcome measures include the percentage of the population with immunoglobulin G antibodies to dengue but cross-reactive to other flaviviruses and the specific dengue serotype among the immunoglobulin G-positive population."
851,"GPT4 Correct Assistant: This clinical trial aims to assess the performance of COVID-19 antigen rapid diagnostic tests (RDTs) and algorithms in low-prevalence settings. It focuses on the Abbott Panbio™ COVID-19 Ag Rapid Test and the SD Biosensor COVID-19 Ag test kit. The study will measure the performance characteristics of these tests, comparing them to the reference standard reverse transcription polymerase chain reaction (RT-PCR) tests. It will also estimate the cost of Ag testing compared to PCR testing for COVID-19 case detection. The trial is designed to enroll participants aged 18 to 75 years who cross ports of entry in Greater Gaborone Health District."
852,"GPT4 Correct Assistant: The DESC-HBR trial aims to compare the impact of de-escalating P2Y12 inhibitor to clopidogrel 75mg, prasugrel 5mg, or ticagrelor 60mg bid, with full-dose potent P2Y12 inhibitors, on the proportion of patients with optimal platelet reactivity (OPR) in high bleeding risk patients with recent ACS. The secondary objective is to explore the effect of de-escalating P2Y12 inhibitor therapy on clinical events and patients' quality of life. The primary outcome is the proportion of patients in the OPR range measured through the VerifyNow system at peak level after drug maintenance dose (MD) at 14±2 days. The study will also assess cost-effectiveness."
853,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of different dietary and exercise mitigators on blood glucose levels and metabolite responses after consuming a standard rice meal. Participants, aged 18 or older, will be provided with a Continuous Glucose Monitor (CGM) and a Fitbit fitness tracker for 10 days. They will follow a specific meal plan and exercise regimen during the study period, and blood samples will be collected at various time points for metabolomics and proteomics analysis. The primary outcome measures are the comparison of blood glucose levels and changes in postprandial metabolites response after consuming the rice meal with different mitigators."
854,"GPT4 Correct Assistant: This clinical trial, titled ""Adapting and Testing a Behavioural Intervention to Prevent FASD and Adverse Infant Outcomes,"" aims to test the effectiveness of a behavioral intervention in preventing Fetal Alcohol Spectrum Disorders (FASD) and adverse infant outcomes. The study seeks to include pregnant or breastfeeding women between 18 years and older who report alcohol, tobacco, or cannabis use. The intervention consists of contingent incentives on abstinence from alcohol, tobacco, and cannabis, along with text-based support based on educational components. The primary outcome measures include urinalysis for alcohol metabolite (EtG), urinalysis for cotinine, urinalysis for cannabis metabolite (THC), and blood analysis of alcohol metabolite (PEth), among others. The study is designed as a randomized, parallel assignment, double-masked trial with an experimental group receiving the intervention and an active comparator group receiving usual care."
855,"GPT4 Correct Assistant: This clinical trial aims to investigate the effectiveness of operant conditioning of sensory brain responses to reduce phantom limb pain in individuals with limb amputation. The study involves three 1-hour sessions per week for 8-9 weeks, followed by two follow-up sessions at 3 and 6 months after the last session. Participants will undergo non-painful peripheral stimulation with electrodes placed on the scalp to record electrical brain responses. Visual feedback based on the response will be provided in pseudo real-time. The study will measure changes in pain intensity and quality, neurophysiological sensorimotor responses, and inter- and intra-hemispheric functional connectivity using electroencephalography (EEG) assessments."
856,"GPT4 Correct Assistant: This is a single-center retrospective study investigating the use of ultrasound-guided axillary vein catheterization in the Trauma Intensive Care Unit (TICU). The study includes trauma patients admitted to the TICU who receive axillary vein catheterization. The primary outcome measure is the accurate placement of the CVC catheter tip for measuring Central Venous Pressure (CVP) or invasive hemodynamic monitoring. Secondary outcome measures include puncture complications, thromboembolism events, TICU mortality, TICU length of stay, and ventilator support duration."
857,"GPT4 Correct Assistant: The Phase 2 study, ""Cevostamab Consolidation Following BCMA CAR T Cell Therapy for Relapsed/Refractory Multiple Myeloma,"" aims to evaluate the safety, tolerability, and efficacy of cevostamab administration post-BCMA CAR T cell therapy in patients with relapsed/refractory multiple myeloma. The primary outcome measure is the proportion of participants who achieve MRD-negative complete remission (CR) at 12 months post-CAR T cell therapy. Secondary outcome measures include safety and tolerability of cevostamab administration, feasibility of cevostamab administration post-BCMA CAR T cell therapy, and the impact of cevostamab consolidation on other clinical outcomes."
858,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of rehabilitative ultrasonography imaging on core muscles function in patients with visceral adiposity. The study includes 45 participants aged between 25 and 45 years with a BMI ranging from 25 to 29.9 kg/m2. The trial is designed as a randomized controlled trial with three arms: cavitation ultrasonic lipolysis on the abdomen, rehabilitative ultrasonography imaging guided core muscle exercise, and a combination of both. The primary outcomes measured are diaphragm excursion and transverse abdominis contraction ratio by ultrasound imaging at five weeks. Secondary outcomes include visceral fat thickness and waist circumference."
859,"GPT4 Correct Assistant: This is a prospective cardiac MRI pilot study investigating the impact of atrial fibrosis surface area on the occurrence of atrial fibrillation in patients with ischemic stroke of undetermined origin. The study includes participants aged 18 years or older, with cryptogenic ischemic stroke within 7 days of inclusion, and no history of atrial fibrillation. The intervention is a cardiac MRI with contrast agent. The primary outcome measure is the occurrence of an episode of atrial fibrillation lasting more than 30 seconds on the implantable loop recorder at the 3-year follow-up."
860,"GPT4 Correct Assistant: This is a phase II, open-label, randomized study for premenopausal metastatic or locally advanced breast cancer patients. The study aims to compare the efficacy of different treatment arms, including hormone therapy, immunotherapy, and AKT inhibitor, in improving objective response rate and progression-free survival. The primary endpoint is objective response rate, while the major secondary endpoint is progression-free survival or overall response rate among different treatment arms."
861,"GPT4 Correct Assistant: The University of Maryland Charles Regional Medical Center (UM CRMC) is conducting a pilot study to test the effectiveness of a novel AI-based risk score, the RecuR Score, in identifying patients at high risk of 30-day unplanned hospital readmission and providing them with more complex interventions. The RecuR Score accurately identifies patients at high risk of readmission with an area under the ROC curve of 0.83. The pilot aims to reduce the 30-day unplanned readmission rate by accurately identifying higher risk patients and providing them with a more robust set of interventions, including additional educational materials, a focus on the patient's readmission risk during interdisciplinary medical team huddles, and home health services. The first primary hypothesis is that using the RecuR Score combined with enhanced pre-discharge and follow-up care interventions can reduce 30-day unplanned hospital readmissions in the high-risk group by 30%. The second primary hypothesis is that using the enhanced interventions, there will be a 30% reduction of unplanned hospital readmission risk in patients determined to be a medium-high risk of readmission (RecuR Score level 2 or 3). The study is a parallel-group, two-arm, prospective, randomized, non-blinded, fallback design, controlled superiority study of the impact of a new transitional care model for patients determined to be at higher risk of 30-day unplanned hospital readmission conducted at UM CRMC."
862,"GPT4 Correct Assistant: The ANCAR trial is an open-label, randomized, monocenter study aiming to evaluate the effects of an acupuncture treatment protocol for nasal congestion in allergic rhinitis (AR) compared to azelastine nasal spray (Carelastin®). The study includes participants with diagnosed AR aged 18 and above. The acupuncture treatment protocol consists of 8 treatments over 6 weeks. The primary outcome measure is the Visual Analog Scale (VAS) score for nasal congestion after 6 weeks of treatment. Secondary outcome measures include VAS score at different visits, Peak Nasal Inspiratory Flow (PNIF) score, Adapted Nasal Obstruction Symptom Evaluation (NOSE) score, and assessment of the effects of acupuncture on general health, concentration, and energy level in AR."
863,"GPT4 Correct Assistant: This study aims to investigate the feasibility and recruitment rate of a pilot trial to determine the safety and efficacy of trans-coronary cooling and dilution for cardioprotection during revascularisation for ST-elevation myocardial infarction (STEMI). The study will enroll 60 patients with STEMI who are undergoing primary percutaneous coronary intervention (PCI) at Harefield Hospital. Participants will be randomly assigned to either the intervention group (n=30) receiving trans-coronary cooling and dilution, or the control group (n=30) receiving standard care. The primary outcome measures are recruitment rate, feasibility, and safety. Secondary outcomes include microvascular resistance, fractional flow reserve, coronary flow reserve, and myocardial salvage assessed by magnetic resonance imaging."
864,"GPT4 Correct Assistant: This clinical trial, titled ""Targeting Maternal Gut to Improve Mental Health Outcomes-- A Feasibility Pilot Clinical Trial,"" aims to study the effects of dietary supplements and behavioral interventions on perinatal depression and anxiety in pregnant women. The study will recruit 100 pregnant women with a history of anxiety and/or depression who are currently stable, and randomize them into one of four groups: Gutopia, Gutboost, Gutless, or Gutnone. The primary outcome measure is feasibility, focusing on recruitment and completion of study visits. Secondary outcome measures include adherence to supplement intake, dietary protocol, and completion of study visits. The study will assess the impact of fish oil, probiotics, prebiotics, and diet quality on maternal gut microbiome and mental health outcomes."
865,"GPT4 Correct Assistant: This study aims to evaluate remotely delivered, culturally tailored weight loss interventions among Latina breast cancer survivors. The study consists of a baseline run-in and randomized stage I and stage II studies. Participants receive various interventions, including health education online sessions, dietary modifications, home-based exercise sessions, and supportive materials. The primary outcome measure is the percent change in body weight at month 12, assessed across four embedded adaptive intervention groups. Secondary outcomes include determining if the effectiveness of the interventions is moderated by baseline patient characteristics."
866,"GPT4 Correct Assistant: This retrospective study aims to evaluate the effectiveness of high dose Follitropin Delta in an IVF/ICSI cycle in combination with human chorionic gonadotropin (hCG) or highly-purified human menopausal gonadotropin (HP-hMG) in women aged 18 to 42 with regular menstrual cycles and both ovaries. The study will measure the number of good quality blastocysts obtained. Exclusion criteria include endometriosis stage III/IV, history of recurrent miscarriages, certain medical conditions, and use of growth hormone during the stimulation cycle."
867,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of telemedicine in the management of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. The study includes 60 patients, randomly assigned to two groups: a telemedical intervention group and an observation group without telemedical intervention. The telemedical intervention group is required to log in to a web platform at least once a month and fill out questionnaires to assess disease activity, quality of life, and other outcomes. The study's primary outcome measures include changes in quality of life according to the SIBDQ and WHOQOL-26 questionnaires. Secondary outcome measures include maintaining/achieving clinical remission of IBD, maintaining/achieving endoscopic and histological remission of IBD, and changes in patient satisfaction and psychological well-being."
868,"GPT4 Correct Assistant: The SAUNA trial is a study designed to evaluate the efficacy of continuing somatostatin analogs upon progression in patients with gastroenteropancreatic neuroendocrine tumors. The study includes two substudies: one for targeted therapy with sunitinib or everolimus and another for peptide receptor radionuclide therapy (PRRT) with lutetium (177Lu) oxodotreotide. The primary outcome measures are progression-free survival (PFS) and time to deterioration (TTD) at 18 months after starting second-line treatment. Secondary outcome measures include overall survival, response rates, and quality of life assessments. The study aims to determine the potential benefits of continuing somatostatin analogs after progression in patients with neuroendocrine tumors."
869,"GPT4 Correct Assistant: The study aims to investigate the effects of peer-mediated pivotal response intervention on children with language impairment and social isolation in inclusive preschool classrooms. The study involves 25 classrooms with 12 in the treatment group and 13 in the control group. The intervention focuses on training peers to engage in play and communication with the target child using specific strategies. The primary outcome measures include the Preschool Language Screener 5 (PLS-5) and the Developmental Pragmatic Profile (DPP). Secondary outcome measures include the Teacher-Child Rating Scale (TCRS), peer incoming talk, peer outgoing talk, peer interactions, and play interactions. The study duration is approximately 9 months."
870,"GPT4 Correct Assistant: The study aims to test the hypothesis that combining dalfampridine with motor-relearning physical therapy intervention will produce superior gains in mobility through enhanced neuroplasticity in individuals with multiple sclerosis (MS). The study will enroll 48 participants with MS-related mobility deficits and EDSS ≤6.5. In the first treatment phase, all participants will receive 6 weeks of dalfampridine treatment. Following a 2-week dalfampridine washout, participants will be randomly assigned to either 6 weeks of physical therapy with resumed dalfampridine or 6 weeks of physical therapy without dalfampridine. The primary efficacy outcome is the percent change from baseline in Timed 25-Foot Walk. Secondary and tertiary clinical outcomes will examine restoration of function beyond just walking speed."
871,"GPT4 Correct Assistant: The study aims to assess the test-retest reliability, responsiveness, and interpretability of the CLEFT-Q, a questionnaire on health-related quality of life specific to patients with cleft lip and palate. It includes 50 patients for each surgery type (secondary nose, lip, jaw, and speech improving surgeries) who will answer the CLEFT-Q before and after surgery. Additionally, 20 healthcare professionals will be interviewed about their experiences with CLEFT-Q. The study will measure CLEFT-Q change scores at different time points and use photographs and speech recordings as secondary measures."
872,"GPT4 Correct Assistant: This clinical trial aims to compare the effectiveness of core stabilization and dynamic stretching exercises in reducing the intensity, frequency, duration, and severity of primary dysmenorrhea symptoms and improving quality of life. The study includes unmarried young females aged 18-25 with primary dysmenorrhea who have no history of regular physical activity. Participants will be randomly assigned to either the stretching exercises group or the dynamic core stabilizing exercises group and will undergo the intervention for 8 weeks. The primary outcome measures include the WaLIDD score, side bridge test, McGill Quality of Life, and PFSD scale."
873,"GPT4 Correct Assistant: This clinical trial aims to measure non-invasively, easily, and reliably the variations of cerebral perfusion in patients with or without cardiovascular risk factors during controlled variations performed during routine care to adjust the blood pressure level within the recommended safety standards during general anesthesia. The primary objective is to identify a significant linear relationship between the percentage change in mean velocity (Vm) and the percentage change in the 95% spectral frequency front (SEF95) during the MAP change. The study will enroll 100 adult patients undergoing scheduled surgery at Lariboisière Hospital under general anesthesia. The measures obtained will not influence the prescribing physician's decisions, as the data will not be analyzed and available until after the study's completion."
874,"GPT4 Correct Assistant: The PediQUEST Response to Pain Of Children With Neurologic Disability Pilot Randomized Controlled Trial aims to evaluate the feasibility of running a full-scale study comparing the effect of the PediQUEST ResPOND intervention vs. usual care in children and adolescents with severe neurologic impairment (SNI) and uncontrolled pain. The study includes 45 children and adolescents with SNI and moderate to severe recurrent pain behaviors, assigned to either the intervention (n=30) or control (usual care, n=15) group. The intervention includes parent-mediated activation through weekly collection and feedback of child pain and symptom reports, PPC team-mediated activation of primary clinicians and parents, and PPC team activation through training in a standardized approach to recurrent pain. The study measures feasibility and acceptability of the intervention, as well as potential intervention efficacy."
875,"GPT4 Correct Assistant: This is a prospective observational study examining the use of Serplulimab plus chemotherapy in the treatment of extensive small cell lung cancer. The study includes participants aged between 18 to 75 years who have not previously been treated for extensive small cell lung cancer. The primary outcome measure is progression-free survival, while secondary outcome measures include overall survival, objective response rate, and disease-control rate."
876,"GPT4 Correct Assistant: The Aktivplan Digital Intervention (ACTIVE-CaRe Pilot) is a clinical pilot study that aims to evaluate the effectiveness of the aktivplan digital intervention in supporting regular heart-healthy physical activity following completion of a Phase II rehabilitation program. The study includes participants who have enrolled in a cardiac rehabilitation program or a rehabilitation program due to non-cardiac indications but display cardiovascular risk factors. Participants are randomly assigned to either the experimental group, receiving the aktivplan digital intervention, or the control group, receiving usual care. The primary outcome measures include recruitment rate, drop-out rate, data completeness, adherence to the aktivplan digital intervention, usability, user experience, user acceptance, and technical stability. Secondary outcome measures include exercise capacity, physical activity behavior, weight, blood pressure, blood cholesterol, HbA1c, smoking, health-related quality of life, exercise self-efficacy, and patient safety."
877,"GPT4 Correct Assistant: This clinical trial is a randomized, double-blind, placebo-controlled study investigating the effects of intranasal oxytocin on social and repetitive behaviors in youth with autism spectrum disorders. Participants aged 12 to 20 years are randomly assigned to receive either 24IU of oxytocin nasal spray or a placebo twice daily for four weeks. The primary outcome measures are social behavior, assessed using the Social Responsiveness Scale-Second Edition (SRS-2), and repetitive behavior, assessed using the Repetitive Behavior Scale-Revised (RBS-R). Secondary outcome measures include behavioral inflexibility, social cognition, repetitive cognition, and vagally-mediated heart rate variability."
878,"GPT4 Correct Assistant: This is an observational study aimed at validating a clinical evaluation scale for abdominal condition of premature infants called the ECAP scale. The study includes premature infants hospitalized in the neonatal intensive care units who are at least 3 days old. The ECAP scale is used to assess the abdominal condition of the infants, and the primary outcome measure is the score on the ECAP scale. The study also measures the indication for abdominal massage on the ECAP scale, the validity of the ECAP scale, and the impact of massage on the ECAP scale. The assessment is performed by a nurse, a physiotherapist, and a resident, and each assessment is blinded. The study assesses the premature infants' abdomen blindly and within a maximum time window of 30 minutes. The study's duration is up to 18 months."
879,"GPT4 Correct Assistant: This is a randomized controlled trial comparing the effects of Empowered Relief (ER) to a Wait-List Control (WLC) for participants with persistent pain. The study aims to assess the feasibility and acceptability of ER provided by ER-trained ASPMN nurses. Participants (N=170) aged 18 and above with persistent pain are recruited and randomized 1:1 to ER or WLC. The primary outcome measure is change in pain catastrophizing, while the secondary outcome measure is change in pain intensity."
880,"GPT4 Correct Assistant: This clinical trial aims to study the mental effort and confidence in the accuracy of pain intensity ratings among patients and healthcare nurses. The study will focus on various pain intensity rating scales and their impact on mental effort. The trial will also explore the relationship between mental effort and confidence in the accuracy of pain intensity ratings, and their importance in pain communication between patients and nurses."
881,"GPT4 Correct Assistant: This clinical trial, titled ""Clinical Study of MSCs for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation,"" aims to investigate the effectiveness of mesenchymal stromal cells (MSCs) in treating poor graft function after allogeneic hematopoietic stem cell transplantation. The study includes participants aged 18 to 60 years who are eligible for allogeneic hematopoietic stem cell transplantation and have no other contraindications. The intervention involves the injection of 1×10^6/kg mesenchymal stem cells of cord blood weekly for four consecutive weeks. The primary outcome measures include white blood cell, red blood cell, and platelet recovery in patients with poor graft function after treatment. Secondary outcome measures include infection rate, graft-versus-host disease, and survival rate."
882,"GPT4 Correct Assistant: The ""MOVIN' CARE for PD"" study aims to investigate the effectiveness of mind-body interventions (yoga and arts-based therapies) in improving the psychosocial-spiritual well-being among Parkinson's disease (PD) patients. The study is a 2-arm randomized controlled trial, with participants randomly assigned to either the mindful yoga intervention or the arts-based therapy intervention. The primary outcomes measured are perceived stress level, overall quality of life, and PD-related quality of life. Secondary outcomes include PD-related symptoms, self-compassion, self-efficacy, perceived social support, constipation severity, bowel habits, and gut microbiota composition. The study plans to conduct follow-up assessments at 3, 6, and 9 months after baseline."
883,"GPT4 Correct Assistant: The study is a randomized controlled trial evaluating the effectiveness of a digital intervention for alcohol use disorder (AUD) called Quit Genius - Alcohol (QG-A) compared to usual care medical management (MM). QG-A is a smartphone application that combines cognitive-behavioral therapy (CBT), Motivational Enhancement Therapy (MET), and community reinforcement with pharmacotherapy (naltrexone) to help adults with AUD reduce their alcohol consumption. The study aims to compare the efficacy of QG-A to MM in reducing alcohol use and associated psychological and functional outcomes. Participants will be followed up for 12, 24, 36, and 52 weeks."
884,"GPT4 Correct Assistant: The Seven Trial is an investigator-initiated, open-label, phase 1/2 study that aims to determine the maximum tolerated dose (MTD) and safety of Botensilimab, a novel PD-1 checkpoint inhibitor, in combination with balstilimab, a PD-L1 inhibitor, and triplet chemotherapy regimen (nab-paclitaxel, gemcitabine, and cisplatin) plus chloroquine and celecoxib in patients with previously untreated metastatic pancreatic cancer. The primary outcome measure is the MTD of Botensilimab, and secondary outcome measures include overall response rate, progression-free survival, overall survival, and change in carbohydrate antigen 19-9 levels."
885,"GPT4 Correct Assistant: This clinical trial aims to compare the clinical pregnancy rate of frozen embryo transfer (FET) in natural vs substituted cycles. The study includes women under 40 years old who have undergone FET cycles at Clinique OVO. The primary outcome measure is the clinical pregnancy rate, measured by the presence of a fetal heartbeat at the viability ultrasound, 6 to 8 weeks after FET."
886,"GPT4 Correct Assistant: This clinical trial aims to determine the effects of intravenous vs. inhalational anesthesia on postoperative delirium and cognitive dysfunction, functional decline, blood biomarkers, and patient-reported outcomes in older adults undergoing non-cardiac surgery. The study will compare sevoflurane (inhalational) and propofol (intravenous) anesthesia in a 1:1 randomized, double-blind trial. The primary outcomes include incidence of postoperative delirium and cognitive dysfunction, while secondary outcomes include delirium severity, delirium duration, blood phosphorylated tau 181 levels, postoperative functional decline, and patient-reported outcomes."
887,"GPT4 Correct Assistant: This clinical trial aims to assess the nutritional status of children with congenital heart disease and develop a protocol to avoid nutritional deficiencies and achieve normal growth. The study includes children aged between 5 weeks and 18 years with cyanotic and acyanotic congenital heart disease, excluding those with comorbidities. The trial involves anthropometric measurements, nutritional assessments, and general and systemic examinations. The primary outcome measure is to assess the nutritional status of the children at baseline."
888,"GPT4 Correct Assistant: The study aims to investigate the use of pH-sensitive magnetic resonance imaging (MRI) based resections in patients with glioblastoma. The researchers will randomize patients to either standard glioblastoma resection with standard of care adjuvant therapy or resection guided by pH-weighted amine chemical exchange saturation transfer MRI, along with standard of care adjuvant therapy. The primary outcome measure is progression-free survival, while secondary outcome measures include overall survival and quality of life metrics."
889,"GPT4 Correct Assistant: This clinical trial, titled ""Patterns of Urinary Bladder Cancer in Darfur, Sudan 2020-2022,"" aims to investigate the patterns of urinary bladder cancer (BC) in Darfur, Sudan. The study focuses on understanding the clinical outcomes, etiology, histology, and demographic distribution of the disease. It is a cross-sectional, hospital-based study conducted at Nyala Specialized Hospital in Darfur, with a duration of 2 years (2020-2022). The study includes all Sudanese patients above 18 years of age living in Darfur with urinary bladder mass, excluding those who do not live in Darfur or refuse to participate."
890,"GPT4 Correct Assistant: This cross-sectional study aims to analyze the correlation between physical and mental stress and the quality of bowel preparation for colonoscopy in 1000 patients aged 18 to 75 years at the Endoscopy Centre of the Department of Gastroenterology, Renji Hospital, from May to August 2023. The Boston Rating Scale (BPS) will be used to assess the quality of bowel preparation, with a score of less than 6 indicating poor preparation."
891,"GPT4 Correct Assistant: The study aims to examine the effects of playful interactions on cognitive, social, and mood in older people. Participants are randomly assigned to four arms: playful interactions in a face-to-face format, playful interactions in an online format, an active control condition in a face-to-face format, and an active control condition in an online format. The study measures various cognitive and emotional outcomes, such as digit span, phonetic fluency, attention, perceived partner responsiveness, closeness, mood, flow, and mindfulness. The study hypothesizes that playful interactions will induce greater effects on emotional and social indices, as well as on executive functioning, compared to more familiar social interactions. The effects of short-term playful interaction tasks as compared to the matched social control condition will be preserved in the online format. Individuals' characteristics and personality traits will influence the effects of the interaction on the dependent variables."
892,"GPT4 Correct Assistant: The study aims to evaluate the efficacy of SkillFlix for Parents, an online video library, in improving the sexual health communication skills of parents of youth with autism spectrum disorder (ASD). A randomized controlled trial will assess the impact of the resource on parent skill demonstration and confidence, conversation frequency, and teen knowledge, attitudes, and behaviors. Participants will include parent and youth dyads aged 13-17, with ASD and reciprocal communication skills. The study will use pre- and post-assessments and a 3-month follow-up assessment to measure the outcomes. The intervention group will have access to SkillFlix for 3 months, while the control group will receive written materials with similar content."
893,"GPT4 Correct Assistant: This clinical trial aims to investigate the role of DDX17 in septic vascular endothelial pyroptosis and its control over Gasdermin D pore formation. The study includes participants aged 18 to 80 with sepsis or septic shock, excluding certain conditions. The primary outcome measure is 28-day mortality, while secondary outcomes include correlations between plasma levels of DDX17 and GSDMD with vascular endothelial injury, severity, and prognosis in sepsis patients."
894,"GPT4 Correct Assistant: The study is a single-center, prospective study aimed at evaluating non-invasive methods for diagnosing postoperative complications in liver transplant recipients. The primary outcome measure is early allograft dysfunction (EAD) as per Olthoff criteria, measured within 2 weeks of liver transplantation. The study includes patients eligible for liver transplantation aged between 18 and 75 years, and excludes re-transplant patients and those with liver transplant in fulminant hepatitis."
895,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy and safety of Elemene plus Stupp Protocol compared to Stupp Protocol alone for newly-diagnosed Glioblastoma patients. The study is a multi-center, phase II, randomized, controlled trial with participants receiving either Elemene or a placebo, alongside the standard Stupp Protocol. The primary outcome measure is the overall survival rate in the 12th month, with secondary outcome measures including overall survival, progression-free survival, and adverse events."
896,"GPT4 Correct Assistant: This clinical trial aims to study the physiological effects of prone vs. supine position on lung recruitability in infants and children with Acute Respiratory Distress Syndrome (ARDS). The trial compares the effects of the two positions on lung recruitability, gas exchange, ventilatory ratio, end-expiratory lung volume, tidal volume distribution, and lung dynamic strain. The primary outcome measure is the PaO2/FiO2 ratio at the end of the supine and prone positions. The study is a non-randomized, 2x2 crossover design with an open-label intervention."
897,"GPT4 Correct Assistant: This clinical trial investigates the effects of Progressive Relaxation Training (PRT) on pain characteristics, attack frequency, activity self-efficacy perception, and social participation in women with tension-type headache (TTH) and migraine. The study aims to compare the effects of PRT on these two distinct headache groups, as PRT is a non-pharmacological treatment that can be applied in women with TTH or migraine complaints to relax various muscle groups, improving occupational performance, participation in daily life activities, and quality of life. The trial includes 44 women aged 20-45, with 22 in each group, and uses self-reported questionnaires and visual analog scale to measure the outcomes."
898,"GPT4 Correct Assistant: This clinical trial aims to investigate the potential use of microRNA biomarkers for diagnosing Neonatal Opioid Withdrawal Syndrome (NOWS) and Neonatal Abstinence Syndrome (NAS). The study will enroll newborns with chronic in-utero opioid exposure (≥1 month of gestation) and collect buccal swab saliva samples for further genetic testing, specifically measuring the levels of microRNA let-7a, microRNA-146a, and microRNA-192. The primary outcome measures include neurodevelopmental outcome scores, maximum concentration of morphine required for withdrawal symptom control, and salivary microRNA levels."
899,"GPT4 Correct Assistant: The study aims to investigate the effect of patient education on pain level and fear of pain in orthopedics and traumatology patients. The study participants are 52 patients who underwent elective surgery and were divided into an intervention group (26 patients) and a control group (26 patients). The intervention group received patient education on preoperative preparation, operating room environment, breathing exercises, cough exercises, non-pharmacological methods related to pain management, and pharmacological methods related to pain management. The control group received patient education on preoperative preparation and operating theatre environment. Pain levels and fear of pain were measured using the Visual/Visual Analogue Scale and Fear of Pain Scale-III, respectively, before and after surgery. The study aims to determine if the intervention group has lower postoperative pain levels and fear of pain compared to the control group."
900,"GPT4 Correct Assistant: The Patch BRIDGE Trial is a randomized controlled trial investigating the use of a buprenorphine transdermal matrix patch for the induction of buprenorphine during pregnancy. The study aims to compare the efficacy and safety of the buprenorphine patch with a sham patch in pregnant women with opioid use disorder. The primary outcome measure is induction withdrawal severity, while secondary outcomes include induction success, treatment adherence, and recovery success."
901,"GPT4 Correct Assistant: This clinical trial aims to assess vascular compression in patients suspected of having Thoracic Outlet Syndrome using transcutaneous oxymetry. The study includes patients aged 18 and above, who have undergone additional examinations as part of the diagnostic assessment, and have carried out a dynamic TcpO2 recording. The primary outcome measure is the variation in upper limb ischemia estimated by TcpO2 measurement and calculating of the DROPmin (TcpO2 variation regarding a reference) depending on the type of damage (arterial, venous, or both arterial and venous). The secondary outcome measure is the correlation between the severity of upper limb ischemia by TcpO2 measurement and the degree of arterial stenosis observed in diagnostic arteriography."
902,"GPT4 Correct Assistant: The SmartCP study is a feasibility study designed to determine if the SmartCP mobile health app is feasible in the management of patients with chronic pancreatitis, complementing current specialist clinical care. The app includes a symptom tracker, diet/physical activity log, alert system for escalating symptoms, quality of life assessment, red-flag alerts for diabetes/pancreatic cancer, educational content, push notifications, and messaging function. The study has an uncontrolled, within-group baseline and post-intervention (16-week) design, with an embedded quantitative and qualitative process evaluation. The primary outcome measures include recruitment, acceptability, retention, incidents, and user statistics. Secondary outcome measures include occurrence of crisis events, symptoms, quality of life, hospitalization, and use of communications and educational features."
903,"GPT4 Correct Assistant: This retrospective cross-sectional study conducted at Mansoura University isolation hospital investigated anal fissure among COVID-19 survivors. The study included patients aged 20-70 years with or without comorbidities who were treated for COVID-19, discharged home safely, and presented with anal fissure during follow-up. The primary outcome measure was the incidence of anal fissure among COVID-19 survivors, while the secondary outcome measure was the risk factors associated with the development of anal fissure."
904,"GPT4 Correct Assistant: This study is a randomized, controlled trial investigating the effects of platelet-rich fibrin (PRF) on palatal wound healing following connective tissue harvesting. The trial includes patients with Miller class 1 or 2 gingival recession who need root coverage surgery in the Department of Periodontology. The primary outcome measures are tissue thickness and pulsatility index, measured using ultrasonography at various time points after the operation. The study aims to determine if the use of PRF in the donor site during connective tissue harvesting improves wound healing and tissue vascularization in the palate."
905,"GPT4 Correct Assistant: The ARRC III Trial is a pilot registry study at Royal Adelaide Hospital (RAH) aiming to collect high-quality data on Advanced Recovery Room Care (ARRC) model. ARRC has been shown to improve patient outcomes, hospital utilization, and costs of care compared to usual ward care. The study includes participants aged 18 years or older who are scheduled for elective or unplanned surgery at RAH and stay in the hospital at least one night after surgery. The primary outcome measure is Days at Home after surgery within 90 days after surgery. Secondary outcome measures include in-hospital complications, mortality at 1, 3, and 12 months after surgery, and cost-effectiveness. The study aims to provide a robust mechanism to maintain and improve outcomes within the institution, allow benchmarking across institutions, identify surgical subgroups benefiting from ARRC, and generate hypotheses on how benefits are achieved."
906,"GPT4 Correct Assistant: This clinical trial aims to assess the effectiveness and implementation of oral (event-driven and daily) and long-acting pre-exposure prophylaxis (PrEP) in mobile men in sub-Saharan Africa. The study is conducted in South Africa and Uganda and includes 400 participants. The primary objective is to compare short-term (9 months) and longer-term (18 months) PrEP persistence patterns across different PrEP modalities (oral and injectable) among men who are mobile for work. The study also explores the adoption, coital coverage, and participant choice of PrEP modalities. The results of this study will inform PrEP implementation in men and help prioritize prevention resources and guidelines for African governments and donors."
907,"GPT4 Correct Assistant: The study, titled ""Preliminary Assessment of the Psycho-emotional State of Patients With TMD,"" aims to evaluate the emotional state of patients with temporomandibular disorders (TMD). The study includes 130 patients diagnosed with TMD (group I) and 130 control patients without TMD (group II). Both groups undergo clinical diagnostic tests and complete a questionnaire assessing their emotional state over the past four weeks. The primary outcome measure is the questionnaire score, which covers various aspects of emotional well-being. The study is planned to be conducted from 2021 to 2023."
908,"GPT4 Correct Assistant: This clinical trial aims to study the effects of therapeutic touch, affective touch, and static/nonspecific touch on brain connectivity and metabolic biomarkers in preterm infants. The study includes 3 arms: experimental (therapeutic touch), active comparator (affective touch), and placebo comparator (static touch). The primary outcome measure is pre-post changes in BOLD levels among different brain areas, while secondary outcome measures include electroencephalogram (EEG) changes, Proton Nuclear Magnetic Resonance Spectroscopy (1H NMR) changes, and mass spectrometry changes. The study includes preterm infants between 32 and 34 weeks of gestational age, excluding those with severe comorbidities or additional complications."
909,"GPT4 Correct Assistant: This clinical trial aims to study the effectiveness of non-myeloablative haploidentical hematopoietic cell transplantation as a potential curative option for patients with sickle cell disease, particularly those with compromised organ function. The study will evaluate the regimen's success rate, defined as successful engraftment and absence of acute grade 3 or higher GVHD or moderate to severe chronic GVHD at one year post-transplant. Secondary outcomes include event-free survival, overall survival, and the incidence of other complications. The study will also explore the impact of this non-myeloablative conditioning regimen on organs including the heart, lung, kidneys, liver, brain, neurocognitive function, and endocrine organs."
910,"GPT4 Correct Assistant: The study aims to investigate the effectiveness of microfluidic chip and density gradient centrifugation methods on the euploidy rate of pre-implantation genetic testing in couples undergoing in vitro fertilization (IVF). Eligible couples will be randomly assigned to one of the two groups, with the microfluidic chip group using the Sperm Separation Device and the density gradient centrifugation group using a discontinuous density gradient centrifugation method. The primary outcome measure is the euploid rate of blastocysts, while secondary outcome measures include live birth rate, positive pregnancy test rate, clinical pregnancy rate, ongoing pregnancy rate, miscarriage rate, multiple pregnancy rate, DNA fragmentation, and ectopic pregnancy rate."
911,"GPT4 Correct Assistant: This clinical trial aims to investigate the role of Brain-derived Neurotrophic Factor (BDNF) Single Nucleotide Gene Polymorphism and Nerve Growth Factor as risk factors that increase the severity of allergic rhinitis. The study includes participants aged 20-70 years of both sexes, who are chronic allergic rhinitis patients not on anti-allergic therapy. The intervention involves diagnostic testing through genotyping. The primary outcome measures include BDNF gene single nucleotide polymorphism, nerve growth factor serum level, IL-1 serum level, and C-reactive protein serum level measured in blood samples collected over a 2-month period."
912,"GPT4 Correct Assistant: This clinical trial aims to investigate the effect of mindfulness on EEG brain activity for cognitive and psychological well-being in older adults aged 60-75 years. The intervention consists of 8 weekly group sessions, adapted from mindfulness-based stress reduction and mindfulness-based cognitive therapy protocols, specifically tailored for older adults. Participants will undergo cognitive and psychological evaluation, EEG recording, and follow-up assessments. The primary outcome measures are changes in dispositional mindfulness, verbal memory, and interoceptive mindfulness at week 8. Secondary outcome measures include changes in EEG alpha power."
913,"GPT4 Correct Assistant: This clinical trial aims to study the prevalence of Mycoplasma Genitalium (MG) infection and associated antimicrobial resistance among HIV-infected males in Hong Kong. A total of 750 HIV-infected males attending the HIV specialist clinic will be recruited. Participants will self-administer an online questionnaire and self-collect urine samples, rectal, and pharyngeal swabs for MG, Chlamydia trachomatis, and Neisseria Gonorrhoeae screening. The study will measure the prevalence of MG infection, MG resistance mutations, and other associated infections."
914,"GPT4 Correct Assistant: The DAWNA-FES study aims to explore the efficacy of Dalpiciclib in combination with endocrine therapy for HR-positive and HER2-negative recurrent/metastatic breast cancer patients after CDK4/6 inhibitor treatment failure using 18F-FES PET/CT. The study will randomize participants to either Arm A, receiving the combination of Dalpiciclib with physician-selected endocrine therapy, or Arm B, receiving chemotherapy selected by the physician. The primary outcome measure is investigator-assessed progression-free survival (PFS)."
915,"GPT4 Correct Assistant: The FISSION Study is a prospective, single-arm, multicenter trial evaluating the efficacy and safety of XELOX combined with Fruquintinib and Sintilimab regimen conversion therapy for patients with gastric cancer/gastroesophageal junction adenocarcinoma with liver and/or retroperitoneal lymph node metastasis. The primary outcome measure is progression-free survival, while secondary outcome measures include overall survival, objective response rate, disease control rate, duration of response, translational rate, and adverse events."
916,"GPT4 Correct Assistant: This clinical trial, titled ""Incentives for Physical Activity - An RCT With Older Adults,"" aims to evaluate the impact of alternative incentives on the step count of older adults in the short and long term. The study plans to recruit 200 older adults aged 55 and above, randomizing half of them to receive additional prosocial and personal incentives for their walking behavior, while the other half will not receive these incentives. The primary outcome measure is the change in step count, while the secondary outcome measure is the change in CES-D (Center for Epidemiologic Studies Depression Scale) Score."
917,"GPT4 Correct Assistant: The study aims to evaluate the clinical impact and cost-effectiveness of a wireless vital sign monitor, neoGuard, for hospitalized newborns in Kenya. It is an interrupted time series study conducted at the Moi Teaching and Referral Hospital neonatal ward between April 2022 and June 2023. Newborns admitted during this period are the study participants. The intervention group consists of patients admitted to subunits with neoGuard installed, while the comparison group receives standard-of-care monitoring. The primary outcome measures include nurse's response time to patients in distress and the percentage of actionable alarms. Secondary outcome measures include incidence of patient complications, in-hospital mortality, and frequency of key interventions."
918,"GPT4 Correct Assistant: This study aims to evaluate pre- or post-operative hypofractionated radiation therapy in aged (≥ 70 years old) or fragile (≥ 65 years old) patients with limb or trunk soft tissue sarcomas. The study will have two cohorts: neo-adjuvant and adjuvant. The primary outcome measure is the rate of patients free of major surgical complications within 6 months of surgery. Secondary outcome measures include disease-free survival, surgical complications, wound disorders, healing time, quality of life, patient autonomy, geriatric parameters, and toxicities of radiation therapy."
919,"GPT4 Correct Assistant: This retrospective study aims to investigate the prevalence of head and neck cancer at the ENT-Head and Neck Surgery department of Shree Birendra Hospital in Nepal. The study includes patients aged 17 to 84 years with histologically proven head and neck cancer, excluding those with incomplete data. The primary outcome measures include age-wise distribution of head and neck cancers, distribution according to subsite, histopathology, TNM staging, and treatment modalities. The data was collected from medical records between May 2022 and April 2023 and analyzed using SPSS version 22."
920,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of a health communication message on the detection of obstructive sleep apnea (OSA) in children. The study involves randomizing parents of children with OSA symptoms to either view the health communication message or receive usual care. The primary outcome measure is the rate of completed OSA referral, and secondary measures include OSA referral rate, evidence-based evaluation rate, OSA diagnosis rate, OSA treatment rate, and parent activation rate."
921,"GPT4 Correct Assistant: This is a multi-country, prospective, post-marketing study evaluating the speed of onset and durability of effectiveness of upadacitinib in adult participants with moderate to severe Crohn's disease in real-world clinical practice. The primary outcome measures are the time to achieve first clinical response per patient-reported outcome 2 (Daily CR-PRO) and the percentage of participants achieving clinical remission per Harvey Bradshaw Index (HBI) among those with clinical response-Harvey Bradshaw Index (CR-HBI) at end of induction therapy. The study includes participants with a diagnosis of moderate-to-severe Crohn's disease, aged 18 years or older, who initiate upadacitinib at the clinician's discretion as part of their routine clinical care. The study will measure these outcomes up to Week 12 and Week 52, respectively."
922,"GPT4 Correct Assistant: The study, titled ""Testing of Online Version of QAPS,"" aims to assess prewriting skills in children aged 3-7 years old. Participants will complete various tasks, such as playing a drawing game on a tablet, copying shapes using a pencil, and writing letters. The study measures primary outcomes, including online QAPS, Beery VMI, functional hand tasks, demographics survey, emotionality assessment, strengths & difficulties questionnaire inattention/hyperactivity subscale, and ego resiliency scale."
923,"GPT4 Correct Assistant: The study aims to evaluate the effectiveness of the Critical Time Intervention-Peer Support (CTI-PS) model for individuals with serious mental illness discharged from inpatient psychiatric treatment facilities in Portugal. The intervention is a time-limited, 9-month long behavioral intervention provided by Community Mental Health Workers and Peer Support Workers. The study includes participants aged 18-65 with psychotic disorders, such as schizophrenia and bipolar disorder. The primary outcome measures are health-related quality of life and unmet needs, assessed at 18 months. Secondary outcome measures include psychopathology, level of disability, orientation towards recovery, self-stigma, and substance use."
924,"GPT4 Correct Assistant: The Registry for Vascular Trauma and Follow-up Examinations is a study that aims to assess the long-term outcomes of patients with vascular injuries. The study includes patients aged 18 years and above who have experienced vascular involvement in trauma. The primary outcome measures are vessel/graft patency, documented through ultrasound, ABI-measurement, and clinical evaluation. Secondary outcome measures include reintervention rate and development of treatment patterns. Assessments are performed at different time points throughout the first year after trauma, with an average of 1 year."
925,"GPT4 Correct Assistant: This clinical trial is a prospective randomized control trial studying the effects of Blood Flow Restriction Rehabilitation (BFR) after ORIF of distal radius fractures. The study will include adults aged 18 and above with acute distal radius fractures requiring ORIF surgery. Participants will be divided into two groups based on age and then randomly assigned to either a control group receiving standard rehabilitation or an intervention group incorporating BFR during selected exercises. The study will measure body composition, forearm girth, grip strength, and pinch grip strength, as well as patient-reported outcome surveys."
926,"GPT4 Correct Assistant: This is a randomized clinical trial investigating the effects of a computer app called Stand up for Your Health® and educational information on sitting time, musculoskeletal symptoms, cardiometabolic markers, and physical activity in office workers. Participants are recruited from educational establishments and measured at baseline, 3rd, and 6th months. The experimental group receives the computer app and educational information, while the control group receives only educational information. The study aims to determine the adherence to the intervention program by identifying barriers and facilitators referred by the participants."
927,"GPT4 Correct Assistant: The study, titled ""The Chronic Effects of Low-Load Blood Flow Restriction and Creatine Supplementation in Women,"" aims to investigate the effects of creatine supplementation and blood flow restriction exercise on leg strength, body composition, neuromuscular function, and endothelial function in physically inactive women aged 18-35. The study will last for approximately 10 weeks and involve 27 visits, including questionnaires, blood draws, and exercise tests. Participants will be randomized into one of five groups: control, creatine and blood flow restriction exercise, creatine and no-BFR with training, placebo and blood flow restriction exercise, and placebo and no-BFR with training. The primary outcome measures include leg strength, body composition, neuromuscular function, and endothelial function, while the secondary outcome measure is mood states."
928,"GPT4 Correct Assistant: The Novel Targetable BIOmarkers in ANorexia NervosA study aims to evaluate GDF-15 and cytokines as potential novel targets for the treatment of anorexia nervosa. The study includes 8 adult patients with anorexia nervosa restrictive type, non-exercising subtype, 8 adult patients with anorexia nervosa restrictive type, exercising subtype, and 16 control participants. The primary outcome measures are the Growth Differentiation Factor-15 (GDF-15) (pg/ml) level in the plasma and cerebrospinal fluids of AN patients and normal-weight controls. The study will also assess body composition via Dual Energy X-ray Absorptiometry (DEXA) scans and energy expenditure via indirect calorimetry, in order to correlate GDF-15, Nfl and GFAP and cytokine levels with lean and fat mass measures as well as with energy expenditure, respectively, of AN patients and the matched controls. The findings of this study may challenge the viewpoint that AN is a condition which can be controlled by the individual and demonstrate that AN is a biological disease that should be treated by targeting the right biological players in addition to psychiatric treatment."
929,"GPT4 Correct Assistant: The PROSPECT study is a prospective, observational study collecting data on complications and key outcomes from patients undergoing pleural procedures. The study aims to provide a best practice standard for pleural interventions, allowing new and smaller volume centres to benchmark their practice and ensure patient safety. The primary outcome measure is the occurrence of complications within 30 days, while secondary outcome measures include patient-reported outcomes of dyspnoea and chest pain within 4 weeks."
930,"GPT4 Correct Assistant: The Artificial Intelligence for Preventing Heart Disease (AiPHD) is a prospective and retrospective observational study aimed at developing an AI-based model for coronary artery disease (CAD) risk stratification. It includes two cohorts: a retrospective cohort of 2500 patients and a prospective cohort of 500 patients. The primary outcome is a composite of death by cardiovascular events or non-fatal myocardial infarction within 36 months from the coronary computed tomography angiography (cCTA) examination. The secondary outcome is a composite of all-cause mortality, non-fatal myocardial infarction, hospitalization due to angina or angina-like symptoms, and late coronary revascularization within 36 months from the cCTA examination. The study aims to create an AI-based model to identify and categorize high-risk patients and provide personalized management to improve patient outcomes."
931,"GPT4 Correct Assistant: The SIM0355-201 trial is a multicenter, randomized, double-blind, placebo-controlled exploratory clinical trial evaluating the safety and tolerability of different doses of Edaravone Dexborneol concentrate for injection combined with conventional medical therapy in patients with cerebral hemorrhage. The study includes two periods (Period A and Period B), with Period A being a dose escalation period divided into two dose levels (the first dose level group and the second dose level group), and safety being assessed in each group. The primary outcome measure is the incidence of serious adverse events up to 90 days after the first dose of treatment. Secondary outcome measures include the incidence of deaths, adverse events, modified Rankin Score, Glasgow Outcome Score, National Institutes of Health Stroke Scale, Barthel index, and imaging and pharmacokinetic endpoints."
932,"GPT4 Correct Assistant: The study aims to investigate the effectiveness and safety of Manzhi Guben granules in improving exercise tolerance and promoting body rehabilitation in patients with COVID-19. It is a multicenter, randomized, double-blind, placebo-controlled clinical study, where patients are randomly assigned to either the Manzhi Guben granules group or the placebo group. The primary outcome measure is the results of the 6-minute walking test on day 14. Secondary outcome measures include the results of the 6-minute walking test on day 28 and pulmonary ventilation function on days 14 and 28."
933,"GPT4 Correct Assistant: This study is a non-interventional fMRI study aimed at investigating the neural bases of decision-making in healthy individuals. The study will involve 150 participants aged between 18 and 60 years. Participants will undergo behavioral assessments of decision-making and executive skills, followed by an fMRI session. The fMRI session will involve brain activity associated with decision-making and executive functioning in social and non-social contexts, brain structural morphometry, and brain structural connectivity. The primary outcome measure is participants' decision-making performance, while the secondary outcome measures include participants' executive performance and brain activity, structure, and connectivity related to decision-making and executive performance. The study aims to provide insights into the relationship between executive and decision-making skills and their possible changes with ageing."
934,"GPT4 Correct Assistant: The Neutrocheck Summative Usability Study aims to investigate the usability of Neutrocheck among healthy volunteers and healthcare professionals. The study includes participants aged 18 or older, and excludes those with certain medical conditions or phobias. Participants will use either paper instructions or app instructions to use Neutrocheck, and their experiences will be assessed through questionnaires and observed task completion rates. The primary outcome measures include the identification of use errors and the effectiveness of key safety information. Secondary outcome measures include user satisfaction and comparisons between paper and app instruction groups. The study will last for two months."
935,"GPT4 Correct Assistant: The study aims to improve walking in people with Parkinson's using the Heel2Toe sensor, a wearable device that provides real-time auditory feedback. The study uses an individualized, blocked, stepped-wedge design and participants are randomly assigned to either immediate or delayed assignment of the sensor. The primary outcomes measured are changes in ankle angular velocity during walking, while secondary outcomes include motivation, walking behavior, quality of life, and cognitive performance. The study aims to determine the extent to which participants require support from the technology and rehabilitation team, and how they change their gait pattern, walking behaviors, motivation, and functional and quality of life indicators over a period of 3 months."
936,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of a 4-week laughter yoga program on mood, anxiety, and loneliness in adolescents with intellectual and physical disabilities. The study will involve 40 participants aged 10-18 years old, randomly allocated to either the intervention group (laughter yoga program) or the control group (routine care). The primary outcome measures include mood, anxiety, and loneliness, assessed using the Mood Scale, State-Trait Anxiety Inventory (STAI-6), and UCLA Loneliness Scale, respectively. Data will be collected before and immediately after the intervention."
937,"GPT4 Correct Assistant: This study aims to investigate the effects of decision aids on the participation of South Asian women in cervical cancer screening. The study is a randomized controlled trial, with participants randomly assigned to one of three groups: a placebo comparator group (control factsheet about healthy living), an experimental group with a printed decision aid, and an experimental group with a mobile decision aid. The primary outcome measures are decisional conflict, assessed using a 16-item Decisional Conflict Scale, and cervical cancer screening uptake, assessed by asking participants if they have undergone screening in the past three months. Secondary outcome measures include risk perception, choice predisposition, and screening decision. The study includes women aged 25 to 64 years, of Indian, Pakistani, or Nepalese origin, with no history of cervical cancer or total hysterectomy, and who have a history of sexual activity and can understand English, Hindi, Urdu, or Nepali."
938,"GPT4 Correct Assistant: This clinical trial aims to investigate the additional effect of forward head posture correction on temporomandibular dysfunction. The study will randomize participants into two groups: one receiving conservative treatment and another receiving conservative treatment with Denneroll cervical traction orthodontic. The primary outcome measures include the Anamnestic questionnaire by Fonseca, Craniocervical angle (CVA), and Boley Gauge. Secondary outcome measures include the Visual Analog Scale (VAS) and Mandibular Opening. The study will be limited to participants aged between 18 and 40 with myogenic TMD and forward head posture."
939,"GPT4 Correct Assistant: This clinical trial is comparing the efficacy of Clindamycin Phosphate 1% Gel and Dapsone 5% Gel in the treatment of moderate acne vulgaris. The study includes participants aged 20 to 50 years, with moderate acne vulgaris, and excludes pregnant or lactating women and those with hematological abnormalities. The intervention consists of applying the respective gels for three months. The primary outcome measure is the comparison of efficacy using the Global Acne Grading Score (GAGS). The study is designed as a randomized, parallel assignment, open-label trial."
940,"GPT4 Correct Assistant: This clinical trial aims to investigate the relationship between rotator cuff tear severity and scapular and rotator cuff muscle activation patterns. The study involves participants with rotator cuff tears, aged between 18 and 60 years, who undergo surface electromyography (sEMG) assessment to evaluate muscle activation patterns during functional tasks. The primary outcome measure is muscle activation amplitude for scapular and rotator cuff muscles, while the secondary outcome measure is the identification of differences in muscle activation patterns by tear size."
941,"GPT4 Correct Assistant: The SENIOR RCT is a multicenter study in two North Italian hospitals, aimed at evaluating the efficacy of a 6-month sustainable nutrition protocol on malnourished older adults (≥65 years old) compared to the hospital standard of care. The primary endpoint is the improvement of nutritional status between pre- and post-intervention in experimental and control groups, measured by weight gain and strength (handgrip). Secondary endpoints include changes in blood biomarkers, dietary habits, quality of life, and evaluation of sarcopenia. The study includes older adults over 65, diagnosed with malnutrition according to GLIM criteria. The experimental group receives a personalized nutritional protocol, while the control group receives standard care. The study measures changes in nutritional status, blood biomarkers, dietary habits, quality of life, and sarcopenia markers at various time points during the study."
942,"GPT4 Correct Assistant: This study, titled ""Dynamic Changes of Torquetenovirus Load in Chinese Renal Transplant Recipients During Immunosuppressive Therapy: A Double-blind Multicenter Prospective Observational Cohort Study,"" aims to investigate the dynamic changes of Torquetenovirus (TTV) load in Chinese renal transplant recipients. The study includes participants aged 18 to 65 who have received ABO compatible renal allotransplantation and are receiving maintenance immunosuppression with tacrolimus, mycophenolate mofetil, or prednisone. The primary outcome measures are any biopsy-proven acute rejection and clinical diagnosed acute rejection from day 0 to day 365 after kidney transplantation. Secondary outcome measures include infection events, donor-specific antibodies, and donor-derived cell-free DNA. The study focuses on the roles of TTV in renal transplant recipients and the impact of immunosuppressive therapy on TTV load."
943,"GPT4 Correct Assistant: This clinical trial investigates the efficacy of vitamin B12 vs B3 therapy in nerve regeneration and functional recovery after pediatric traumatic brain injury (TBI). The study includes 300 children aged 6 to 15 years with severe TBI, divided into two groups. Group 1 receives vitamin B3 (16 mg/day) and group 2 receives vitamin B12 (125-250 mcg/day). The primary outcome measure is the change in Stair Climb Test (SCT) score at 18 months. The trial is non-randomized, parallel assignment, and open label."
944,GPT4 Correct Assistant: This clinical trial is designed to evaluate the efficacy and safety of Pyrotinib after adjuvant anti-HER2 therapy in women with high-risk early or locally advanced stage breast cancer. The primary outcome measure is invasive disease-free survival (iDFS) at year 2. Participants will receive Pyrotinib 400mg orally daily for one year after anti-HER2 therapy.
945,"GPT4 Correct Assistant: This clinical trial aims to assess the effects of consuming pasta at lunch or dinner on sleep quality, anthropometric parameters, cardiovascular risk factors, gut microbiota composition, and functionality in normal-weight subjects. The study is a randomized controlled trial with two phases: one where participants consume pasta at dinner, and another where they consume pasta at lunch. Participants will be followed for seven months, with assessments made at the beginning and end of each intervention phase. The study will also consider individual chronotype, a construct indicating when a subject is most active during the day, as recent studies have highlighted its impact on dietary habits and human health."
946,"GPT4 Correct Assistant: This is a phase 2 clinical trial evaluating the use of 18F-fluciclovine PET/CT imaging in participants with multiple myeloma to determine its concordance with 18F-FDG PET/CT imaging. The study includes 55 participants with multiple myeloma, divided into two cohorts based on disease status: newly diagnosed multiple myeloma (NDMM) and relapsed and/or refractory multiple myeloma (RRMM). Participants undergo 18F-fluciclovine injections at three time points and results are compared to 18F-FDG PET/CT imaging. The study aims to assess the performance of 18F-fluciclovine PET/CT and evaluate its efficacy in measuring disease volume, identifying minimal residual disease, evaluating response after treatment, and determining the safety of 18F-fluciclovine as a radiotracer in patients with multiple myeloma."
947,"GPT4 Correct Assistant: This clinical trial aims to study the arm swing during walking in patients with early multiple sclerosis and healthy controls. Participants will undergo evaluation of arm swing amplitude and functional tests, including the Two Minute Walk Test (2MWT), Timed Up and Go (TUG), and Timed 25Foot Walk Test (T25FW). The primary outcome measures are arm swing amplitude in shoulder and elbow flexion-extension directions, step-speed, and functional mobility tests. The study is designed to understand the changes in arm swing amplitude and functional mobility in patients with early multiple sclerosis."
948,"GPT4 Correct Assistant: This clinical trial, titled ""Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer,"" aims to study the effectiveness of adjuvant Pyrotinib and Capecitabine treatment in HER2 positive micro invasive breast cancer patients. The trial includes women aged 18-70 with stage I breast cancer, who meet specific eligibility criteria. The study is designed with a randomized parallel assignment and no masking, with two arms: one receiving Pyrotinib and Capecitabine for half a year and the other receiving no adjuvant chemotherapy or targeted therapy. The primary outcome measure is invasive disease-free survival (iDFS) at 5 years, with secondary outcome measures being distant disease-free survival (DDFS) and overall survival (OS) also at 5 years."
949,"GPT4 Correct Assistant: This is a pilot randomized controlled trial (RCT) comparing the effectiveness of video biofeedback and laryngeal control therapy in the treatment of Paradoxical Vocal Fold Motion (PVFM). The primary endpoint is the change in Dyspnea Index score before and one month after treatment. Participants are aged 18 or older, have a pre-treatment Dyspnea Index score of 11 or higher, and experience difficulty breathing, particularly during inhalation. The investigators hypothesize that no clinically meaningful difference will be detected between the two interventions."
950,"GPT4 Correct Assistant: This study aims to evaluate the implementation of a multidisciplinary protocol to improve sleep quality in critically ill patients. It is a multicenter clinical trial with a quasi-experimental design. The primary outcome measure is the change in the Richards-Campbell Sleep Quality Score before and one month after the implementation of the sleep protocol. Secondary outcome measures include changes in the Sleep in the ICU Questionnaire, Confusion Assessment Method for the ICU, Questionnaire on the patient's perception of sleep from the family member's point of view, and Questionnaire for assessing and perceiving patients' sleep from the point of view of the care team. The study includes adult patients who have spent at least two nights in the ICU and have no neuropsychiatric conditions that prevent them from responding to the sleep questionnaire. The intervention includes adjusting sound intensity, reducing noise, thermal comfort adjustments, dimming of lights, and optimization of analgesics and other medications. The study aims to demonstrate better sleep quality in critical patients and evaluate the incidence of delirium and its duration according to sleep quality."
951,"GPT4 Correct Assistant: The study is a pilot trial assessing the effectiveness of the PACHA program in enhancing adherence to adjuvant endocrine therapy among breast cancer survivors. It is a cluster randomized controlled pilot trial using mixed methods (quantitative and qualitative). Pharmacists and women are randomly assigned to either the control group, receiving usual care, or the intervention group, receiving the PACHA program in addition to usual care. The PACHA program consists of an 85-minute web-based training for pharmacists, and web video capsules, self-management strategies, and resources for women. The primary outcomes measured are intention to adhere to adjuvant endocrine therapy, adjuvant endocrine therapy knowledge, attitude towards adjuvant endocrine therapy, perceived social support, perceived behavioral control, anticipated regret, coping planning, fear of recurrence, side effects, and cognitive representations of medication. The secondary outcomes include proportion of days covered by an adjuvant endocrine therapy, proportion of women having an AET, and mean change in quality of life."
952,"GPT4 Correct Assistant: The study aims to investigate the effects of Melissa extract in phytosome form on sleep quality and duration in individuals with insomnia or sleep disturbances. The study uses a randomized crossover design with two arms: one group receives Melissa phytosome followed by placebo, and the other receives placebo followed by Melissa phytosome. The primary outcome measure is total sleep duration and time spent in different sleep phases, assessed using wearable smartwatches. Secondary outcome measures include perceived sleep quality, perceived anxiety levels, and quality of life, all assessed using validated questionnaires. The study also monitors possible adverse symptoms using the DOTES scale."
953,"GPT4 Correct Assistant: This clinical trial aims to investigate the efficacy of lenvatinib and tislelizumab plus CapeOX chemotherapy as first-line treatment for advanced gastric cancer or gastroesophageal junction adenocarcinoma with positive PD-L1 and low TMEscore. The study is a multi-center, prospective, phase II study with two parallel arms. Participants are randomly assigned to receive either lenvatinib and tislelizumab plus CapeOX chemotherapy or tislelizumab plus CapeOX chemotherapy. The primary outcome measure is progression-free survival, while secondary outcome measures include overall survival, objective response rate, disease control rate, and duration of response."
954,"GPT4 Correct Assistant: This is a single-arm trial of Social Engage Coaching (S-ENG) for 30 adults aged 60 and older living in senior living communities who report significant loneliness and suicide ideation. The study uses smartphone-based target assessment and ambulatory assessment via smartphones for 16 weeks. S-ENG consists of 10 individual coaching sessions to increase social connection. The primary outcome measures are loneliness, satisfaction with social activities, time in conversations, and time outside the home, all assessed at the 16-week follow-up."
955,"GPT4 Correct Assistant: The study aims to evaluate the efficacy, safety, and tolerability of higher doses of estrogen therapy in women with primary ovarian insufficiency. Participants, aged 18-45, will receive either transdermal estradiol gel 0.1% 1.5mg/day or 2.0mg/day as hormone replacement therapy. The primary outcome measures are the severity of estrogen deficiency symptoms, quality of life, and menopause-related quality of life assessed using various questionnaires. Secondary outcome measures include changes in sex hormone levels and bone mineral density."
956,"GPT4 Correct Assistant: The Symbiont-Restore Study aims to investigate the immunological effects of synbiotic supplementation with a probiotic, L. reuteri PB-W1™, and a prebiotic blend (comprising 50% raffinose and 50% xylooligosaccharide) on markers of immune health, host metabolome, and gut microbiome in adults with a BMI of 30-40 kg/m². The study will compare four groups: probiotic capsule (L. reuteri PB-W1™) and placebo sachet, prebiotic sachet (Prebiotic Blend) and placebo capsule, synbiotic (probiotic capsule and prebiotic sachet) and placebo capsule, and placebo sachet and placebo capsule. The primary outcome measure is the change from baseline immune profile at 8 weeks. Secondary outcome measures include changes in faecal microbiome composition and diversity, metabolic profile, satiety rating, and gastrointestinal tolerance to dietary fibre."
957,"GPT4 Correct Assistant: This clinical trial aims to investigate the safety, tolerability, and pharmacokinetics of AD16 tablets in adult healthy subjects after a single administration. The study involves two groups: the experimental group receiving AD16 tablets in dosages of 5mg, 10mg, 20mg, 30mg, 40mg, 60mg, or 80mg, and the placebo group receiving a matching placebo. The primary outcome measures include adverse events, serious adverse events, abnormal laboratory test results, abnormal vital signs, abnormal electrocardiogram readings, abnormal physical examination findings, and concomitant medication. Secondary outcome measures include the time to reach the maximum plasma concentration, maximum plasma drug concentration, elimination half-life, area under the plasma concentration-time curve, total clearance, apparent volume of distribution, terminal disposition rate constant, mean retention time, amount of drug excreted in urine, and cumulative excretion rate of drugs."
958,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of urolithin A supplementation on endothelial function, cerebral blood flow regulation, and serum biomarkers of nitric oxide bioavailability and mitochondrial function in middle-aged adults with obesity. Participants aged 40-64 with a BMI of 30 kg/m2 or greater will be randomly assigned to receive either 1,000 mg of urolithin A daily or a placebo for 4 weeks. The study will measure changes in arterial function and local stiffness, blood flow on the surface of the hand, homeostatic cerebral blood flow, plasma biomarkers of nitric oxide homeostasis, and plasma biomarkers of mitochondrial function."
959,"GPT4 Correct Assistant: This clinical trial aims to examine the effects of vibration therapy applied at different frequencies with a percussion massage gun on joint range of motion, pain, functionality, and kinesiophobia in individuals with cervical disc herniation. Participants will receive a conventional treatment program 4 days a week, which includes heat application, TENS application, and joint range of motion exercises. In addition to the conventional treatment, the experimental group will receive vibration therapy applied to specific muscles with a percussion massage gun for 3 weeks. The primary outcome measure is the evaluation of joint position sense, and secondary outcome measures include neck disability index, visual analogue scale for pain intensity, and kinesiophobia."
960,"GPT4 Correct Assistant: The study aims to create a register of patients with heart failure with preserved ejection fraction (HFpEF) to assess the influence of various factors on the outcomes of patients with acute decompensated heart failure. The study will analyze clinical and anamnestic factors, body composition, congestion, inflammation, and other markers to optimize the diagnostic and treatment algorithm for these patients. The study design is descriptive, open-label, and observational, with two arms: patients with HFpEF and a control group of healthy individuals. The primary outcome measure is the amount of secondary hospitalizations within 6 months, while secondary outcome measures include hospitalizations with acute coronary syndrome, stroke, pulmonary embolism, and other cardiovascular events within the same time frame."
961,"GPT4 Correct Assistant: The Brothers Building Brothers by Breaking Barriers (B6) study aims to improve engagement across the HIV continuum of care (HIV-CoC) by enhancing individual- and community-level resilience processes among young Black gay, bisexual and other men who have sex with men (YB-GBMSM) living with HIV. The study adapts and pilots the novel B6 intervention for telehealth delivery (creating tele-B6) within the context of an established community-based organization (CBO) as a strategy for enhancing feasibility and scalability before a larger efficacy trial. The study uses a randomized, parallel assignment design with an experimental group receiving the tele-B6 intervention and a control group receiving delayed intervention. The primary outcome measures include acceptability, change in the acceptability surveys, change in recruitment rates, change in retention, and safety (adverse events). Secondary outcome measures include changes in perception of structural racism and discrimination, change in perception of discrimination, change in perception of HIV stigma, change in perception of internalized homonegativity inventory, qualitative description of intersectional stigma, change in logistical barriers, qualitative description of logistical barriers, changes in perception of individual resilience process: Identity Affirmation, qualitative description of individual resilience process: Identity Affirmation, changes in the community resilience process: social capital, qualitative description of the community resilience process: social capital, changes in the perception of minority stress: depression, changes in the perception of minority stress: general well-being, and qualitative description of the minority stress."
962,"GPT4 Correct Assistant: This clinical trial aims to investigate the impact of parent/caregiver involvement on DTTC treatment outcomes in children with CAS. Forty children aged 2;5 to 7;11 years will receive DTTC treatment 2x/week over an 8-week period with home practice. Participants will be randomized into one of two groups: Direct Training Group (DTTC + Home Practice + Direct Caregiver Training) or Indirect Training Group (DTTC + Home Practice + Indirect Caregiver Training). The study will address four aims: quantifying the effects of direct vs. indirect caregiver training on whole word accuracy, phoneme accuracy, speech intelligibility, and functional communication at post-treatment and maintenance."
963,"GPT4 Correct Assistant: This clinical trial aims to test and validate the creation of self-help and support groups for laryngectomized patients. The study will include patients who have had a total laryngectomy and are able to travel to Bichat Hospital for four sessions. The primary outcome measure is the difference in quality of life scores before and after the program, between the program and non-program control groups. The study will use two questionnaires, WHOQOL-BREF and EORTC QLQH&n43, to assess the benefit of the meetings. Patients who cannot participate due to geographical or personal reasons will form the control group."
964,"GPT4 Correct Assistant: The MS-DETECT trial aims to evaluate the effectiveness of the MSCopilot® Detect mobile application in detecting multiple sclerosis progression in patients living with relapsing-remitting or secondary progressive multiple sclerosis. The study will assess the application's sensitivity to detect disability worsening based on revised-Multiple Sclerosis Functional Composite (revised-MSFC) scores and its ability to detect disease progression in the absence of relapsing activity. The trial will also explore the application's association with clinical scores, its reproducibility between in-clinic and at-home digital tests, and its impact on patient satisfaction and user experience."
965,"GPT4 Correct Assistant: The PCOS Challenge Study aims to collect information to advance research and improve care for PCOS patients. The study is designed for individuals diagnosed with PCOS by a healthcare provider, self-diagnosed with PCOS, or exhibiting PCOS symptoms who are willing to sign the consent form and able to understand the registry surveys. The target population includes individuals with PCOS, while the control population consists of people born biologically female without PCOS or PCOS symptoms. The study measures information collected through survey questions for one year."
966,"GPT4 Correct Assistant: This is a cluster-randomized trial evaluating the use of low molecular weight heparins, specifically Dalteparin and Tinzaparin, in patients with indication for low molecular weight heparin. The primary outcome measure is 30-day all-cause mortality and bleeding requiring blood transfusion. Secondary outcome measures include 30-day and 365-day all-cause mortality, blood transfusion during admission, 90-day risk of pulmonary embolism and deep venous thrombosis, heparin-induced thrombocytopenia, liver failure, length of hospital admission, and days alive out of hospital. The study is open-label and uses parallel assignment."
967,"GPT4 Correct Assistant: This clinical trial is designed to compare the effects of Inspiratory Muscle Training (IMT) and Expiratory Muscle Training (EMT) on acquired brain injury patients. The study will measure inspiratory and expiratory muscle strength, as well as pulmonary volume and flow. Participants will undergo 8 weeks of training, with one session per day, five days a week. The primary outcome measures are inspiratory and expiratory muscle strength, while the secondary outcome measures are pulmonary volume (forced expiratory volume in 1 second) and pulmonary flow (peak expiratory flow)."
968,"GPT4 Correct Assistant: This clinical trial aims to investigate the effects of technological balance and gait rehabilitation on functional, motor, and cognitive outcomes in patients with multiple sclerosis. The study will involve 24 participants, randomly assigned to either the experimental group or the control group. The experimental group will undergo specific rehabilitation treatments for balance disorders using the robotic platform Hunova® Movendo Technology srl for 4 weeks, followed by 4 weeks of observation. The control group will undergo 4 weeks of observation, followed by 4 weeks of rehabilitation treatment using the same platform. Primary outcome measures include the Berg Balance Scale, Modified Fatigue Impact Scale, Fatigue Scale for Motor and Cognitive Function, Timed Up and Go test, Ambulation Index, Walking handicap scale, Functional Ambulation Classification, 10 Meter Walk Test, Six-minute walk test, Multiple Sclerosis Walking Scale, Modified Barthel Index, Multiple Sclerosis Impact Scale, Beck Depression Inventory-II, State-Trait Anxiety Inventory, Stroop Colour Word Test, and Symbol Digit Modalities Test."
969,"GPT4 Correct Assistant: The ASARD-TMA Study is a clinical trial designed to evaluate the effectiveness of an automated algorithm for the surveillance, alert, and rapid diagnosis of Thrombotic Microangiopathies (TMA) in hospitals. The study includes patients aged 18 to 100 years, and the primary outcome measure is the time of diagnosis and treatment of TMA. The study aims to evaluate the algorithm's ability to speed up the diagnosis and treatment of TMA in smaller hospitals that do not have a 24-hour hematological guard service available and the same awareness for TMA."
970,"GPT4 Correct Assistant: The Access-H20 trial aims to develop an innovative faucet for individuals with spinal cord injuries (SCI) to access water more independently for basic activities of daily living. The faucet incorporates electromechanical controls, software programs, a proximity sensor, and voice recognition function. The study includes subjects with SCI and controls, who test the faucet's functionality. The primary outcome measures are water access for activities of daily living, and a System Usability Scale."
971,"GPT4 Correct Assistant: This study aims to examine the effects of an activity wristband-based intermittent teaching unit in Physical Education on students' physical activity and its psychological mediators. The study is a cluster-randomized controlled trial, involving secondary school students aged 12-16 years, and is designed to measure changes in perceived autonomy support, basic psychological needs, motivation towards Physical Education, self-determined motivation towards physical activity, intention to be physically active, and habitual physical activity. Students are randomly assigned to either an experimental group (intermittent teaching unit) or a control group (no intervention). The study will assess these outcomes at pre-intervention, post-intervention, and 6-week follow-up."
972,"GPT4 Correct Assistant: The trial, titled ""Continuous and Non-invasive Measurements by Task Force® CORE/CARDIO in Autonomic Function Testing (AFT),"" aims to evaluate the agreement of blood pressure, heart rate, and cardiac output measurements between the investigational and reference devices in adult patients with autonomic dysfunction and orthostatic intolerance. The study includes participants aged 18 years and older, with both hands showing intact perfusion, and excludes those with vascular implants at the measurement sites, severe vascular diseases, and those with significant edema in the fingers. The primary outcome measures include the agreement of blood pressure and heart rate variables between the devices during various tests, such as the Valsalva maneuver, deep breathing test, and head-up tilt table test."
973,"GPT4 Correct Assistant: The trial aims to develop and evaluate an online mental healthcare hub for post-secondary students using AI-assisted interventions and e-CBT programs. The hub will target a diverse population and provide comprehensive care through a stepped-care approach. The study will assess the efficacy and cost-effectiveness of the online psychoeducation and diagnosis-specific e-CBT programs using validated clinical assessment tools. The primary outcomes measured include changes in anxiety severity, depression severity, stress severity, quality of life, resilience, social anxiety severity, and ADHD severity."
974,"GPT4 Correct Assistant: This clinical trial aims to assess the efficacy of Omnivirol-Salicylic Acid (AV2-SA) combination therapy for cutaneous warts, with a focus on persistent warts. Participants must have one or more cutaneous warts and be 12 years or older. The study uses a randomized, parallel assignment design with quadruple masking. The primary outcome measures are the cure rate and recurrence rate of the index warts at 12 weeks and 6 months after enrollment, respectively. Secondary outcomes include safety assessments, time to clearance of index wart, change in size of index wart, number of verrucae remaining, and genotype-specific distribution of wart-associated HPV types in a Belgian population."
975,"GPT4 Correct Assistant: This clinical trial aims to assess the efficacy of letrozole in comparison to methotrexate in the treatment of ectopic pregnancy. The study includes 75 women diagnosed with ectopic pregnancy, who are randomly allocated to three groups. The first group receives a single dose of methotrexate, the second group receives letrozole twice a day for 10 days, and the third group receives letrozole three times a day for 5 days. The primary outcome measures are βhCG on day 14 and anti-mullerian hormone levels 3 months after treatment."
976,"GPT4 Correct Assistant: This cross-sectional study aims to evaluate the effect of ASD closure with fenestrated patch compared to non-fenestrated patch on the left ventricular size at systole and diastole in patients with ASD secundum and pulmonary hypertension. The study includes patients with complete preoperative and postoperative echocardiography data, and those with complete preoperative but incomplete postoperative data who are willing to present upon invitation. The primary outcome measure is the improvement in left ventricular diameter during systole and diastole."
977,"GPT4 Correct Assistant: This clinical trial aims to investigate the role of oxidative stress and mitochondrial TERT in the progression and therapeutic resistance of papillary thyroid cancer. It includes patients with papillary thyroid cancer, and the primary outcome measures are H2O2 generation, TERT mitochondrial localization, and the effect of exogenous oxidative stress and therapeutic agents on TERT nuclear to mitochondrial translocation in thyroid cancer cell lines. Secondary outcome measures include genetic characterization of tumor tissues and expression profile of tumor tissues."
978,"GPT4 Correct Assistant: The COMET trial is a phase III, prospective, multi-centre, open-label, two-arm, randomised controlled trial comparing whole-body hypothermia and targeted normothermia in neonates with mild encephalopathy. The primary outcome measure is the mean cognitive composite scale score from the Bayley IV examination at 22-26 months. Secondary outcomes include neonatal seizures, duration of intensive care, duration of hospital stay, duration of mechanical ventilation, duration of inotropic support, bloodstream or cerebrospinal fluid positive infection, thrombocytopenia or coagulopathy requiring blood product transfusion, opioid use, exclusive breastfeeding at hospital discharge, brain injury scores on conventional magnetic resonance imaging, and survival without any neurological impairment at 22-26 months."
979,"GPT4 Correct Assistant: This trial is an open-label, first-in-human, phase I/IIa study evaluating the safety and tolerability of the novel T cell immunotherapy, pTTL, in patients with advanced colorectal cancer. The primary objective is to determine the safety of pTTL administration, as determined by the incidence and severity of adverse events. Secondary objectives include evaluating objective response, time to treatment response, duration of treatment response, time to tumor progression, kinetics of tumor progression/growth, overall survival, progression-free survival, and disease-specific survival."
980,"GPT4 Correct Assistant: The study aims to investigate the diagnostic and prognostic role of Serum Amyloid A (SAA) in intrathoracic sarcoidosis patients. It is a prospective, observational study that enrolls patients with intrathoracic sarcoidosis and healthy controls. The primary outcome measures include the correlation of mean serum concentration of SAA in patients to mean value in healthy controls, correlation of SAA concentrations at the time of diagnosis with other biomarkers, lung function tests, radiologic extent of disease, and changes in lung function tests and HRCT disease extent after 3 years of follow-up. The study aims to determine the potential role of SAA in clinical decision-making concerning sarcoidosis patients."
981,"GPT4 Correct Assistant: This is a randomized, single-blind, multicenter controlled trial investigating the benefit of early intrauterine transfer of blank culture medium prior to transfer of a thawed embryo from the first in vitro fertilization. The study aims to determine if this procedure increases the clinically progressive pregnancy rate and live birth rate compared to a sham transfer. The trial is designed for females aged 18-39 years who have had a previous fresh or frozen embryo transfer with pregnancy failure. The primary outcome measure is the clinically progressive pregnancy rate between groups, measured at 12 weeks of amenorrhea. Secondary outcome measures include various pregnancy outcomes and cost-effectiveness."
982,"GPT4 Correct Assistant: This study aims to construct a database of prognostic risk factors and quality of life of patients with primary solid malignant cancers receiving immunotherapy for the first time. It is a multicenter, observable, and controlled cohort study conducted in multiple clinical centers. The study includes patients with solid tumors who received immunotherapy for the first time and collects baseline information and follow-up information after treatment. The primary outcome measure is progression-free survival (PFS). The study aims to provide evidence-based medical evidence for the selection of immunotherapy schemes, precise prevention and health management of adverse reactions after immunotherapy, and the improvement of survival prognosis of patients."
983,"GPT4 Correct Assistant: The study aims to examine the effect of acupressure on back pain in the late postpartum period after cesarean section. It is a randomized controlled experimental study with a sample size of 70 participants, divided into an acupressure group and a control group. The study measures back pain using the Visual Analog Scale (VAS) before and after acupressure application. The primary outcome measures are the VAS scores before and after the application in the acupressure group, while the secondary outcome measures are the VAS scores in the control group."
984,"GPT4 Correct Assistant: The study titled ""Confidential Social Network Referrals for HIV Testing"" aims to investigate the effectiveness of SMS-based confidential social network referrals (CONSORT referrals) and physical invitation cards (Card referrals) in increasing HIV testing uptake among individuals aged 18 and above in Moshi, Tanzania. Participants are randomly assigned to either the experimental group, which receives both CONSORT and Card referrals, or the control group, which receives Card referrals alone. The primary outcome measure is the number of referred clients presenting for HIV testing within 30 days of the testing offer, per 100 index clients."
985,"GPT4 Correct Assistant: This is a randomized, placebo-controlled trial studying the effects of paroxetine on cardiovascular function in septic patients. The study includes patients aged 18 years and older with a diagnosis of septic shock for less than 48 hours. Participants are randomly assigned to receive either paroxetine or a placebo. The primary outcome measure is time to vasopressor discontinuation within 28 days of enrollment. Secondary outcome measures include cumulative vasopressor dose, variation in cardiovascular sequential organ failure assessment score, cumulative vasopressor dose for 120 hours after randomization, total sequential organ failure assessment score variation, length of stay in the ICU, and mortality during ICU stay."
986,GPT4 Correct Assistant: The clinical trial aims to investigate the effectiveness of a tele-education program on patients with moderate depressive episodes in primary care. The study is a randomized controlled trial with two arms: an experimental group receiving a psychoeducation program and a control group receiving standard care. The primary outcome measure is medication adherence at 6 months post-inclusion. Secondary outcome measures include changes in self-efficacy and barriers to treatment at 3 months post-inclusion. The tele-education program consists of five individual sessions and is designed to adapt to changes in depressive symptoms over time.
987,"GPT4 Correct Assistant: This is a pilot observational study aiming to assess the ability of continuous 'home' EEG to accurately diagnose Narcolepsy Type 1 and demonstrate response to treatment. The study includes participants aged 12 to 25 years with hypersomnolence, excluding those with other sleep disorders, medical or psychiatric conditions, or regular use of medications affecting sleep. The study measures sensitivity, specificity, positive predictive value, and negative predictive value of Dreem headband-derived EEG in predicting a final diagnosis of Narcolepsy Type 1 compared to the gold standard ICSD-3 protocol. The study duration is 2 years."
988,"GPT4 Correct Assistant: This study aims to compare the safety and efficacy of a lignocaine-embedded microneedle patch to a standard EMLA patch for topical analgesia before venepuncture in adult patients undergoing eye surgery. The study is a phase I/II, triple-blind, randomized, parallel-group, active-controlled trial. Patients aged 18 years and above requiring venous cannulation for blood investigations before eye surgery are eligible. The primary outcome measures are the Visual Analogue Score (VAS) and Skin Conductance Algesimeter Index, measured at 1 minute after venipuncture."
989,"GPT4 Correct Assistant: This clinical trial aims to evaluate the effectiveness of psychopharmacological intervention versus cognitive behavioural couple therapy (CBCT) and their combination in perinatal distressed couples through a randomized clinical trial. The study will include participants with major depressive disorder and/or generalized anxiety disorder, and will assess the impact of various interventions on perceived social support, dyadic coping, flourishing scale, quality of life, and blood concentration levels for escitalopram, sertraline, and alprazolam. The study will also monitor treatment-related adverse events."
990,"GPT4 Correct Assistant: This is a Phase 1/Phase 2 open-label study evaluating the safety, tolerability, and efficacy of a single intravenous administration of SAR444836 in adult participants with phenylketonuria (PKU). The study aims to assess the primary outcome measure, incidence of treatment-emergent adverse events (TEAEs), from baseline to week 96. Secondary outcome measures include the proportion of participants with sustained plasma phenylalanine (Phe) levels below specific thresholds, changes in Phe levels, and changes in dietary protein intake. The study will enroll participants aged 18-65 years with a diagnosis of PKU due to PAH deficiency and with a history of high Phe levels while on a restricted diet. Participants will receive a single dose of SAR444836 on Day 1."
991,"GPT4 Correct Assistant: This clinical trial investigates the clinical applicability of pseudo-continuous arterial spin labeling (pCASL) as a substitute for fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with mild cognitive impairment (MCI) and subjective cognitive decline (SCD). The study aims to determine the correlation between brain hypoperfusion and brain hypometabolism at baseline, as well as the differences in brain perfusion patterns according to amyloid and tau status. It also explores the predictive properties of brain hypoperfusion and hypometabolism for conversion to dementia and correlations between brain hypoperfusion and CSF and blood biomarkers. The study includes participants aged 18-80 years, both male and female, with MCI or SCD, and excludes those with contraindications to brain MRI, FDG-PET, or lumbar puncture."
992,"GPT4 Correct Assistant: This is a prospective, single-arm, multicenter, observational safety surveillance study of VyndaMx® (Tafamidis Capsule 61 mg) in patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India. The primary objective is to assess the safety of VyndaMx® Capsules based on adverse events within 6 months from first dosing. Adult patients (age ≥18 years) with a diagnosis of cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) are eligible for participation, while patients with hypersensitivity to VyndaMx® Capsule, rare hereditary fructose intolerance, or a contraindication to VyndaMx® Capsules according to the approved local product label are excluded."
993,"GPT4 Correct Assistant: This is a randomised controlled clinical trial to evaluate the STERN FIX device as a sternal stabilisation system in patients after sternotomy. The study includes patients undergoing surgery requiring median sternotomy with at least one of the following risk criteria: obesity, diabetes, COPD, non-serious osteoporosis, creatinine > 200 µmol/L and/or under dialysis treatment, scheduled Bilateral Internal Mammary Artery (BIMA) grafting, and patients willing and capable of granting informed consent. The study compares two groups: one using a combination of STERN FIX and wires for sternotomy closure, and another using standard wires. The primary outcome measure is sternal stability evaluated at one month after surgery. Secondary outcome measures include safety, prevalence of device deficiencies, reinterventions, sternal wound infections, dehiscence, sternal closure time, ease of use, surgeon satisfaction, chest pain, blood loss, upper limb functional index, quality of life, sternal halves union/malunion, sternal halves alignment, sternum integrity, and closure system integrity."
994,"GPT4 Correct Assistant: This clinical trial, titled ""The Effect of an Active Break Intervention on Nonspecific Low Back Pain and Musculoskeletal Discomfort During Prolonged Sitting Among Young People (SPINE-have&Care)"", aims to evaluate the effect of an active break intervention on reducing low back pain (LBP) and perceived musculoskeletal discomfort during prolonged sitting among young people with LBP. The study will employ a randomized controlled design with pre and post-intervention assessment, involving 50 participants aged 18-25 years with non-specific LBP. The experimental group will receive recommendations for active breaks with lumbar and hip extension exercises every 30 minutes of sitting, while the control group will receive self-care recommendations in a book. Primary outcome measures include pain intensity, disability, and perceived musculoskeletal discomfort during prolonged sitting. Secondary outcome measures include a post-intervention questionnaire focused on participants' opinions about the Active Break Program."
995,"GPT4 Correct Assistant: This clinical trial aims to study the performance and safety of vaginal administration of tocopherol acetate (vitamin E) in pre-peri and postmenopausal women. The study plans to assess the effects of tocopherol acetate on vaginal microbiota, acidity measure of vaginal secretions, mucosa dryness, mucosal integrity, mucosa pallor, vaginal discharge assessment, Whiff test, and lactobacillus grade according to Ison Hay's classification by bacterioscopic smear. The study will use Filme Gyno-V® Vaginal Ovules for 14 days as the intervention and will measure the primary outcome of acidity measure of vaginal secretions. The study will include women aged 50 to 70 years, and the duration of the study will be from January 1st, 2020, to December 31st, 2022, with data collection from June 30th, 2023, to July 31st, 2023."
996,"GPT4 Correct Assistant: This clinical trial is designed to study the Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in patients with Polycythemia Vera and Secondary Erythrocytosis. The study will collect data on clinical manifestations, history of thrombosis, complete blood picture, serum uric acid, JAK2V617F mutation status, bone marrow aspiration, and biopsy with reticulin stain. Patients aged 18 years and older, newly diagnosed with Polycythemia Vera between September 2014 and November 2022 at Sohag University Hospital, will be included in the study. Patients with secondary erythrocytosis will be included as controls. The primary outcome measures are the Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in both patient groups. The study will collect data from December 2022 to September 2023."
997,"GPT4 Correct Assistant: This clinical trial aims to determine the effect of Perfusion Index (PI) measurement on emergency triage classification in patients with dyspnea using the Masimo Radical-7 device. Adult patients over 18 years old who presented with dyspnea and had PI values measured at the time of admission, first hour, and second hour of admission were included. The primary outcome measures are the use of perfusion index for triage status at different time points. Patients with known vascular diseases, trauma, or COVID-19 PCR positivity were excluded. The study is designed as a single-group assignment, open-label trial."
998,"GPT4 Correct Assistant: This is a randomized, double-blind, active-placebo controlled phase II study investigating the effects of Lysergic Acid Diethylamide (LSD) in palliative care. The study includes participants aged 25 years and older with end-stage fatal diseases and evaluates the effects of LSD on state anxiety, pain levels, quality of life, demoralization, spiritual well-being, and caregiver burden. The study compares two groups: one receiving 100-200 μg LSD and another receiving 25 μg LSD. The primary outcome measure is changes in state anxiety assessed by the State Anxiety Inventory (STAI-S) at various time points. Secondary outcome measures include changes in pain levels, opioid use, spiritual well-being, demoralization, quality of life, and caregiver burden. The study also explores associations between acute LSD effects and long-lasting therapeutic effects, as well as the role of expectancy as a mediator for treatment effects. Adverse events and physical discomfort during drug sessions are also assessed as safety measures."
999,"GPT4 Correct Assistant: The SmartMom trial is a randomized controlled study that aims to evaluate the effectiveness of SmartMom text messaging intervention in promoting healthy behaviors during pregnancy compared to control messaging. The study includes pregnant individuals at 15 weeks gestation or earlier, who are living in Canada (excluding British Columbia) and can read and understand English at grade 8 level. The primary outcomes measured are change in weight during pregnancy and attendance at prenatal care visits. Secondary outcomes include changes in health knowledge, health literacy, fear of childbirth, depression, anxiety, use of tobacco, vaping, alcohol, or cannabis, rates of planned vaginal birth after cesarean, exclusive breastfeeding at hospital discharge, and rates of adverse pregnancy outcomes. The study aims to assess the cost-effectiveness of the intervention compared to the control group."
